<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33543942</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-6890</ISSN><JournalIssue CitedMedium="Internet"><Volume>121</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Feb</Month><Day>24</Day></PubDate></JournalIssue><Title>Chemical reviews</Title><ISOAbbreviation>Chem Rev</ISOAbbreviation></Journal><ArticleTitle>Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>2545</StartPage><EndPage>2647</EndPage><MedlinePgn>2545-2647</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.chemrev.0c01122</ELocationID><Abstract><AbstractText>Protein misfolding and aggregation is observed in many amyloidogenic diseases affecting either the central nervous system or a variety of peripheral tissues. Structural and dynamic characterization of all species along the pathways from monomers to fibrils is challenging by experimental and computational means because they involve intrinsically disordered proteins in most diseases. Yet understanding how amyloid species become toxic is the challenge in developing a treatment for these diseases. Here we review what computer, <i>in vitro</i>, <i>in vivo</i>, and pharmacological experiments tell us about the accumulation and deposition of the oligomers of the (A&#x3b2;, tau), &#x3b1;-synuclein, IAPP, and superoxide dismutase 1 proteins, which have been the mainstream concept underlying Alzheimer's disease (AD), Parkinson's disease (PD), type II diabetes (T2D), and amyotrophic lateral sclerosis (ALS) research, respectively, for many years.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Phuong H</ForeName><Initials>PH</Initials><Identifier Source="ORCID">0000-0003-1284-967X</Identifier><AffiliationInfo><Affiliation>CNRS, UPR9080, Universit&#xe9; de Paris, Laboratory of Theoretical Biochemistry, IBPC, Fondation Edmond de Rothschild, PSL Research University, Paris 75005, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramamoorthy</LastName><ForeName>Ayyalusamy</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1964-1900</Identifier><AffiliationInfo><Affiliation>Biophysics and Department of Chemistry, University of Michigan, Ann Arbor, Michigan 48109-1055, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahoo</LastName><ForeName>Bikash R</ForeName><Initials>BR</Initials><Identifier Source="ORCID">0000-0002-3683-1178</Identifier><AffiliationInfo><Affiliation>Biophysics and Department of Chemistry, University of Michigan, Ann Arbor, Michigan 48109-1055, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Jie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1547-3612</Identifier><AffiliationInfo><Affiliation>Department of Chemical &amp; Biomolecular Engineering, The University of Akron, Akron, Ohio 44325, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faller</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-8013-0806</Identifier><AffiliationInfo><Affiliation>Institut de Chimie, UMR 7177, CNRS-Universit&#xe9; de Strasbourg, 4 rue Blaise Pascal, 67000 Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Straub</LastName><ForeName>John E</ForeName><Initials>JE</Initials><Identifier Source="ORCID">0000-0002-2355-3316</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Boston University, 590 Commonwealth Avenue, Boston, Massachusetts 02215, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dominguez</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-3666-2789</Identifier><AffiliationInfo><Affiliation>Facultad de Qu&#xed;mica, Departamento de Fisicoqu&#xed;mica, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico, Mexico City 04510, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shea</LastName><ForeName>Joan-Emma</ForeName><Initials>JE</Initials><Identifier Source="ORCID">0000-0002-9801-9273</Identifier><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, and Department of Physics, University of California, Santa Barbara, California 93106, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dokholyan</LastName><ForeName>Nikolay V</ForeName><Initials>NV</Initials><Identifier Source="ORCID">0000-0002-8225-4025</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology and Biochemistry &amp; Molecular Biology, Penn State University College of Medicine, Hershey, Pennsylvania 17033, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry, and Biomedical Engineering, Pennsylvania State University, University Park, Pennsylvania 16802, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Simone</LastName><ForeName>Alfonso</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, Imperial College London, London SW7 2AZ, U.K.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Biology, University of Naples Federico II, Naples 80138, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Buyong</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-7383-719X</Identifier><AffiliationInfo><Affiliation>Basic Science Program, Leidos Biomedical Research, Inc., Cancer and Inflammation Program, National Cancer Institute, Frederick, Maryland 21702, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nussinov</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Basic Science Program, Leidos Biomedical Research, Inc., Cancer and Inflammation Program, National Cancer Institute, Frederick, Maryland 21702, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sackler Institute of Molecular Medicine, Department of Human Genetics and Molecular Medicine Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Najafi</LastName><ForeName>Saeed</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, and Department of Physics, University of California, Santa Barbara, California 93106, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngo</LastName><ForeName>Son Tung</ForeName><Initials>ST</Initials><Identifier Source="ORCID">0000-0003-1034-1768</Identifier><AffiliationInfo><Affiliation>Laboratory of Theoretical and Computational Biophysics &amp; Faculty of Applied Sciences, Ton Duc Thang University, 33000 Ho Chi Minh City, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loquet</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7176-7813</Identifier><AffiliationInfo><Affiliation>Institute of Chemistry &amp; Biology of Membranes &amp; Nanoobjects, (UMR5248 CBMN), CNRS, Universit&#xe9; Bordeaux, Institut Europ&#xe9;en de Chimie et Biologie, 33600 Pessac, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiricotto</LastName><ForeName>Mara</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Chemical Engineering and Analytical Science, University of Manchester, Manchester M13 9PL, U.K.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganguly</LastName><ForeName>Pritam</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-6299-3111</Identifier><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, and Department of Physics, University of California, Santa Barbara, California 93106, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCarty</LastName><ForeName>James</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3838-6004</Identifier><AffiliationInfo><Affiliation>Chemistry Department, Western Washington University, Bellingham, Washington 98225, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mai Suan</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0001-7021-7916</Identifier><AffiliationInfo><Affiliation>Institute for Computational Science and Technology, SBI Building, Quang Trung Software City, Tan Chanh Hiep Ward, District 12, Ho Chi Minh City 700000, Vietnam.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Physics, Polish Academy of Sciences, Al. Lotnikow 32/46, 02-668 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Carol</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-7425-587X</Identifier><AffiliationInfo><Affiliation>Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina 27695-7905, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yiming</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-3657-6100</Identifier><AffiliationInfo><Affiliation>Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina 27695-7905, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Yifat</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-1163-9745</Identifier><AffiliationInfo><Affiliation>Department of Chemistry and The Ilse Katz Institute for Nanoscale Science &amp; Technology, Ben-Gurion University of the Negev, Be'er Sheva 84105, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melchionna</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>ISC-CNR, via dei Taurini, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Habenstein</LastName><ForeName>Birgit</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Chemistry &amp; Biology of Membranes &amp; Nanoobjects, (UMR5248 CBMN), CNRS, Universit&#xe9; Bordeaux, Institut Europ&#xe9;en de Chimie et Biologie, 33600 Pessac, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Timr</LastName><ForeName>Stepan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>CNRS, UPR9080, Universit&#xe9; de Paris, Laboratory of Theoretical Biochemistry, IBPC, Fondation Edmond de Rothschild, PSL Research University, Paris 75005, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jiaxing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Biochemistry &amp; Molecular Biology, Penn State University College of Medicine, Hershey, Pennsylvania 17033, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hnath</LastName><ForeName>Brianna</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Biochemistry &amp; Molecular Biology, Penn State University College of Medicine, Hershey, Pennsylvania 17033, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strodel</LastName><ForeName>Birgit</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-8734-7765</Identifier><AffiliationInfo><Affiliation>Institute of Complex Systems: Structural Biochemistry (ICS-6), Forschungszentrum J&#xfc;lich, 52425 J&#xfc;lich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kayed</LastName><ForeName>Rakez</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-6216-8640</Identifier><AffiliationInfo><Affiliation>Mitchell Center for Neurodegenerative Diseases, and Departments of Neurology, Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, Texas 77555, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lesn&#xe9;</LastName><ForeName>Sylvain</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, University of Minnesota, Minneapolis, Minnesota 55455, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Guanghong</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-5814-3328</Identifier><AffiliationInfo><Affiliation>Department of Physics, State Key Laboratory of Surface Physics, and Key Laboratory for Computational Physical Science, Multiscale Research Institute of Complex Systems, Fudan University, Shanghai 200438, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sterpone</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-0894-8069</Identifier><AffiliationInfo><Affiliation>CNRS, UPR9080, Universit&#xe9; de Paris, Laboratory of Theoretical Biochemistry, IBPC, Fondation Edmond de Rothschild, PSL Research University, Paris 75005, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doig</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0000-0003-0346-2270</Identifier><AffiliationInfo><Affiliation>Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, U.K.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Derreumaux</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-9110-5585</Identifier><AffiliationInfo><Affiliation>CNRS, UPR9080, Universit&#xe9; de Paris, Laboratory of Theoretical Biochemistry, IBPC, Fondation Edmond de Rothschild, PSL Research University, Paris 75005, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Theoretical Chemistry, Ton Duc Thang University, 33000 Ho Chi Minh City, Vietnam.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Pharmacy, Ton Duc Thang University, 33000 Ho Chi Minh City, Vietnam.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG054025</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 NS113549</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG062135</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM134864</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG020135</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG044342</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002014</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS094557</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM107703</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG048934</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS092918</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AG065693</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM118560</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Chem Rev</MedlineTA><NlmUniqueID>2985134R</NlmUniqueID><ISSNLinking>0009-2665</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000682">Amyloid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058228">Islet Amyloid Polypeptide</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051844">alpha-Synuclein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000682" MajorTopicYN="N">Amyloid</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058228" MajorTopicYN="N">Islet Amyloid Polypeptide</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066263" MajorTopicYN="N">Protein Aggregation, Pathological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057165" MajorTopicYN="N">Proteostasis Deficiencies</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051844" MajorTopicYN="N">alpha-Synuclein</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing financial interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>5</Day><Hour>12</Hour><Minute>10</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33543942</ArticleId><ArticleId IdType="mid">NIHMS1774603</ArticleId><ArticleId IdType="pmc">PMC8836097</ArticleId><ArticleId IdType="doi">10.1021/acs.chemrev.0c01122</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Benson MD; Buxbaum JN; Eisenberg DS; Merlini G; Saraiva MJM; Sekijima Y; Sipe JD; Westermark P Amyloid Nomenclature 2018: Recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee. Amyloid 2018, 25, 215&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pubmed">30614283</ArticleId></ArticleIdList></Reference><Reference><Citation>Edler MK; Sherwood CC; Meindl RS; Hopkins WD; Ely JJ; Erwin JM; Mufson EJ; Hof PR; Raghanti MA Aged Chimpanzees Exhibit Pathologic Hallmarks of Alzheimer&#x2019;s Disease. Neurobiol. Aging 2017, 59, 107&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6343147</ArticleId><ArticleId IdType="pubmed">28888720</ArticleId></ArticleIdList></Reference><Reference><Citation>Berchtold NC; Cotman CW Evolution in the Conceptualization of Dementia and Alzheimer&#x2019;s Disease: Greco-Roman Period to the 1960s. Neurobiol. Aging 1998, 19, 173&#x2013;189.</Citation><ArticleIdList><ArticleId IdType="pubmed">9661992</ArticleId></ArticleIdList></Reference><Reference><Citation>Glenner GG; Wong CW Alzheimer&#x2019;s Disease and Down&#x2019;s Syndrome: Sharing of a Unique Cerebrovascular Amyloid Fibril Protein. Biochem. Biophys. Res. Commun 1984, 122, 1131&#x2013;1135.</Citation><ArticleIdList><ArticleId IdType="pubmed">6236805</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberg MS; Lansbury PT Jr Is there a Cause-and-Effect Relationship Between Alpha-synuclein Fibrillization and Parkinson&#x2019;s Disease? Nat. Cell Biol 2000, 2, E115&#x2013;E119.</Citation><ArticleIdList><ArticleId IdType="pubmed">10878819</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy J; Selkoe DJ The Amyloid Hypothesis of Alzheimer&#x2019;s Disease: Progress and Problems on the Road to Therapeutics. Science 2002, 297, 353&#x2013;356.</Citation><ArticleIdList><ArticleId IdType="pubmed">12130773</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo EH; Lansbury PT Jr; Kelly JW Amyloid Diseases: Abnormal Protein Aggregation in Neurodegeneration. Proc. Natl. Acad. Sci. U. S. A 1999, 96, 9989&#x2013;9990.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC33726</ArticleId><ArticleId IdType="pubmed">10468546</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson CM Protein Misfolding, Evolution and Disease. Trends Biochem. Sci 1999, 24, 329&#x2013;332.</Citation><ArticleIdList><ArticleId IdType="pubmed">10470028</ArticleId></ArticleIdList></Reference><Reference><Citation>Forman MS; Trojanowski JQ; Lee VM TDP-43: A Novel Neurodegenerative Proteinopathy. Curr. Opin. Neurobiol 2007, 17, 548&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2678676</ArticleId><ArticleId IdType="pubmed">17936612</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan MAI; Respondek M; Kjellstr&#xf6;m S; Deep S; Linse S; Akke M Cu/Zn Superoxide Dismutase Forms Amyloid Fibrils under Near-Physiological Quiescent Conditions: The Roles of Disulfide Bonds and Effects of Denaturant. ACS Chem. Neurosci 2017, 8, 2019&#x2013;2026.</Citation><ArticleIdList><ArticleId IdType="pubmed">28585802</ArticleId></ArticleIdList></Reference><Reference><Citation>Meisl G; Michaels TCT; Linse S; Knowles TPJ Kinetic Analysis of Amyloid Formation. Methods Mol. Biol 2018, 1779, 181&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pubmed">29886534</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilie IM; Caflisch A Simulation Studies of Amyloidogenic Polypeptides and Their Aggregates. Chem. Rev 2019, 119, 6956&#x2013;6993.</Citation><ArticleIdList><ArticleId IdType="pubmed">30973229</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson M; Knowles TPJ; Vendruscolo M The Amyloid Phenomenon and its Significance in Biology and Medicine. Cold Spring Harbor Perspect. Biol 2020, 12, No. a033878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6996456</ArticleId><ArticleId IdType="pubmed">30936117</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasica-Labouze J; Nguyen PH; Sterpone F; Berthoumieu O; Buchete NV; Cot&#xe9; S; De Simone A; Doig AJ; Faller P; Garcia A; et al. Amyloid beta Protein and Alzheimer&#x2019;s Disease: When Computer Simulations Complement Experimental Studies. Chem. Rev 2015, 115, 3518&#x2013;3563.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5504919</ArticleId><ArticleId IdType="pubmed">25789869</ArticleId></ArticleIdList></Reference><Reference><Citation>Owen MC; Gnutt D; Gao M; W&#xe4;rml&#xe4;nder SKTS; Jarvet J; Gr&#xe4;slund A; Winter R; Ebbinghaus S; Strodel B Effects of in vivo Conditions on Amyloid Aggregation. Chem. Soc. Rev 2019, 48, 3946&#x2013;3996.</Citation><ArticleIdList><ArticleId IdType="pubmed">31192324</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson J; Kumar A; Willis LF; Tuma R; Higazi DR; Turner R; Lowe DC; Ashcroft AE; Radford SE; Kapur N; et al. Inducing Protein Aggregation by Extensional Flow. Proc. Natl. Acad. Sci. U. S. A 2017, 114, 4673&#x2013;4678.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5422818</ArticleId><ArticleId IdType="pubmed">28416674</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiti F; Webster P; Taddei N; Clark A; Stefani M; Ramponi G; Dobson CM Designing Conditions for in vitro Formation of Amyloid Protofilaments and Fibrils. Proc. Natl. Acad. Sci. U. S. A 1999, 96, 3590&#x2013;3594.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC22338</ArticleId><ArticleId IdType="pubmed">10097081</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler-Abramovich L; Vaks L; Carny O; Trudler D; Magno A; Caflisch A; Frenkel D; Gazit E Phenylalanine Assembly into Toxic Fibrils Suggests Amyloid Etiology in Phenylketonuria. Nat. Chem. Biol 2012, 8, 701&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pubmed">22706200</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu K; Jacob J; Thiyagarajan P; Conticello VP; Lynn DG Exploiting Amyloid Fibril Lamination for Nanotube Self-assembly. J. Am. Chem. Soc 2003, 125, 6391&#x2013;6393.</Citation><ArticleIdList><ArticleId IdType="pubmed">12785778</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherny I; Gazit E Amyloids: Not only Pathological Agents but also Ordered Nanomaterials. Angew. Chem., Int. Ed 2008, 47, 4062&#x2013;4069.</Citation><ArticleIdList><ArticleId IdType="pubmed">18412209</ArticleId></ArticleIdList></Reference><Reference><Citation>Monsellier E; Chiti F Prevention of Amyloid-like Aggregation as a Driving Force of Protein Evolution. EMBO Rep 2007, 8, 737&#x2013;742.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1978086</ArticleId><ArticleId IdType="pubmed">17668004</ArticleId></ArticleIdList></Reference><Reference><Citation>Loquet A; Saupe SJ; Romero D Functional Amyloids in Health and Disease. J. Mol. Biol 2018, 430, 3629&#x2013;3630.</Citation><ArticleIdList><ArticleId IdType="pubmed">30055166</ArticleId></ArticleIdList></Reference><Reference><Citation>Rufo CM; Moroz YS; Moroz OV; St&#xf6;hr J; Smith TA; Hu X; DeGrado WF; Korendovych IV Short Peptides Self-assemble to Produce Catalytic Amyloids. Nat. Chem 2014, 6, 303&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3996680</ArticleId><ArticleId IdType="pubmed">24651196</ArticleId></ArticleIdList></Reference><Reference><Citation>Omosun TO; Hsieh MC; Childers WS; Das D; Mehta AK; Anthony NR; Pan T; Grover MA; Berland KM; Lynn DG Catalytic Diversity in Self-propagating Peptide Assemblies. Nat. Chem 2017, 9, 805&#x2013;809.</Citation><ArticleIdList><ArticleId IdType="pubmed">28754939</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Garawi ZS; McIntosh BA; Neill-Hall D; Hatimy AA; Sweet SM; Bagley MC; Serpell LC The Amyloid Architecture Provides a Scaffold for Enzyme-like Catalysts. Nanoscale 2017, 9, 10773&#x2013;10783.</Citation><ArticleIdList><ArticleId IdType="pubmed">28722055</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenwald J; Friedmann MP; Riek R Amyloid Aggregates Arise from Amino Acid Condensations under Prebiotic Conditions. Angew. Chem., Int. Ed 2016, 55, 11609&#x2013;11613.</Citation><ArticleIdList><ArticleId IdType="pubmed">27511635</ArticleId></ArticleIdList></Reference><Reference><Citation>Brack A; Orgel LE Beta Structures of Alternating Polypeptides and their Possible Prebiotic Significance. Nature 1975, 256, 383&#x2013;387.</Citation><ArticleIdList><ArticleId IdType="pubmed">238134</ArticleId></ArticleIdList></Reference><Reference><Citation>Langenberg T; Gallardo R; van der Kant R; Louros N; Michiels E; Duran-Roma&#xf1;a R; Houben B; Cassio R; Wilkinson H; Garcia T; et al. Thermodynamic and Evolutionary Coupling between the Native and Amyloid State of Globular Proteins. Cell Rep 2020, 31, 107512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7175379</ArticleId><ArticleId IdType="pubmed">32294448</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai M; Sugase K; Dyson HJ; Wright PE Conformational Propensities of Intrinsically Disordered Proteins Influence the Mechanism of Binding and Folding. Proc. Natl. Acad. Sci. U. S. A 2015, 112, 9614&#x2013;9619.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4534220</ArticleId><ArticleId IdType="pubmed">26195786</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunker AK; Babu MM; Barbar E; Blackledge M; Bondos SE; Doszt&#xe1;nyi Z; Dyson HJ; Forman-Kay J; Fuxreiter M; Gsponer J; et al. What&#x2019;s in a name? Why These Proteins are Intrinsically Disordered: Why these Proteins are Intrinsically Disordered. Intrinsically Disord. Proteins 2013, 1, No. e24157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5424803</ArticleId><ArticleId IdType="pubmed">28516007</ArticleId></ArticleIdList></Reference><Reference><Citation>Baul U; Chakraborty D; Mugnai ML; Straub JE; Thirumalai D Sequence Effects on Size, Shape, and Structural Heterogeneity in Intrinsically Disordered Proteins. J. Phys. Chem. B 2019, 123, 3462&#x2013;3474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6920032</ArticleId><ArticleId IdType="pubmed">30913885</ArticleId></ArticleIdList></Reference><Reference><Citation>Aliyan A; Cook NP; Mart&#xed; AA Interrogating Amyloid Aggregates using Fluorescent Probes. Chem. Rev 2019, 119, 11819&#x2013;11856.</Citation><ArticleIdList><ArticleId IdType="pubmed">31675223</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono K; Condron MM; Teplow DB Structure-neurotoxicity Relationships of Amyloid beta-protein Oligomers. Proc. Natl. Acad. Sci. U. S. A 2009, 106, 14745&#x2013;14750.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2736424</ArticleId><ArticleId IdType="pubmed">19706468</ArticleId></ArticleIdList></Reference><Reference><Citation>Gralle M; Botelho MM; de Oliveira CL; Torriani I; Ferreira ST Solution Studies and Structural Model of the Extracellular Domain of the Human Amyloid Precursor Protein. Biophys. J 2002, 83, 3513&#x2013;3524.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1302426</ArticleId><ArticleId IdType="pubmed">12496118</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser PE; Nguyen JT; Inouye H; Surewicz WK; Selkoe DJ; Podlisny MB; Kirschner DA Fibril Formation by Primate, Rodent, and Dutch-hemorrhagic Analogues of Alzheimer amyloid beta protein. Biochemistry 1992, 31, 10716&#x2013;10723.</Citation><ArticleIdList><ArticleId IdType="pubmed">1420187</ArticleId></ArticleIdList></Reference><Reference><Citation>Garzon-Rodriguez W; Sepulveda-Becerra M; Milton S; Glabe CG Soluble Amyloid Abeta-(1&#x2013;40) Exists as a Stable Dimer at Low Concentrations. J. Biol. Chem 1997, 272, 21037&#x2013;21044.</Citation><ArticleIdList><ArticleId IdType="pubmed">9261105</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang C; Ghirlando R; Clore GM Visualization of Transient Ultra-weak Protein Self-association in Solution using Paramagnetic Relaxation Enhancement. J. Am. Chem. Soc 2008, 130, 4048&#x2013;4056.</Citation><ArticleIdList><ArticleId IdType="pubmed">18314985</ArticleId></ArticleIdList></Reference><Reference><Citation>Safar J; Roller PP; Gajdusek DC; Gibbs CJ Jr Scrapie Amyloid (prion) Protein has the Conformational Characteristics of an Aggregated Molten Globule Folding Intermediate. Biochemistry 1994, 33, 8375&#x2013;8383.</Citation><ArticleIdList><ArticleId IdType="pubmed">8031772</ArticleId></ArticleIdList></Reference><Reference><Citation>Wasmer C; Lange A; Van Melckebeke H; Siemer AB; Riek R; Meier BH Amyloid Fibrils of the HET-s(218&#x2013;289) Prion Form a beta Solenoid with a Triangular Hydrophobic Core. Science 2008, 319, 1523&#x2013;1526.</Citation><ArticleIdList><ArticleId IdType="pubmed">18339938</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzpatrick AWP; Falcon B; He S; Murzin AG; Murshudov G; Garringer HJ; Crowther RA; Ghetti B; Goedert M; Scheres SHW Cryo-EM Structures of Tau Filaments from Alzheimer&#x2019;s Disease. Nature 2017, 547, 185&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5552202</ArticleId><ArticleId IdType="pubmed">28678775</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcon B; Zhang W; Murzin AG; Murshudov G; Garringer HJ; Vidal R; Crowther RA; Ghetti B; Scheres SHW; Goedert M Structures of Filaments from Pick&#x2019;s Disease Reveal a Novel Tau Protein Fold. Nature 2018, 561, 137&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6204212</ArticleId><ArticleId IdType="pubmed">30158706</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson R; Sawaya MR; Balbirnie M; Madsen A; Riekel C; Grothe R; Eisenberg D Structure of the Cross-beta Spine of Amyloid-like Fibrils. Nature 2005, 435, 773&#x2013;778.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1479801</ArticleId><ArticleId IdType="pubmed">15944695</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha UR; Juneja P; Zhang Q; Gurumoorthy V; Borreguero JM; Urban V; Cheng X; Pingali SV; Smith JC; O&#x2019;Neill HM; et al. Generation of the Configurational Ensemble of an Intrinsically Disordered Protein from Unbiased Molecular Dynamics Simulation. Proc. Natl. Acad. Sci. U. S. A 2019, 116, 20446&#x2013;20452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6789927</ArticleId><ArticleId IdType="pubmed">31548393</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen PH; Derreumaux P Structures of the Intrinsically Disordered A&#x3b2;, tau and &#x3b1;-synuclein Proteins in Aqueous Solution from Computer Simulations. Biophys. Chem 2020, 264, 106421.</Citation><ArticleIdList><ArticleId IdType="pubmed">32623047</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietrek LM; Stelzl LS; Hummer G Hierarchical Ensembles of Intrinsically Disordered Proteins at Atomic Resolution in Molecular Dynamics Simulations. J. Chem. Theory Comput 2020, 16, 725&#x2013;737.</Citation><ArticleIdList><ArticleId IdType="pubmed">31809054</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindorff-Larsen K; Maragakis P; Piana S; Shaw DE Picosecond to Millisecond Structural Dynamics in Human Ubiquitin. J. Phys. Chem. B 2016, 120, 8313&#x2013;8320.</Citation><ArticleIdList><ArticleId IdType="pubmed">27082121</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkoe DG; Hardy J The Amyloid Hypothesis of Alzheimer&#x2019;s disease at 25 years. EMBO Mol. Med 2016, 8, 595&#x2013;608.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4888851</ArticleId><ArticleId IdType="pubmed">27025652</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi ML; Gandhi S Crucial Role of Protein Oligomerization in the Pathogenesis of Alzheimer&#x2019;s and Parkinson&#x2019;s Diseases. FEBS J 2018, 285, 3631&#x2013;3644.</Citation><ArticleIdList><ArticleId IdType="pubmed">29924502</ArticleId></ArticleIdList></Reference><Reference><Citation>Haataja L; Gurlo T; Huang CJ; Butler PC Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis. Endocr. Rev 2008, 29, 303&#x2013;316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2528855</ArticleId><ArticleId IdType="pubmed">18314421</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright GSA; Antonyuk SV; Hasnain SS The Biophysics of Superoxide dismutase-1 and Amyotrophic Lateral Sclerosis. Q. Rev. Biophys 2019, 52, No. e12.</Citation><ArticleIdList><ArticleId IdType="pubmed">31760962</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton RL Lewy Bodies in Alzheimer&#x2019;s Disease: a Neuropathological Review of 145 Cases using alpha-synuclein Immunohistochemistry. Brain Pathol 2000, 10, 378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8098522</ArticleId><ArticleId IdType="pubmed">10885656</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhuri P; Prajapati KP; Anand BG; Dubey K; Kar K Amyloid Cross-seeding Raises New Dimensions to Understanding of Amyloidogenesis Mechanism. Ageing Res. Rev 2019, 56, 100937.</Citation><ArticleIdList><ArticleId IdType="pubmed">31430565</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren B; Zhang Y; Zhang M; Liu Y; Zhang D; Gong X; Feng Z; Tang J; Chang Y; Zheng J Fundamentals of Cross-seeding of Amyloid Proteins: An Introduction. J. Mater. Chem. B 2019, 7, 7267&#x2013;7282.</Citation><ArticleIdList><ArticleId IdType="pubmed">31647489</ArticleId></ArticleIdList></Reference><Reference><Citation>Krotee P; Griner SL; Sawaya MR; Cascio D; Rodriguez JA; Shi D; Philipp S; Murray K; Saelices L; Lee J; et al. Common Fibrillar Spines of Amyloid-&#x3b2; and Human Islet Amyloid Polypeptide Revealed by Microelectron Diffraction and Structure-based Inhibitors. J. Biol. Chem 2018, 293, 2888&#x2013;2902.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5827424</ArticleId><ArticleId IdType="pubmed">29282295</ArticleId></ArticleIdList></Reference><Reference><Citation>Laferla FM; Tinkle BT; Bieberich CJ; Haudenschild CC; Jay G The Alzheimer&#x2019;s A&#x3b2; Peptide Induces Neurodegeneration and Apoptotic Cell Death in Transgenic Mice. Nat. Genet 1995, 9, 21&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">7704018</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson MI; Shaw CM Presenile Dementia and Alzheimer&#x2019;s Disease in Mongolism. Brain 1969, 92, 147&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">4237656</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwers N; Sleegers K; Engelborghs S; Maurer-Stroh S; Gijselinck I; Van Der Zee J; Pickut BA; Van Den Broeck M; Mattheijssens M; Peeters.; et al. Genetic Variability in Progranulin Contributes to Risk for Clinically Diagnosed Alzheimer Disease. Neurology 2008, 71, 656&#x2013;664.</Citation><ArticleIdList><ArticleId IdType="pubmed">18565828</ArticleId></ArticleIdList></Reference><Reference><Citation>Langosch D; Scharnagl C; Steiner H; Lemberg MK Understanding Intramembrane Proteolysis: From Protein Dynamics to Reaction Kinetics. Trends Biochem. Sci 2015, 40, 318&#x2013;227.</Citation><ArticleIdList><ArticleId IdType="pubmed">25941170</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler E; Julius A; Steiner H; Langosch D Homodimerization Protects the Amyloid Precursor Protein C99 Fragment from Cleavage by Secretase. Biochemistry 2015, 54, 6149&#x2013;6152.</Citation><ArticleIdList><ArticleId IdType="pubmed">26403946</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders CR How &#x3b3;-Secretase Hits a Moving Target. eLife 2016, 5, No. e20043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5007112</ArticleId><ArticleId IdType="pubmed">27580373</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagishita S; Morishima-Kawashima M; Ishiura S; Ihara Y A&#x3b2;46 Is Processed to A&#x3b2;40 and A&#x3b2;43, but Not to A&#x3b2;42, in the Low Density Membrane Domains. J. Biol. Chem 2008, 283, 733&#x2013;738.</Citation><ArticleIdList><ArticleId IdType="pubmed">18024430</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumura N; Takami M; Okochi M; Wada-Kakuda S; Fujiwara H; Tagami S; Funamoto S; Ihara Y; Morishima-Kawashima M &#x3b3;-Secretase Associated with Lipid Rafts: Multiple Interactive Pathways in the Stepwise Processing Of &#x3b2;-Carboxylterminal Fragment. J. Biol. Chem 2014, 289, 5109&#x2013;5121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3931069</ArticleId><ArticleId IdType="pubmed">24375443</ArticleId></ArticleIdList></Reference><Reference><Citation>Beel AJ; Mobley CK; Kim HJ; Tian F; Hadziselimovic A; Jap B; Prestegard JH; Sanders CR Structural Studies of the Transmembrane {C}-Terminal Domain of the Amyloid Precursor Protein (APP): Does APP Function as a Cholesterol Sensor? Biochemistry 2008, 47, 9428&#x2013;9446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2572687</ArticleId><ArticleId IdType="pubmed">18702528</ArticleId></ArticleIdList></Reference><Reference><Citation>Haapasalo A; Kovacs DM The Many Substrates of Presenilin/&#x3b3;-Secretase. J. Alzheimer&#x2019;s Dis 2011, 25, 3&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3281584</ArticleId><ArticleId IdType="pubmed">21335653</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurisch-Yaksi N; Sannerud R; Annaert W A Fast Growing Spectrum of Biological Functions of &#x3b3;-Secretase in Development and Disease. Biochim. Biophys. Acta, Biomembr 2013, 1828, 2815&#x2013;2827.</Citation><ArticleIdList><ArticleId IdType="pubmed">24099003</ArticleId></ArticleIdList></Reference><Reference><Citation>Struhl G; Adachi A Requirements for Presenilin-Dependent Cleavage of Notch and Other Transmembrane Proteins. Mol. Cell 2000, 6, 625&#x2013;636.</Citation><ArticleIdList><ArticleId IdType="pubmed">11030342</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen GF; Xu TH; Yan Y; Zhou YR; Jiang Y; Melcher K; Xu HE Defining the Minimum Substrate and Charge Recognition Model of Gamma-Secretase. Acta Pharmacol. Sin 2017, 38, 1205&#x2013;1235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5630670</ArticleId><ArticleId IdType="pubmed">28414207</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu TH; Yan Y; Kang Y; Jiang Y; Melcher K; Xu HE Alzheimer&#x2019;s Disease-Associated Mutations Increase Amyloid Precursor Protein Resistance to &#x3b3;-Secretase Cleavage and the A&#x3b2;42/A&#x3b2;40 Ratio. Cell Discovery 2016, 2, 16026.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4994064</ArticleId><ArticleId IdType="pubmed">27625790</ArticleId></ArticleIdList></Reference><Reference><Citation>Hitzenberger M; Zacharias M &#x3b3;-Secretase Studied by Atomistic Molecular Dynamics Simulations: Global Dynamics, Enzyme Activation, Water Distribution and Lipid Binding. Front. Chem 2019, 6, 640.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6328467</ArticleId><ArticleId IdType="pubmed">30662893</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah S; Lee SF; Tabuchi K; Hao YH; Yu C; LaPlant Q; Ball H; Dann CE; S&#xfc;dhof T; Yu G Nicastrin Functions as a &#x3b3;-Secretase-Substrate Receptor. Cell 2005, 122, 435&#x2013;447.</Citation><ArticleIdList><ArticleId IdType="pubmed">16096062</ArticleId></ArticleIdList></Reference><Reference><Citation>Vetrivel KS; Cheng H; Lin W; Sakurai T; Li T; Nukina N; Wong PC; Xu H; Thinakaran G Association of &#x3b3;-Secretase with Lipid Rafts in Post-Golgi and Endosome Membranes. J. Biol. Chem 2004, 279, 44945&#x2013;44954.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1201506</ArticleId><ArticleId IdType="pubmed">15322084</ArticleId></ArticleIdList></Reference><Reference><Citation>Chyung JH; Raper DM; Selkoe DJ &#x3b3;-Secretase Exists on the Plasma Membrane as an Intact Complex That Accepts Substrates and Effects Intramembrane Cleavage. J. Biol. Chem 2005, 280, 4383&#x2013;4392.</Citation><ArticleIdList><ArticleId IdType="pubmed">15569674</ArticleId></ArticleIdList></Reference><Reference><Citation>Frykman S; Hur JY; Fr&#xe8;nberg J; Aoki M; Winblad B; Nahalkova J; Behbahani H; Tjernberg LO Synaptic and Endosomal Localization of Active &#x3b3;-Secretase in Rat Brain. PLoS One 2010, 5, No. e8948.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2812513</ArticleId><ArticleId IdType="pubmed">20126630</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler E; Kamp F; Scheuring J; Ebke A; Fukumori A; Steiner H Generation of Alzheimer Disease-Associated Amyloid &#x3b2; 42/43 Peptide by &#x3b3;-Secretase Can Be Inhibited Directly by Modulation of Membrane Thickness. J. Biol. Chem 2012, 287, 21326&#x2013;21334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3375553</ArticleId><ArticleId IdType="pubmed">22532566</ArticleId></ArticleIdList></Reference><Reference><Citation>Benilova I; Karran E; De Strooper B The Toxic A&#x3b2; Oligomer and Alzheimer&#x2019;s Disease: An Emperor in Need of Clothes. Nat. Neurosci 2012, 15, 349&#x2013;357.</Citation><ArticleIdList><ArticleId IdType="pubmed">22286176</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayed R; Lasagna-Reeves CA Molecular Mechanisms of Amyloid Oligomers Toxicity. J. Alzheimer&#x2019;s Dis 2012, 33 (1), S67&#x2013;S78.</Citation><ArticleIdList><ArticleId IdType="pubmed">22531422</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurry T; Stultz CM Mechanism of Amyloid-&#x3b2; Fibril Elongation. Biochemistry 2014, 53, 6981&#x2013;6991.</Citation><ArticleIdList><ArticleId IdType="pubmed">25330398</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengupta U; Nilson AN; Kayed R The Role of Amyloid-&#x3b2; Oligomers in Toxicity, Propagation, and Immunotherapy. EBioMedicine 2016, 6, 42&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4856795</ArticleId><ArticleId IdType="pubmed">27211547</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SJC; Nam E; Lee HJ; Savelieff MG; Lim MH Towards an Understanding of Amyloid-&#x3b2; Oligomers: Characterization, Toxicity Mechanisms, and Inhibitors. Chem. Soc. Rev 2017, 46, 310&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pubmed">27878186</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenman DJ; Connors CR; Chen W; Wang C; Garc&#xed;a AE A&#x3b2; Monomers Transiently Sample Oligomer and Fibril-like Configurations: Ensemble Characterization Using a Combined MD/NMR Approach. J. Mol. Biol 2013, 425, 3338&#x2013;3359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3780797</ArticleId><ArticleId IdType="pubmed">23811057</ArticleId></ArticleIdList></Reference><Reference><Citation>Ball KA; Phillips AH; Wemmer DE; Head-Gordon T Differences in &#x3b2;-Strand Populations of Monomeric A&#x3b2;40 and A&#x3b2;42. Biophys. J 2013, 104, 2714&#x2013;2724.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3686344</ArticleId><ArticleId IdType="pubmed">23790380</ArticleId></ArticleIdList></Reference><Reference><Citation>Straub JE; Thirumalai D Principles Governing Oligomer Formation in Amyloidogenic Peptides. Curr. Opin. Struct. Biol 2010, 20, 1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2854190</ArticleId><ArticleId IdType="pubmed">20106655</ArticleId></ArticleIdList></Reference><Reference><Citation>Mengel D; Hong W; Corbett GT; Liu W; DeSousa A; Solforosi L; Fang C; Frosch MP; Collinge J; Harris DA; et al. PrP-Grafted Antibodies Bind Certain Amyloid &#x3b2;-Protein Aggregates, but Do Not Prevent Toxicity. Brain Res 2019, 1710, 125&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6431553</ArticleId><ArticleId IdType="pubmed">30593771</ArticleId></ArticleIdList></Reference><Reference><Citation>Weidemann A; K&#xf6;nig G; Bunke D; Fischer P; Salbaum JM; Masters CL; Beyreuther K Identification, Biogenesis, and Localization of Precursors of Alzheimer&#x2019;s Disease A4 Amyloid Protein. Cell 1989, 57, 115&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pubmed">2649245</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldgaber D; Lerman MI; McBride OW; Saffiotti U; Gajdusek DC Characterization and Chromosomal Localization of a CDNA Encoding Brain Amyloid of Alzheimer&#x2019;s Disease. Science 1987, 235, 877&#x2013;880.</Citation><ArticleIdList><ArticleId IdType="pubmed">3810169</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldgaber D; Lerman MI; McBride WO; Saffiotti U; Gajdusek DC Isolation, Characterization, and Chromosomal Localization of Human Brain CDNA Clones Coding for the Precursor of the Amyloid of Brain in Alzheimer&#x2019;s Disease, Down&#x2019;s Syndrome and Aging. J. Neural Transm. Suppl 1987, 24, 23&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">2960782</ArticleId></ArticleIdList></Reference><Reference><Citation>Goate A; Chartier-Harlin MC; Mullan M; Brown J; Crawford F; Fidani L; Giuffra L; Haynes A; Irving N; James L; et al.; Segregation of a Missense Mutation in the Amyloid Precursor Protein Gene with Familial Alzheimer&#x2019;s Disease. Nature 1991, 349, 704&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pubmed">1671712</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimberly WT; LaVoie MJ; Ostaszewski BL; Ye W; Wolfe MS; Selkoe DJ &#x3b3;-Secretase Is a Membrane Protein Complex Comprised of Presenilin, Nicastrin, Aph-1, and Pen-2. Proc. Natl. Acad. Sci. U. S. A 2003, 100, 6382&#x2013;6387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC164455</ArticleId><ArticleId IdType="pubmed">12740439</ArticleId></ArticleIdList></Reference><Reference><Citation>Edbauer D; Winkler E; Regula JT; Pesold B; Steiner H; Haass C Reconstitution of &#x3b3;- Secretase Activity. Nat. Cell Biol 2003, 5, 486&#x2013;488.</Citation><ArticleIdList><ArticleId IdType="pubmed">12679784</ArticleId></ArticleIdList></Reference><Reference><Citation>Takasugi N; Tomita T; Hayashi I; Tsuruoka M; Niimura M; Takahashi Y; Thinakaran G; Iwatsubo T The Role of Presenilin Cofactors in the &#x3b3;-Secratase Complex. Nature 2003, 422, 438&#x2013;441.</Citation><ArticleIdList><ArticleId IdType="pubmed">12660785</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolduc DM; Montagna DR; Gu Y; Selkoe DJ; Wolfe MS Nicastrin Functions to Sterically Hinder &#x3b3;-Secretase-Substrate Interactions Driven by Substrate Transmembrane Domain. Proc. Natl. Acad. Sci. U. S. A 2016, 113, E509&#x2013;E518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4747693</ArticleId><ArticleId IdType="pubmed">26699478</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguayo-Ortiz R; Dominguez L APH-1A Component of &#x3b3;-Secretase Forms an Internal Water and Ion-Containing Cavity. ACS Chem. Neurosci 2019, 10, 2931&#x2013;2938.</Citation><ArticleIdList><ArticleId IdType="pubmed">30979338</ArticleId></ArticleIdList></Reference><Reference><Citation>De Strooper B; Iwatsubo T; Wolfe MS Presenilins and &#x3b3;-Secretase: Structure, Function, and Role in Alzheimer Disease. Cold Spring Harbor Perspect. Med 2012, 2, No. a006304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3253024</ArticleId><ArticleId IdType="pubmed">22315713</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe MS; Xia W; Ostaszewski BL; Diehl TS; Kimberly WT; Selkoe DJ Two Transmembrane Aspartates in Presenilin-1 Required for Presenilin Endoproteolysis and &#x3b3;-Secretase Activity. Nature 1999, 398, 513&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pubmed">10206644</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou R; Yang G; Guo X; Zhou Q; Lei J; Shi Y Recognition of the Amyloid Precursor Protein by Human G-Secretase. Science 2019, 363, No. eaaw0930.</Citation><ArticleIdList><ArticleId IdType="pubmed">30630874</ArticleId></ArticleIdList></Reference><Reference><Citation>Szaruga M; Munteanu B; Lismont S; Veugelen S; Horr&#xe9; K; Mercken M; Saido TC; Ryan NS; De Vos T; Savvides SN; et al. Alzheimer&#x2019;s-Causing Mutations Shift A&#x3b2; Length by Destabilizing &#x3b3;-Secretase-A&#x3b2;n Interactions. Cell 2017, 170, 443&#x2013;456 (e14).</Citation><ArticleIdList><ArticleId IdType="pubmed">28753424</ArticleId></ArticleIdList></Reference><Reference><Citation>De Strooper B; Karran E The Cellular Phase of Alzheimer&#x2019;s Disease. Cell 2016, 164, 603&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pubmed">26871627</ArticleId></ArticleIdList></Reference><Reference><Citation>Ch&#xe1;vez-Guti&#xe9;rrez L; Bammens L; Benilova I; Vandersteen A; Benurwar M; Borgers M; Lismont S; Zhou L; Van Cleynenbreugel S; Esselmann H; et al. The Mechanism of &#x3b3;-Secretase Dysfunction in Familial Alzheimer Disease. EMBO J 2012, 31, 2261&#x2013;2274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3364747</ArticleId><ArticleId IdType="pubmed">22505025</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuperstein I; Broersen K; Benilova I; Rozenski J; Jonckheere W; Debulpaep M; Vandersteen A; Segers-Nolten I; Van Der Werf K; Subramaniam V; et al. Neurotoxicity of Alzheimer&#x2019;s Disease A&#x3b2; Peptides Is Induced by Small Changes in the A&#x3b2;42 to A&#x3b2;40 Ratio. EMBO J 2010, 29, 3408&#x2013;3020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2957213</ArticleId><ArticleId IdType="pubmed">20818335</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyashita N; Straub JE; Thirumalai D Structures of &#x3b2;-Amyloid Peptide 1&#x2013;40, 1&#x2013;42, and 1&#x2013;55-the 672&#x2013;726 Fragment of APP-in a Membrane Environment with Implications for Interactions with &#x3b3;-Secretase. J. Am. Chem. Soc 2009, 131, 17843&#x2013;17852.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2791510</ArticleId><ArticleId IdType="pubmed">19995075</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu JX; Yau WM; Tycko R Evidence from Solid-State NMR for Nonhelical Conformations in the Transmembrane Domain of the Amyloid Precursor Protein. Biophys. J 2011, 100, 711&#x2013;719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3030151</ArticleId><ArticleId IdType="pubmed">21281586</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang T-C; Hu Y; Kienlen-Campard P; El Haylani L; Decock M; Van Hees J; Fu Z; Octave J-N; Constantinescu SN; Smith SO Conformational Changes Induced by the A21G Flemish Mutation in the Amyloid Precursor Protein lead to Increased A&#x3b2; Production. Structure 2014, 22, 387&#x2013;396.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3952111</ArticleId><ArticleId IdType="pubmed">24462250</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantelopulos GA; Straub JE; Thirumalai D; Sugita Y Structure of APP-C991-99 and Implications for Role of Extra-Membrane Domains in Function and Oligomerization. Biochim. Biophys. Acta Biomembr 2018, S0005&#x2013;2736(18)30112&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6202261</ArticleId><ArticleId IdType="pubmed">29702072</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato T; Tang TC; Reubins G; Fei JZ; Fujimoto T; Kienlen-Campard P; Constantinescu SN; Octave JN; Aimoto S; Smith SO A Helix-to-Coil Transition at the &#x3a3;-Cut Site in the Transmembrane Dimer of the Amyloid Precursor Protein Is Required for Proteolysis. Proc. Natl. Acad. Sci. U. S. A 2009, 106, 1421&#x2013;1426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2635791</ArticleId><ArticleId IdType="pubmed">19164538</ArticleId></ArticleIdList></Reference><Reference><Citation>Czirr E; Cottrell BA; Leuchtenberger S; Kukar T; Ladd TB; Esselmann H; Paul S; Schubenel R; Torpey JW; Pietrzik CU; et al. Independent Generation of A&#x3b2;42 and A&#x3b2;38 Peptide Species by &#x3b3;-Secretase. J. Biol. Chem 2008, 283, 17049&#x2013;17054.</Citation><ArticleIdList><ArticleId IdType="pubmed">18426795</ArticleId></ArticleIdList></Reference><Reference><Citation>Munter LM; Voigt P; Harmeier A; Kaden D; Gottschalk KE; Weise C; Pipkorn R; Schaefer M; Langosch D; Multhaup G GxxxG Motifs within the Amyloid Precursor Protein Transmembrane Sequence Are Critical for the Etiology of A&#x3b2;42. EMBO J 2007, 26, 1702&#x2013;1712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1829382</ArticleId><ArticleId IdType="pubmed">17332749</ArticleId></ArticleIdList></Reference><Reference><Citation>Kienlen-Campard P; Tasiaux B; Van Hees J; Li M; Huysseune S; Sato T; Fei JZ; Aimoto S; Courtoy PJ; Smith SO; Constantinescu SN; Octave JN Amyloidogenic Processing but Not Amyloid Precursor Protein (APP) Intracellular C-Terminal Domain Production Requires a Precisely Oriented APP Dimer Assembled by Transmembrane GXXXG Motifs. J. Biol. Chem 2008, 283, 7733&#x2013;7734.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2702479</ArticleId><ArticleId IdType="pubmed">18201969</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalifa N; Ben Van Hees J; Tasiaux B; Huysseune S; Smith SO; Constantinescu SN; Octave JN; Kienlen-Campard P What Is the Role of Amyloid Precursor Protein Dimerization? Cell Adhes. Migr 2010, 4, 268&#x2013;272.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2900624</ArticleId><ArticleId IdType="pubmed">20400860</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y; Hustedt EJ; Brandon S; Sanders CR Competition between Homodimerization and Cholesterol Binding to the C99 Domain of the Amyloid Precursor Protein. Biochemistry 2013, 52, 5051&#x2013;5064.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3758481</ArticleId><ArticleId IdType="pubmed">23865807</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez L; Foster L; Meredith SC; Straub JE; Thirumalai D Structural Heterogeneity in Transmembrane Amyloid Precursor Protein Homodimer Is a Consequence of Environmental Selection. J. Am. Chem. Soc 2014, 136, 9619&#x2013;9626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4105063</ArticleId><ArticleId IdType="pubmed">24926593</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez L; Foster L; Straub JE; Thirumalai D Impact of Membrane Lipid Composition on the Structure and Stability of the Transmembrane Domain of Amyloid Precursor Protein. Proc. Natl. Acad. Sci. U. S. A 2016, 113, E5281&#x2013;E5287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5018773</ArticleId><ArticleId IdType="pubmed">27559086</ArticleId></ArticleIdList></Reference><Reference><Citation>Capone RF; Tiwari A; Fricke N; Hadziselimovic A; Kenworthy AK; Sanders CR Use of Giant Plasma Membrane Vesicles (GPMV) to Examine the Lo/Ld Phase Preference of the C99 Domain of the Amyloid Precursor Protein. Biophys. J 2020, 118 (1), 392A.</Citation></Reference><Reference><Citation>Miyashita N; Straub JE; Thirumalai D; Sugita Y Transmembrane Structures of Amyloid Precursor Protein Dimer Predicted by Replica-Exchange Molecular Dynamics Simulations. J. Am. Chem. Soc 2009, 131, 3438&#x2013;3439.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2727648</ArticleId><ArticleId IdType="pubmed">19275251</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez L; Meredith SC; Straub JE; Thirumalai D Transmembrane Fragment Structures of Amyloid Precursor Protein Depend on Membrane Surface Curvature. J. Am. Chem. Soc 2014, 136, 854&#x2013;857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3928069</ArticleId><ArticleId IdType="pubmed">24364734</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler RG; Kelly J; Storie K; Pedersen WA; Tammara A; Hatanpaa K; Troncoso JC; Mattson MP Involvement of Oxidative Stress-Induced Abnormalities in Ceramide and Cholesterol Metabolism in Brain Aging and Alzheimer&#x2019;s Disease. Proc. Natl. Acad. Sci. U. S. A 2004, 101, 2070&#x2013;2075.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC357053</ArticleId><ArticleId IdType="pubmed">14970312</ArticleId></ArticleIdList></Reference><Reference><Citation>Shobab LA; Hsiung GYR; Feldman HH Cholesterol in Alzheimer&#x2019;s Disease. Lancet Neurol 2005, 4, P841&#x2013;P852.</Citation><ArticleIdList><ArticleId IdType="pubmed">16297842</ArticleId></ArticleIdList></Reference><Reference><Citation>Puglielli L; Ellis BC; Saunders AJ; Kovacs DM Ceramide Stabilizes &#x3b2;-Site Amyloid Precursor Protein-Cleaving Enzyme 1 and Promotes Amyloid &#x3b2;-Peptide Biogenesis. J. Biol. Chem 2003, 278, 19777&#x2013;19783.</Citation><ArticleIdList><ArticleId IdType="pubmed">12649271</ArticleId></ArticleIdList></Reference><Reference><Citation>Kojro E; Gimpl G; Lammich S; M&#xe4;rz W; Fahrenholz F Low Cholesterol Stimulates the Nonamyloidogenic Pathway by Its Effect on the &#x3b1;-Secretase ADAM 10. Proc. Natl. Acad. Sci. U. S. A 2001, 98, 5815&#x2013;5820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC33296</ArticleId><ArticleId IdType="pubmed">11309494</ArticleId></ArticleIdList></Reference><Reference><Citation>De Meyer F; Smit B Effect of Cholesterol on the Structure of a Phospholipid Bilayer. Proc. Natl. Acad. Sci. U. S. A 2009, 106, 3654&#x2013;3658.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2656135</ArticleId><ArticleId IdType="pubmed">19225105</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehehalt R; Keller P; Haass C; Thiele C; Simons K Amyloidogenic Processing of the Alzheimer &#x3b2;-Amyloid Precursor Protein Depends on Lipid Rafts. J. Cell Biol 2003, 160, 113&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2172747</ArticleId><ArticleId IdType="pubmed">12515826</ArticleId></ArticleIdList></Reference><Reference><Citation>Hicks DA; Nalivaeva NN; Turner AJ Lipid Rafts and Alzheimer&#x2019;s Disease: Protein-Lipid Interactions and Perturbation of Signaling. Front. Physiol 2012, 3, 189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3381238</ArticleId><ArticleId IdType="pubmed">22737128</ArticleId></ArticleIdList></Reference><Reference><Citation>Panahi A; Bandara A; Pantelopulos GA; Dominguez L; Straub JE Specific Binding of Cholesterol to C99 Domain of Amyloid Precursor Protein Depends Critically on Charge State of Protein. J. Phys. Chem. Lett 2016, 7, 3535&#x2013;3541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5293176</ArticleId><ArticleId IdType="pubmed">27525349</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordy JM; Hussain I; Dingwall C; Hooper NM; Turner AJ Exclusively Targeting &#x3b2;-Secretase to Lipid Rafts by GPI-Anchor Addition up-Regulates &#x3b2;-Site Processing of the Amyloid Precursor Protein. Proc. Natl. Acad. Sci. U. S. A 2003, 100, 11735&#x2013;11740.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC208827</ArticleId><ArticleId IdType="pubmed">14504402</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S Il; Yi JS; Ko YG Amyloid &#x3b2; Oligomerization Is Induced by Brain Lipid Rafts. J. Cell. Biochem 2006, 99, 878&#x2013;889.</Citation><ArticleIdList><ArticleId IdType="pubmed">16721824</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosicek M; Malnar M; Goate A; Hecimovic S Cholesterol Accumulation in Niemann Pick Type C (NPC) Model Cells Causes a Shift in APP Localization to Lipid Rafts. Biochem. Biophys. Res. Commun 2010, 393, 404&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2853640</ArticleId><ArticleId IdType="pubmed">20138836</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharyya R; Barren C; Kovacs DM Palmitoylation of Amyloid Precursor Protein Regulates Amyloidogenic Processing in Lipid Rafts. J. Neurosci 2013, 33, 11169&#x2013;11183.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3718372</ArticleId><ArticleId IdType="pubmed">23825420</ArticleId></ArticleIdList></Reference><Reference><Citation>Vetrivel KS; Thinakaran G Membrane Rafts in Alzheimer&#x2019;s Disease Beta-Amyloid Production. Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 2010, 1801, 860&#x2013;867.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2886169</ArticleId><ArticleId IdType="pubmed">20303415</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L; Ding L; Rovere M; Wolfe MS; Selkoe DJ A Cellular Complex of BACE1 and &#x3b3;-Secretase Sequentially Generates A&#x3b2; from Its Full-Length Precursor. J. Cell Biol 2019, 218, 644&#x2013;663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6363461</ArticleId><ArticleId IdType="pubmed">30626721</ArticleId></ArticleIdList></Reference><Reference><Citation>De Strooper B; Saftig P; Craessaerts K; Vanderstichele H; Guhde G; Annaert W; Von Figura K; Van Leuven F Deficiency of Presenilin-1 Inhibits the Normal Cleavage of Amyloid Precursor Protein. Nature 1998, 391, 387&#x2013;390.</Citation><ArticleIdList><ArticleId IdType="pubmed">9450754</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabelo N; Mart&#xed;n V; Mar&#xed;n R; Moreno D; Ferrer I; D&#xed;az M Altered Lipid Composition in Cortical Lipid Rafts Occurs at Early Stages of Sporadic Alzheimer&#x2019;s Disease and Facilitates APP/BACE1 Interactions. Neurobiol. Aging 2014, 35, 1801&#x2013;1812.</Citation><ArticleIdList><ArticleId IdType="pubmed">24613671</ArticleId></ArticleIdList></Reference><Reference><Citation>Osenkowski P; Ye W; Wang R; Wolfe MS; Selkoe DJ Direct and Potent Regulation of &#x3b3;-Secretase by Its Lipid Microenvironment. J. Biol. Chem 2008, 283, 22529&#x2013;22540.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2504869</ArticleId><ArticleId IdType="pubmed">18539594</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes O; Paturi S; Ye W; Wolfe MS; Selkoe DJ Effects of Membrane Lipids on the Activity and Processivity of Purified &#x3b3;-Secretase. Biochemistry 2012, 51, 3565&#x2013;3575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3347702</ArticleId><ArticleId IdType="pubmed">22489600</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguayo-Ortiz R; Straub JE; Dominguez L Influence of Membrane Lipid Composition on the Structure and Activity of &#x3b3;-Secretase. Phys. Chem. Chem. Phys 2018, 20, 27294&#x2013;27304.</Citation><ArticleIdList><ArticleId IdType="pubmed">30357233</ArticleId></ArticleIdList></Reference><Reference><Citation>Hitzenberger M; G&#xf6;tz A; Menig S; Brunschweiger B; Zacharias M; Scharnagl C Seminars in Cell &amp; Developmental Biology The Dynamics of &#x3b3;-Secretase and Its Substrates. Semin. Cell Dev. Biol 2020, 105, 86&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">32423851</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong R; Chang S; Xia W; Wong STC Molecular Dynamics Simulation Study Reveals Potential Substrate Entry Path into &#x3b3;-Secretase/Presenilin-1. J. Struct. Biol 2015, 191, 120&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pubmed">26142917</ArticleId></ArticleIdList></Reference><Reference><Citation>Audagnotto M; Kengo Lorkowski A; Dal Peraro M Recruitment of the Amyloid Precursor Protein by &#x3b3;-Secretase at the Synaptic Plasma Membrane. Biochem. Biophys. Res. Commun 2018, 498, 334&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pubmed">29097209</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;Del Moral A; Fortique F Omega-3 fatty Acids and Cognitive Decline: a Systematic Review. Nutr. Hosp 2019, 36, 939&#x2013;949.</Citation><ArticleIdList><ArticleId IdType="pubmed">31215788</ArticleId></ArticleIdList></Reference><Reference><Citation>Loef M; Walach H The omega-6/omega-3 Ratio and Dementia or Cognitive Decline: a Systematic Review on Human Studies and Biological Evidence. J. Nutr. Gerontol. Geriatr 2013, 32, 1&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">23451843</ArticleId></ArticleIdList></Reference><Reference><Citation>  https://www.alzforum.org/mutations.</Citation></Reference><Reference><Citation>Humphrey W; Dalke A; Schulten K VMD - Visual Molecular Dynamics. J. Mol. Graphics 1996, 14, 33&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">8744570</ArticleId></ArticleIdList></Reference><Reference><Citation>Nizynski B; Dzwolak W; Nieznanski K Amyloidogenesis of Tau Protein. Protein Sci 2017, 26, 2126&#x2013;2150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5654847</ArticleId><ArticleId IdType="pubmed">28833749</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellogg EH; Hejab NMA; Poepsel S; Downing KH; DiMaio F; Nogales E Near-atomic Model of Microtubule-tau Interactions. Science 2018, 360, 1242&#x2013;1246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6225777</ArticleId><ArticleId IdType="pubmed">29748322</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P; Cehlar O; Skrabana R; Novak M Tau Conformation as a Target for Disease-Modifying Therapy: The Role of Truncation. J. Alzheimer&#x2019;s Dis 2018, 64, S535&#x2013;S546.</Citation><ArticleIdList><ArticleId IdType="pubmed">29865059</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn JP; Corbett NJ; Kellett KAB; Hooper NM Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers. J. Alzheimer&#x2019;s Dis 2018, 63, 13&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5900574</ArticleId><ArticleId IdType="pubmed">29630551</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hilaly YK; Foster BE; Biasetti L; Lutter L; Pollack SJ; Rickard JE; Storey JMD; Harrington CR; Xue WF; Wischik CM; et al. Tau (297&#x2013;391) Forms Filaments that Structurally Mimic the Core of Paired Helical Filaments in Alzheimer&#x2019;s Disease Brain. FEBS Lett 2020, 594, 944&#x2013;950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7078754</ArticleId><ArticleId IdType="pubmed">31721178</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlegel K; Awwad K; Heym RG; Holzinger D; Doell A; Barghorn S; Jahn TR; Klein C; Mordashova Y; Schulz M; et al. N368-Tau fragments Generated by Legumain are Detected Only in Trace Amount in the Insoluble Tau Aggregates Isolated from AD Brain. Acta Neuropathol. Commun 2019, 7, 177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6854719</ArticleId><ArticleId IdType="pubmed">31722749</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed T; Gujral SS; Rao PPN Tau Derived Hexapeptide AcPHF6 Promotes Beta-Amyloid (Abeta) Fibrillogenesis. ACS Chem. Neurosci 2018, 9, 773&#x2013;782.</Citation><ArticleIdList><ArticleId IdType="pubmed">29239599</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D; Drombosky KW; Hou Z; Sari L; Kashmer OM; Ryder BD; Perez VA; Woodard DR; Lin MM; Diamond MI; et al. Tau Local Structure shields an Amyloid-forming Motif and Controls Aggregation Propensity. Nat. Commun 2019, 10, 2493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6555816</ArticleId><ArticleId IdType="pubmed">31175300</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi R; Luo Y; Wei G; Nussinov R; Ma B A&#x3b2; &#x201c;Stretching-and-Packing&#x201d; Cross-Seeding Mechanism Can Trigger Tau Protein Aggregation. J. Phys. Chem. Lett 2015, 6, 3276&#x2013;3282.</Citation></Reference><Reference><Citation>Stohr J; Wu H; Nick M; Wu Y; Bhate M; Condello C; Johnson N; Rodgers J; Lemmin T; Acharya S; et al. A 31-residue Peptide Induces Aggregation of Tau&#x2019;s Microtubule-binding Region in Cells. Nat. Chem 2017, 9, 874&#x2013;881.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5759337</ArticleId><ArticleId IdType="pubmed">28837163</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H; Zhong H; Liu X; Zhou S; Tan S; Liu H; Yao X Disclosing the Mechanism of Spontaneous Aggregation and Template-Induced Misfolding of the Key Hexapeptide (PHF6) of Tau Protein Based on Molecular Dynamics Simulation. ACS Chem. Neurosci 2019, 10, 4810&#x2013;4823.</Citation><ArticleIdList><ArticleId IdType="pubmed">31661961</ArticleId></ArticleIdList></Reference><Reference><Citation>Chemerovski-Glikman M; Frenkel-Pinter M; Mdah R; Abu-Mokh A; Gazit E; Segal D Inhibition of the Aggregation and Toxicity of the Minimal Amyloidogenic Fragment of Tau by Its Pro-Substituted Analogues. Chem. - Eur. J 2017, 23, 9618.</Citation><ArticleIdList><ArticleId IdType="pubmed">28544138</ArticleId></ArticleIdList></Reference><Reference><Citation>Seidler PM; Boyer DR; Murray KA; Yang TP; Bentzel M; Sawaya MR; Rosenberg G; Cascio D; Williams CK; Newell KL; et al. Structure-based Inhibitors halt Prion-like Seeding by Alzheimer&#x2019;s Disease-and Tauopathy-derived Brain Tissue Samples. J. Biol. Chem 2019, 294, 16451&#x2013;16464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6827308</ArticleId><ArticleId IdType="pubmed">31537646</ArticleId></ArticleIdList></Reference><Reference><Citation>Seidler PM; Boyer DR; Rodriguez JA; Sawaya MR; Cascio D; Murray K; Gonen T; Eisenberg DS Structure-based Inhibitors of Tau Aggregation. Nat. Chem 2018, 10, 170&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5784779</ArticleId><ArticleId IdType="pubmed">29359764</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuret J; Congdon EE; Li G; Yin H; Yu X; Zhong Q Evaluating Triggers and Enhancers of Tau Fibrillization. Microsc. Res. Tech 2005, 67, 141&#x2013;155.</Citation><ArticleIdList><ArticleId IdType="pubmed">16103995</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippens G; Sillen A; Landrieu I; Amniai L; Sibille N; Barbier P; Leroy A; Hanoulle X; Wieruszeski JM Tau Aggregation in Alzheimer&#x2019;s Disease: What Role for Phosphorylation? Prion 2007, 1, 21&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2633703</ArticleId><ArticleId IdType="pubmed">19164903</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson GV; Stoothoff WH Tau Phosphorylation in Neuronal Cell Function and Dysfunction. J. Cell Sci 2004, 117, 5721&#x2013;5729.</Citation><ArticleIdList><ArticleId IdType="pubmed">15537830</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L; Latypova X; Terro F Post-translational Modifications of Tau Protein: Implications for Alzheimer&#x2019;s Disease. Neurochem. Int 2011, 58, 458&#x2013;471.</Citation><ArticleIdList><ArticleId IdType="pubmed">21215781</ArticleId></ArticleIdList></Reference><Reference><Citation>Funk KE; Thomas SN; Schafer KN; Cooper GL; Liao Z; Clark DJ; Yang AJ; Kuret J Lysine Methylation is an Endogenous Post-translational Modification of Tau Protein in Human Brain and a Modulator of Aggregation Propensity. Biochem. J 2014, 462, 77&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4292886</ArticleId><ArticleId IdType="pubmed">24869773</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen TJ; Guo JL; Hurtado DE; Kwong LK; Mills IP; Trojanowski JQ; Lee VMY The Acetylation of Tau Inhibits its Function and Promotes Pathological Tau Aggregation. Nat. Commun 2011, 2, 252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3120096</ArticleId><ArticleId IdType="pubmed">21427723</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanger DP; Byers HL; Wray S; Leung KY; Saxton MJ; Seereeram A; Reynolds CH; Ward MA; Anderton BH Novel Phosphorylation Sites in Tau from Alzheimer Brain Support a Role for Casein Kinase 1 in Disease Pathogenesis. J. Biol. Chem 2007, 282, 23645&#x2013;23654.</Citation><ArticleIdList><ArticleId IdType="pubmed">17562708</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippens G; Gigant B Elucidating Tau Function and Dysfunction in the Era of Cryo-EM. J. Biol. Chem 2019, 294, 9316&#x2013;9325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6579466</ArticleId><ArticleId IdType="pubmed">31088912</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W; Tarutani A; Newell KL; Murzin AG; Matsubara T; Falcon B; Vidal R; Garringer HJ; Shi Y; Ikeuchi T; et al. Novel Tau Filament Fold in Corticobasal Degeneration. Nature 2020, 580, 283&#x2013;287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7148158</ArticleId><ArticleId IdType="pubmed">32050258</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcon B; Zivanov J; Zhang W; Murzin AG; Garringer HJ; Vidal R; Crowther RA; Newell KL; Ghetti B; Goedert M; et al. Novel Tau Filament Fold in Chronic Traumatic Encephalopathy Encloses Hydrophobic Molecules. Nature 2019, 568, 420&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6472968</ArticleId><ArticleId IdType="pubmed">30894745</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y; Dinkel P; Yu X; Margittai M; Zheng J; Nussinov R; Wei G; Ma B Molecular Insights into the Reversible Formation of Tau Protein Fibrils. Chem. Commun (Cambridge, U. K.) 2013, 49, 3582&#x2013;3584.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3637047</ArticleId><ArticleId IdType="pubmed">23527380</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamcik J; S&#xe1;nchez-Ferrer A; Ait-Bouziad N; Reynolds NP; Lashuel HA; Mezzenga R Microtubule-Binding R3 Fragment from Tau Self-Assembles into Giant Multistranded Amyloid Ribbons. Angew. Chem., Int. Ed 2016, 55, 618&#x2013;622.</Citation><ArticleIdList><ArticleId IdType="pubmed">26636567</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes BB; DeVos SL; Kfoury N; Li M; Jacks R; Yanamandra K; Ouidja MO; Brodsky FM; Marasa J; Bagchi DP; et al. Heparan Sulfate Proteoglycans Mediate Internalization and Propagation of Specific Proteopathic Seeds. Proc. Natl. Acad. Sci. U. S. A 2013, 110, E3138&#x2013;E31147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3746848</ArticleId><ArticleId IdType="pubmed">23898162</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickramasinghe SP; Lempart J; Merens HE; Murphy J; Huettemann P; Jakob U; Rhoades E Polyphosphate Initiates Tau Aggregation through Intra- and Intermolecular Scaffolding. Biophys. J 2019, 117, 717&#x2013;728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6712485</ArticleId><ArticleId IdType="pubmed">31400913</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukrasch MD; Biernat J; von Bergen M; Griesinger C; Mandelkow E; Zweckstetter M Sites of Tau Important for Aggregation Populate &#x3b2;-Structure and Bind to Microtubules and Polyanions. J. Biol. Chem 2005, 280, 24978&#x2013;24986.</Citation><ArticleIdList><ArticleId IdType="pubmed">15855160</ArticleId></ArticleIdList></Reference><Reference><Citation>Akoury E; Mukrasch MD; Biernat J; Tepper K; Ozenne V; Mandelkow E; Blackledge M; Zweckstetter M Remodeling of the Conformational Ensemble of the Repeat Domain of Tau by an Aggregation Enhancer. Protein Sci 2016, 25, 1010&#x2013;1020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4838641</ArticleId><ArticleId IdType="pubmed">26940799</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J; Huvent I; Lippens G; Eliezer D; Zhang A; Li Q; Tessier P; Linhardt RJ; Zhang F; Wang C Glycan Determinants of Heparin-Tau Interaction. Biophys. J 2017, 112, 921&#x2013;932.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5355497</ArticleId><ArticleId IdType="pubmed">28297651</ArticleId></ArticleIdList></Reference><Reference><Citation>Fichou Y; Vigers M; Goring AK; Eschmann NA; Han S Heparin-induced Tau Filaments are Structurally Heterogeneous and Differ from Alzheimer&#x2019;s Disease Filaments. Chem. Commun (Cambridge, U. K.) 2018, 54, 4573&#x2013;4576.</Citation><ArticleIdList><ArticleId IdType="pubmed">29664486</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W; Falcon B; Murzin AG; Fan J; Crowther RA; Goedert M; Scheres SH Heparin-induced Tau Filaments are Polymorphic and Differ from those in Alzheimer&#x2019;s and Pick&#x2019;s Diseases. eLife 2019, 8, 8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6375701</ArticleId><ArticleId IdType="pubmed">30720432</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X; Chen M; Schafer NP; Wolynes PG Exploring the Interplay between Fibrillization and Amorphous Aggregation Channels on the Energy Landscapes of Tau Repeat Isoforms. Proc. Natl. Acad. Sci. U. S. A 2020, 117, 4125&#x2013;4130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7049151</ArticleId><ArticleId IdType="pubmed">32029593</ArticleId></ArticleIdList></Reference><Reference><Citation>Kjaergaard M; Dear AJ; Kundel F; Qamar S; Meisl G; Knowles TPJ; Klenerman D Oligomer Diversity during the Aggregation of the Repeat Region of Tau. ACS Chem. Neurosci 2018, 9, 3060&#x2013;3071.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6302314</ArticleId><ArticleId IdType="pubmed">29953200</ArticleId></ArticleIdList></Reference><Reference><Citation>Dregni AJ; Mandala VS; Wu H; Elkins MR; Wang HK; Hung I; DeGrado WF; Hong M In vitro 0N4R Tau Fibrils Contain a Monomorphic beta-sheet Core Enclosed by Dynamically Heterogeneous Fuzzy Coat Segments. Proc. Natl. Acad. Sci. U. S. A 2019, 116, 16357&#x2013;16366.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6697781</ArticleId><ArticleId IdType="pubmed">31358628</ArticleId></ArticleIdList></Reference><Reference><Citation>Brion JP; Hanger DP; Bruce MT; Couck AM; Flament-Durand J; Anderton BH Tau in Alzheimer Neurofibrillary Tangles. N- and C-terminal Regions are Differentially Associated with Paired Helical Filaments and the Location of a Putative Abnormal Phosphorylation Site. Biochem. J 1991, 273, 127&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1150212</ArticleId><ArticleId IdType="pubmed">1899184</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng J; Xia L; Li W; Dou F The C-Terminus of Tau Protein Plays an Important Role in Its Stability and Toxicity. J. Mol. Neurosci 2015, 55, 251&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">24788226</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamblin TC; Berry RW; Binder LI Tau Polymerization: Role of the Amino Terminus. Biochemistry 2003, 42, 2252&#x2013;2257.</Citation><ArticleIdList><ArticleId IdType="pubmed">12590615</ArticleId></ArticleIdList></Reference><Reference><Citation>Horowitz PM; LaPointe N; Guillozet-Bongaarts AL; Berry RW; Binder LI N-Terminal Fragments of Tau Inhibit Full-Length Tau Polymerization in Vitro. Biochemistry 2006, 45, 12859&#x2013;12866.</Citation><ArticleIdList><ArticleId IdType="pubmed">17042504</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanagawa H; Chung S-H; Ogawa Y; Sato K; Shibata-Seki T; Masai J; Ishiguro K Protein Anatomy: C-Tail Region of Human Tau Protein as a Crucial Structural Element in Alzheimer&#x2019;s Paired Helical Filament Formation in Vitro. Biochemistry 1998, 37, 1979&#x2013;1988.</Citation><ArticleIdList><ArticleId IdType="pubmed">9485325</ArticleId></ArticleIdList></Reference><Reference><Citation>Weismiller HA; Murphy R; Wei G; Ma B; Nussinov R; Margittai M Structural Disorder in Four-repeat Tau Fibrils Reveals a New Mechanism for Barriers to Cross-seeding of Tau isoforms. J. Biol. Chem 2018, 293, 17336&#x2013;17348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6231118</ArticleId><ArticleId IdType="pubmed">30242125</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L; Zheng J; Margittai M; Nussinov R; Ma B How Does Hyperphopsphorylation Promote Tau Aggregation and Modulate Filament Structure and Stability? ACS Chem. Neurosci 2016, 7, 565&#x2013;575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7831686</ArticleId><ArticleId IdType="pubmed">26854860</ArticleId></ArticleIdList></Reference><Reference><Citation>Lashuel HA; Overk CR; Oueslati A; Masliah E The Many Faces of alpha-synuclein: From Structure and Toxicity to Therapeutic Target. Nat. Rev. Neurosci 2013, 14, 38&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4295774</ArticleId><ArticleId IdType="pubmed">23254192</ArticleId></ArticleIdList></Reference><Reference><Citation>Theillet FX; Binolfi A; Bekei B; Martorana A; Rose HM; Stuiver M; Verzini S; Lorenz D; van Rossum M; Goldfarb D; et al. Structural Disorder of Monomeric alpha-synuclein Persists in Mammalian Cells. Nature 2016, 530, 45&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">26808899</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauvet B; Mbefo MK; Fares MB; Desobry C; Michael S; Ardah MT; Tsika E; Coune P; Prudent M; Lion N; et al. alpha-Synuclein in Central Nervous System and From Erythrocytes, Mammalian Cells, and Escherichia coli Exists Predominantly as Disordered Monomer. J. Biol. Chem 2012, 287, 15345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3346117</ArticleId><ArticleId IdType="pubmed">22315227</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartels T; Choi JG; Selkoe DJ Alpha-Synuclein Occurs Physiologically as a Helically Folded Tetramer that Resists Aggregation. Nature 2011, 477, 107&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3166366</ArticleId><ArticleId IdType="pubmed">21841800</ArticleId></ArticleIdList></Reference><Reference><Citation>Uversky VN; Eliezer D Biophysics of Parkinson&#x2019;s Disease: Structure and Aggregation of alpha-synuclein. Curr. Protein Pept. Sci 2009, 10, 483&#x2013;499.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3786709</ArticleId><ArticleId IdType="pubmed">19538146</ArticleId></ArticleIdList></Reference><Reference><Citation>Snead D; Eliezer D Alpha-synuclein Function and Dysfunction on Cellular Membranes. Exp. Neurobiol 2014, 23, 292&#x2013;313.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4276801</ArticleId><ArticleId IdType="pubmed">25548530</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueda K; Fukushima H; Masliah E; Xia Y; Iwai A; Yoshimoto M; Otero DA; Kondo J; Ihara Y; Saitoh T Molecular Cloning of cDNA Encoding an Unrecognized Component of Amyloid in Alzheimer Disease. Proc. Natl. Acad. Sci. U. S. A 1993, 90, 11282&#x2013;11286.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC47966</ArticleId><ArticleId IdType="pubmed">8248242</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvin JE; Uryu K; Lee VM; Trojanowski JQ Axon Pathology in Parkinson&#x2019;s Disease and Lewy Body Dementia Hippocampus Contains alpha-, beta-, and gamma-synuclein. Proc. Natl. Acad. Sci. U. S. A 1999, 96, 13450&#x2013;13455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC23968</ArticleId><ArticleId IdType="pubmed">10557341</ArticleId></ArticleIdList></Reference><Reference><Citation>Spillantini MG; Crowther RA; Jakes R; Cairns NJ; Lantos PL; Goedert M Filamentous alpha-synuclein Inclusions Link Multiple System Atrophy with Parkinson&#x2019;s Disease and Dementia with Lewy Bodies. Neurosci. Lett 1998, 251, 205&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">9726379</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiti F; Dobson CM Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade. Annu. Rev. Biochem 2017, 86, 27&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">28498720</ArticleId></ArticleIdList></Reference><Reference><Citation>Burre J The Synaptic Function of alpha-Synuclein. J. Parkinson&#x2019;s Dis 2015, 5, 699&#x2013;713.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4927875</ArticleId><ArticleId IdType="pubmed">26407041</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy DD; Rueter SM; Trojanowski JQ; Lee VM Synucleins are Developmentally Expressed, and alpha-synuclein Regulates the Size of the Presynaptic Vesicular Pool in Primary Hippocampal Neurons. J. Neurosci 2000, 20, 3214&#x2013;3220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6773130</ArticleId><ArticleId IdType="pubmed">10777786</ArticleId></ArticleIdList></Reference><Reference><Citation>George JM; Jin H; Woods WS; Clayton DF Characterization of a Novel protein Regulated during the Critical Period for Song Learning in the Zebra Finch. Neuron 1995, 15, 361&#x2013;372.</Citation><ArticleIdList><ArticleId IdType="pubmed">7646890</ArticleId></ArticleIdList></Reference><Reference><Citation>Burre J; Sharma M; Sudhof TC Alpha-synuclein Assembles into Higher-order Multimers upon Membrane Binding to Promote SNARE Complex Formation. Proc. Natl. Acad. Sci. U. S. A 2014, 111, E4274&#x2013;E4283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4210039</ArticleId><ArticleId IdType="pubmed">25246573</ArticleId></ArticleIdList></Reference><Reference><Citation>Auluck PK; Caraveo G; Lindquist S Alpha-Synuclein: Membrane Interactions and Toxicity in Parkinson&#x2019;s Disease. Annu. Rev. Cell Dev. Biol 2010, 26, 211&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pubmed">20500090</ArticleId></ArticleIdList></Reference><Reference><Citation>Lautenschlager J; Stephens AD; Fusco G; Strohl F; Curry N; Zacharopoulou M; Michel CH; Laine R; Nespovitaya N; Fantham M; et al. C-terminal Calcium Binding of alpha-synuclein Modulates Synaptic Vesicle Interaction. Nat. Commun 2018, 9, 712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5818535</ArticleId><ArticleId IdType="pubmed">29459792</ArticleId></ArticleIdList></Reference><Reference><Citation>Burre J; Sharma M; Tsetsenis T; Buchman V; Etherton MR; Sudhof TC Alpha-synuclein Promotes SNARE-complex Assembly in vivo and in vitro. Science 2010, 329, 1663&#x2013;1667.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3235365</ArticleId><ArticleId IdType="pubmed">20798282</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandra S; Gallardo G; Fernandez-Chacon R; Schluter OM; Sudhof TC Alpha-synuclein Cooperates with CSPalpha in Preventing Neurodegeneration. Cell 2005, 123, 383&#x2013;396.</Citation><ArticleIdList><ArticleId IdType="pubmed">16269331</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelkonen A; Yavich L Neuromuscular Pathology in Mice Lacking Alpha-synuclein. Neurosci. Lett 2011, 487, 350&#x2013;353.</Citation><ArticleIdList><ArticleId IdType="pubmed">21029764</ArticleId></ArticleIdList></Reference><Reference><Citation>Fusco G; Pape T; Stephens AD; Mahou P; Costa AR; Kaminski CF; Kaminski Schierle GS; Vendruscolo M; Veglia G; Dobson CM; et al. Structural Basis of Synaptic Vesicle Assembly Promoted by a-synuclein. Nat. Commun 2016, 7, 12563.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5031799</ArticleId><ArticleId IdType="pubmed">27640673</ArticleId></ArticleIdList></Reference><Reference><Citation>Diao J; Burre J; Vivona S; Cipriano DJ; Sharma M; Kyoung M; Sudhof TC; Brunger AT Native alpha-synuclein Induces Clustering of Synaptic-vesicle Mimics via Binding to Phospholipids and Synaptobrevin-2/VAMP2. eLife 2013, 2, No. e00592.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3639508</ArticleId><ArticleId IdType="pubmed">23638301</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper AA; Gitler AD; Cashikar A; Haynes CM; Hill KJ; Bhullar B; Liu K; Xu K; Strathearn KE; Liu F; et al. Alpha-synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson&#x2019;s Models. Science 2006, 313, 324&#x2013;328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1983366</ArticleId><ArticleId IdType="pubmed">16794039</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltsev AS; Chen J; Levine RL; Bax A Site-specific Interaction between Alpha-synuclein and Membranes Probed by NMR-observed Methionine Oxidation Rates. J. Am. Chem. Soc 2013, 135, 2943&#x2013;2946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3585462</ArticleId><ArticleId IdType="pubmed">23398174</ArticleId></ArticleIdList></Reference><Reference><Citation>Newberry RW; Leong JT; Chow ED; Kampmann M; DeGrado WF Deep Mutational Scanning Reveals the Structural Basis for alpha-synuclein Activity. Nat. Chem. Biol 2020, 16, 653&#x2013;659.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7339969</ArticleId><ArticleId IdType="pubmed">32152544</ArticleId></ArticleIdList></Reference><Reference><Citation>Eliezer D; Kutluay E; Bussell R, Jr; Browne, G. Conformational Properties of alpha-synuclein in its Free and Lipid-associated States. J. Mol. Biol 2001, 307, 1061&#x2013;1073.</Citation><ArticleIdList><ArticleId IdType="pubmed">11286556</ArticleId></ArticleIdList></Reference><Reference><Citation>Cookson MR The Biochemistry of Parkinson&#x2019;s disease. Annu. Rev. Biochem 2005, 74, 29&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">15952880</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoppener JW; Ahren B; Lips CJ Islet Amyloid and Type 2 Diabetes Mellitus. N. Engl. J. Med 2000, 343, 411&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pubmed">10933741</ArticleId></ArticleIdList></Reference><Reference><Citation>Higham CE; Hull RL; Lawrie L; Shennan KI; Morris JF; Birch NP; Docherty K; Clark A Processing of Synthetic Pro-islet Amyloid Polypeptide (proIAPP) &#x2018;amylin&#x2019; by Recombinant Prohormone Convertase Enzymes, PC2 and PC3, in vitro. Eur. J. Biochem 2000, 267, 4998&#x2013;5004.</Citation><ArticleIdList><ArticleId IdType="pubmed">10931181</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenzo A; Razzaboni B; Weir GC; Yankner BA Pancreatic Islet Cell Toxicity of Amylin associated with Type-2 Diabetes Mellitus. Nature 1994, 368, 756&#x2013;760.</Citation><ArticleIdList><ArticleId IdType="pubmed">8152488</ArticleId></ArticleIdList></Reference><Reference><Citation>Janciauskiene S; Ahren B Different Sensitivity to the Cytotoxic Action of IAPP Fibrils in two Insulin-producing Cell Lines, HIT-T15 and RINm5F Cells. Biochem. Biophys. Res. Commun 1998, 251, 888&#x2013;893.</Citation><ArticleIdList><ArticleId IdType="pubmed">9791005</ArticleId></ArticleIdList></Reference><Reference><Citation>Narita R; Toshimori H; Nakazato M; Kuribayashi T; Toshimori T; Kawabata K; Takahashi K; Masukura S Islet Amyloid Polypeptide (IAPP) and Pancreatic Islet Amyloid Deposition in Diabetic and Non-diabetic Patients. Diabetes Res. Clin. Pract 1992, 15, 3&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">1541232</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J; Tan J; Pei R; Ye S Acidic Environment Significantly Alters Aggregation Pathway of Human Islet Amyloid Polypeptide at Negative Lipid Membrane. Langmuir 2020, 36, 1530&#x2013;1537.</Citation><ArticleIdList><ArticleId IdType="pubmed">31995712</ArticleId></ArticleIdList></Reference><Reference><Citation>Luca S; Yau WM; Leapman R; Tycko R Peptide Conformation and Supramolecular Organization in Amylin Fibrils: Constraints from Solid-state NMR. Biochemistry 2007, 46, 13505&#x2013;13522.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2562526</ArticleId><ArticleId IdType="pubmed">17979302</ArticleId></ArticleIdList></Reference><Reference><Citation>Tycko R; Wickner RB Molecular Structures of Amyloid and Prion Fibrils: Consensus versus Controversy. Acc. Chem. Res 2013, 46, 1487&#x2013;1496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3632659</ArticleId><ArticleId IdType="pubmed">23294335</ArticleId></ArticleIdList></Reference><Reference><Citation>Berman HM; Bhat TN; Bourne PE; Feng Z; Gilliland G; Weissig H; Westbrook J The Protein Data Bank and the Challenge of Structural Genomics. Nat. Struct. Biol 2000, 7, 957&#x2013;959.</Citation><ArticleIdList><ArticleId IdType="pubmed">11103999</ArticleId></ArticleIdList></Reference><Reference><Citation>Serpell LC; Berriman J; Jakes R; Goedert M; Crowther RA Fiber Diffraction of Synthetic Alpha-synuclein Filaments Shows Amyloid-like Cross-beta Conformation. Proc. Natl. Acad. Sci. U. S. A 2000, 97, 4897&#x2013;4902.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC18329</ArticleId><ArticleId IdType="pubmed">10781096</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronsoms S; Trejo SA Applications of Mass Spectrometry to the Study of Protein Aggregation. Methods Mol. Biol 2015, 1258, 331&#x2013;345.</Citation><ArticleIdList><ArticleId IdType="pubmed">25447874</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YH; Goto Y Kinetic Intermediates of Amyloid Fibrillation Studied by Hydrogen Exchange Methods with Nuclear Magnetic Resonance. Biochim. Biophys. Acta, Proteins Proteomics 2012, 1824, 1307&#x2013;1323.</Citation><ArticleIdList><ArticleId IdType="pubmed">22885025</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Y; Delaglio F; Cornilescu G; Bax A TALOS+: a Hybrid Method for Predicting Protein Backbone Torsion Angles from NMR Chemical Shifts. J. Biomol. NMR 2009, 44, 213&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2726990</ArticleId><ArticleId IdType="pubmed">19548092</ArticleId></ArticleIdList></Reference><Reference><Citation>Luca S; Filippov DV; van Boom JH; Oschkinat H; de Groot HJ; Baldus M Secondary Chemical Shifts in Immobilized Peptides and Proteins: a Qualitative Basis for Structure Refinement under Magic Angle Spinning. J. Biomol. NMR 2001, 20, 325&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="pubmed">11563556</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzpatrick AW; Saibil HR Cryo-EM of Amyloid Fibrils and Cellular Aggregates. Curr. Opin. Struct. Biol 2019, 58, 34&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6778506</ArticleId><ArticleId IdType="pubmed">31200186</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero-Ferreira R; Taylor NM; Arteni AA; et al. Two New Polymorphic Structures of Human Full-length alpha-synuclein Fibrils Solved by Cryo-electron Microscopy. eLife 2019, 8, No. e48907.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6957273</ArticleId><ArticleId IdType="pubmed">31815671</ArticleId></ArticleIdList></Reference><Reference><Citation>Gremer L; Sch&#xf6;lzel D; Schenk C; Reinartz E; Labahn J; Ravelli RBG; Tusche M; Lopez-Iglesias C; Hoyer W; Heise H; et al. Fibril Structure of amyloid-&#x3b2;(1&#x2013;42) by Cryo-electron Microscopy. Science 2017, 358, 116&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6080689</ArticleId><ArticleId IdType="pubmed">28882996</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunde M; Serpell LC; Bartlam M; Fraser PE; Pepys MB; Blake CC Common Core Structure of Amyloid Fibrils by Synchrotron X-ray Diffraction. J. Mol. Biol 1997, 273, 729&#x2013;739.</Citation><ArticleIdList><ArticleId IdType="pubmed">9356260</ArticleId></ArticleIdList></Reference><Reference><Citation>Lashuel HA; Wall JS Molecular Electron Microscopy Approaches to Elucidating the Mechanisms of Protein Fibrillogenesis. Methods Mol. Biol 2004, 299, 81&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">15980597</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B; Thurber KR; Shewmaker F; Wickner RB; Tycko R Measurement of Amyloid Fibril Mass-per-length by Tilted-Beam Transmission Electron Microscopy. Proc. Natl. Acad. Sci. U. S. A 2009, 106, 14339&#x2013;14344.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2732815</ArticleId><ArticleId IdType="pubmed">19706519</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellani F; van Rossum B; Diehl A; Schubert M; Rehbein K; Oschkinat H Structure of a Protein Determined by Solid-state Magic-angle-spinning NMR Spectroscopy. Nature 2002, 420, 99&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">12422222</ArticleId></ArticleIdList></Reference><Reference><Citation>Etzkorn M; B&#xf6;ckmann A; Lange A; Baldus M Probing Molecular Interfaces using 2D Magic-angle-spinning NMR on Protein Mixtures with Different Uniform Labeling. J. Am. Chem. Soc 2004, 126, 14746&#x2013;14751.</Citation><ArticleIdList><ArticleId IdType="pubmed">15535698</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer V; Margittai M Spin Labeling and Characterization of Tau Fibrils Using Electron Paramagnetic Resonance (EPR). Methods Mol. Biol 2016, 1345, 185&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pubmed">26453213</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez JA; Eisenberg DS; Gonen T Taking the Measure of MicroED. Curr. Opin. Struct. Biol 2017, 46, 79&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5683914</ArticleId><ArticleId IdType="pubmed">28648726</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidd M Paired Helical Filaments in Electron Microscopy of Alzheimer&#x2019;s Disease. Nature 1963, 197, 192&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pubmed">14032480</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagishita S; Itoh Y; Nan W; Amano N Reappraisal of the Fine Structure of Alzheimer&#x2019;s Neurofibrillary Tangles. Acta Neuropathol 1981, 54, 239&#x2013;246.</Citation><ArticleIdList><ArticleId IdType="pubmed">7257733</ArticleId></ArticleIdList></Reference><Reference><Citation>Fichou Y; Lin Y; Rauch JN; Vigers M; Zeng Z; Srivastava M; Keller TJ; Freed JH; Kosik KS; Han S Cofactors are Essential Constituents of Stable and Seeding-active Tau Fibrils. Proc. Natl. Acad. Sci. U. S. A 2018, 115, 13234&#x2013;13239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6310788</ArticleId><ArticleId IdType="pubmed">30538196</ArticleId></ArticleIdList></Reference><Reference><Citation>Prusiner SB Biology and Genetics of Prions Causing Neurodegeneration. Annu. Rev. Genet 2013, 47, 601&#x2013;623.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4010318</ArticleId><ArticleId IdType="pubmed">24274755</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuttle MD; Comellas G; Nieuwkoop AJ; Covell DJ; Berthold DA; Kloepper KD; Courtney JM; Kim JK; Barclay AM; Kendall A; et al. Solid-state NMR Structure of a Pathogenic Fibril of Full-length Human &#x3b1;-synuclein. Nat. Struct. Mol. Biol 2016, 23, 409&#x2013;415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5034296</ArticleId><ArticleId IdType="pubmed">27018801</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyer DR; Li B; Sun C; Fan W; Zhou K; Hughes MP; Sawaya MR; Jiang L; Eisenberg DS Structures of Fibrils formed by &#x3b1;-synuclein Hereditary Disease Mutant H50Q Reveal New Polymorphs. Nat. Struct. Mol. Biol 2019, 26, 1044&#x2013;1052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6907165</ArticleId><ArticleId IdType="pubmed">31695184</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweighauser M; Shi Y; Tarutani A; Kametani F; Murzin AG; Ghetti B; Matsubara T; Tomita T; Ando T; Hasegawa K; et al. Structures of &#x3b1;-synuclein Filaments from Multiple System Atrophy. Nature 2020, 585, 464&#x2013;469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116528</ArticleId><ArticleId IdType="pubmed">32461689</ArticleId></ArticleIdList></Reference><Reference><Citation>Lansbury PTJ; Costa PR; Griffiths JM; Simon EJ; Auger M; Halverson KJ; Kocisko DA; Hendsch ZS; Ashburn TT; Spencer RG; et al. Structural Model for the beta-amyloid Fibril Based on Interstrand Alignment of an Antiparallel-sheet Comprising a C-terminal Peptide. Nat. Struct. Mol. Biol 1995, 2, 990&#x2013;998.</Citation><ArticleIdList><ArticleId IdType="pubmed">7583673</ArticleId></ArticleIdList></Reference><Reference><Citation>Antzutkin ON; Balbach JJ; Leapman RD; Rizzo NW; Reed J; Tycko R Multiple Quantum solid-state NMR Indicates a Parallel, not Antiparallel, Organization of beta-sheets in Alzheimer&#x2019;s beta-amyloid Fibrils. Proc. Natl. Acad. Sci. U. S. A 2000, 97, 13045&#x2013;13050.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC27175</ArticleId><ArticleId IdType="pubmed">11069287</ArticleId></ArticleIdList></Reference><Reference><Citation>Petkova AT; Ishii Y; Balbach JJ; Antzutkin ON; Leapman RD; Delaglio F; Tycko R A Structural Model for Alzheimer&#x2019;s beta -amyloid Fibrils Based on Experimental Constraints from Solid state NMR. Proc. Natl. Acad. Sci. U. S. A 2002, 99, 16742&#x2013;16747.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC139214</ArticleId><ArticleId IdType="pubmed">12481027</ArticleId></ArticleIdList></Reference><Reference><Citation>Petkova AT; Yau WM; Tycko R Experimental Constraints on Quaternary Structure in Alzheimer&#x2019;s beta-amyloid Fibrils. Biochemistry 2006, 45, 498&#x2013;512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1435828</ArticleId><ArticleId IdType="pubmed">16401079</ArticleId></ArticleIdList></Reference><Reference><Citation>Paravastu AK; Leapman RD; Yau WM; Tycko R Molecular Structural Basis for Polymorphism in Alzheimer&#x2019;s beta-amyloid Fibrils. Proc. Natl. Acad. Sci. U. S. A 2008, 105, 18349&#x2013;18354.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2587602</ArticleId><ArticleId IdType="pubmed">19015532</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R; Hu X; Khant H; Ludtke SJ; Chiu W; Schmid MF; Frieden C; Lee JM Interprotofilament Interactions between Alzheimer&#x2019;s Abeta1&#x2013;42 Peptides in Amyloid Fibrils Revealed by CryoEM. Proc. Natl. Acad. Sci. U. S. A 2009, 106, 4653&#x2013;4658.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2660777</ArticleId><ArticleId IdType="pubmed">19264960</ArticleId></ArticleIdList></Reference><Reference><Citation>W&#xe4;lti MA; Ravotti F; Arai H; Glabe CG; Wall JS; B&#xf6;ckmann A; G&#xfc;ntert P; Meier BH; Riek R Atomic-resolution Structure of a Disease-relevant A&#x3b2;(1&#x2013;42) Amyloid Fibril. Proc. Natl. Acad. Sci. U. S. A 2016, 113, E4976&#x2013;E4984.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5003276</ArticleId><ArticleId IdType="pubmed">27469165</ArticleId></ArticleIdList></Reference><Reference><Citation>Petkova AT; Leapman RD; Guo Z; Yau WM; Mattson MP; Tycko R Self-propagating, Molecular-level Polymorphism in Alzheimer&#x2019;s beta-amyloid Fibrils. Science 2005, 307, 262&#x2013;265.</Citation><ArticleIdList><ArticleId IdType="pubmed">15653506</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu JX; Qiang W; Yau WM; Schwieters CD; Meredith SC; Tycko R Molecular Structure of &#x3b2;-amyloid Fibrils in Alzheimer&#x2019;s Disease Brain Tissue. Cell 2013, 154, 1257&#x2013;1268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3814033</ArticleId><ArticleId IdType="pubmed">24034249</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiang W; Yau WM; Lu JX; Collinge J; Tycko R Structural Variation in Amyloid-&#x3b2; Fibrils from Alzheimer&#x2019;s Disease Clinical Subtypes. Nature 2017, 541, 217&#x2013;221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5233555</ArticleId><ArticleId IdType="pubmed">28052060</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen ML; Kim C; Haldiman T; ElHag M; Mehndiratta P; Pichet T; Lissemore F; Shea M; Cohen Y; Chen W; et al. Rapidly Progressive Alzheimer&#x2019;s Disease Features Distinct Structures of Amyloid-&#x3b2;. Brain 2015, 138, 1009&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5014074</ArticleId><ArticleId IdType="pubmed">25688081</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedrood S; Li Y; Isas JM; Hegde BG; Baxa U; Haworth IS; Langen R Fibril Structure of Human Islet Amyloid Polypeptide. J. Biol. Chem 2012, 287, 5235&#x2013;5241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3285303</ArticleId><ArticleId IdType="pubmed">22187437</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;der C; Kupreichyk T; Gremer L; Sch&#xe4;fer LU; Pothula KR; Ravelli RBG; Willbold D; Hoyer W; Schr&#xf6;der GF Cryo-EM Structure of Islet Amyloid Polypeptide Fibrils Reveals Similarities with Amyloid-&#x3b2; Fibrils. Nat. Struct. Mol. Biol 2020, 27, 660&#x2013;667.</Citation><ArticleIdList><ArticleId IdType="pubmed">32541895</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLano WL PyMOL; DeLano Scientific: San Carlos, CA, 2002; p 700.</Citation></Reference><Reference><Citation>Roche J; Shen Y; Lee JH; Ying J; Bax A Monomeric A&#x3b2;1&#x2013;40 and A&#x3b2;1&#x2013;42 Peptides in Solution Adopt Very Similar Ramachandran Map Distributions That Closely Resemble Random Coil. Biochemistry 2016, 55, 762&#x2013;775.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4750080</ArticleId><ArticleId IdType="pubmed">26780756</ArticleId></ArticleIdList></Reference><Reference><Citation>Coles M; Bicknell W; Watson RA; Fairlie DP; Craik DJ Solution Structure of Amyloid &#x3b2;-Peptide(1&#x2013;40) in a Water-Micelle Environment. Is the Membrane-Spanning Domain Where We Think It Is? Biochemistry 1998, 37, 11064&#x2013;11077.</Citation><ArticleIdList><ArticleId IdType="pubmed">9693002</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson AA; Fairlie DP; Craik DJ Solution Structure of Methionine-Oxidized Amyloid &#x3b2;-Peptide (1&#x2013;40). Does Oxidation Affect Conformational Switching? Biochemistry 1998, 37, 12700&#x2013;12706.</Citation><ArticleIdList><ArticleId IdType="pubmed">9737846</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivekanandan S; Brender JR; Lee SY; Ramamoorthy A A Partially Folded Structure of Amyloid-Beta(1&#x2013;40) in an Aqueous Environment. Biochem. Biophys. Res. Commun 2011, 411, 312&#x2013;316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3148408</ArticleId><ArticleId IdType="pubmed">21726530</ArticleId></ArticleIdList></Reference><Reference><Citation>Bossis F; Palese LL Amyloid Beta(1&#x2013;42) in Aqueous Environments: Effects of Ionic Strength and E22Q (Dutch) Mutation. Biochim. Biophys. Acta, Proteins Proteomics 2013, 1834, 2486&#x2013;2493.</Citation><ArticleIdList><ArticleId IdType="pubmed">24016775</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyung SJ; Detoma AS; Brender JR; Lee S; Vivekanandan S; Kochi A; Choi JS; Ramamoorthy A; Ruotolo BT; Lim MH Insights into Antiamyloidogenic Properties of the Green Tea Extract (&#x2212;)-Epigallocatechin-3-Gallate toward Metal-Associated Amyloid-&#x3b2; Species. Proc. Natl. Acad. Sci. U. S. A 2013, 110, 3743&#x2013;3748.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3593904</ArticleId><ArticleId IdType="pubmed">23426629</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreutzer AG; Nowick JS Elucidating the Structures of Amyloid Oligomers with Macrocyclic &#x3b2;-Hairpin Peptides: Insights into Alzheimer&#x2019;s Disease and Other Amyloid Diseases. Acc. Chem. Res 2018, 51, 706&#x2013;718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5911177</ArticleId><ArticleId IdType="pubmed">29508987</ArticleId></ArticleIdList></Reference><Reference><Citation>Pham JD; Spencer RK; Chen KH; Nowick JS A Fibril-like Assembly of Oligomers of a Peptide Derived from &#x3b2;-Amyloid. J. Am. Chem. Soc 2014, 136, 12682&#x2013;12690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4183627</ArticleId><ArticleId IdType="pubmed">25068693</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahoo BR; Genjo T; Bekier M; Cox SJ; Stoddard AK; Ivanova M; Yasuhara K; Fierke CA; Wang Y; Ramamoorthy A Alzheimer&#x2019;s Amyloid-Beta Intermediates Generated Using Polymer-Nanodiscs. Chem. Commun 2018, 54, 12883&#x2013;12886.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6247814</ArticleId><ArticleId IdType="pubmed">30379172</ArticleId></ArticleIdList></Reference><Reference><Citation>Lashuel HA; Hartley D; Petre BM; Walz T; Lansbury PT Neurodegenerative Disease: Amyloid Pores from Pathogenic Mutations. Nature 2002, 418, 291.</Citation><ArticleIdList><ArticleId IdType="pubmed">12124613</ArticleId></ArticleIdList></Reference><Reference><Citation>Irie Y; Murakami K; Hanaki M; Hanaki Y; Suzuki T; Monobe Y; Takai T; Akagi KI; Kawase T; Hirose K; Irie K Synthetic Models of Quasi-Stable Amyloid B40 Oligomers with Significant Neurotoxicity. ACS Chem. Neurosci 2017, 8, 807&#x2013;816.</Citation><ArticleIdList><ArticleId IdType="pubmed">28026168</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsushima Y; Yanagita RC; Irie K Control of the Toxic Conformation of Amyloid B42 by Intramolecular Disulfide Bond Formation. Chem. Commun 2020, 56, 4118&#x2013;4121.</Citation><ArticleIdList><ArticleId IdType="pubmed">32163091</ArticleId></ArticleIdList></Reference><Reference><Citation>Irie Y; Hanaki M; Murakami K; Imamoto T; Furuta T; Kawabata T; Kawase T; Hirose K; Monobe Y; Akagi K; Ichi Yanagita RC; Irie K Synthesis and Biochemical Characterization of Quasi-Stable Trimer Models of Full-Length Amyloid B40 with a Toxic Conformation. Chem. Commun 2019, 55, 182&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">30519688</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotler SA; Brender JR; Vivekanandan S; Suzuki Y; Yamamoto K; Monette M; Krishnamoorthy J; Walsh P; Cauble M; Holl MMB; Marsh ENG; Ramamoorthy A High-Resolution NMR Characterization of Low Abundance Oligomers of Amyloid-&#x3b2; without Purification. Sci. Rep 2015, 5, 11811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4490348</ArticleId><ArticleId IdType="pubmed">26138908</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes CA; Robertson AJ; Louis JM; Anfinrud P; Bax A Observation of &#x3b2;-Amyloid Peptide Oligomerization by Pressure-Jump NMR Spectroscopy. J. Am. Chem. Soc 2019, 141, 13762&#x2013;13766.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9357264</ArticleId><ArticleId IdType="pubmed">31432672</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed R; Akcan M; Khondker A; Rheinst&#xe4;dter MC; Bozelli JC Jr; Epand RM; Huynh V; Wylie RG; Boulton S; Huang J; et al. Atomic Resolution Map of the Soluble Amyloid beta Assembly Toxic Surfaces. Chem. Sci 2019, 10, 6072&#x2013;6082.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6585597</ArticleId><ArticleId IdType="pubmed">31360412</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorosh L; Stepanova M Probing Oligomerization of Amyloid Beta Peptide in Silico. Mol. BioSyst 2017, 13, 165&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pubmed">27844078</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldassarre M; Baronio CM; Morozova-Roche LA; Barth A Amyloid &#x3b2;-Peptides 1&#x2013;40 and 1&#x2013;42 Form Oligomers with Mixed &#x3b2;-Sheets. Chem. Sci 2017, 8, 8247&#x2013;8254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5857929</ArticleId><ArticleId IdType="pubmed">29568473</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahoo BR; Bekier ME; Liu Z; Kocman V; Stoddard AK; Anantharamaiah GM; Nowick J; Fierke CA; Wang Y; Ramamoorthy A Structural Interaction of Apolipoprotein A-I Mimetic Peptide with Amyloid-&#x3b2; Generates Toxic Hetero-Oligomers. J. Mol. Biol 2020, 432, 1020&#x2013;1034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7054163</ArticleId><ArticleId IdType="pubmed">31866295</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahoo BR; Genjo T; Cox SJ; Stoddard AK; Anantharamaiah GM; Fierke C; Ramamoorthy A Nanodisc-Forming Scaffold Protein Promoted Retardation of Amyloid-Beta Aggregation. J. Mol. Biol 2018, 430, 4230&#x2013;4244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6186505</ArticleId><ArticleId IdType="pubmed">30170005</ArticleId></ArticleIdList></Reference><Reference><Citation>Younan ND; Sarell CJ; Davies P; Brown DR; Viles JH The Cellular Prion Protein Traps Alzheimer&#x2019;s A&#x3b2; in an Oligomeric Form and Disassembles Amyloid Fibers. FASEB J 2013, 27, 1847&#x2013;1858.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3767752</ArticleId><ArticleId IdType="pubmed">23335053</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahoo BR; Cox SJ; Ramamoorthy A High-Resolution Probing of Early Events in Amyloid-&#x3b2; Aggregation Related to Alzheimer&#x2019;s Disease. Chem. Commun (Cambridge, U. K.) 2020, 56, 4627&#x2013;4639.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7254607</ArticleId><ArticleId IdType="pubmed">32300761</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson JA; Miranker AD Direct Detection of Transient &#x3b1;-Helical States in Islet Amyloid Polypeptide. Protein Sci 2007, 16, 110&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2222845</ArticleId><ArticleId IdType="pubmed">17123962</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel HR; Pithadia AS; Brender JR; Fierke CA; Ramamoorthy A In Search of Aggregation Pathways of IAPP and Other Amyloidogenic Proteins: Finding Answers through NMR Spectroscopy. J. Phys. Chem. Lett 2014, 5, 1864&#x2013;1870.</Citation><ArticleIdList><ArticleId IdType="pubmed">26273866</ArticleId></ArticleIdList></Reference><Reference><Citation>Nanga RPR; Brender JR; Vivekanandan S; Ramamoorthy A Structure and Membrane Orientation of IAPP in Its Natively Amidated Form at Physiological pH in a Membrane Environment. Biochim. Biophys. Acta, Biomembr 2011, 1808, 2337&#x2013;2342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3156962</ArticleId><ArticleId IdType="pubmed">21723249</ArticleId></ArticleIdList></Reference><Reference><Citation>Nanga RPR; Brender JR; Xu J; Veglia G; Ramamoorthy A Structures of Rat and Human Islet Amyloid Polypeptide IAPP1&#x2013;19 in Micelles by NMR Spectroscopy. Biochemistry 2008, 47, 12689&#x2013;12697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2953382</ArticleId><ArticleId IdType="pubmed">18989932</ArticleId></ArticleIdList></Reference><Reference><Citation>Nanga RPR; Brender JR; Xu J; Hartman K; Subramanian V; Ramamoorthy A Three-Dimensional Structure and Orientation of Rat Islet Amyloid Polypeptide Protein in a Membrane Environment by Solution NMR Spectroscopy. J. Am. Chem. Soc 2009, 131, 8252&#x2013;8261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4163022</ArticleId><ArticleId IdType="pubmed">19456151</ArticleId></ArticleIdList></Reference><Reference><Citation>Abedini A; Plesner A; Cao P; Ridgway Z; Zhang J; Tu LH; Middleton CT; Chao B; Sartori DJ; Meng F; et al. Time-Resolved Studies Define the Nature of Toxic IAPP Intermediates, Providing Insight for Anti-Amyloidosis Therapeutics. eLife 2016, 5, No. e12977.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4940161</ArticleId><ArticleId IdType="pubmed">27213520</ArticleId></ArticleIdList></Reference><Reference><Citation>Young LM; Cao P; Raleigh DP; Ashcroft AE; Radford SE Ion Mobility Spectrometry-Mass Spectrometry Defines the Oligomeric Intermediates in Amylin Amyloid Formation and the Mode of Action of Inhibitors. J. Am. Chem. Soc 2014, 136, 660&#x2013;670.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3928500</ArticleId><ArticleId IdType="pubmed">24372466</ArticleId></ArticleIdList></Reference><Reference><Citation>Bram Y; Frydman-Marom A; Yanai I; Gilead S; Shaltiel-Karyo R; Amdursky N; Gazit E Apoptosis Induced by Islet Amyloid Polypeptide Soluble Oligomers Is Neutralized by Diabetes-Associated Specific Antibodies. Sci. Rep 2014, 4, 1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3940978</ArticleId><ArticleId IdType="pubmed">24589570</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez Camargo DC; Korshavn KJ; Jussupow A; Raltchev K; Goricanec D; Fleisch M; Sarkar R; Xue K; Aichler M; Mettenleiter G; et al. Stabilization and Structural Analysis of a Membrane-Associated HIAPP Aggregation Intermediate. eLife 2017, 6, No. e31226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5706959</ArticleId><ArticleId IdType="pubmed">29148426</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez Camargo DC; Tripsianes K; Buday K; Franko A; G&#xf6;bl C; Hartlm&#xfc;ller C; Sarkar R; Aichler M; Mettenleiter G; Schulz M; et al. The Redox Environment Triggers Conformational Changes and Aggregation of HIAPP in Type II Diabetes. Sci. Rep 2017, 7, 44041.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5347123</ArticleId><ArticleId IdType="pubmed">28287098</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchanan LE; Dunkelberger EB; Tran HQ; Cheng PN; Chiu CC; Cao P; Raleigh DP; De Pablo JJ; Nowick JS; Zanni MT Mechanism of IAPP Amyloid Fibril Formation Involves an Intermediate with a Transient &#x3b2;-Sheet. Proc. Natl. Acad. Sci. U. S. A 2013, 110, 19285&#x2013;19290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3845187</ArticleId><ArticleId IdType="pubmed">24218609</ArticleId></ArticleIdList></Reference><Reference><Citation>Brender JR; Krishnamoorthy J; Sciacca MFM; Vivekanandan S; D&#x2019;Urso L; Chen J; La Rosa C; Ramamoorthy A Probing the Sources of the Apparent Irreproducibility of Amyloid Formation: Drastic Changes in Kinetics and a Switch in Mechanism Due to Micellelike Oligomer Formation at Critical Concentrations of IAPP. J. Phys. Chem. B 2015, 119, 2886&#x2013;2896.</Citation><ArticleIdList><ArticleId IdType="pubmed">25645610</ArticleId></ArticleIdList></Reference><Reference><Citation>Akter R; Cao P; Noor H; Ridgway Z; Tu LH; Wang H; Wong AG; Zhang X; Abedini A; Schmidt AM; Raleigh DP Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology. J. Diabetes Res 2016, 2016, 2798269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4662979</ArticleId><ArticleId IdType="pubmed">26649319</ArticleId></ArticleIdList></Reference><Reference><Citation>Pithadia A; Brender JR; Fierke CA; Ramamoorthy A Inhibition of IAPP Aggregation and Toxicity by Natural Products and Derivatives. J. Diabetes Res 2016, 2016, 2046327.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4662995</ArticleId><ArticleId IdType="pubmed">26649317</ArticleId></ArticleIdList></Reference><Reference><Citation>Khemtemourian L; Gazit E; Miranker A Recent Insight in Islet Amyloid Polypeptide Morphology, Structure, Membrane Interaction, and Toxicity in Type 2 Diabetes. J. Diabetes Res 2016, 2016, 2535878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4685125</ArticleId><ArticleId IdType="pubmed">26770986</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L; Kurouski D Structural Characterization of Individual &#x3b1;-Synuclein Oligomers Formed at Different Stages of Protein Aggregation by Atomic Force Microscopy-Infrared Spectroscopy. Anal. Chem 2020, 92, 6806&#x2013;6810.</Citation><ArticleIdList><ArticleId IdType="pubmed">32347706</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen SW; Drakulic S; Deas E; Ouberai M; Aprile FA; Arranz R; Ness S; Roodveldt C; Guilliams T; De-Genst EJ; et al. Structural Characterization of Toxic Oligomers That Are Kinetically Trapped during &#x3b1;-Synuclein Fibril Formation. Proc. Natl. Acad. Sci. U. S. A 2015, 112, E1994&#x2013;E2003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4413268</ArticleId><ArticleId IdType="pubmed">25855634</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X; Dong C; Hoffmann M; Garen CR; Cortez LM; Petersen NO; Woodside MT Early Stages of Aggregation of Engineered &#x3b1;-Synuclein Monomers and Oligomers in Solution. Sci. Rep 2019, 9, 1734.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6370846</ArticleId><ArticleId IdType="pubmed">30741954</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhak G; Lee S; Kim TH; Lee JH; Yang JE; Joo K; Lee J; Char K; Paik SR Morphological Evaluation of Meta-Stable Oligomers of &#x3b1;-Synuclein with Small-Angle Neutron Scattering. Sci. Rep 2018, 8, 14295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6155208</ArticleId><ArticleId IdType="pubmed">30250173</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JE; Sang JC; Rodrigues M; Carr AR; Horrocks MH; De S; Bongiovanni MN; Flagmeier P; Dobson CM; Wales DJ; et al. Mapping Surface Hydrophobicity of &#x3b1;-Synuclein Oligomers at the Nanoscale. Nano Lett 2018, 18, 7494&#x2013;7501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6295917</ArticleId><ArticleId IdType="pubmed">30380895</ArticleId></ArticleIdList></Reference><Reference><Citation>Candreva J; Chau E; Rice ME; Kim JR Interactions between Soluble Species of &#x3b2;-Amyloid and &#x3b1;-Synuclein Promote Oligomerization While Inhibiting Fibrillization. Biochemistry 2020, 59, 425&#x2013;435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7269195</ArticleId><ArticleId IdType="pubmed">31854188</ArticleId></ArticleIdList></Reference><Reference><Citation>Favretto F; Baker JD; Stroh&#xe4;ker T; Andreas LB; Blair LJ; Becker S; Zweckstetter M The Molecular Basis of the Interaction of Cyclophilin A with &#x3b1;-Synuclein. Angew. Chem., Int. Ed 2020, 59, 5643&#x2013;5646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7085457</ArticleId><ArticleId IdType="pubmed">31830361</ArticleId></ArticleIdList></Reference><Reference><Citation>Fusco G; De Simone A; Gopinath T; Vostrikov V; Vendruscolo M; Dobson CM; Veglia G Direct Observation of the Three Regions in &#x3b1;-Synuclein That Determine Its Membrane-Bound Behaviour. Nat. Commun 2014, 5, 3827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4046108</ArticleId><ArticleId IdType="pubmed">24871041</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H; Braak E Neuropathological Stageing of Alzheimer-Related Changes. Acta Neuropathol 1991, 82, 239&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">1759558</ArticleId></ArticleIdList></Reference><Reference><Citation>Ercan-Herbst E; Ehrig J; Sch&#xf6;ndorf DC; Behrendt A; Klaus B; Gomez Ramos B; Prat Oriol N; Weber C; Ehrnhoefer DE A Post-Translational Modification Signature Defines Changes in Soluble Tau Correlating with Oligomerization in Early Stage Alzheimer&#x2019;s Disease Brain. Acta Neuropathol. Commun 2019, 7, 192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6892178</ArticleId><ArticleId IdType="pubmed">31796124</ArticleId></ArticleIdList></Reference><Reference><Citation>Karikari TK; Nagel DA; Grainger A; Clarke-Bland C; Hill EJ; Moffat KG Preparation of Stable Tau Oligomers for Cellular and Biochemical Studies. Anal. Biochem 2019, 566, 67&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6331036</ArticleId><ArticleId IdType="pubmed">30315761</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasagna-Reeves CA; Castillo-Carranza DL; Guerrero-Mu&#xf1;oz MJ; Jackson GR; Kayed R Preparation and Characterization of Neurotoxic Tau Oligomers. Biochemistry 2010, 49, 10039&#x2013;10041.</Citation><ArticleIdList><ArticleId IdType="pubmed">21047142</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasari AKR; Kayed R; Wi S; Lim KH Tau Interacts with the C-Terminal Region of &#x3b1;-Synuclein, Promoting Formation of Toxic Aggregates with Distinct Molecular Conformations. Biochemistry 2019, 58, 2814&#x2013;2821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6754703</ArticleId><ArticleId IdType="pubmed">31132261</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo JAA; Liu T; Fang CC; Casta&#xf1;o MA; Kee T; Yrigoin K; Yan Y; Cazzaro S; Matlack J; Wang X; et al. &#x3b2;-Arrestin2 Oligomers Impair the Clearance of Pathological Tau and Increase Tau Aggregates. Proc. Natl. Acad. Sci. U. S. A 2020, 117, 5006&#x2013;5015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7060747</ArticleId><ArticleId IdType="pubmed">32071246</ArticleId></ArticleIdList></Reference><Reference><Citation>Oroz J; Chang BJ; Wysoczanski P; Lee CT; P&#xe9;rez-Lara &#xc1;; Chakraborty P; Hofele RV; Baker JD; Blair LJ; Biernat J; et al. Structure and Pro-Toxic Mechanism of the Human Hsp90/PPIase/Tau Complex. Nat. Commun 2018, 9, 4532.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6208366</ArticleId><ArticleId IdType="pubmed">30382094</ArticleId></ArticleIdList></Reference><Reference><Citation>Skachokova Z; Martinisi A; Flach M; Sprenger F; Naegelin Y; Steiner-Monard V; Sollberger M; Monsch AU; Goedert M; Tolnay M; et al. Cerebrospinal Fluid from Alzheimer&#x2019;s Disease Patients Promotes Tau Aggregation in Transgenic Mice. Acta Neuropathol. Commun 2019, 7, 72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6503541</ArticleId><ArticleId IdType="pubmed">31064413</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeda S; Takashima A Tau Oligomers. Adv. Exp. Med. Biol 2019, 1184, 373&#x2013;380.</Citation><ArticleIdList><ArticleId IdType="pubmed">32096050</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xf6;rnquist M; Michaels TCT; Sanagavarapu K; Yang X; Meisl G; Cohen SIA; Knowles TPJ; Linse S Secondary Nucleation in Amyloid Formation. Chem. Commun 2018, 54, 8667&#x2013;8684.</Citation><ArticleIdList><ArticleId IdType="pubmed">29978862</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellstrand E; Boland B; Walsh DM; Linse S Amyloid &#x3b2;-protein Aggregation Produces highly Reproducible Kinetic Data and Occurs by a Two-phase Process. ACS Chem. Neurosci 2010, 1, 13&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3368626</ArticleId><ArticleId IdType="pubmed">22778803</ArticleId></ArticleIdList></Reference><Reference><Citation>Jan A; Hartley DM; Lashuel HA Preparation and Characterization of Toxic Abeta Aggregates for Structural and Functional Studies in Alzheimer&#x2019;s Disease Research. Nat. Protoc 2010, 5, 1186&#x2013;1209.</Citation><ArticleIdList><ArticleId IdType="pubmed">20539293</ArticleId></ArticleIdList></Reference><Reference><Citation>Marvian AT; Koss DJ; Aliakbari F; Morshedi D; Outeiro TF In vitro Models of Synucleinopathies: Informing on Molecular mechanisms and protective strategies. J. Neurochem 2019, 150, 535&#x2013;565.</Citation><ArticleIdList><ArticleId IdType="pubmed">31004503</ArticleId></ArticleIdList></Reference><Reference><Citation>Weibull MGM; Simonsen S; Oksbjerg CR; Tiwari MK; Hemmingsen L Effects of Cu(II) on the Aggregation of Amyloid-&#x3b2;. JBIC, J. Biol. Inorg. Chem 2019, 24, 1197&#x2013;1215.</Citation><ArticleIdList><ArticleId IdType="pubmed">31602542</ArticleId></ArticleIdList></Reference><Reference><Citation>Doig AJ; Del Castillo-Frias MP; Berthoumieu O; Tarus B; Nasica-Labouze J; Sterpone F; Nguyen PH; Hooper NM; Faller P; Derreumaux P Why Is Research on Amyloid-&#x3b2; Failing to Give New Drugs for Alzheimer&#x2019;s Disease? ACS Chem. Neurosci 2017, 8, 1435&#x2013;1437.</Citation><ArticleIdList><ArticleId IdType="pubmed">28586203</ArticleId></ArticleIdList></Reference><Reference><Citation>Alder BJ; Wainwright TE Studies in Molecular Dynamics.1. General Method. J. Chem. Phys 1959, 31, 459&#x2013;466.</Citation></Reference><Reference><Citation>Smith AV; Hall CK Alpha-helix Formation: Discontinuous Molecular Dynamics on an Intermediate-resolution Protein Model. Proteins: Struct., Funct., Genet 2001, 44, 344&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pubmed">11455608</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith AV; Hall CK Assembly of a Tetrameric Alpha-helical Bundle: Computer Simulations on an Intermediate-resolution Protein Model. Proteins: Struct., Funct., Genet 2001, 44, 376&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pubmed">11455611</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith AV; Hall CK Protein Refolding versus Aggregation: Computer Simulations on an Intermediate-resolution Protein Model. J. Mol. Biol 2001, 312, 187&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">11545596</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HD; Hall CK Molecular Dynamics Simulations of Spontaneous Fibril Formation by Random-coil Peptides. Proc. Natl. Acad. Sci. U. S. A 2004, 101, 16180&#x2013;16185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC526199</ArticleId><ArticleId IdType="pubmed">15534217</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HD; Hall CK Spontaneous Fibril Formation by Polyalanines; Discontinuous Molecular Dynamics Simulations. J. Am. Chem. Soc 2006, 128, 1890&#x2013;1901.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3215763</ArticleId><ArticleId IdType="pubmed">16464090</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheon M; Chang I; Hall CK Extending the PRIME Model for Protein Aggregation to all 20 Amino Acids. Proteins: Struct., Funct., Genet 2010, 78, 2950&#x2013;2960.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2945877</ArticleId><ArticleId IdType="pubmed">20740494</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y; Shao Q; Hall CK N-terminal Prion Protein Peptides (PrP(120&#x2013;144)) Form Parallel In-register &#x3b2;-Sheets via Multiple Nucleation-dependent Pathways. J. Biol. Chem 2016, 291, 22093&#x2013;22105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5063992</ArticleId><ArticleId IdType="pubmed">27576687</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheon M; Chang I; Hall CK Spontaneous Formation of Twisted A beta(16&#x2013;22) Fibrils in Large-Scale Molecular-Dynamics Simulations. Biophys. J 2011, 101, 2493&#x2013;2501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3218340</ArticleId><ArticleId IdType="pubmed">22098748</ArticleId></ArticleIdList></Reference><Reference><Citation>Latshaw DC; Cheon M; Hall CK Effects of Macromolecular Crowding on Amyloid Beta (16&#x2013;22) Aggregation Using Coarse-Grained Simulations. J. Phys. Chem. B 2014, 118, 13513&#x2013;13526.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4254002</ArticleId><ArticleId IdType="pubmed">25347801</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagoner VA; Cheon M; Chang I; Hall CK Fibrillization Propensity for Short Designed Hexapeptides Predicted by Computer Simulation. J. Mol. Biol 2012, 416, 598&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3288580</ArticleId><ArticleId IdType="pubmed">22227390</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Paz ML; Serrano L Sequence Determinants of Amyloid Fibril Formation. Proc. Natl. Acad. Sci. U. S. A 2004, 101, 87&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC314143</ArticleId><ArticleId IdType="pubmed">14691246</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheon M; Chang I; Hall CK Influence of Temperature on Formation of Perfect Tau Fragment Fibrils using PRIME20/DMD Simulations. Protein Sci 2012, 21, 1514&#x2013;1527.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3526993</ArticleId><ArticleId IdType="pubmed">22887126</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y; Latshaw DC; Hall CK Aggregation of A&#x3b2;(17&#x2013;36) in the Presence of Naturally Occurring Phenolic Inhibitors Using Coarse-Grained Simulations. J. Mol. Biol 2017, 429, 3893&#x2013;3908.</Citation><ArticleIdList><ArticleId IdType="pubmed">29031698</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheon M; Hall CK; Chang I Structural Conversion of Abeta(17&#x2013;42) Peptides from Disordered Oligomers to U-Shape Protofilaments via Multiple Kinetic Pathways. PLoS Comput. Biol 2015, 11, No. e1004258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4425657</ArticleId><ArticleId IdType="pubmed">25955249</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunce SJ; Wang Y; Stewart KL; Ashcroft AE; Radford SE; Hall CK; Wilson AJ Molecular Insights into the Surface Catalysed Secondary Nucleation of amyloid-&#x3b2; (A&#x3b2;40) by the Peptide Fragment A&#x3b2;16&#x2013;22. Sci. Adv 2019, 5, No. eaav8216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6588359</ArticleId><ArticleId IdType="pubmed">31245536</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao Q; Wong KM; Seroski DT; Wang Y; Liu R; Paravastu AK; Hudalla GA; Hall CK Anatomy of a Selectively Coassembled &#x3b2;-sheet Peptide Nanofiber. Proc. Natl. Acad. Sci. U. S. A 2020, 117, 4710&#x2013;4717.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7060663</ArticleId><ArticleId IdType="pubmed">32071201</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xe1;cha R; Frenkel D Relation between Molecular Shape and the Morphology of Self-assembling Aggregates: a Simulation Study. Biophys. J 2011, 101, 1432&#x2013;1439.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3177051</ArticleId><ArticleId IdType="pubmed">21943424</ArticleId></ArticleIdList></Reference><Reference><Citation>Li MS; Klimov DK; Straub JE; Thirumalai D Probing the Mechanisms of Fibril Formation using Lattice Models. J. Chem. Phys 2008, 129, 175101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2671665</ArticleId><ArticleId IdType="pubmed">19045373</ArticleId></ArticleIdList></Reference><Reference><Citation>Abeln S; Frenkel D Accounting for Protein-solvent Contacts Facilitates Design of Nonaggregating Lattice Proteins. Biophys. J 2011, 100, 693&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3030183</ArticleId><ArticleId IdType="pubmed">21281584</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellesia G; Shea J-E Self-assembly of &#x3b2;-sheet Forming Peptides into Chiral Fibrillar Aggregates. J. Chem. Phys 2007, 126, 245104.</Citation><ArticleIdList><ArticleId IdType="pubmed">17614592</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas AV; Maisuradze GG; Scheraga HA Dependence of the Formation of Tau and A&#x3b2; Peptide Mixed Aggregates on the Secondary Structure of the N-terminal of A&#x3b2;. J. Phys. Chem. B 2018, 122, 7049&#x2013;7056.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6524542</ArticleId><ArticleId IdType="pubmed">29940109</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterpone F; Melchionna S; Tuffery P; Pasquali S; Mousseau N; Cragnolini T; Chebaro Y; St-Pierre JF; Kalimeri M; Barducci A; et al., The OPEP Protein Model: from Single Molecules, Amyloid Formation, Crowding and Hydrodynamics to DNA/RNA Systems. Chem. Soc. Rev 2014, 43, 4871&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4426487</ArticleId><ArticleId IdType="pubmed">24759934</ArticleId></ArticleIdList></Reference><Reference><Citation>Santini S; Wei G; Mousseau N; Derreumaux P Pathway Complexity of Alzheimer&#x2019;s &#x3b2;-amyloid A&#x3b2;16&#x2013;22 Peptide Assembly. Structure 2004, 12, 1245&#x2013;1255.</Citation><ArticleIdList><ArticleId IdType="pubmed">15242601</ArticleId></ArticleIdList></Reference><Reference><Citation>Urbanc B; Borreguero JM; Cruz L; Stanley HE Ab initio Discrete Molecular Dynamics Approach to Protein Folding and Aggregation. Methods Enzymol 2006, 412, 314&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pubmed">17046666</ArticleId></ArticleIdList></Reference><Reference><Citation>Darr&#xe9; L; Machado MR; Brandner AF; Gonz&#xe1;lez HC; Ferreira S; Pantano S SIRAH: A Structurally Unbiased Coarse-grained Force Field for Proteins with Aqueous Solvation and Long-range Electrostatics. J. Chem. Theory Comput 2015, 11, 723&#x2013;739.</Citation><ArticleIdList><ArticleId IdType="pubmed">26575407</ArticleId></ArticleIdList></Reference><Reference><Citation>Morriss-Andrews A; Shea JE Simulations of Protein Aggregation: Insights from Atomistic and Coarse-grained Models. J. Phys. Chem. Lett 2014, 5, 1899&#x2013;1908.</Citation><ArticleIdList><ArticleId IdType="pubmed">26273871</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HD; Hall CK Phase Diagrams Describing Fibrillization by Polyalanine Peptides. Biophys. J 2004, 87, 4122&#x2013;4134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1304921</ArticleId><ArticleId IdType="pubmed">15465859</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranganathan S; Maji SK; Padinhateeri R Defining a Physical Basis for Diversity in Protein Self-Assemblies Using a Minimal Model. J. Am. Chem. Soc 2016, 138, 13911&#x2013;13922.</Citation><ArticleIdList><ArticleId IdType="pubmed">27690405</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni R; Abeln S; Schor M; Cohen Stuart MA; Bolhuis PG Interplay between Folding and Assembly of Fibril Forming Polypeptides. Phys. Rev. Lett 2013, 111, 058101.</Citation><ArticleIdList><ArticleId IdType="pubmed">23952447</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashchiev D; Auer S Nucleation of amyloid fibrils. J. Chem. Phys 2010, 132, 215101.</Citation><ArticleIdList><ArticleId IdType="pubmed">20528047</ArticleId></ArticleIdList></Reference><Reference><Citation>Auer S; Kashchiev D Phase Diagram of &#x3b1;-helical and &#x3b2;-sheet Forming Peptides. Phys. Rev. Lett 2010, 104, 168105.</Citation><ArticleIdList><ArticleId IdType="pubmed">20482086</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai XM; Li M Calculation of Solid-liquid Interfacial Free Energy: A Classical Nucleation Theory Based Approach. J. Chem. Phys 2006, 124, 124707.</Citation><ArticleIdList><ArticleId IdType="pubmed">16599718</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoang TX; Trovato A; Seno F; Banavar JR; Maritan A Geometry and Symmetry Presculpt the Free-energy Landscape of Proteins. Proc. Natl. Acad. Sci. U. S. A 2004, 101, 7960&#x2013;7964.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC419539</ArticleId><ArticleId IdType="pubmed">15148372</ArticleId></ArticleIdList></Reference><Reference><Citation>Auer S Phase Diagram of Polypeptide Chains. J. Chem. Phys 2011, 135, 175103.</Citation><ArticleIdList><ArticleId IdType="pubmed">22070325</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y; Bunce SJ; Radford SE; Wilson AJ; Auer S; Hall CK Thermodynamic Phase Diagram of Amyloid-&#x3b2; (16&#x2013;22) Peptide. Proc. Natl. Acad. Sci. U. S. A 2019, 116, 2091&#x2013;2096.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6369758</ArticleId><ArticleId IdType="pubmed">30674664</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirschner DA; Inouye H; Duffy LK; Sinclair A; Lind M; Selkoe DJ Synthetic Peptide Homologous to beta Protein from Alzheimer Disease Forms Amyloid-like Fibrils in vitro. Proc. Natl. Acad. Sci. U. S. A 1987, 84, 6953&#x2013;6957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC299203</ArticleId><ArticleId IdType="pubmed">3477820</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh MC; Liang C; Mehta AK; Lynn DG; Grover MA Multistep Conformation Selection in Amyloid Assembly. J. Am. Chem. Soc 2017, 139, 17007&#x2013;17010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5709775</ArticleId><ArticleId IdType="pubmed">29111722</ArticleId></ArticleIdList></Reference><Reference><Citation>Childers WS; Anthony NR; Mehta AK; Berland KM; Lynn DG Phase Networks of Cross-&#x3b2; Peptide Assemblies. Langmuir 2012, 28, 6386&#x2013;6395.</Citation><ArticleIdList><ArticleId IdType="pubmed">22439620</ArticleId></ArticleIdList></Reference><Reference><Citation>Petty SA; Decatur SM Experimental Evidence for the Reorganization of &#x3b2;-strands within Aggregates of the A&#x3b2;(16&#x2013;22) Peptide. J. Am. Chem. Soc 2005, 127, 13488&#x2013;13489.</Citation><ArticleIdList><ArticleId IdType="pubmed">16190699</ArticleId></ArticleIdList></Reference><Reference><Citation>Preston GW Analysis of Biomolecular Interactions using Photo-induced Covalent Cross-linking. PhD thesis, University of Leeds, 2012.</Citation><ArticleIdList><ArticleId IdType="pubmed">23396550</ArticleId></ArticleIdList></Reference><Reference><Citation>Balbach JJ; Ishii Y; Antzutkin ON; Leapman RD; Rizzo NW; Dyda F; Reed J; Tycko R Amyloid Fibril Formation by Abeta(16&#x2013;22), a seven-residue Fragment of the Alzheimer&#x2019;s beta-amyloid Peptide, and Structural Characterization by Solid state NMR. Biochemistry 2000, 39, 13748&#x2013;13759.</Citation><ArticleIdList><ArticleId IdType="pubmed">11076514</ArticleId></ArticleIdList></Reference><Reference><Citation>Senguen FT; Lee NR; Gu X; Ryan DM; Doran TM; Anderson EA; Nilsson BL Probing Aromatic, Hydrophobic, and Steric Effects on the Self-assembly of an Amyloid-&#x3b2; Fragment Peptide. Mol. BioSyst 2011, 7, 486&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pubmed">21060949</ArticleId></ArticleIdList></Reference><Reference><Citation>Auer S; Ricchiuto P; Kashchiev D Two-step Nucleation of Amyloid Fibrils: Omnipresent or Not? J. Mol. Biol 2012, 422, 723&#x2013;730.</Citation><ArticleIdList><ArticleId IdType="pubmed">22721952</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella AE; Dignon GL; Zerze GH; Schmidt HB; D&#x2019;Ordine AM; Kim YC; Rohatgi R; Ayala YM; Mittal J; Fawzi NL TDP-43 &#x3b1;-helical Structure Tunes Liquid-liquid Phase Separation and Function. Proc. Natl. Acad. Sci. U. S. A 2020, 117, 5883&#x2013;5894.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7084079</ArticleId><ArticleId IdType="pubmed">32132204</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi M; Noji M; So M; Sasahara K; Kardos J; Naiki H; Goto Y Aggregation Phase Diagram of &#x3b2;2 Microglobulin Reveal Temperature and Salt Effects on Competitive Formation of Amyloids versus Amorphous Aggregates. J. Biol. Chem 2018, 293, 14775&#x2013;14785.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6153281</ArticleId><ArticleId IdType="pubmed">30077972</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi M; So M; Sakurai K; Kardos J; Goto Y Supersaturation-Limited and Unlimited Phase Transitions Compete to Produce the Pathway Complexity in Amyloid Formation. J. Biol. Chem 2015, 290, 18134&#x2013;18145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4505058</ArticleId><ArticleId IdType="pubmed">26063798</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawada M; Yamaguchi K; Hirano M; Noji M; So M; Otzen DE; Kawata Y; Goto Y Amyloid Formation of &#x3b1;-synculein Based on the Solubility and Supersaturation Dependent Mechanism. Langmuir 2020, 36, 4671&#x2013;4681.</Citation><ArticleIdList><ArticleId IdType="pubmed">32271585</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C; Shea JE Coarse-Grained Models for Protein Aggregation. Curr. Opin. Struct. Biol 2011, 21, 209&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">21371882</ArticleId></ArticleIdList></Reference><Reference><Citation>Carballo-Pacheco M; Strodel B Advances in the Simulation of Protein Aggregation at the Atomistic Scale. J. Phys. Chem. B 2016, 120, 2991&#x2013;2999.</Citation><ArticleIdList><ArticleId IdType="pubmed">26965454</ArticleId></ArticleIdList></Reference><Reference><Citation>Saric A; Chebaro YC; Knowles TPJ; Frenkel D Crucial Role of Nonspecific Interactions in Amyloid Nucleation. Proc. Natl. Acad. Sci. U. S. A 2014, 111, 17869&#x2013;17874.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4273401</ArticleId><ArticleId IdType="pubmed">25453085</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiricotto M; Melchionna S; Derreumaux P; Sterpone F Multiscale Aggregation of the Amyloid A&#x3b2;16&#x2013;22 Peptide: From Disordered Coagulation and Lateral Branching to Amorphous Prefibrils. J. Phys. Chem. Lett 2019, 10, 1594&#x2013;1599.</Citation><ArticleIdList><ArticleId IdType="pubmed">30892042</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y; Tang X; Yuan M; Han W Computational Studies of Protein Aggregation Mediated by Amyloid: Fibril Elongation and Secondary Nucleation. Prog. Mol. Biol. Transl. Sci 2020, 170, 461&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pubmed">32145951</ArticleId></ArticleIdList></Reference><Reference><Citation>Serio TR; Cashikar AG; Kowal AS; Sawicki GJ; Moslehi JJ; Serpell L; Arnsdorf M; Lindquist SL Nucleated Conformational Conversion and the Replication of Conformational Information by a Prion Determinant. Science 2000, 289, 1317&#x2013;1321.</Citation><ArticleIdList><ArticleId IdType="pubmed">10958771</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J; Culyba EK; Powers ET; Kelly JW Amyloid-&#x3b2; Forms Fibrils by Nucleated Conformational Conversion of Oligomers. Nat. Chem. Biol 2011, 7, 602&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3158298</ArticleId><ArticleId IdType="pubmed">21804535</ArticleId></ArticleIdList></Reference><Reference><Citation>Michaels TCT; &#x106;ari&#x107; A; Curk S; Bernfur K; Arosio P; Meisl G; Dear AJ; Cohen SIA; Dobson CM; Vendruscolo M; et al. Dynamics of Oligomer Populations Formed during the Aggregation of Alzheimer&#x2019;s A&#x3b2;42 Peptide. Nat. Chem 2020, 12, 445&#x2013;451.</Citation><ArticleIdList><ArticleId IdType="pubmed">32284577</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellarin R; Schuetz P; Guarnera E; Caflisch A Amyloid Fibril Polymorphism is under Kinetic Control. J. Am. Chem. Soc 2010, 132, 14960&#x2013;14970.</Citation><ArticleIdList><ArticleId IdType="pubmed">20923147</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellesia G; Shea JE Effect of &#x3b2;-Sheet Propensity on Peptide Aggregation. J. Chem. Phys 2009, 130, 145103.</Citation><ArticleIdList><ArticleId IdType="pubmed">19368476</ArticleId></ArticleIdList></Reference><Reference><Citation>Straub JE; Thirumalai D Toward a Molecular Theory of Early and Late Events in Monomer to Amyloid Fibril Formation. Annu. Rev. Phys. Chem 2011, 62, 437&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">21219143</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran TT; Nguyen PH; Derreumaux P Lattice Model for Amyloid Peptides: OPEP Force Field Parametrization and Applications to the Nucleus Size of Alzheimer&#x2019;s Peptides. J. Chem. Phys 2016, 144, 205103.</Citation><ArticleIdList><ArticleId IdType="pubmed">27250331</ArticleId></ArticleIdList></Reference><Reference><Citation>Massi F; Straub J Energy Landscape Theory for Alzheimer&#x2019;s Amyloid &#x3b2;-Peptide Fibril Elongation. Proteins: Struct., Funct., Genet 2001, 42, 217&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">11119646</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown S; Fawzi NJ; Head-Gordon T Coarse-Grained Sequences for Protein Folding and Design. Proc. Natl. Acad. Sci. U. S. A 2003, 100, 10712&#x2013;10717.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC196869</ArticleId><ArticleId IdType="pubmed">12963815</ArticleId></ArticleIdList></Reference><Reference><Citation>Han W; Schulten K Fibril Elongation by A&#x3b2;(17&#x2013;42): Kinetic Network Analysis of Hybrid-Resolution Molecular Dynamics Simulations. J. Am. Chem. Soc 2014, 136, 12450&#x2013;12460.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4156860</ArticleId><ArticleId IdType="pubmed">25134066</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy G; Straub JE; Thirumalai D Dynamics of Locking of Peptides onto Growing Amyloid Fibrils. Proc. Natl. Acad. Sci. U. S. A 2009, 106, 11948&#x2013;11953.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2715474</ArticleId><ArticleId IdType="pubmed">19581575</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwierz N; Frost CV; Geissler PL; Zacharias M Dynamics of Seeded A&#x3b2;40-Fibril Growth from Atomistic Molecular Dynamics Simulations: Kinetic Trapping and Reduced Water Mobility in the Locking Step. J. Am. Chem. Soc 2016, 138, 527&#x2013;539.</Citation><ArticleIdList><ArticleId IdType="pubmed">26694883</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas AV; Liwo A; Scheraga HA Molecular Dynamics with the United-Residue Force Field: Ab Initio Folding Simulations of Multichain Proteins. J. Phys. Chem. B 2007, 111, 293&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2597722</ArticleId><ArticleId IdType="pubmed">17201452</ArticleId></ArticleIdList></Reference><Reference><Citation>Roder K; Wales DJ Energy Landscapes for the Aggregation of A&#x3b2;17&#x2013;42. J. Am. Chem. Soc 2018, 140, 4018&#x2013;4027.</Citation><ArticleIdList><ArticleId IdType="pubmed">29482324</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia Z; Schmit JD; Chen J Amyloid Assembly is Dominated by Misregistered Kinetic Traps on an Unbiased Energy Landscape. Proc. Natl. Acad. Sci. U. S. A 2020, 117, 10322&#x2013;10328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7229673</ArticleId><ArticleId IdType="pubmed">32345723</ArticleId></ArticleIdList></Reference><Reference><Citation>Saric A.&#x111;e.; Buell AK; Meisl G; Michaels TCT; Dobson CM; Linse S; Knowles TPJ; Frenkel D Physical Determinants of the Self-Replication of Protein Fibrils. Nat. Phys 2016, 12, 874.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6485595</ArticleId><ArticleId IdType="pubmed">31031819</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen SIA; Linse S; Luheshi LM; Hellstrand E; White DA; Rajah L; Otzen DE; Vendruscolo M; Dobson CM; Knowles TPJ Proliferation of Amyloid-&#x3b2;42 Aggregates Occurs through a Secondary Nucleation Mechanism. Proc. Natl. Acad. Sci. U. S. A 2013, 110, 9758&#x2013;9763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3683769</ArticleId><ArticleId IdType="pubmed">23703910</ArticleId></ArticleIdList></Reference><Reference><Citation>Ermak DL; McCammon JA Brownian Dynamics with Hydrodynamic Interactions. J. Chem. Phys 1978, 69, 1352.</Citation></Reference><Reference><Citation>Malevanets A; Kapral R Mesoscopic Model for Solvent Dynamics. J. Chem. Phys 1999, 110, 8605&#x2013;8613.</Citation></Reference><Reference><Citation>Ahlrichs P; D&#xfc;nweg B Simulation of a Single Polymer Chain in Solution by Combining Lattice Boltzmann and Molecular Dynamics. J. Chem. Phys 1999, 111, 8225&#x2013;8239.</Citation></Reference><Reference><Citation>Frembgen-Kesner T; Elcock AH Striking Effects of Hydrodynamic Interactions on the Simulated Diffusion and Folding of Proteins. J. Chem. Theory Comput 2009, 5, 242&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pubmed">26610102</ArticleId></ArticleIdList></Reference><Reference><Citation>Zegarra FC; Homouz D; Eliaz Y; Gasic AG; Cheung MS The Impact of Hydrodynamic Interactions on Protein Folding Rates Depends on Temperature. Phys. Rev. E: Stat. Phys., Plasmas, Fluids, Relat. Interdiscip. Top 2018, 97, 032402.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6080349</ArticleId><ArticleId IdType="pubmed">29776093</ArticleId></ArticleIdList></Reference><Reference><Citation>Ando T; Skolnick J Crowding and Hydrodynamic Interactions Likely Dominate In Vivo Macromolecular Motion. Proc. Natl. Acad. Sci. U. S. A 2010, 107, 18457&#x2013;18462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2973006</ArticleId><ArticleId IdType="pubmed">20937902</ArticleId></ArticleIdList></Reference><Reference><Citation>Ando T; Skolnick J On the Importance of Hydrodynamic Interactions in Lipid Membrane Formation. Biophys. J 2013, 104, 96&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3540244</ArticleId><ArticleId IdType="pubmed">23332062</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimm BH Dynamics of Polymer Molecules in Dilute Solution: Viscoelasticity, Flow Birefringence and Dielectric Loss. J. Chem. Phys 1956, 24, 269&#x2013;278.</Citation></Reference><Reference><Citation>Sterpone F; Derreumaux P; Melchionna S Protein Simulations in Fluids: Coupling the OPEP Coarse-Grained Force Field with Hydrodynamics. J. Chem. Theory Comput 2015, 11, 1843&#x2013;1853.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5242371</ArticleId><ArticleId IdType="pubmed">26574390</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiricotto M; Melchionna S; Derreumaux P; Sterpone F Hydrodynamic Effects on &#x3b2;-Amyloid (16&#x2013;22) Peptide Aggregation. J. Chem. Phys 2016, 145, 035102.</Citation><ArticleIdList><ArticleId IdType="pubmed">27448906</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill EK; Krebs B; Goodall DG; Howlett GJ; Dunstan DE Shear Flow Induces Amyloid Fibril Formation. Biomacromolecules 2006, 7, 10&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">16398490</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins SR; Douglass A; Vale RD; Weissman JS Mechanism of Prion Propagation: Amyloid Growth Occurs by Monomer Addition. PLoS Biol 2004, 2, No. e321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC517824</ArticleId><ArticleId IdType="pubmed">15383837</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekard IB; Dunstan DE Chapter 44 - The Effect of Shear Flow on Amyloid Fibril Formation and Morphology. Bio-nanoimaging. Protein Misfolding and Aggregation 2014, 503&#x2013;513.</Citation></Reference><Reference><Citation>Kinoshita M; Lin Y; Dai I; Okumura M; Markova N; Ladbury JE; Sterpone F; Lee Y-H Energy Landscape of Polymorphic Amyloid Generation of &#x3b2;2-Microglobulin Revealed by Calorimetry. Chem. Commun 2018, 54, 7995&#x2013;7998.</Citation><ArticleIdList><ArticleId IdType="pubmed">29967909</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaspe J; Hagen SJ Do Protein Molecules Unfold in a Simple Shear Flow? Biophys. J 2006, 91, 3415&#x2013;3424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1614479</ArticleId><ArticleId IdType="pubmed">16891374</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashton L; Dusting J; Imomoh E; Balabani S; Blanch EW Susceptibility of Different Proteins to Flow-Induced Conformational Changes Monitored with Raman Spectroscopy. Biophys. J 2010, 98, 707&#x2013;714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2820655</ArticleId><ArticleId IdType="pubmed">20159167</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterpone F; Derreumaux P; Melchionna S Molecular Mechanism of Protein Unfolding under Shear: A Lattice Boltzmann Molecular Dynamics Study. J. Phys. Chem. B 2018, 122, 1573&#x2013;1579.</Citation><ArticleIdList><ArticleId IdType="pubmed">29328657</ArticleId></ArticleIdList></Reference><Reference><Citation>Languin-Catto&#xeb;n O; Melchionna S; Derreumaux P; Stirnemann G; Sterpone F Three Weaknesses for Three Perturbations: Comparing Protein Unfolding Under Shear, Force, and Thermal Stresses. J. Phys. Chem. B 2018, 122, 11922&#x2013;11930.</Citation><ArticleIdList><ArticleId IdType="pubmed">30444631</ArticleId></ArticleIdList></Reference><Reference><Citation>Trumbore CN Shear-Induced Amyloid Formation of IDPs in the Brain. Prog. Mol. Biol. Transl. Sci 2019, 166, 225&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">31521233</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai J; Liu M; Pielak GJ; Li C Macromolecular and Small Molecular Crowding Have Similar Effects on &#x3b1;-Synuclein Structure. ChemPhysChem 2017, 18, 55&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">27860069</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee PR; Moosa MM; Deniz AA Two-Dimensional Crowding Uncovers a Hidden Conformation of &#x3b1;-Synuclein. Angew. Chem., Int. Ed 2016, 55, 12789&#x2013;12792.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5166577</ArticleId><ArticleId IdType="pubmed">27612332</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z; Fan JB; Zhu HL; Shewmaker F; Yan X; Chen X; Chen J; Xiao GF; Guo L; Liang Y Crowded Cell-like Environment Accelerates the Nucleation Step of Amyloidogenic Protein Misfolding. J. Biol. Chem 2009, 284, 30148&#x2013;30158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2781570</ArticleId><ArticleId IdType="pubmed">19748895</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteith WB; Cohen RD; Smith AE; Guzman-Cisneros E; Pielak GJ Quinary Structure Modulates Protein Stability in Cells. Proc. Natl. Acad. Sci. U. S. A 2015, 112, 1739&#x2013;1742.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4330749</ArticleId><ArticleId IdType="pubmed">25624496</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnutt D; Timr S; Ahlers J; Ko B; Manderfeld E; Heyden M; Sterpone F; Ebbinghaus S Stability Effect of Quinary Interactions Reversed by Single Point Mutations. J. Am. Chem. Soc 2019, 141, 4660&#x2013;4669.</Citation><ArticleIdList><ArticleId IdType="pubmed">30740972</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang L; Zetterstrom P; Brannstrom T; Marklund SL; Danielsson J; Oliveberg M SOD1 Aggregation in ALS Mice Shows Simplistic Test Tube Behavior. Proc. Natl. Acad. Sci. U. S. A 2015, 112, 9878&#x2013;9883.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4538623</ArticleId><ArticleId IdType="pubmed">26221023</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xfc;ning S; Sharma A; Vachharajani S; Newcombe E; Ormsby A; Gao M; Gnutt D; V&#xf6;pel T; Hatters DM; Ebbinghaus S Conformational Dynamics and Self-Association of Intrinsically Disordered Huntingtin Exon 1 in Cells. Phys. Chem. Chem. Phys 2017, 19, 10738&#x2013;10747.</Citation><ArticleIdList><ArticleId IdType="pubmed">28094373</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X; Mehler EL Simulation of Molecular Crowding Effects on an Alzheimer&#x2019;s &#x3b1;-Amyloid Peptide. Cell Biochem. Biophys 2006, 46, 123&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pubmed">17012754</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguemaha V; Qin S; Zhou HX Atomistic Modeling of Intrinsically Disordered Proteins Under Polyethylene Glycol Crowding: Quantitative Comparison with Experimental Data and Implication of Protein-Crowder Attraction. J. Phys. Chem. B 2018, 122, 11262&#x2013;11270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6447477</ArticleId><ArticleId IdType="pubmed">30230839</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagerberg E; Lenton S; Skep&#xf6; M Evaluating Models of Varying Complexity of Crowded Intrinsically Disordered Protein Solutions Against SAXS. J. Chem. Theory Comput 2019, 15, 6968&#x2013;6983.</Citation><ArticleIdList><ArticleId IdType="pubmed">31714774</ArticleId></ArticleIdList></Reference><Reference><Citation>Magno A; Caflisch A; Pellarin R Crowding Effects on Amyloid Aggregation Kinetics. J. Phys. Chem. Lett 2010, 1, 3027&#x2013;3032.</Citation></Reference><Reference><Citation>Timr S; Gnutt D; Ebbinghaus S; Sterpone F The Unfolding Journey of Superoxide Dismutase 1 Barrels under Crowding: Atomistic Simulations Shed Light on Intermediate States and Their Interactions with Crowders. J. Phys. Chem. Lett 2020, 11, 4206&#x2013;4212.</Citation><ArticleIdList><ArticleId IdType="pubmed">32364389</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber OC; Uversky VN How Accurate are your Simulations? Effects of Confined Aqueous Volume and AMBER FF99SB and CHARMM22/CMAP Force Field Parameters on Structural Ensembles of Intrinsically Disordered Proteins: Amyloid-&#x3b2;42 in water. Intrinsically Disord. Proteins 2017, 5, No. e1377813.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6149486</ArticleId><ArticleId IdType="pubmed">30250773</ArticleId></ArticleIdList></Reference><Reference><Citation>Carballo-Pacheco M; Strodel B Comparison of Force Fields for Alzheimer&#x2019;s: A Case Study for Intrinsically Disordered Proteins. Protein Sci 2017, 26, 174&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5275744</ArticleId><ArticleId IdType="pubmed">27727496</ArticleId></ArticleIdList></Reference><Reference><Citation>Krupa P; Huy PDQ; Li MS Properties of Monomeric A&#x3b2;42 Probed by Different Sampling Methods and Force Fields: Role of Energy Components. J. Chem. Phys 2019, 151, 055101.</Citation></Reference><Reference><Citation>Rosenman DJ; Wang C; Garc&#xed;a AE Characterization of A&#x3b2; Monomers through the Convergence of Ensemble Properties among Simulations with Multiple Force Fields. J. Phys. Chem. B 2016, 120, 259&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pubmed">26562747</ArticleId></ArticleIdList></Reference><Reference><Citation>Lincoff J; Sasmal S; Head-Gordon T The Combined Force Field-sampling Problem in Simulations of Disordered Amyloid-&#x3b2; Peptides. J. Chem. Phys 2019, 150, 104108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6417907</ArticleId><ArticleId IdType="pubmed">30876367</ArticleId></ArticleIdList></Reference><Reference><Citation>Linh NH; Minh Thu TT; Tu L; Hu C-K; Li MS Impact of Mutations at C-Terminus on Structures and Dynamics of A&#x3b2;40 and A&#x3b2;42: A Molecular Simulation Study. J. Phys. Chem. B 2017, 121, 4341&#x2013;4354.</Citation><ArticleIdList><ArticleId IdType="pubmed">28414234</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HL; Thi Minh Thu T; Truong PM; Lan PD; Man VH; Nguyen PH; Tu LA; Chen Y-C; Li MS A&#x3b2;41 Aggregates More Like A&#x3b2;40 than Like A&#x3b2;42: In Silico and in Vitro Study. J. Phys. Chem. B 2016, 120, 7371&#x2013;7379.</Citation><ArticleIdList><ArticleId IdType="pubmed">27388669</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y; Wang C A&#x3b2;42 is More Rigid than A&#x3b2;40 at the C Terminus: Implications for A&#x3b2; Aggregation and Toxicity. J. Mol. Biol 2006, 364, 853&#x2013;862.</Citation><ArticleIdList><ArticleId IdType="pubmed">17046788</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkitadze MD; Condron MM; Teplow DB Identification and Characterization of Key Kinetic Intermediates in amyloid &#x3b2;-protein Fibrillogenesis. J. Mol. Biol 2001, 312, 1103&#x2013;1119.</Citation><ArticleIdList><ArticleId IdType="pubmed">11580253</ArticleId></ArticleIdList></Reference><Reference><Citation>Roychaudhuri R; Yang M; Deshpande A; Cole GM; Frautschy S; Lomakin A; Benedek GB; Teplow DB C-Terminal Turn Stability Determines Assembly Differences between A&#x3b2;40 and A&#x3b2;42. J. Mol. Biol 2013, 425, 292&#x2013;308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3540122</ArticleId><ArticleId IdType="pubmed">23154165</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya S; Xu L; Thompson D Molecular Simulations Reveal Terminal Group Mediated Stabilization of Helical Conformers in Both Amyloid-&#x3b2;42 and &#x3b1;-Synuclein. ACS Chem. Neurosci 2019, 10, 2830&#x2013;2842.</Citation><ArticleIdList><ArticleId IdType="pubmed">30917651</ArticleId></ArticleIdList></Reference><Reference><Citation>Shea D; Hsu C-C; Bi TM; Paranjapye N; Childers MC; Cochran J; Tomberlin CP; Wang L; Paris D; Zonderman J; et al. &#x3b1;-Sheet Secondary Structure in amyloid &#x3b2;-peptide Drives Aggregation and Toxicity in Alzheimer&#x2019;s Disease. Proc. Natl. Acad. Sci. U. S. A 2019, 116, 8895&#x2013;8900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6500163</ArticleId><ArticleId IdType="pubmed">31004062</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng F; Bellaiche MMJ; Kim J-Y; Zerze GH; Best RB; Chung HS Highly Disordered Amyloid-&#x3b2; Monomer Probed by Single-Molecule FRET and MD Simulation. Biophys. J 2018, 114, 870&#x2013;884.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5984999</ArticleId><ArticleId IdType="pubmed">29490247</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuler B; Soranno A; Hofmann H; Nettels D Single-Molecule FRET Spectroscopy and the Polymer Physics of Unfolded and Intrinsically Disordered Proteins. Annu. Rev. Biophys 2016, 45, 207&#x2013;231.</Citation><ArticleIdList><ArticleId IdType="pubmed">27145874</ArticleId></ArticleIdList></Reference><Reference><Citation>Granata D; Baftizadeh F; Habchi J; Galvagnion C; De Simone A; Camilloni C; Laio A; Vendruscolo M The Inverted Free Energy Landscape of an Intrinsically Disordered Peptide by Simulations and Experiments. Sci. Rep 2015, 5, 15449.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4620491</ArticleId><ArticleId IdType="pubmed">26498066</ArticleId></ArticleIdList></Reference><Reference><Citation>Li MS; Co NT; Reddy G; Hu CK; Straub JE; Thirumalai D Factors Governing Fibrillogenesis of Polypeptide Chains Revealed by Lattice Models. Phys. Rev. Lett 2010, 105, 218101.</Citation><ArticleIdList><ArticleId IdType="pubmed">21231356</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiti F; Stefani M; Taddei N; Ramponi G; Dobson CM Rationalization of the Effects of Mutations on Peptide and Protein Aggregation Rates. Nature 2003, 424, 805.</Citation><ArticleIdList><ArticleId IdType="pubmed">12917692</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong SH; Ham S Interaction with the Surrounding Water Plays a Key role in Determining the Aggregation Propensity of Proteins. Angew. Chem 2014, 126, 4042&#x2013;4045.</Citation><ArticleIdList><ArticleId IdType="pubmed">24615814</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal L; Biswas P Effect of Alzheimer&#x2019;s Disease Causative and Protective Mutations on the Hydration Environment of Amyloid-&#x3b2;. J. Phys. Chem. B 2020, 124, 2311&#x2013;2322.</Citation><ArticleIdList><ArticleId IdType="pubmed">32130011</ArticleId></ArticleIdList></Reference><Reference><Citation>Thu TTM; Co NT; Tu LA; Li MS Aggregation Rate of Amyloid beta Peptide is Controlled by beta-content in Monomeric State. J. Chem. Phys 2019, 150, 225101.</Citation><ArticleIdList><ArticleId IdType="pubmed">31202253</ArticleId></ArticleIdList></Reference><Reference><Citation>Nam HB; Kouza M; Zung H; Li MS Relationship between Population of the Fibril-prone Conformation in the Monomeric State and Oligomer Formation Times of Peptides: Insights from all-atom Simulations. J. Chem. Phys 2010, 132, 165104.</Citation><ArticleIdList><ArticleId IdType="pubmed">20441312</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty D; Straub JE; Thirumalai D Differences in the Free Energies between the Excited States of A&#x3b2;40 and A&#x3b2;42 Monomers Encode their Distinct Aggregation Propensities. Proc. Natl. Acad. Sci. U. S. A 2020, 117, 19926&#x2013;19937.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7443889</ArticleId><ArticleId IdType="pubmed">32732434</ArticleId></ArticleIdList></Reference><Reference><Citation>Frigori RB; Barroso da Silva FL; Carvalho PPD; Alves NA Occurrence of Biased Conformations as Precursors of Assembly States in Fibril Elongation of Amyloid-&#x3b2; Fibril Variants: An In Silico Study. J. Phys. Chem. B 2020, 124, 2798&#x2013;2805.</Citation><ArticleIdList><ArticleId IdType="pubmed">32204595</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagel-Steger L; Owen MC; Strodel B An Account of Amyloid Oligomers: Facts and Figures Obtained from Experiments and Simulations. ChemBioChem 2016, 17, 657&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pubmed">26910367</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y; Hashemi M; Lv Z; Lyubchenko YL Self-assembly of the Full-length Amyloid A&#x3b2;42 Protein in Dimers. Nanoscale 2016, 8, 18928&#x2013;18937.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5114164</ArticleId><ArticleId IdType="pubmed">27714140</ArticleId></ArticleIdList></Reference><Reference><Citation>Maity S; Lyubchenko YL Force Clamp Approach for Characterization of Nano-assembly in Amyloid beta 42 Dimer. Nanoscale 2019, 11, 12259&#x2013;12265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6597289</ArticleId><ArticleId IdType="pubmed">31210224</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehrazma B; Rauk A Exploring Amyloid-&#x3b2; Dimer Structure Using Molecular Dynamics Simulations. J. Phys. Chem. A 2019, 123, 4658&#x2013;4670.</Citation><ArticleIdList><ArticleId IdType="pubmed">31082235</ArticleId></ArticleIdList></Reference><Reference><Citation>Das P; Chacko AR; Belfort G Alzheimer&#x2019;s Protective Cross-Interaction between Wild-Type and A2T Variants Alters A&#x3b2;42 Dimer Structure. ACS Chem. Neurosci 2017, 8, 606&#x2013;618.</Citation><ArticleIdList><ArticleId IdType="pubmed">28292185</ArticleId></ArticleIdList></Reference><Reference><Citation>Man VH; Nguyen PH; Derreumaux P Conformational Ensembles of the Wild-Type and S8C A&#x3b2;1&#x2013;42 Dimers. J. Phys. Chem. B 2017, 121, 2434&#x2013;2442.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5944329</ArticleId><ArticleId IdType="pubmed">28245647</ArticleId></ArticleIdList></Reference><Reference><Citation>Man VH; Nguyen PH; Derreumaux P High-Resolution Structures of the Amyloid-&#x3b2; 1&#x2013;42 Dimers from the Comparison of Four Atomistic Force Fields. J. Phys. Chem. B 2017, 121, 5977&#x2013;5987.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5944325</ArticleId><ArticleId IdType="pubmed">28538095</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarus B; Tran TT; Nasica-Labouze J; Sterpone F; Nguyen PH; Derreumaux P Structures of the Alzheimer&#x2019;s Wild-Type A&#x3b2;1&#x2013;40 Dimer from Atomistic Simulations. J. Phys. Chem. B 2015, 119, 10478&#x2013;10487.</Citation><ArticleIdList><ArticleId IdType="pubmed">26228450</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen PH; Sterpone F; Pouplana R; Derreumaux P; Campanera JM Dimerization Mechanism of Alzheimer A&#x3b2;40 Peptides: The High Content of Intrapeptide-Stabilized Conformations in A2V and A2T Heterozygous Dimers Retards Amyloid Fibril Formation. J. Phys. Chem. B 2016, 120, 12111&#x2013;12126.</Citation><ArticleIdList><ArticleId IdType="pubmed">27933940</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen PH; Sterpone F; Campanera JM; Nasica-Labouze J; Derreumaux P Impact of the A2V Mutation on the Heterozygous and Homozygous A&#x3b2;1&#x2013;40 Dimer Structures from Atomistic Simulations. ACS Chem. Neurosci 2016, 7, 823&#x2013;832.</Citation><ArticleIdList><ArticleId IdType="pubmed">27007027</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y; Jiang X; Han W Self-Assembly Pathways of &#x3b2;-Sheet-Rich Amyloid-&#x3b2;(1&#x2013;40) Dimers: Markov State Model Analysis on Millisecond Hybrid-Resolution Simulations. J. Chem. Theory Comput 2017, 13, 5731&#x2013;5744.</Citation><ArticleIdList><ArticleId IdType="pubmed">29019683</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayan B; Yuan Y; Fathizadeh A; Elber R; Buchete N-V Chapter Five - Long-time methods for molecular dynamics simulations: Markov State Models and Milestoning. In Progress in Molecular Biology and Translational Science; Strodel B; Barz B, Eds.; Academic Press: 2020, Vol. 170, pp 215&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pubmed">32145946</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HL; Krupa P; Hai NM; Linh HQ; Li MS Structure and Physicochemical Properties of the A&#x3b2;42 Tetramer: Multiscale Molecular Dynamics Simulations. J. Phys. Chem. B 2019, 123, 7253&#x2013;7269.</Citation><ArticleIdList><ArticleId IdType="pubmed">31365254</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernstein SL; Dupuis NF; Lazo ND; Wyttenbach T; Condron MM; Bitan G; Teplow DB; Shea J-E; Ruotolo BT; Robinson CV; et al. Amyloid-&#x3b2; protein Oligomerization and the Importance of Tetramers and Dodecamers in the Aetiology of Alzheimer&#x2019;s Disease. Nat. Chem 2009, 1, 326&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2918915</ArticleId><ArticleId IdType="pubmed">20703363</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S; Fox DM; Urbanc B Insights into Formation and Structure of A&#x3b2; Oligomers Cross-Linked via Tyrosines. J. Phys. Chem. B 2017, 121, 5523&#x2013;5535.</Citation><ArticleIdList><ArticleId IdType="pubmed">28482661</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu M; Bode DC; Viles JH Copper Redox Cycling Inhibits A&#x3b2; Fibre Formation and Promotes Fibre Fragmentation, while Generating a Dityrosine A&#x3b2; Dimer. Sci. Rep 2018, 8, 16190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6212427</ArticleId><ArticleId IdType="pubmed">30385800</ArticleId></ArticleIdList></Reference><Reference><Citation>La Penna G; Li M S Computational Models Explain how Copper Binding to amyloid-&#x3b2; Peptide Oligomers Enhances Oxidative Pathways. Phys. Chem. Chem. Phys 2019, 21, 8774&#x2013;8784.</Citation><ArticleIdList><ArticleId IdType="pubmed">30968896</ArticleId></ArticleIdList></Reference><Reference><Citation>Voelker MJ; Barz B; Urbanc B Fully Atomistic A&#x3b2;40 and A&#x3b2;42 Oligomers in Water: Observation of Porelike Conformations. J. Chem. Theory Comput 2017, 13, 4567&#x2013;4583.</Citation><ArticleIdList><ArticleId IdType="pubmed">28727426</ArticleId></ArticleIdList></Reference><Reference><Citation>Do TD; LaPointe NE; Nelson R; Krotee P; Hayden EY; Ulrich B; Quan S; Feinstein SC; Teplow DB; Eisenberg D; et al. Amyloid &#x3b2;-Protein C-Terminal Fragments: Formation of Cylindrins and &#x3b2;-Barrels. J. Am. Chem. Soc 2016, 138, 549&#x2013;557.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4741107</ArticleId><ArticleId IdType="pubmed">26700445</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi W; Vanderford EK; Hansmann UH E. Out-of-Register A&#x3b2;42 Assemblies as Models for Neurotoxic Oligomers and Fibrils. J. Chem. Theory Comput 2018, 14, 1099&#x2013;1110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5821112</ArticleId><ArticleId IdType="pubmed">29357242</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen PH; Campanera JM; Ngo ST; Loquet A; Derreumaux P Tetrameric A&#x3b2;40 and A&#x3b2;42 &#x3b2;-Barrel Structures by Extensive Atomistic Simulations. II. In Aqueous Solution. J. Phys. Chem. B 2019, 123, 6750&#x2013;6756.</Citation><ArticleIdList><ArticleId IdType="pubmed">31296000</ArticleId></ArticleIdList></Reference><Reference><Citation>Davtyan A; Schafer NP; Zheng W; Clementi C; Wolynes PG; Papoian GA AWSEM-MD: Protein Structure Prediction Using Coarse-Grained Physical Potentials and Bioinformatically Based Local Structure Biasing. J. Phys. Chem. B 2012, 116, 8494&#x2013;8503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3406225</ArticleId><ArticleId IdType="pubmed">22545654</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng W; Tsai M-Y; Chen M; Wolynes PG Exploring the Aggregation Free Energy Landscape of the amyloid-&#x3b2; Protein (1&#x2013;40). Proc. Natl. Acad. Sci. U. S. A 2016, 113, 11835&#x2013;11840.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5081630</ArticleId><ArticleId IdType="pubmed">27698130</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng W; Tsai M-Y; Wolynes PG Comparing the Aggregation Free Energy Landscapes of Amyloid Beta(1&#x2013;42) and Amyloid Beta(1&#x2013;40). J. Am. Chem. Soc 2017, 139, 16666&#x2013;16676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5805378</ArticleId><ArticleId IdType="pubmed">29057654</ArticleId></ArticleIdList></Reference><Reference><Citation>Barz B; Liao Q; Strodel B Pathways of Amyloid-&#x3b2; Aggregation Depend on Oligomer Shape. J. Am. Chem. Soc 2018, 140, 319&#x2013;327.</Citation><ArticleIdList><ArticleId IdType="pubmed">29235346</ArticleId></ArticleIdList></Reference><Reference><Citation>Man VH; He X; Ji B; Liu S; Xie X-Q; Wang J Molecular Mechanism and Kinetics of Amyloid-&#x3b2;42 Aggregate Formation: A Simulation Study. ACS Chem. Neurosci 2019, 10, 4643&#x2013;4658.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7336531</ArticleId><ArticleId IdType="pubmed">31660732</ArticleId></ArticleIdList></Reference><Reference><Citation>Robustelli P; Piana S; Shaw DE Developing a Molecular Dynamics Force Field for both Folded and Disordered Protein States. Proc. Natl. Acad. Sci. U. S. A 2018, 115, E4758&#x2013;E4766.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6003505</ArticleId><ArticleId IdType="pubmed">29735687</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha S; Deep S Protein Aggregation: Elucidation of the Mechanism and Determination of Associated Thermodynamic and Kinetic Parameters. Curr. Phys. Chem 2014, 4, 114&#x2013;136.</Citation></Reference><Reference><Citation>Sharma B; Ranganathan SV; Belfort G Weaker N-Terminal Interactions for the Protective over the Causative A&#x3b2; Peptide Dimer Mutants. ACS Chem. Neurosci 2018, 9, 1247&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pubmed">29465978</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H; Salimi A; Lee JY Intrinsic Origin of Amyloid Aggregation: Collective Effects of the Mutation and Tautomerism of Histidine. ACS Chem. Neurosci 2019, 10, 4729&#x2013;4734.</Citation><ArticleIdList><ArticleId IdType="pubmed">31600048</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C; Zhao W; Xing X; Shi H; Kang B; Liu H; Li P; Ai H An Original Monomer Sampling from a Ready-Made A&#x3b2;42 NMR Fibril Suggests a Turn-&#x3b2;-Strand Synergetic Seeding Mechanism. ChemPhysChem 2019, 20, 1649&#x2013;1660.</Citation><ArticleIdList><ArticleId IdType="pubmed">30977257</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashemi M; Zhang Y; Lv Z; Lyubchenko YL Spontaneous self-assembly of Amyloid &#x3b2; (1&#x2013;40) into Dimers. Nanoscale Adv 2019, 1, 3892&#x2013;3899.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9417245</ArticleId><ArticleId IdType="pubmed">36132110</ArticleId></ArticleIdList></Reference><Reference><Citation>Press-Sandler O; Miller Y Distinct Primary Nucleation of Polymorphic A&#x3b2; Dimers Yields to Distinguished Fibrillation Pathways. ACS Chem. Neurosci 2019, 10, 4407&#x2013;4413.</Citation><ArticleIdList><ArticleId IdType="pubmed">31532176</ArticleId></ArticleIdList></Reference><Reference><Citation>Cremades N; Chen SW; Dobson CM Structural Characteristics of &#x3b1;-Synuclein Oligomers. Int. Rev. Cell Mol. Biol 2017, 329, 79&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pubmed">28109332</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilie IM; Den Otter WK; Briels WJ A Coarse Grained Protein Model with Internal Degrees of Freedom. Application to &#x3b1;-synuclein Aggregation. J. Chem. Phys 2016, 144, 085103.</Citation><ArticleIdList><ArticleId IdType="pubmed">26931727</ArticleId></ArticleIdList></Reference><Reference><Citation>Eliezer D Biophysical Characterization of Intrinsically Disordered Proteins David. Curr. Opin. Struct. Biol 2009, 19, 23&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2728036</ArticleId><ArticleId IdType="pubmed">19162471</ArticleId></ArticleIdList></Reference><Reference><Citation>Dokholyan NV Experimentally-driven Protein Structure Modeling. J. Proteomics 2020, 220, 103777.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7214187</ArticleId><ArticleId IdType="pubmed">32268219</ArticleId></ArticleIdList></Reference><Reference><Citation>Piana S; Donchev AG; Robustelli P; Shaw DE Water Dispersion Interactions strongly Influence Simulated Structural Properties of Disordered Protein States. J. Phys. Chem. B 2015, 119, 5113&#x2013;5123.</Citation><ArticleIdList><ArticleId IdType="pubmed">25764013</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramis R; Ortega-Castro J; Casasnovas R; Mari&#xf1;o L; Vilanova B; Adrover M; Frau J A Coarse-Grained Molecular Dynamics Approach to the Study of the Intrinsically Disordered Protein &#x3b1;-Synuclein. J. Chem. Inf. Model 2019, 59, 1458&#x2013;1471.</Citation><ArticleIdList><ArticleId IdType="pubmed">30933517</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y; Liu H; Yang S; Luo R; Chen HF Well-Balanced Force Field ff03 CMAP for Folded and Disordered Proteins. J. Chem. Theory Comput 2019, 15, 6769&#x2013;6780.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7196277</ArticleId><ArticleId IdType="pubmed">31657215</ArticleId></ArticleIdList></Reference><Reference><Citation>Latham AP; Zhang B Maximum Entropy Optimized Force Field for Intrinsically Disordered Proteins. J. Chem. Theory Comput 2020, 16, 773&#x2013;781.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7241281</ArticleId><ArticleId IdType="pubmed">31756104</ArticleId></ArticleIdList></Reference><Reference><Citation>Song D; Liu H; Luo R; Chen H-F Environment-Specific Force Field for Intrinsically Disordered and Ordered Proteins. J. Chem. Inf. Model 2020, 60, 2257&#x2013;2267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10449432</ArticleId><ArticleId IdType="pubmed">32227937</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L; Li DW; Br&#xfc;schweiler R Balanced Amino-Acid-Specific Molecular Dynamics Force Field for the Realistic Simulation of Both Folded and Disordered Proteins. J. Chem. Theory Comput 2020, 16, 1311&#x2013;1318.</Citation><ArticleIdList><ArticleId IdType="pubmed">31877033</ArticleId></ArticleIdList></Reference><Reference><Citation>Dedmon MM; Lindorff-Larsen K; Christodoulou J; Vendruscolo M; Dobson CM Mapping Long-range Interactions in &#x3b1;-synuclein Using Spin-label NMR and Ensemble Molecular Dynamics Simulations. J. Am. Chem. Soc 2005, 127, 476&#x2013;477.</Citation><ArticleIdList><ArticleId IdType="pubmed">15643843</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu K-H; Weinstock DS; Narayanan C; Levy RM; Baum J Structural Reorganization of &#x3b1;-synuclein at Low pH Observed by NMR and REMD Simulations. J. Mol. Biol 2009, 391, 784&#x2013;796.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2766395</ArticleId><ArticleId IdType="pubmed">19576220</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullman O; Fisher CK; Stultz CM Explaining the Structural Plasticity of &#x3b1;-synuclein. J. Am. Chem. Soc 2011, 133, 19536&#x2013;19546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3227348</ArticleId><ArticleId IdType="pubmed">22029383</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath A; Sammalkorpi M; DeWitt DC; Trexler AJ; Elbaum-Garfinkle S; O&#x2019;Hern CS; Rhoades E The Conformational Ensembles of &#x3b1;-synuclein and tau: Combining Single-molecule FRET and Simulations. Biophys. J 2012, 103, 1940&#x2013;1949.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3491709</ArticleId><ArticleId IdType="pubmed">23199922</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayanan C; Weinstock DS; Wu KP; Baum J; Levy RM Investigation of the Polymeric Properties of &#x3b1;-Synuclein and Comparison with NMR Experiments: A Replica Exchange Molecular Dynamics Study. J. Chem. Theory Comput 2012, 8, 3929&#x2013;3942.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3496295</ArticleId><ArticleId IdType="pubmed">23162382</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrie JJ; Haney CM; Yoon J; Pan B; Lin YC; Fakhraai Z; Rhoades E; Nath A; Petersson EJ Using a FRET Library with Multiple Probe Pairs To Drive Monte Carlo Simulations of &#x3b1;-Synuclein. Biophys. J 2018, 114, 53&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5773763</ArticleId><ArticleId IdType="pubmed">29320696</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodie NI; Popov KI; Petrotchenko EV; Dokholyan NV; Borchers CH Conformational Ensemble of Native &#x3b1;-synuclein in Solution as Determined by Short-distance Crosslinking Constraint-guided Discrete Molecular Dynamics Simulations. PLoS Comput. Biol 2019, 15, 1&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6453469</ArticleId><ArticleId IdType="pubmed">30917118</ArticleId></ArticleIdList></Reference><Reference><Citation>Proctor EA; Ding F; Dokholyan NV Discrete Molecular Dynamics. Wiley Interdiscip. Rev.: Comput. Mol. Sci 2011, 1, 80&#x2013;92.</Citation></Reference><Reference><Citation>Dokholyan NV; Buldyrev SV; Stanley HE; Shakhnovich EI Discrete Molecular Dynamics Studies of the Folding of a Protein-like Model. Folding Des 1998, 3, 577&#x2013;587.</Citation><ArticleIdList><ArticleId IdType="pubmed">9889167</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirvanyants D; Ding F; Tsao D; Ramachandran S; Dokholyan NV Discrete Molecular Dynamics: An Efficient and Versatile Simulation Method for Fine Protein Characterization. J. Phys. Chem. B 2012, 116, 8375&#x2013;8382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3406226</ArticleId><ArticleId IdType="pubmed">22280505</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodie NI; Popov KI; Petrotchenko EV; Dokholyan NV; Borchers CH Solving Protein Structures using Short-distance Cross-linking Constraints as a Guide for Discrete Molecular Dynamics Simulations. Sci. Adv 2017, 3, No. e1700479.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5501500</ArticleId><ArticleId IdType="pubmed">28695211</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding F; Jha RK Scaling Behavior and Structure of Denatured Proteins. Structure 2005, 13, 1047&#x2013;1054.</Citation><ArticleIdList><ArticleId IdType="pubmed">16004876</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y; Campbell SL; Dokholyan NV Deciphering Protein Dynamics from NMR data Using Explicit Structure Sampling and Selection. Biophys. J 2007, 93, 2300&#x2013;2306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1965439</ArticleId><ArticleId IdType="pubmed">17557784</ArticleId></ArticleIdList></Reference><Reference><Citation>Churchill CDM; Healey MA; Preto J; Tuszynski JA; Woodside MT Probing the Basis of &#x3b1;-Synuclein Aggregation by Comparing Simulations to Single-Molecule Experiments. Biophys. J 2019, 117, 1125&#x2013;1135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6818160</ArticleId><ArticleId IdType="pubmed">31477241</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y; Hashemi M; Lv Z; Williams B; Popov KI; Dokholyan NV; Lyubchenko YL High-speed Atomic Force Microscopy Reveals Structural Dynamics of &#x3b1;-synuclein Monomers and Dimers. J. Chem. Phys 2018, 148, 123322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5764752</ArticleId><ArticleId IdType="pubmed">29604892</ArticleId></ArticleIdList></Reference><Reference><Citation>Du&#x142;ak D; Gadza&#x142;a M; Banach M; Konieczny L; Roterman I Alternative Structures of &#x3b1;-synuclein. Molecules 2020, 25, 1&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7038196</ArticleId><ArticleId IdType="pubmed">32019169</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossetti G; Musiani F; Abad E; Dibenedetto D; Mouhib H; Fernandez CO; Carloni P Conformational Ensemble of Human &#x3b1;-synuclein Physiological Form Predicted by Molecular Simulations. Phys. Chem. Chem. Phys 2016, 18, 5702&#x2013;5706.</Citation><ArticleIdList><ArticleId IdType="pubmed">26553504</ArticleId></ArticleIdList></Reference><Reference><Citation>Graen T; Klement R; Grupi A; Haas E; Grubmu&#xfc;ller H Transient Secondary and Tertiary Structure Formation Kinetics in the Intrinsically Disordered State of &#x3b1;-Synuclein from Atomistic Simulations. ChemPhysChem 2018, 19, 2507&#x2013;2511.</Citation><ArticleIdList><ArticleId IdType="pubmed">30047198</ArticleId></ArticleIdList></Reference><Reference><Citation>Balupuri A; Choi KE; Kang NS Computational Insights into the Role of &#x3b1;-strand/sheet in Aggregation of &#x3b1;-synuclein. Sci. Rep 2019, 9, 1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6329781</ArticleId><ArticleId IdType="pubmed">30635607</ArticleId></ArticleIdList></Reference><Reference><Citation>Healey MA; Woodside MT; Tuszynski JA Phase Transitions and Structure Analysis in wild-type, A30P, E46K, and A53T Mutants of &#x3b1;-synuclein. Eur. Biophys. J 2016, 45, 355&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pubmed">26695014</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xf3;nsson SA; Mohanty S; Irb&#xe4;ck A Distinct Phases of Free &#x3b1;-synuclein - A Monte Carlo Study. Proteins: Struct., Funct., Genet 2012, 80, 2169&#x2013;2177.</Citation><ArticleIdList><ArticleId IdType="pubmed">22552968</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H; Han W; Ma W; Schulten K Transient &#x3b2;-hairpin Formation in alpha-synuclein Monomer Revealed by Coarse-grained Molecular Dynamics Simulation. J. Chem. Phys 2015, 143, 1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4684271</ArticleId><ArticleId IdType="pubmed">26723627</ArticleId></ArticleIdList></Reference><Reference><Citation>Chwastyk M; Cieplak M Conformational Biases of &#x3b1;-Synuclein and Formation of Transient Knots. J. Phys. Chem. B 2020, 124, 11&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">31805238</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinreb PH; Zhen W; Poon AW; Conway KA; Lansbury PT NACP, a Protein Implicated in Alzheimer&#x2019;s Disease and Learning, is Natively Unfolded. Biochemistry 1996, 35, 13709&#x2013;13715.</Citation><ArticleIdList><ArticleId IdType="pubmed">8901511</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson WS; Jonas A; Clayton DF; George JM Stabilization of &#x3b1;-Synuclein Secondary Structure upon Binding to Synthetic Membranes. J. Biol. Chem 1998, 273, 9443&#x2013;9449.</Citation><ArticleIdList><ArticleId IdType="pubmed">9545270</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwalbe M; Ozenne V; Bibow S; Jaremko M; Jaremko L; Gajda M; Jensen MR; Biernat J; Becker S; Mandelkow E; et al. Predictive Atomic Resolution Descriptions of Intrinsically Disordered hTau40 and &#x3b1;-synuclein in solution from NMR and Small Angle Scattering. Structure 2014, 22, 238&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pubmed">24361273</ArticleId></ArticleIdList></Reference><Reference><Citation>Dibenedetto D; Rossetti G; Caliandro R; Carloni P A Molecular Dynamics Simulation-based Interpretation of Nuclear Magnetic Resonance Multidimensional Heteronuclear Spectra of &#x3b1;-synuclein&#xb7;dopamine Adducts. Biochemistry 2013, 52, 6672&#x2013;6683.</Citation><ArticleIdList><ArticleId IdType="pubmed">23964651</ArticleId></ArticleIdList></Reference><Reference><Citation>Mane JY; Stepanova M Understanding the Dynamics of Monomeric, Dimeric, and Tetrameric &#x3b1;-synuclein Structures in Water. FEBS Open Bio 2016, 6, 666&#x2013;686.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4932447</ArticleId><ArticleId IdType="pubmed">27398307</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahu KK; Woodside MT; Tuszynski JA A-Synuclein Dimer Structures Found From Computational Simulations. Biochimie 2015, 116, 133&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pubmed">26193124</ArticleId></ArticleIdList></Reference><Reference><Citation>Cote Y; Delarue P; Scheraga HA; Senet P; Maisuradze GG From a Highly Disordered to a Metastable State: Uncovering Insights of &#x3b1;-Synuclein. ACS Chem. Neurosci 2018, 9, 1051&#x2013;1065.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5955826</ArticleId><ArticleId IdType="pubmed">29451381</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaffert LN; Carter WG Do Post-Translational Modifications Influence Protein Aggregation in Neurodegenerative Diseases: A Systematic Review. Brain Sci 2020, 10, 232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7226274</ArticleId><ArticleId IdType="pubmed">32290481</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao J; Shi R; Li L; Chen F; Zhou Y; Tung YC; Hu W; Gong CX; Iqbal K; Liu F Pathological Tau From Alzheimer&#x2019;s Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau in vivo. Front. Aging Neurosci 2019, 11, 34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6411797</ArticleId><ArticleId IdType="pubmed">30890929</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y; Ma B; Nussinov R; Wei G Structural Insight into Tau Protein&#x2019;s Paradox of Intrinsically Disordered Behavior, Self-Acetylation Activity, and Aggregation. J. Phys. Chem. Lett 2014, 5, 3026&#x2013;3021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4154703</ArticleId><ArticleId IdType="pubmed">25206938</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlomagno Y; Chung DC; Yue M; Castanedes-Casey M; Madden BJ; Dunmore J; Tong J; DeTure M; Dickson DW; Petrucelli L; et al. An Acetylation-phosphorylation Switch that Regulates Tau Aggregation Propensity and Function. J. Biol. Chem 2017, 292, 15277&#x2013;15286.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5602388</ArticleId><ArticleId IdType="pubmed">28760828</ArticleId></ArticleIdList></Reference><Reference><Citation>Prokopovich DV; Whittaker JW; Muthee MM; Ahmed A; Larini L Impact of Phosphorylation and Pseudophosphorylation on the Early Stages of Aggregation of the Microtubule-Associated Protein Tau. J. Phys. Chem. B 2017, 121, 2095&#x2013;2103.</Citation><ArticleIdList><ArticleId IdType="pubmed">28218850</ArticleId></ArticleIdList></Reference><Reference><Citation>Despres C; Di J; Cantrelle FX; Li Z; Huvent I; Chambraud B; Zhao J; Chen J; Chen S; Lippens G; et al. Major Differences between the Self-Assembly and Seeding Behavior of Heparin-Induced and in Vitro Phosphorylated Tau and Their Modulation by Potential Inhibitors. ACS Chem. Biol 2019, 14, 1363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6636790</ArticleId><ArticleId IdType="pubmed">31046227</ArticleId></ArticleIdList></Reference><Reference><Citation>Arakhamia T; Lee CE; Carlomagno Y; Duong DM; Kundinger SR; Wang K; Williams D; DeTure M; Dickson DW; Cook CN; et al. Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains. Cell 2020, 180, 633&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491959</ArticleId><ArticleId IdType="pubmed">32032505</ArticleId></ArticleIdList></Reference><Reference><Citation>Despres C; Byrne C; Qi H; Cantrelle FX; Huvent I; Chambraud B; Baulieu EE; Jacquot Y; Landrieu I; Lippens G; et al. Identification of the Tau Phosphorylation Pattern that Drives its Aggregation. Proc. Natl. Acad. Sci. U. S. A 2017, 114, 9080&#x2013;9085.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5576827</ArticleId><ArticleId IdType="pubmed">28784767</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyons AJ; Gandhi NS; Mancera RL Molecular Dynamics Simulation of the Phosphorylation-induced Conformational Changes of a Tau Peptide Fragment. Proteins: Struct., Funct., Genet 2014, 82, 1907&#x2013;1918.</Citation><ArticleIdList><ArticleId IdType="pubmed">24577753</ArticleId></ArticleIdList></Reference><Reference><Citation>Rani L; Mittal J; Mallajosyula SS Effect of Phosphorylation and O-GlcNAcylation on Proline-Rich Domains of Tau. J. Phys. Chem. B 2020, 124, 1909&#x2013;1918.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7459333</ArticleId><ArticleId IdType="pubmed">32065850</ArticleId></ArticleIdList></Reference><Reference><Citation>Haj-Yahya M; Gopinath P; Rajasekhar K; Mirbaha H; Diamond MI; Lashuel HA Site-Specific Hyperphosphorylation Inhibits, Rather than Promotes, Tau Fibrillization, Seeding Capacity, and Its Microtubule Binding. Angew. Chem., Int. Ed 2020, 59, 4059&#x2013;4067.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7065254</ArticleId><ArticleId IdType="pubmed">31863676</ArticleId></ArticleIdList></Reference><Reference><Citation>Barthelemy NR; Li Y; Joseph-Mathurin N; Gordon BA; Hassenstab J; Benzinger TLS; Buckles V; Fagan AM; Perrin RJ; Goate AM; et al. A Soluble Phosphorylated Tau Signature Links Tau, Amyloid and the Evolution of Stages of Dominantly Inherited Alzheimer&#x2019;s Disease. Nat. Med 2020, 26, 398&#x2013;407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7309367</ArticleId><ArticleId IdType="pubmed">32161412</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin AF; Toptygin D; Elam WA; Schrank TP; Hilser VJ Phosphorylation Increases Persistence Length and End-to-End Distance of a Segment of Tau Protein. Biophys. J 2016, 110, 362&#x2013;371.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4725354</ArticleId><ArticleId IdType="pubmed">26789759</ArticleId></ArticleIdList></Reference><Reference><Citation>Naserkhaki R; Zamanzadeh S; Baharvand H; Nabavi SM; Pakdaman H; Shahbazi S; Vosough M; Ghaedi G; Barzegar A; Mirtorabi D; et al. cis pT231-Tau Drives Neurodegeneration in Bipolar Disorder. ACS Chem. Neurosci 2019, 10, 1214&#x2013;1221.</Citation><ArticleIdList><ArticleId IdType="pubmed">30644730</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih HH; Tu C; Cao W; Klein A; Ramsey R; Fennell BJ; Lambert M; Sh&#xfa;illeabh&#xe1;in DN; Autin B; Kouranova E An Ultra-specific Avian Antibody to Phosphorylated Tau Protein Reveals a unique Mechanism for Phosphoepitope Recognition. J. Biol. Chem 2012, 287, 44425&#x2013;44434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3531756</ArticleId><ArticleId IdType="pubmed">23148212</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura K; Zhou XZ; Lu KP Distinct Functions of Cis and Trans Phosphorylated Tau in Alzheimer&#x2019;s Disease and their Therapeutic Implications. Curr. Mol. Med 2013, 13, 1098&#x2013;1109.</Citation><ArticleIdList><ArticleId IdType="pubmed">23157676</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JZ; Zhang Y Configuration-specific Immunotherapy Targeting cis pThr231-Pro232 Tau for Alzheimer Disease. J. Neurol. Sci 2015, 348, 253&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pubmed">25467137</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahuja P; Cantrelle FX; Huvent I; Hanoulle X; Lopez J; Smet C; Wieruszeski JM; Landrieu I; Lippens G Proline Conformation in a Functional Tau Fragment. J. Mol. Biol 2016, 428, 79&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">26655856</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikura T; Tochio N; Kawasaki R; Matsuzaki M; Narita A; Kikumoto M; Utsunomiya-Tate N; Tate SI; Ito N The Trans Ssomer of Tau Peptide is Prone to Aggregate, and the WW Domain of Pin1 Drastically Decreases its Aggregation. FEBS Lett 2018, 592, 3082&#x2013;3091.</Citation><ArticleIdList><ArticleId IdType="pubmed">30079475</ArticleId></ArticleIdList></Reference><Reference><Citation>Barman A; Hamelberg D Loss of Intramolecular Electrostatic Interactions and Limited Conformational Ensemble May Promote Self-association of cis-tau Peptide. Proteins: Struct., Funct., Genet 2015, 83, 436&#x2013;444.</Citation><ArticleIdList><ArticleId IdType="pubmed">25524218</ArticleId></ArticleIdList></Reference><Reference><Citation>Strang KH; Sorrentino ZA; Riffe CJ; Gorion KM; Vijayaraghavan N; Golde TE; Giasson BI Phosphorylation of Serine 305 in Tau Inhibits Aggregation. Neurosci. Lett 2019, 692, 187&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6351168</ArticleId><ArticleId IdType="pubmed">30423399</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandhu P; Naeem MM; Lu C; Kumarathasan P; Gomes J; Basak A Ser(422) Phosphorylation Blocks Human Tau Cleavage by Caspase-3: Biochemical Implications to Alzheimer&#x2019;s Disease. Bioorg. Med. Chem. Lett 2017, 27, 642&#x2013;653.</Citation><ArticleIdList><ArticleId IdType="pubmed">27989667</ArticleId></ArticleIdList></Reference><Reference><Citation>Ait-Bouziad N; Chiki A; Limorenko G; Xiao S; Eliezer D; Lashuel HA Phosphorylation of the Overlooked Tyrosine 310 Regulates the Structure, Aggregation, and Microtubule- and Lipid-binding Properties of Tau. J. Biol. Chem 2020, 295, 7905&#x2013;7922.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7278352</ArticleId><ArticleId IdType="pubmed">32341125</ArticleId></ArticleIdList></Reference><Reference><Citation>Amar F; Sherman MA; Rush T; Larson M; Boyle G; Chang L; Gotz J; Buisson A; Lesne SE The amyloid-beta Aligomer Abeta*56 Induces Specific Alterations in Neuronal Signaling that lead to Tau Phosphorylation and Aggregation. Sci. Signaling 2017, 10, No. eaal2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5859319</ArticleId><ArticleId IdType="pubmed">28487416</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H; Wei S; Huang Y; Chen L; Wang Y; Wu X; Zhang Z; Pei Y; Wang D Abeta Monomer Induces Phosphorylation of Tau at Ser-214 through beta2AR-PKA-JNK Signaling Pathway. FASEB J 2020, 34, 5092&#x2013;5105.</Citation><ArticleIdList><ArticleId IdType="pubmed">32067279</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo JP; Arai T; Miklossy J; McGeer PL Abeta and Tau Form Soluble Complexes that May Promote Self Aggregation of both into the Insoluble Forms Observed in Alzheimer&#x2019;s Disease. Proc. Natl. Acad. Sci. U. S. A 2006, 103, 1953&#x2013;1958.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1413647</ArticleId><ArticleId IdType="pubmed">16446437</ArticleId></ArticleIdList></Reference><Reference><Citation>Ando K; Oka M; Ohtake Y; Hayashishita M; Shimizu S; Hisanaga S; Iijima KM Tau Phosphorylation at Alzheimer&#x2019;s Disease-related Ser356 Contributes to tau stabilization when PAR-1/MARK Activity is Elevated. Biochem. Biophys. Res. Commun 2016, 478, 929&#x2013;934.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5675734</ArticleId><ArticleId IdType="pubmed">27520376</ArticleId></ArticleIdList></Reference><Reference><Citation>Derreumaux P; Man VH; Wang J; Nguyen PH Tau R3-R4 Domain Dimer of the Wild Type and Phosphorylated Ser356 Sequences. I. In Solution by Atomistic Simulations. J. Phys. Chem. B 2020, 124, 2975&#x2013;2983.</Citation><ArticleIdList><ArticleId IdType="pubmed">32216358</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YX; McCarty J; Rauch JN; Delaney KT; Kosik KS; Fredrickson GH; Shea JE; Han S Narrow Equilibrium Window for Complex Coacervation of Tau and RNA under Cellular Conditions. eLife 2019, 8, No. e42571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6450672</ArticleId><ArticleId IdType="pubmed">30950394</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegmann S; Eftekharzadeh B; Tepper K; Zoltowska KM; Bennett RE; Dujardin S; Laskowski PR; MacKenzie D; Kamath T; Commins C; et al. Tau Protein liquid-liquid Phase Separation can Initiate Tau Aggregation. EMBO J 2018, 37, No. e98049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5881631</ArticleId><ArticleId IdType="pubmed">29472250</ArticleId></ArticleIdList></Reference><Reference><Citation>Battisti A; Ciasca G; Grottesi A; Bianconi A; Tenenbaum A Temporary Secondary Structures in Tau, an Intrinsically Disordered Protein. Mol. Simul 2012, 38, 525&#x2013;533.</Citation></Reference><Reference><Citation>Larini L; Gessel MM; LaPointe NE; Do TD; Bowers MT; Feinstein SC; Shea JE Initiation of Assembly of tau(273&#x2013;284) and its Delta K280 Mutant: an Experimental and Computational study. Phys. Chem. Chem. Phys 2013, 15, 8916&#x2013;8928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3663921</ArticleId><ArticleId IdType="pubmed">23515417</ArticleId></ArticleIdList></Reference><Reference><Citation>Thirumalai D; Klimov DK; Dima RI Emerging ideas on the Molecular Basis of Protein and Peptide Aggregation. Curr. Opin. Struct. Biol 2003, 13, 146&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pubmed">12727507</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuravlev PI; Reddy G; Straub JE; Thirumalai D Propensity to Form Amyloid Fibrils Is Encoded as Excitations in the Free Energy Landscape of Monomeric Proteins. J. Mol. Biol 2014, 426, 2653&#x2013;2666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4100209</ArticleId><ArticleId IdType="pubmed">24846645</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganguly P; Do TD; Larini L; LaPointe NE; Sercel AJ; Shade MF; Feinstein SC; Bowers MT; Shea JE Tau Assembly: The Dominant Role of PHF6 (VQIVYK) in Microtubule Binding Region Repeat R3. J. Phys. Chem. B 2015, 119, 4582&#x2013;4593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4428543</ArticleId><ArticleId IdType="pubmed">25775228</ArticleId></ArticleIdList></Reference><Reference><Citation>Eschmann NA; Georgieva ER; Ganguly P; Borbat PP; Rappaport MD; Akdogan Y; Freed JH; Shea JE; Han S Signature of an Aggregation-prone Conformation of Tau. Sci. Rep 2017, 7, 44739.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5356194</ArticleId><ArticleId IdType="pubmed">28303942</ArticleId></ArticleIdList></Reference><Reference><Citation>Battisti A; Ciasca G; Grottesi A; Tenenbaum A Thermal Compaction of the Intrinsically Disordered Protein Tau: Entropic, Structural, and Hydrophobic Factors. Phys. Chem. Chem. Phys 2017, 19, 8435&#x2013;8446.</Citation><ArticleIdList><ArticleId IdType="pubmed">28287224</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciasca G; Campi G; Battisti A; Rea G; Rodio M; Papi M; Pernot P; Tenenbaum A; Bianconi A Continuous Thermal Collapse of the Intrinsically Disordered Protein Tau Is Driven by Its Entropic Flexible Domain. Langmuir 2012, 28, 13405&#x2013;13410.</Citation><ArticleIdList><ArticleId IdType="pubmed">22891813</ArticleId></ArticleIdList></Reference><Reference><Citation>Li DW; Mohanty S; Irback A; Huo SH Formation and Growth of Oligomers: A Monte Carlo Study of an Amyloid Tau Fragment. PLoS Comput. Biol 2008, 4, No. e1000238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2583953</ArticleId><ArticleId IdType="pubmed">19057640</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqua A; Luo Y; Meyer V; Swanson MA; Yu X; Wei GH; Zheng J; Eaton GR; Ma BY; Nussinov R; Eaton SS; Margittai M Conformational Basis for Asymmetric Seeding Barrier in Filaments of Three- and Four-Repeat Tau. J. Am. Chem. Soc 2012, 134, 10271&#x2013;10278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3381011</ArticleId><ArticleId IdType="pubmed">22656332</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X; Luo Y; Dinkel P; Zheng J; Wei GH; Margittai M; Nussinov R; Ma BY Cross-seeding and Conformational Selection between Three- and Four-repeat Human Tau Proteins. J. Biol. Chem 2012, 287, 14950&#x2013;14959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3340261</ArticleId><ArticleId IdType="pubmed">22393063</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer V; Dinkel PD; Luo Y; Yu X; Wei GH; Zheng J; Eaton GR; Ma BY; Nussinov R; Eaton SS; Margittai M Single Mutations in Tau Modulate the Populations of Fibril Conformers through Seed Selection. Angew. Chem., Int. Ed 2014, 53, 1590&#x2013;1593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4083751</ArticleId><ArticleId IdType="pubmed">24453187</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthes D; Gapsys V; Daebel V; de Groot BL Mapping the Conformational Dynamics and Pathways of Spontaneous Steric Zipper Peptide Oligomerization. PLoS One 2011, 6, No. e19129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3086902</ArticleId><ArticleId IdType="pubmed">21559277</ArticleId></ArticleIdList></Reference><Reference><Citation>Li XH; Dong XW; Wei GH; Margittai M; Nussinov R; Ma BY The Distinct Structural Preferences of tau Protein Repeat Domains. Chem. Commun 2018, 54, 5700&#x2013;5703.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5986281</ArticleId><ArticleId IdType="pubmed">29774342</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine ZA; Larini L; LaPointe NE; Feinstein SC; Shea JE Regulation and Aggregation of Intrinsically Disordered Peptides. Proc. Natl. Acad. Sci. U. S. A 2015, 112, 2758&#x2013;2763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4352815</ArticleId><ArticleId IdType="pubmed">25691742</ArticleId></ArticleIdList></Reference><Reference><Citation>Fichou Y; Schiro G; Gallat FX; Laguri C; Moulin M; Combete J; Zamponi M; Hartlein M; Picart C; Mossou E; Lortat-Jacob H; Colletier JP; Tobias DJ; Weik M Hydration Water Mobility is Enhanced around Tau Amyloid Fibers. Proc. Natl. Acad. Sci. U. S. A 2015, 112, 6365&#x2013;6370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4443308</ArticleId><ArticleId IdType="pubmed">25918405</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambadipudi S; Biernat J; Riedel D; Mandelkow E; Zweckstetter M Liquid-liquid Phase Separation of the Microtubule-binding Repeats of the Alzheimer-related protein Tau. Nat. Commun 2017, 8, 275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5561136</ArticleId><ArticleId IdType="pubmed">28819146</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson P; Kedersha N RNA granules. J. Cell Biol 2006, 172, 803&#x2013;808.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2063724</ArticleId><ArticleId IdType="pubmed">16520386</ArticleId></ArticleIdList></Reference><Reference><Citation>Wippich F; Bodenmiller B; Trajkovska MG; Wanka S; Aebersold R; Pelkmans L Dual Specificity Kinase DYRK3 Couples Stress Granule Condensation/Dissolution to mTORC1 Signaling. Cell 2013, 152, 791&#x2013;805.</Citation><ArticleIdList><ArticleId IdType="pubmed">23415227</ArticleId></ArticleIdList></Reference><Reference><Citation>Brangwynne CP; Eckmann CR; Courson DS; Rybarska A; Hoege C; Gharakhani J; Julicher F; Hyman AA Germline P Granules Are Liquid Droplets That Localize by Controlled Dissolution/Condensation. Science 2009, 324, 1729&#x2013;1732.</Citation><ArticleIdList><ArticleId IdType="pubmed">19460965</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A; Temirov J; Lee J; Coughlin M; Kanagaraj AP; Kim HJ; Mittag T; Taylor JP Phase Separation by Low Complexity Domains Promotes Stress Granule Assembly and Drives Pathological Fibrillization. Cell 2015, 163, 123&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyman AA; Weber CA; Juelicher F Liquid-Liquid Phase Separation in Biology. Annu. Rev. Cell Dev. Biol 2014, 30, 39&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">25288112</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami T; Qamar S; Lin JQ; Schierle GSK; Rees E; Miyashita A; Costa AR; Dodd RB; Chan FTS; Michel CH; et al. ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function. Neuron 2015, 88, 678&#x2013;690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4660210</ArticleId><ArticleId IdType="pubmed">26526393</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A; Lee HO; Jawerth L; Maharana S; Jahnel M; Hein MY; Stoynov S; Mahamid J; Saha S; Franzmann TM; et al. A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation. Cell 2015, 162, 1066&#x2013;1077.</Citation><ArticleIdList><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreev M; Prabhu VM; Douglas JF; Tirrell M; de Pablo JJ Complex Coacervation in Polyelectrolytes from a Coarse-Grained Model. Macromolecules 2018, 51, 6717&#x2013;6723.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7722290</ArticleId><ArticleId IdType="pubmed">33299652</ArticleId></ArticleIdList></Reference><Reference><Citation>Dignon GL; Zheng WW; Kim YC; Best RB; Mittal J Sequence Determinants of Protein Phase Behavior from a Coarse-grained Lodel. PLoS Comput. Biol 2018, 14, No. e1005941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5798848</ArticleId><ArticleId IdType="pubmed">29364893</ArticleId></ArticleIdList></Reference><Reference><Citation>Feric M; Vaidya N; Harmon TS; Mitrea DM; Zhu L; Richardson TM; Kriwacki RW; Pappu RV; Brangwynne CP Coexisting Liquid Phases Underlie Nucleolar Subcompartments. Cell 2016, 165, 1686&#x2013;1697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5127388</ArticleId><ArticleId IdType="pubmed">27212236</ArticleId></ArticleIdList></Reference><Reference><Citation>Delaney KT; Fredrickson GH Recent Developments in Fully Fluctuating Field-Theoretic Simulations of Polymer Melts and Solutions. J. Phys. Chem. B 2016, 120, 7615&#x2013;7634.</Citation><ArticleIdList><ArticleId IdType="pubmed">27414265</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarty J; Delaney KT; Danielsen SPO; Fredrickson GH; Shea JE Complete Phase Diagram for Liquid-Liquid Phase Separation of Intrinsically Disordered Proteins. J. Phys. Chem. Lett 2019, 10, 1644&#x2013;1652.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7379843</ArticleId><ArticleId IdType="pubmed">30873835</ArticleId></ArticleIdList></Reference><Reference><Citation>Voorn MJ Complex Coacervation.5. Experiments on the Distribution of Salts - Comparison of Theory and Experiment. Recl. Trav. Chim. Pay B 1956, 75, 1021&#x2013;1030.</Citation></Reference><Reference><Citation>Kotler SA; Walsh P; Brender JR; Ramamoorthy A Differences between Amyloid-&#x3b2; Aggregation in Solution and on the Membrane: Insights into Elucidation of the Mechanistic Details of Alzheimer&#x2019;s Disease. Chem. Soc. Rev 2014, 43, 6692&#x2013;6700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4110197</ArticleId><ArticleId IdType="pubmed">24464312</ArticleId></ArticleIdList></Reference><Reference><Citation>Butterfield SM; Lashuel HA Amyloidogenic Protein-membrane Interactions: Mechanistic Insight from Model Systems. Angew. Chem., Int. Ed 2010, 49, 5628&#x2013;5654.</Citation><ArticleIdList><ArticleId IdType="pubmed">20623810</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y; Ren B; Zhang Y; Sun Y; Chang Y; Liang G; Xu L; Zheng J Molecular Simulation Aspects of Amyloid Peptides at Membrane Interface. Biochim. Biophys. Acta, Biomembr 2018, 1860, 1906&#x2013;1916.</Citation><ArticleIdList><ArticleId IdType="pubmed">29421626</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S; Zheng XY; Krishnamoorthy J; Savelieff MG; Park HM; Brender JR; Kim JH; Derrick JS; Kochi A; Lee HJ; et al. Rational Design of a Structural Framework with Potential Use to Develop Chemical Reagents That Target and Modulate Multiple Facets of Alzheimer&#x2019;s Disease. J. Am. Chem. Soc 2014, 136, 299&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4096303</ArticleId><ArticleId IdType="pubmed">24397771</ArticleId></ArticleIdList></Reference><Reference><Citation>Brender JR; Salamekh S; Ramamoorthy A Membrane Disruption and Early Events in the Aggregation of the Diabetes Related Peptide IAPP from a Molecular Perspective. Acc. Chem. Res 2012, 45, 454&#x2013;462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3272313</ArticleId><ArticleId IdType="pubmed">21942864</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang MZ; Zhao J; Zheng J Molecular Understanding of a Potential Functional Link between Antimicrobial and Amyloid Peptides. Soft Matter 2014, 10, 7425&#x2013;7451.</Citation><ArticleIdList><ArticleId IdType="pubmed">25105988</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray IV; Liu L; Komatsu H; Uryu K; Xiao G; Lawson JA; Axelsen PH Membrane-mediated Amyloidogenesis and the Promotion of Oxidative Lipid Damage by Amyloid beta Proteins. J. Biol. Chem 2007, 282, 9335&#x2013;9345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2253689</ArticleId><ArticleId IdType="pubmed">17255094</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang H; Zheng J; Nussinov R Models of beta-amyloid Ion Channels in the Membrane Suggest that Channel Formation in the Bilayer is a Dynamic Process. Biophys. J 2007, 93, 1938&#x2013;1949.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1959551</ArticleId><ArticleId IdType="pubmed">17526580</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang H; Connelly L; Arce FT; Ramachandran S; Kagan BL; Lal R; Nussinov R Mechanisms for the Insertion of Toxic, Fibril-like beta-Amyloid Oligomers into the Membrane. J. Chem. Theory Comput 2013, 9, 822&#x2013;833.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3539805</ArticleId><ArticleId IdType="pubmed">23316126</ArticleId></ArticleIdList></Reference><Reference><Citation>Quist A; Doudevski I; Lin H; Azimova R; Ng D; Frangione B; Kagan B; Ghiso J; Lal R Amyloid Ion Channels: A Common Structural Link for Protein-misfolding Disease. Proc. Natl. Acad. Sci. U. S. A 2005, 102, 10427&#x2013;10432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1180768</ArticleId><ArticleId IdType="pubmed">16020533</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H; Bhatia R; Lal R Amyloid-beta Protein Forms Ion Channels: Implications for Alzheimer&#x2019;s Disease Pathophysiology. FASEB J 2001, 15, 2433&#x2013;2444.</Citation><ArticleIdList><ArticleId IdType="pubmed">11689468</ArticleId></ArticleIdList></Reference><Reference><Citation>Connelly L; Jang H; Teran Arce F; Capone R; Kotler SA; Ramachandran S; Kagan BL; Nussinov R; Lal R Atomic Force Microscopy and MD Simulations Reveal Pore-like Structures of all-d-enantiomer of Alzheimer&#x2019;s &#x3b2;-amyloid Peptide: Relevance to the Ion Channel Mechanism of AD Pathology. J. Phys. Chem. B 2012, 116, 1728&#x2013;1735.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4342054</ArticleId><ArticleId IdType="pubmed">22217000</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang H; Arce FT; Ramachandran S; Capone R; Lal R; Nussinov R beta-Barrel Topology of Alzheimer&#x2019;s beta-amyloid Ion Channels. J. Mol. Biol 2010, 404, 917&#x2013;934.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7291702</ArticleId><ArticleId IdType="pubmed">20970427</ArticleId></ArticleIdList></Reference><Reference><Citation>Korshavn KJ; Satriano C; Lin Y; Zhang R; Dulchavsky M; Bhunia A; Ivanova MI; Lee Y-H; La Rosa C; Lim MH; et al. Reduced Lipid Bilayer Thickness Regulates the Aggregation and Cytotoxicity of Amyloid-&#x3b2;. J. Biol. Chem 2017, 292, 4638&#x2013;4650.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5377779</ArticleId><ArticleId IdType="pubmed">28154182</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciudad S; Puig E; Botzanowski T; Meigooni M; Arango AS; Do J; Mayzel M; Bayoumi M; Chaignepain S; Maglia G; et al. A&#x3b2;(1&#x2013;42) Tetramer and Octamer Structures Reveal Edge Conductivity Pores as a Mechanism for Membrane Damage. Nat. Commun 2020, 11, 3014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7296003</ArticleId><ArticleId IdType="pubmed">32541820</ArticleId></ArticleIdList></Reference><Reference><Citation>Luhrs T; Ritter C; Adrian M; Riek-Loher D; Bohrmann B; Dobeli H; Schubert D; Riek R 3D Structure of Alzheimer&#x2019;s amyloid-beta(1&#x2013;42) Fibrils. Proc. Natl. Acad. Sci. U. S. A 2005, 102, 17342&#x2013;17347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1297669</ArticleId><ArticleId IdType="pubmed">16293696</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafrir Y; Durell S; Arispe N; Guy HR Models of Membrane-bound Alzheimer&#x2019;s Abeta Peptide Assemblies. Proteins: Struct., Funct., Genet 2010, 78, 3473&#x2013;3487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2976831</ArticleId><ArticleId IdType="pubmed">20939098</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang H; Arce FT; Ramachandran S; Capone R; Lal R; Nussinov R &#x3b2;-barrel Topology of Alzheimer&#x2019;s &#x3b2;-Amyloid Ion Channels. J. Mol. Biol 2010, 404, 917&#x2013;934.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7291702</ArticleId><ArticleId IdType="pubmed">20970427</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang H; Teran Arce F; Ramachandran S; Capone R; Lal R; Nussinov R Structural Convergence among Diverse, Toxic &#x3b2;-sheet Ion Channels. J. Phys. Chem. B 2010, 114, 9445&#x2013;9451.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2908347</ArticleId><ArticleId IdType="pubmed">20608696</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen PH; Campanera JM; Ngo ST; Loquet A; Derreumaux P Tetrameric A&#x3b2;40 and A&#x3b2;42 &#x3b2;-Barrel Structures by Extensive Atomistic Simulations. I. In a Bilayer Mimicking a Neuronal Membrane. J. Phys. Chem. B 2019, 123, 3643&#x2013;3648.</Citation><ArticleIdList><ArticleId IdType="pubmed">30971084</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo ST; Nguyen PH; Derreumaux P Impact of A2T and D23N Mutations on Tetrameric A&#x3b2;42 Barrel within a Dipalmitoylphosphatidylcholine Lipid Bilayer Membrane by Replica Exchange Molecular Dynamics. J. Phys. Chem. B 2020, 124, 1175&#x2013;1182.</Citation><ArticleIdList><ArticleId IdType="pubmed">31994886</ArticleId></ArticleIdList></Reference><Reference><Citation>Serra-Batiste M; Ninot-Pedrosa M; Bayoumi M; Gair&#xed; M; Maglia G; Carulla N A&#x3b2;42 Assembles into Specific &#x3b2;-barrel Pore-forming Oligomers in Membrane-mimicking Environments. Proc. Natl. Acad. Sci. U. S. A 2016, 113, 10866&#x2013;10871.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5047179</ArticleId><ArticleId IdType="pubmed">27621459</ArticleId></ArticleIdList></Reference><Reference><Citation>Bode DC; Baker MD; Viles JH Ion Channel Formation by Amyloid-&#x3b2;42 Oligomers but Not Amyloid-&#x3b2;40 in Cellular Membranes. J. Biol. Chem 2017, 292, 1404&#x2013;1413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5270483</ArticleId><ArticleId IdType="pubmed">27927987</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;sterlund N; Moons R; Ilag LL; Sobott F; Gr&#xe4;slund A Native Ion Mobility-Mass Spectrometry Reveals the Formation of &#x3b2;-Barrel Shaped Amyloid-&#x3b2; Hexamers in a Membrane-Mimicking Environment. J. Am. Chem. Soc 2019, 141, 10440&#x2013;10450.</Citation><ArticleIdList><ArticleId IdType="pubmed">31141355</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo ST; Derreumaux P; Vu VV Probable Transmembrane Amyloid &#x3b1;-Helix Bundles Capable of Conducting Ca2+ Ions. J. Phys. Chem. B 2019, 123, 2645&#x2013;2653.</Citation><ArticleIdList><ArticleId IdType="pubmed">30831027</ArticleId></ArticleIdList></Reference><Reference><Citation>Fantini J; Di Scala C; Yahi N; Troadec J-D; Sadelli K; Chahinian H; Garmy N Bexarotene Blocks Calcium-Permeable Ion Channels Formed by Neurotoxic Alzheimer&#x2019;s &#x3b2;-Amyloid Peptides. ACS Chem. Neurosci 2014, 5, 216&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4058752</ArticleId><ArticleId IdType="pubmed">24383913</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakio A; Nishimoto S-I; Yanagisawa K; Kozutsumi Y; Matsuzaki K Cholesterol-dependent Formation of GM1 Ganglio-side-bound Amyloid &#x3b2;-Protein, an Endogenous Seed for Alzheimer Amyloid. J. Biol. Chem 2001, 276, 24985&#x2013;24990.</Citation><ArticleIdList><ArticleId IdType="pubmed">11342534</ArticleId></ArticleIdList></Reference><Reference><Citation>Fantini J; Yahi N Molecular Insights into Amyloid Regulation by Membrane Cholesterol and Sphingolipids: Common Mechanisms in Neurodegenerative Diseases. Expert Rev. Mol. Med 2010, 12, 1&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2931503</ArticleId><ArticleId IdType="pubmed">20807455</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandel N; Matos JO; Tatulian SA Structure of amyloid &#x3b2;(25&#x2013;35) in Lipid Environment and Cholesterol-dependent Membrane Pore Formation. Sci. Rep 2019, 9, 2689.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6389947</ArticleId><ArticleId IdType="pubmed">30804528</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis CH; Berkowitz ML Structure of the amyloid-beta (1&#x2013;42) Monomer Absorbed to Model Phospholipid Bilayers: a Molecular Dynamics Study. J. Phys. Chem. B 2009, 113, 14480&#x2013;14486.</Citation><ArticleIdList><ArticleId IdType="pubmed">19807060</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong J; Roach CA; Oshokoya OO; Schroell RP; Yakubu RA; Eagleburger MK; Cooley JW; JiJi RD Role of Bilayer Characteristics on the Structural Fate of A&#x3b2;(1&#x2013;40) and A&#x3b2;(25&#x2013;40). Biochemistry 2014, 53, 3004&#x2013;3011.</Citation><ArticleIdList><ArticleId IdType="pubmed">24702518</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X; Zheng J Cholesterol Promotes the Interaction of Alzheimer &#x3b2;-amyloid Monomer with Lipid bilayer. J. Mol. Biol 2012, 421, 561&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pubmed">22108168</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoshino T; Mahmood MI; Mori K; Matsuzaki K Binding and Aggregation Mechanism of Amyloid &#x3b2;-Peptides onto the GM1 Ganglioside-Containing Lipid Membrane. J. Phys. Chem. B 2013, 117, 8085&#x2013;8094.</Citation><ArticleIdList><ArticleId IdType="pubmed">23688073</ArticleId></ArticleIdList></Reference><Reference><Citation>Manna M; Mukhopadhyay C Binding, Conformational Transition and Dimerization of amyloid-&#x3b2; peptide on GM1-containing Ternary Membrane: Insights from Molecular Dynamics Simulation. PLoS One 2013, 8, No. e71308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3739818</ArticleId><ArticleId IdType="pubmed">23951128</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemkul JA; Bevan DR Lipid Composition Influences the Release of Alzheimer&#x2019;s amyloid &#x3b2;-peptide from Membranes. Protein Sci 2011, 20, 1530&#x2013;1545.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3190148</ArticleId><ArticleId IdType="pubmed">21692120</ArticleId></ArticleIdList></Reference><Reference><Citation>Amaro M; &#x160;achl R; Aydogan G; Mikhalyov II; V&#xe1;cha R; Hof M GM1 Ganglioside Inhibits &#x3b2;-Amyloid Oligomerization Induced by Sphingomyelin. Angew. Chem., Int. Ed 2016, 55, 9411&#x2013;9415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5089616</ArticleId><ArticleId IdType="pubmed">27295499</ArticleId></ArticleIdList></Reference><Reference><Citation>Tofoleanu F; Buchete N-V Molecular Interactions of Alzheimer&#x2019;s A&#x3b2; Protofilaments with Lipid Membranes. J. Mol. Biol 2012, 421, 572&#x2013;586.</Citation><ArticleIdList><ArticleId IdType="pubmed">22281438</ArticleId></ArticleIdList></Reference><Reference><Citation>Tofoleanu F; Brooks BR; Buchete N-V Modulation of Alzheimer&#x2019;s A&#x3b2; Protofilament-Membrane Interactions by Lipid Headgroups. ACS Chem. Neurosci 2015, 6, 446&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6487634</ArticleId><ArticleId IdType="pubmed">25581460</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X; Wang Q; Pan Q; Zhou F; Zheng J Molecular Interactions of Alzheimer amyloid-beta Oligomers with Neutral and Negatively Charged lipid Bilayers. Phys. Chem. Chem. Phys 2013, 15, 8878&#x2013;8889.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3711658</ArticleId><ArticleId IdType="pubmed">23493873</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi X; Zhang Y; Gong M; Yu X; Darabedian N; Zheng J; Zhou F Ca2+ Interacts with Glu-22 of A&#x3b2;(1&#x2013;42) and Phospholipid Bilayers to Accelerate the A&#x3b2;(1&#x2013;42) Aggregation below the Critical Micelle Concentration. Biochemistry 2015, 54, 6323&#x2013;6332.</Citation><ArticleIdList><ArticleId IdType="pubmed">26426973</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamamizu-Kato S; Kosaraju MG; Kato H; Raussens V; Ruysschaert J-M; Narayanaswami V Calcium-Triggered Membrane Interaction of the &#x3b1;-Synuclein Acidic Tail. Biochemistry 2006, 45, 10947&#x2013;10956.</Citation><ArticleIdList><ArticleId IdType="pubmed">16953580</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M; Ren B; Liu Y; Liang G; Sun Y; Xu L; Zheng J Membrane interactions of hIAPP Monomer and Oligomer with Lipid Membranes by Molecular Dynamics Simulations. ACS Chem. Neurosci 2017, 8, 1789&#x2013;1800.</Citation><ArticleIdList><ArticleId IdType="pubmed">28585804</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez Hernandez A; Urbanke H; Gillman AL; Lee J; Ryazanov S; Agbemenyah HY; Benito E; Jain G; Kaurani L; Grigorian G; et al. The Diphenylpyrazole Compound anle138b Blocks A&#x3b2; Channels and Rescues Disease Phenotypes in a Mouse Model for amyloid pathology. EMBO Mol. Med 2018, 10, 32&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5760857</ArticleId><ArticleId IdType="pubmed">29208638</ArticleId></ArticleIdList></Reference><Reference><Citation>Last NB; Miranker AD Common Mechanism Unites Membrane Poration by Amyloid and Antimicrobial Peptides. Proc. Natl. Acad. Sci. U. S. A 2013, 110, 6382&#x2013;6387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3631635</ArticleId><ArticleId IdType="pubmed">23576726</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao Q; Wei G; Yao D; Song Z Formation of &#x3b1;-helical and &#x3b2;-sheet Structures in Membrane-bound Human IAPP Monomer and the Resulting Membrane Deformation. Phys. Chem. Chem. Phys 2019, 21, 20239&#x2013;20251.</Citation><ArticleIdList><ArticleId IdType="pubmed">31490518</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu WX; Wei GH; Su HB; Nordenskiold L; Mu YG Effects of Cholesterol on Pore Formation in Lipid Bilayers induced by Human Islet Amyloid Polypeptide Fragments: A Coarse-grained Molecular Dynamics Study. Phys. Rev. E 2011, 84, 051922.</Citation><ArticleIdList><ArticleId IdType="pubmed">22181459</ArticleId></ArticleIdList></Reference><Reference><Citation>Dignon GL; Zerze GH; Mittal J Interplay Between Membrane Composition and Structural Stability of Membrane-Bound hIAPP. J. Phys. Chem. B 2017, 121, 8661&#x2013;8668.</Citation><ArticleIdList><ArticleId IdType="pubmed">28829144</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo C; Cote S; Mousseau N; Wei GH Distinct Helix Propensities and Membrane Interactions of Human and Rat IAPP(1&#x2013;19) Monomers in Anionic Lipid Bilayers. J. Phys. Chem. B 2015, 119, 3366&#x2013;3376.</Citation><ArticleIdList><ArticleId IdType="pubmed">25646717</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia Y; Qian ZY; Zhang Y; Wei GH Adsorption and Orientation of Human Islet Amyloid Polypeptide (hIAPP) Monomer at Anionic Lipid Bilayers: Implications for Membrane-Mediated Aggregation. Int. J. Mol. Sci 2013, 14, 6241&#x2013;6258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3634446</ArticleId><ArticleId IdType="pubmed">23519103</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y; Luo Y; Deng YH; Mu YG; Wei GH Lipid Interaction and Membrane Perturbation of Human Islet Amyloid Polypeptide Monomer and Dimer by Molecular Dynamics Simulations. PLoS One 2012, 7, No. e38191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3364971</ArticleId><ArticleId IdType="pubmed">22693597</ArticleId></ArticleIdList></Reference><Reference><Citation>Skeby KK; Andersen OJ; Pogorelov TV; Tajkhorshid E; Schiott B Conformational Dynamics of the Human Islet Amyloid Polypeptide in a Membrane Environment: Toward the Aggregation Prone Form. Biochemistry 2016, 55, 2031&#x2013;2042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5733697</ArticleId><ArticleId IdType="pubmed">26953503</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan M; Fan J; Huo S Conformations of Islet Amyloid Polypeptide Monomers in a Membrane Environment: Implications for Fibril Formation. PLoS One 2012, 7, No. e47150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3487734</ArticleId><ArticleId IdType="pubmed">23133593</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y; Kakinen A; Xing Y; Faridi P; Nandakumar A; Purcell AW; Davis TP; Ke PC; Ding F Amyloid Self-Assembly of hIAPP8&#x2013;20 via the Accumulation of Helical Oligomers, &#x3b1;-Helix to &#x3b2;-Sheet Transition, and Formation of &#x3b2;-Barrel Intermediates. Small 2019, 15, 1805166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6499678</ArticleId><ArticleId IdType="pubmed">30908844</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian ZJ; Yan Wei G Binding Orientations and Lipid Interactions of Human Amylin at Zwitterionic and Anionic Lipid Bilayers. J. Diabetes Res 2016, 2016, 1749196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4663351</ArticleId><ArticleId IdType="pubmed">26649316</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen M; Schiott B Revealing a Dual Role of Ganglioside Lipids in the Aggregation of Membrane-Associated Islet Amyloid Polypeptide. J. Membr. Biol 2019, 252, 343&#x2013;356.</Citation><ArticleIdList><ArticleId IdType="pubmed">31222470</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayed R; Head E; Thompson JL; McIntire TM; Milton SC; Cotman CW; Glabe CG Common Structure of Soluble amyloid Oligomers Implies Common Mechanism of Pathogenesis. Science 2003, 300, 486&#x2013;489.</Citation><ArticleIdList><ArticleId IdType="pubmed">12702875</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang P; Xu WX; Mu YG Amyloidogenesis Abolished by Proline Substitutions but Enhanced by Lipid Binding. PLoS Comput. Biol 2009, 5, No. e1000357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2663790</ArticleId><ArticleId IdType="pubmed">19360098</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian ZY; Zou Y; Zhang QW; Chen PJ; Ma BY; Wei GH; Nussinov R Atomistic-level Study of the Interactions between hIAPP Protofibrils and Membranes: Influence of pH and lipid Composition. Biochim. Biophys. Acta, Biomembr 2018, 1860, 1818&#x2013;1825.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6408309</ArticleId><ArticleId IdType="pubmed">29428499</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J; Luo Y; Jang HB; Yu X; Wei GH; Nussinov R; Zheng J Probing Ion Channel Activity of Human islet Amyloid Polypeptide (amylin). Biochim. Biophys. Acta, Biomembr 2012, 1818, 3121&#x2013;3130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3455117</ArticleId><ArticleId IdType="pubmed">22935354</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J; Hu RD; Sciacca MFM; Brender JR; Chen H; Ramamoorthy A; Zheng J Non-selective Ion Channel Activity of Polymorphic Human islet Amyloid Polypeptide (amylin) Double Channels. Phys. Chem. Chem. Phys 2014, 16, 2368&#x2013;2377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3935214</ArticleId><ArticleId IdType="pubmed">24352606</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirzabekov TA; Lin M-C; Kagan BL Pore Formation by the Cytotoxic Islet Amyloid Peptide Amylin. J. Biol. Chem 1996, 271, 1988&#x2013;1992.</Citation><ArticleIdList><ArticleId IdType="pubmed">8567648</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrasate M; Perez M; Avila J Tau Dephosphorylation at tau-1 Site Correlates with its Association to Cell Membrane. Neurochem. Res 2000, 25, 43&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">10685603</ArticleId></ArticleIdList></Reference><Reference><Citation>Shea TB Phospholipids alter Tau Conformation, Phosphorylation, Proteolysis, and Association with Microtubules: Implication for tau Function under Normal and Degenerative Conditions. J. Neurosci. Res 1997, 50, 114&#x2013;122.</Citation><ArticleIdList><ArticleId IdType="pubmed">9379487</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgieva ER; Xiao SF; Borbat PP; Freed JH; Eliezer D Tau Binds to Lipid Membrane Surfaces via Short Amphipathic Helices Located in Its Microtubule-Binding Repeats. Biophys. J 2014, 107, 1441&#x2013;1452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4167292</ArticleId><ArticleId IdType="pubmed">25229151</ArticleId></ArticleIdList></Reference><Reference><Citation>Barre P; Eliezer D Folding of the Repeat Domain of Tau upon Binding to Lipid Surfaces. J. Mol. Biol 2006, 362, 312&#x2013;326.</Citation><ArticleIdList><ArticleId IdType="pubmed">16908029</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandt R; L&#xe9;ger J; Lee G Interaction of Tau with the Neural Plasma Membrane Mediated by Tau&#x2019;s amino-terminal Projection Domain. J. Cell Biol 1995, 131, 1327&#x2013;1340.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2120645</ArticleId><ArticleId IdType="pubmed">8522593</ArticleId></ArticleIdList></Reference><Reference><Citation>Press-Sandler O; Miller Y Molecular Mechanisms of Membrane-associated Amyloid Aggregation: Computational Perspective and Challenges. Biochim. Biophys. Acta, Biomembr 2018, 1860, 1889&#x2013;1905.</Citation><ArticleIdList><ArticleId IdType="pubmed">29555191</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones EM; Dubey M; Camp PJ; Vernon BC; Biernat J; Mandelkow E; Majewski J; Chi EY Interaction of Tau Protein with Model Lipid Membranes Induces Tau Structural Compaction and Membrane Disruption. Biochemistry 2012, 51, 2539&#x2013;2550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3319454</ArticleId><ArticleId IdType="pubmed">22401494</ArticleId></ArticleIdList></Reference><Reference><Citation>Barr&#xe9; P; Eliezer D Structural Transitions in Tau k18 on Micelle Binding Suggest a Hierarchy in the Efficacy of Individual Microtubule-binding Repeats in Filament Nucleation. Protein Sci 2013, 22, 1037&#x2013;1048.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3832040</ArticleId><ArticleId IdType="pubmed">23740819</ArticleId></ArticleIdList></Reference><Reference><Citation>Chirita CN; Necula M; Kuret J Anionic Micelles and Vesicles Induce Tau Fibrillization in vitro. J. Biol. Chem 2003, 278, 25644&#x2013;25650.</Citation><ArticleIdList><ArticleId IdType="pubmed">12730214</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunze G; Barre P; Scheidt HA; Thomas L; Eliezer D; Huster D Binding of the Three-repeat Domain of Tau to Phospholipid Membranes Induces an Aggregated-like State of the Protein. Biochim. Biophys. Acta, Biomembr 2012, 1818, 2302&#x2013;2313.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3595127</ArticleId><ArticleId IdType="pubmed">22521809</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasagna-Reeves CA; Sengupta U; Castillo-Carranza D; Gerson JE; Guerrero-Munoz M; Troncoso JC; Jackson GR; Kayed R The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes. Acta Neuropathol. Commun 2014, 2, 56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4231072</ArticleId><ArticleId IdType="pubmed">24887264</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghio S; Camilleri A; Caruana M; Ruf VC; Schmidt F; Leonov A; Ryazanov S; Griesinger C; Cauchi RJ; Kamp F; et al. Cardiolipin Promotes Pore-Forming Activity of Alpha-Synuclein Oligomers in Mitochondrial Membranes. ACS Chem. Neurosci 2019, 10, 3815&#x2013;3829.</Citation><ArticleIdList><ArticleId IdType="pubmed">31356747</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanni AM; Van der Zanden CM; Majewska PV; Majewski J; Chi EY Membrane-mediated Fibrillation and Toxicity of the tau Hexapeptide PHF6. J. Biol. Chem 2019, 294, 15304&#x2013;15317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6802503</ArticleId><ArticleId IdType="pubmed">31439664</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K; Arikan MC; Andreadis A Modulation of the Membrane-binding Domain of Tau Protein: Splicing Regulation of Exon 2. Mol. Brain Res 2003, 116, 94&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">12941465</ArticleId></ArticleIdList></Reference><Reference><Citation>Fusco G; Sanz-Hernandez M; De Simone A Order and Disorder in the Physiological Membrane Binding of alpha-synuclein. Curr. Opin. Struct. Biol 2018, 48, 49.</Citation><ArticleIdList><ArticleId IdType="pubmed">29100107</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu M; Fink AL Lipid Binding Inhibits alpha-synuclein Fibril Formation. J. Biol. Chem 2003, 278, 16873&#x2013;16877.</Citation><ArticleIdList><ArticleId IdType="pubmed">12621030</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrin RJ; Woods WS; Clayton DF; George JM Exposure to Long Chain Polyunsaturated Fatty Acids Triggers Rapid Multimerization of Synucleins. J. Biol. Chem 2001, 276, 41958&#x2013;41962.</Citation><ArticleIdList><ArticleId IdType="pubmed">11553616</ArticleId></ArticleIdList></Reference><Reference><Citation>Fusco G; Chen SW; Williamson PTF; Cascella R; Perni M; Jarvis JA; Cecchi C; Vendruscolo M; Chiti F; Cremades N; et al. Structural Basis of Membrane Disruption and Cellular Toxicity by alpha-synuclein Oligomers. Science 2017, 358, 1440&#x2013;1443.</Citation><ArticleIdList><ArticleId IdType="pubmed">29242346</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulmer TS; Bax A; Cole NB; Nussbaum RL Structure and Dynamics of Micelle-bound Human alpha-synuclein. J. Biol. Chem 2005, 280, 9595&#x2013;9603.</Citation><ArticleIdList><ArticleId IdType="pubmed">15615727</ArticleId></ArticleIdList></Reference><Reference><Citation>Campioni S; Carret G; Jordens S; Nicoud L; Mezzenga R; Riek R The Presence of an air-water Interface Affects Formation and Elongation of alpha-Synuclein Fibrils. J. Am. Chem. Soc 2014, 136, 2866&#x2013;2875.</Citation><ArticleIdList><ArticleId IdType="pubmed">24460028</ArticleId></ArticleIdList></Reference><Reference><Citation>Middleton ER; Rhoades E Effects of Curvature and Composition on alpha-synuclein Binding to Lipid Vesicles. Biophys. J 2010, 99, 2279&#x2013;2288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3042580</ArticleId><ArticleId IdType="pubmed">20923663</ArticleId></ArticleIdList></Reference><Reference><Citation>Fusco G; De Simone A; Arosio P; Vendruscolo M; Veglia G; Dobson CM Structural Ensembles of Membrane-bound alpha-Synuclein Reveal the Molecular Determinants of Synaptic Vesicle Affinity. Sci. Rep 2016, 6, 27125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4897633</ArticleId><ArticleId IdType="pubmed">27273030</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgieva ER; Ramlall TF; Borbat PP; Freed JH; Eliezer D Membrane-bound alpha-synuclein Forms an Extended Helix: Long-distance Pulsed ESR Measurements using Vesicles, Bicelles, and Rodlike Micelles. J. Am. Chem. Soc 2008, 130, 12856&#x2013;12857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2626176</ArticleId><ArticleId IdType="pubmed">18774805</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodner CR; Dobson CM; Bax A Multiple Tight Phospholipid-binding Modes of alpha-synuclein Revealed by Solution NMR spectroscopy. J. Mol. Biol 2009, 390, 775&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2709488</ArticleId><ArticleId IdType="pubmed">19481095</ArticleId></ArticleIdList></Reference><Reference><Citation>Oueslati A; Paleologou KE; Schneider BL; Aebischer P; Lashuel HA Mimicking Phosphorylation at serine 87 Inhibits the Aggregation of Human alpha-synuclein and Protects against its Toxicity in a Rat model of Parkinson&#x2019;s Disease. J. Neurosci 2012, 32, 1536&#x2013;1544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6703371</ArticleId><ArticleId IdType="pubmed">22302797</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephens AD; Zacharopoulou M; Moons R; Fusco G; Seetaloo N; Chiki A; Hooper PJ; Mela I; Lashuel H; Philips JJ; et al. Extent of N-terminus Exposure by Altered Long-range Interactions of Monomeric alpha-synuclein Determines its Aggregation Propensity. Nat. Commun 2020, 11, 2820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7272411</ArticleId><ArticleId IdType="pubmed">32499486</ArticleId></ArticleIdList></Reference><Reference><Citation>Dikiy I; Fauvet B; Jovicic A; Mahul-Mellier AL; Desobry C; El-Turk F; Gitler AD; Lashuel HA; Eliezer D Semisynthetic and in Vitro Phosphorylation of Alpha-Synuclein at Y39 Promotes Functional Partly Helical Membrane-Bound States Resembling Those Induced by PD Mutations. ACS Chem. Biol 2016, 11, 2428&#x2013;2437.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5240779</ArticleId><ArticleId IdType="pubmed">27356045</ArticleId></ArticleIdList></Reference><Reference><Citation>Runfola M; De Simone A; Vendruscolo M; Dobson CM; Fusco G The N-terminal Acetylation of alpha-Synuclein Changes the Affinity for Lipid Membranes but not the Structural Properties of the Bound State. Sci. Rep 2020, 10, 204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6959233</ArticleId><ArticleId IdType="pubmed">31937832</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltsev AS; Ying J; Bax A Impact of N-terminal Acetylation of alpha-Synuclein on its Random Coil and Lipid Binding Properties. Biochemistry 2012, 51, 5004&#x2013;5013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3383124</ArticleId><ArticleId IdType="pubmed">22694188</ArticleId></ArticleIdList></Reference><Reference><Citation>Lovell MA; Robertson JD; Teesdale WJ; Campbell JL; Markesbery WR Copper, Iron and Zinc in Alzheimer&#x2019;s Disease Senile Plaques. J. Neurol. Sci 1998, 158, 47&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">9667777</ArticleId></ArticleIdList></Reference><Reference><Citation>Chimienti F; Devergnas S; Favier A; Seve M Identification and Cloning of a &#x3b2;-Cell-Specific Zinc Transporter, ZnT-8, Localized into Insulin Secretory Granules. Diabetes 2004, 53, 2330&#x2013;2337.</Citation><ArticleIdList><ArticleId IdType="pubmed">15331542</ArticleId></ArticleIdList></Reference><Reference><Citation>Alghrably M; Czaban I; Jaremko &#x141;; Jaremko M Interaction of Amylin Species with Transition Metals and Membranes. J. Inorg. Biochem 2019, 191, 69&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">30468944</ArticleId></ArticleIdList></Reference><Reference><Citation>W&#xe4;rml&#xe4;nder SKTS; &#xd6;sterlund N; Wallin C; Wu J; Luo J; Tiiman A; Jarvet J; Gr&#xe4;slund A Metal Binding to the Amyloid-&#x3b2; Peptides in the Presence of Biomembranes: Potential Mechanisms of Cell Toxicity. JBIC, J. Biol. Inorg. Chem 2019, 24, 1189&#x2013;1196.</Citation><ArticleIdList><ArticleId IdType="pubmed">31562546</ArticleId></ArticleIdList></Reference><Reference><Citation>Faller P; Hureau C; Berthoumieu O Role of Metal Ions in the Self-Assembly of the Alzheimer&#x2019;s Amyloid-&#x3b2; Peptide. Inorg. Chem 2013, 52, 12193&#x2013;12206.</Citation><ArticleIdList><ArticleId IdType="pubmed">23607830</ArticleId></ArticleIdList></Reference><Reference><Citation>Rana M; Sharma AK Consequence of Coordination on Aggregation and Formation of Neurotoxic Soluble A&#x3b2; Oligomers. Metallomics 2019, 11, 64&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">30234208</ArticleId></ArticleIdList></Reference><Reference><Citation>Atri&#xe1;n-Blasco E; Gonz&#xe1;lez P; Santoro A; Alies B; Faller P; Hureau C Cu and Zn Coordination to Amyloid Peptides: From Fascinating Chemistry to Debated Pathological Relevance. Coord. Chem. Rev 2018, 371, 38&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6152896</ArticleId><ArticleId IdType="pubmed">30262932</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnham KJ; Bush AI Biological Metals and Metal-Targeting Compounds in Major Neurodegenerative Diseases. Chem. Soc. Rev 2014, 43, 6727&#x2013;6749.</Citation><ArticleIdList><ArticleId IdType="pubmed">25099276</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B-E; Nevitt T; Thiele DJ Mechanisms for Copper Acquisition, Distribution and Regulation. Nat. Chem. Biol 2008, 4, 176&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">18277979</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutsenko S; Bhattacharjee A; Hubbard AL Copper Handling Machinery of the Brain. Metallomics 2010, 2, 596.</Citation><ArticleIdList><ArticleId IdType="pubmed">21072351</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe-Nakayama T; Ono K High-Speed Atomic Force Microscopy of Individual Amyloidogenic Protein Assemblies. In Nanoscale Imaging. Methods in Molecular Biology; Lyubchenko Y, Eds.; Humana Press: New York, NY, 2018; p 1814.</Citation><ArticleIdList><ArticleId IdType="pubmed">29956234</ArticleId></ArticleIdList></Reference><Reference><Citation>Faller P; Hureau C; La Penna G Metal Ions and Intrinsically Disordered Proteins and Peptides: From Cu/Zn Amyloid-Beta to General Principles. Acc. Chem. Res 2014, 47, 2252&#x2013;2259.</Citation><ArticleIdList><ArticleId IdType="pubmed">24871565</ArticleId></ArticleIdList></Reference><Reference><Citation>Viles JH Metal Ions and Amyloid Fiber Formation in Neurodegenerative Diseases. Copper, Zinc and Iron in Alzheimer&#x2019;s, Parkinson&#x2019;s and Prion Diseases. Coord. Chem. Rev 2012, 256, 2271&#x2013;2284.</Citation></Reference><Reference><Citation>Xiao Z; Gottschlich L; van der Meulen R; Udagedara SR; Wedd AG Evaluation of Quantitative Probes for Weaker Cu(i) Binding Sites Completes a Set of Four Capable of Detecting Cu(i) Affinities from Nanomolar to Attomolar. Metallomics 2013, 5, 501&#x2013;513.</Citation><ArticleIdList><ArticleId IdType="pubmed">23579336</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefaniak E; Bal W CuII Binding Properties of N-Truncated A&#x3b2; Peptides: In Search of Biological Function. Inorg. Chem 2019, 58, 13561&#x2013;13577.</Citation><ArticleIdList><ArticleId IdType="pubmed">31304745</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez P; Bossak K; Stefaniak E; Hureau C; Raibaut L; Bal W; Faller P N-Terminal Cu-Binding Motifs (Xxx-Zzz-His, Xxx-His) and Their Derivatives: Chemistry, Biology and Medicinal Applications. Chem. - Eur. J 2018, 24, 8029&#x2013;8041.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6152890</ArticleId><ArticleId IdType="pubmed">29336493</ArticleId></ArticleIdList></Reference><Reference><Citation>Bacchella C; Gentili S; Bellotti D; Quartieri E; Draghi S; Baratto MC; Remelli M; Valensin D; Monzani E; Nicolis S; et al. Binding and Reactivity of Copper to R1 and R3 Fragments of Tau Protein. Inorg. Chem 2020, 59, 274&#x2013;286.</Citation><ArticleIdList><ArticleId IdType="pubmed">31820933</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin BK; Saxena S Insight into Potential Cu(II)-Binding Motifs in the Four Pseudorepeats of Tau Protein. J. Phys. Chem. B 2011, 115, 15067&#x2013;15078.</Citation><ArticleIdList><ArticleId IdType="pubmed">22085212</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo ZY; Zhu YZ; Zhu HL; Fan JB; Chen J; Liang Y Low Micromolar Zinc Accelerates the Fibrillization of Human Tau via Bridging of Cys-291 and Cys-322. J. Biol. Chem 2009, 284, 34648&#x2013;34657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2787327</ArticleId><ArticleId IdType="pubmed">19826005</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A; Kukreti R; Saso L; Kukreti S A Key Modulator in Neurodegenerative Diseases. Molecules 2019, 24, 1&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6514564</ArticleId><ArticleId IdType="pubmed">31013638</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilloreau L; Combalbert S; Sournia-Saquet A; Mazarguil H; Faller P Redox Chemistry of Copper-Amyloid-&#x3b2;: The Generation of Hydroxyl Radical in the Presence of Ascorbate Is Linked to Redox-Potentials and Aggregation State. ChemBioChem 2007, 8, 1317&#x2013;1325.</Citation><ArticleIdList><ArticleId IdType="pubmed">17577900</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoro A; Walke G; Vileno B; Kulkarni PP; Raibaut L; Faller P Low Catalytic Activity of the Cu(II)-Binding Motif (Xxx-Zzz-His; ATCUN) in Reactive Oxygen Species Production and Inhibition by the Cu(i)-Chelator BCS. Chem. Commun 2018, 54, 11945&#x2013;11948.</Citation><ArticleIdList><ArticleId IdType="pubmed">30288543</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheignon C; Jones M; Atri&#xe1;n-Blasco E; Kieffer I; Faller P; Collin F; Hureau C Identification of Key Structural Features of the Elusive Cu-A&#x3b2; Complex That Generates ROS in Alzheimer&#x2019;s Disease. Chem. Sci 2017, 8, 5107&#x2013;5118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5613283</ArticleId><ArticleId IdType="pubmed">28970897</ArticleId></ArticleIdList></Reference><Reference><Citation>Prosdocimi T; De Gioia L; Zampella G; Bertini L On the Generation of OH&#xb7; Radical Species from H2O2 by Cu(I) Amyloid Beta Peptide Model Complexes: A DFT Investigation. JBIC, J. Biol. Inorg. Chem 2016, 21, 197&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pubmed">26711660</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez EE; Arcos-L&#xf3;pez T; Trujano-Ortiz LG; Fern&#xe1;ndez CO; Gonz&#xe1;lez FJ; Vela A; Quintanar L Role of N-Terminal Methionine Residues in the Redox Activity of Copper Bound to Alpha-Synuclein. JBIC, J. Biol. Inorg. Chem 2016, 21, 691&#x2013;702.</Citation><ArticleIdList><ArticleId IdType="pubmed">27422629</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice ME Ascorbate Regulation and Its Neuroprotective Role in the Brain. Trends Neurosci 2000, 23, 209&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">10782126</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoro A; Wezynfeld N; Vasak M; Bal W; Faller P Cysteine and Glutathione Trigger the Cu-Zn Swap between Cu(II)-Amyloid-B4&#x2013;16 Peptide and Zn7-Metallothionein-3. Chem. Commun 2017, 53, 11634&#x2013;11637.</Citation><ArticleIdList><ArticleId IdType="pubmed">28948272</ArticleId></ArticleIdList></Reference><Reference><Citation>Danielsson J; Pierattelli R; Banci L; Gr&#xe4;slund A High-Resolution NMR Studies of the Zinc-Binding Site of the Alzheimer&#x2019;s Amyloid &#x3b2;-Peptide. FEBS J 2007, 274, 46&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">17222176</ArticleId></ArticleIdList></Reference><Reference><Citation>Sciarretta KL; Gordon DJ; Petkova AT; Tycko R; Meredith SC A&#x3b2;40-Lactam(D23/K28) Models a Conformation Highly Favorable for Nucleation of Amyloid. Biochemistry 2005, 44, 6003&#x2013;6014.</Citation><ArticleIdList><ArticleId IdType="pubmed">15835889</ArticleId></ArticleIdList></Reference><Reference><Citation>Mithu VS; Sarkar B; Bhowmik D; Chandrakesan M; Maiti S; Madhu PK Zn+2 Binding Disrupts the Asp 23-Lys 28 Salt Bridge without Altering the Hairpin-Shaped Cross-&#x3b2; Structure of A&#x3b2; 42 Amyloid Aggregates. Biophys. J 2011, 101, 2825&#x2013;2832.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3297803</ArticleId><ArticleId IdType="pubmed">22261072</ArticleId></ArticleIdList></Reference><Reference><Citation>Talmard C; Guilloreau L; Coppel Y; Mazarguil H; Faller P Amyloid-Beta Peptide Forms Monomeric Complexes with CuII and ZnII Prior to Aggregation. ChemBioChem 2007, 8, 163&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">17195250</ArticleId></ArticleIdList></Reference><Reference><Citation>Abelein A; Gr&#xe4;slund A; Danielsson J Zinc as Chaperone-Mimicking Agent for Retardation of Amyloid &#x3b2; Peptide Fibril Formation. Proc. Natl. Acad. Sci. U. S. A 2015, 112, 5407&#x2013;5412.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4418866</ArticleId><ArticleId IdType="pubmed">25825723</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezaei-Ghaleh N; Giller K; Becker S; Zweckstetter M Effect of Zinc Binding on &#x3b2;-Amyloid Structure and Dynamics: Implications for A&#x3b2; Aggregation. Biophys. J 2011, 101, 1202&#x2013;1211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3164126</ArticleId><ArticleId IdType="pubmed">21889458</ArticleId></ArticleIdList></Reference><Reference><Citation>Alies B; Conte-Daban A; Sayen S; Collin F; Kieffer I; Guillon E; Faller P; Hureau C Zinc(II) Binding Site to the Amyloid-&#x3b2; Peptide: Insights from Spectroscopic Studies with a Wide Series of Modified Peptides. Inorg. Chem 2016, 55, 10499&#x2013;10509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5069684</ArticleId><ArticleId IdType="pubmed">27665863</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghalebani L; Wahlstr&#xf6;m A; Danielsson J; W&#xe4;rml&#xe4;nder SKTS; Gr&#xe4;slund A PH-Dependence of the Specific Binding of Cu(II) and Zn(II) Ions to the Amyloid-&#x3b2; Peptide. Biochem. Biophys. Res. Commun 2012, 421, 554&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pubmed">22525674</ArticleId></ArticleIdList></Reference><Reference><Citation>Valiente-Gabioud AA; Torres-Monserrat V; Molina-Rubino L; Binolfi A; Griesinger C; Fern&#xe1;ndez CO Structural Basis behind the Interaction of Zn2+ with the Protein &#x3b1;-Synuclein and the A&#x3b2; Peptide: A Comparative Analysis. J. Inorg. Biochem 2012, 117, 334&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pubmed">22832069</ArticleId></ArticleIdList></Reference><Reference><Citation>Syme CD; Viles JH Solution 1H NMR Investigation of Zn2+ and Cd2+ Binding to Amyloid-Beta Peptide (A&#x3b2;) of Alzheimer&#x2019;s Disease. Biochim. Biophys. Acta, Proteins Proteomics 2006, 1764, 246&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pubmed">16266835</ArticleId></ArticleIdList></Reference><Reference><Citation>Istrate AN; Kozin SA; Zhokhov SS; Mantsyzov AB; Kechko OI; Pastore A; Makarov AA; Polshakov VI Interplay of Histidine Residues of the Alzheimer&#x2019;s Disease A&#x3b2; Peptide Governs Its Zn-Induced Oligomerization. Sci. Rep 2016, 6, 21734.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4761979</ArticleId><ArticleId IdType="pubmed">26898943</ArticleId></ArticleIdList></Reference><Reference><Citation>Polshakov VI; Mantsyzov AB; Kozin SA; Adzhubei AA; Zhokhov SS; van Beek W; Kulikova AA; Indeykina MI; Mitkevich VA; Makarov AA A Binuclear Zinc Interaction Fold Discovered in the Homodimer of Alzheimer&#x2019;s Amyloid-&#x3b2; Fragment with Taiwanese Mutation D7H. Angew. Chem., Int. Ed 2017, 56, 11734&#x2013;11739.</Citation><ArticleIdList><ArticleId IdType="pubmed">28570778</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulikova AA; Tsvetkov PO; Indeykina MI; Popov IA; Zhokhov SS; Golovin AV; Polshakov VI; Kozin SA; Nudler E; Makarov AA Phosphorylation of Ser8 Promotes Zinc-Induced Dimerization of the Amyloid-&#x3b2; Metal-Binding Domain. Mol. BioSyst 2014, 10, 2590&#x2013;2596.</Citation><ArticleIdList><ArticleId IdType="pubmed">25023775</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MC; Yu WC; Shih YH; Chen CY; Guo ZH; Huang SJ; Chan JCC; Chen YR Zinc Ion Rapidly Induces Toxic, off-Pathway Amyloid-&#x3b2; Oligomers Distinct from Amyloid-&#x3b2; Derived Diffusible Ligands in Alzheimer&#x2019;s Disease. Sci. Rep 2018, 8, 1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5859292</ArticleId><ArticleId IdType="pubmed">29555950</ArticleId></ArticleIdList></Reference><Reference><Citation>Hureau C Coordination of Redox Active Metal Ions to the Amyloid Precursor Protein and to Amyloid-&#x3b2; Peptides Involved in Alzheimer Disease. Part 1: An Overview. Coord. Chem. Rev 2012, 256, 2164&#x2013;2174.</Citation></Reference><Reference><Citation>Hou L; Zagorski MG NMR Reveals Anomalous Copper(II) Binding to the Amyloid A&#x3b2; Peptide of Alzheimer&#x2019;s Disease. J. Am. Chem. Soc 2006, 128, 9260&#x2013;9261.</Citation><ArticleIdList><ArticleId IdType="pubmed">16848423</ArticleId></ArticleIdList></Reference><Reference><Citation>De Gregorio G; Biasotto F; Hecel A; Luczkowski M; Kozlowski H; Valensin D Structural Analysis of Copper(I) Interaction with Amyloid &#x3b2; Peptide. J. Inorg. Biochem 2019, 195, 31&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">30884319</ArticleId></ArticleIdList></Reference><Reference><Citation>Alies B; Sasaki I; Proux O; Sayen S; Guillon E; Faller P; Hureau C Zn Impacts Cu Coordination to Amyloid-&#x3b2;, the Alzheimer&#x2019;s Peptide, but Not the ROS Production and the Associated Cell Toxicity. Chem. Commun 2013, 49, 1214&#x2013;1216.</Citation><ArticleIdList><ArticleId IdType="pubmed">23282470</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva KI; Saxena S Zn(II) Ions Substantially Perturb Cu(II) Ion Coordination in Amyloid-&#x3b2; at Physiological pH. J. Phys. Chem. B 2013, 117, 9386&#x2013;9394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3775258</ArticleId><ArticleId IdType="pubmed">23841511</ArticleId></ArticleIdList></Reference><Reference><Citation>Karr JW; Akintoye H; Kaupp LJ; Szalai VA N-Terminal Deletions Modify the Cu2+ Binding Site in Amyloid-&#x3b2;. Biochemistry 2005, 44, 5478&#x2013;5487.</Citation><ArticleIdList><ArticleId IdType="pubmed">15807541</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallin C; Jarvet J; Biverst&#xe8;l H; W&#xe4;rml&#xe4;nder S; Danielsson J; Gr&#xe4;slund A; Abelein A Metal Ion Coordination Delays Amyloid-&#x3b2; Peptide Self-Assembly by Forming an Aggregation-Inert Complex. J. Biol. Chem 2020, 295, 7224&#x2013;7234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7247290</ArticleId><ArticleId IdType="pubmed">32241918</ArticleId></ArticleIdList></Reference><Reference><Citation>Strodel B; Coskuner-Weber O Transition Metal Ion Interactions with Disordered Amyloid-&#x3b2; Peptides in the Pathogenesis of Alzheimer&#x2019;s Disease: Insights from Computational Chemistry Studies. J. Chem. Inf. Model 2019, 59, 1782&#x2013;1805.</Citation><ArticleIdList><ArticleId IdType="pubmed">30933519</ArticleId></ArticleIdList></Reference><Reference><Citation>Streltsov VA; Titmuss SJ; Epa VC; Barnham KJ; Masters CL; Varghese JN The Structure of the Amyloid-&#x3b2; Peptide High-Affinity Copper II Binding Site in Alzheimer Disease. Biophys. J 2008, 95, 3447&#x2013;345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2547438</ArticleId><ArticleId IdType="pubmed">18599641</ArticleId></ArticleIdList></Reference><Reference><Citation>Stellato F; Menestrina G; Serra MD; Potrich C; Tomazzolli R; Meyer-Klaucke W; Morante S Metal Binding in Amyloid &#x3b2;-peptides Shows Intra- and Inter-peptide Coordination Modes. Eur. Biophys. J 2006, 35, 340&#x2013;351.</Citation><ArticleIdList><ArticleId IdType="pubmed">16404590</ArticleId></ArticleIdList></Reference><Reference><Citation>Minicozzi V; Stellato F; Comai M; Serra MD; Potrich C; Meyer-Klaucke W; Morante S Identifying the Minimal Copper- and Zinc-binding Site Sequence in Amyloid-&#x3b2; Peptides. J. Biol. Chem 2008, 283, 10784&#x2013;10792.</Citation><ArticleIdList><ArticleId IdType="pubmed">18234670</ArticleId></ArticleIdList></Reference><Reference><Citation>Marino T; Russo N; Toscano M; Pavelka M On the metal ion (Zn(2+), Cu(2+)) coordination with beta-amyloid peptide: DFT computational study. Interdiscip. Sci.: Comput. Life Sci 2010, 2, 57.</Citation><ArticleIdList><ArticleId IdType="pubmed">20640797</ArticleId></ArticleIdList></Reference><Reference><Citation>Coskuner-Weber O Revisiting Cu(II) Bound Amyloid-&#x3b2;40 and Amyloid-&#x3b2;42 Peptides: Varying Coordination Chemistries. J. Turkish Chem. Soc., Section A: Chemistry 2018, 5, 981&#x2013;1008.</Citation></Reference><Reference><Citation>Furlan S; La Penna G Modeling of the Zn2+ binding in the 1&#x2013;16 region of the amyloid &#x3b2; peptide involved in Alzheimer&#x2019;s disease. Phys. Chem. Chem. Phys 2009, 11, 6468&#x2013;6481.</Citation><ArticleIdList><ArticleId IdType="pubmed">19809679</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannozzi P; Jansen K; La Penna G; Minicozzi V; Morante S; Rossi G; Stellato F Zn induced structural aggregation patterns of &#x3b2;-amyloid peptides by first-principle simulations and XAS measurements. Metallomics 2012, 4, 156&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">22170501</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozin SA; Mezentsev YV; Kulikova AA; Indeykina MA; Golovin AV; Ivanov AS; Tsvetkov PO; Makarov AA Zinc-induced dimerization of the amyloid-&#x3b2; metal-binding domain 1&#x2013;16 is mediated by residues 11&#x2013;14. Mol. BioSyst 2011, 7, 1053&#x2013;1055.</Citation><ArticleIdList><ArticleId IdType="pubmed">21350790</ArticleId></ArticleIdList></Reference><Reference><Citation>Furlan S; Hureau C; Faller P; La Penna G Modeling the Cu+ Binding in the 1&#x2013;16 Region of the Amyloid-&#x3b2; Peptide Involved in Alzheimer&#x2019;s Disease. J. Phys. Chem. B 2010, 114, 15119&#x2013;15133.</Citation><ArticleIdList><ArticleId IdType="pubmed">21038888</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Q; Owen MC; Olubiyi OO; Barz B; Strodel B Conformational Transitions of the Amyloid-&#x3b2; Peptide Upon Copper(II) Binding and pH Changes. Isr. J. Chem 2017, 57, 771&#x2013;784.</Citation></Reference><Reference><Citation>Ali-Torres J; Marechal J-D; Rodriguez-Santiago L; Sodupe M Three Dimensional Models of Cu2+-A&#x3b2;(1&#x2013;16) Complexes from Computational Approaches. J. Am. Chem. Soc 2011, 133, 15008&#x2013;15014.</Citation><ArticleIdList><ArticleId IdType="pubmed">21846101</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise-Scira O; Xu L; Perry G; Coskuner O Structures and Free Energy Landscapes of Aqueous Zinc(II)-bound Amyloid-&#x3b2;(1&#x2013;40) and Zinc(II)-bound Amyloid-&#x3b2;(1&#x2013;42) With Dynamics. JBIC, J. Biol. Inorg. Chem 2012, 17, 927&#x2013;938.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4886726</ArticleId><ArticleId IdType="pubmed">22674434</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan L; Patterson JC Molecular Dynamics Study of Zn(Ab) and Zn(Ab)2. PLoS One 2013, 8, No. e70681.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3785486</ArticleId><ArticleId IdType="pubmed">24086248</ArticleId></ArticleIdList></Reference><Reference><Citation>Coskuner O Divalent copper ion bound amyloid-&#x3b2;(40) and amyloid-&#x3b2;(42) alloforms are less preferred than divalent zinc ion bound amyloid-&#x3b2;(40) and amyloid-&#x3b2;(42) alloforms. JBIC, J. Biol. Inorg. Chem 2016, 21, 957&#x2013;973.</Citation><ArticleIdList><ArticleId IdType="pubmed">27659954</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Q; Owen MC; Bali S; Barz B; Strodel B A&#x3b2; under stress: the effects of acidosis, Cu2+-binding, and oxidation on amyloid &#x3b2;-peptide dimers. Chem. Commun 2018, 54, 7766&#x2013;7769.</Citation><ArticleIdList><ArticleId IdType="pubmed">29947363</ArticleId></ArticleIdList></Reference><Reference><Citation>Pham DQH; Li MS; La Penna G Copper Binding Induces Polymorphism in Amyloid-&#x3b2; Peptide: Results of Computational Models. J. Phys. Chem. B 2018, 122, 7243&#x2013;7252.</Citation><ArticleIdList><ArticleId IdType="pubmed">29957993</ArticleId></ArticleIdList></Reference><Reference><Citation>Brender JR; Hartman K; Nanga RPR; Popovych N; de La Salud Bea R; Vivekanandan S; Marsh ENG; Ramamoorthy A Role of Zinc in Human Islet Amyloid Polypeptide Aggregation. J. Am. Chem. Soc 2010, 132, 8973&#x2013;8983.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2904811</ArticleId><ArticleId IdType="pubmed">20536124</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamekh S; Brender JR; Hyung SJ; Nanga RPR; Vivekanandan S; Ruotolo BT; Ramamoorthy A A Two-Site Mechanism for the Inhibition of IAPP Amyloidogenesis by Zinc. J. Mol. Biol 2011, 410, 294&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3115507</ArticleId><ArticleId IdType="pubmed">21616080</ArticleId></ArticleIdList></Reference><Reference><Citation>Brender JR; Krishnamoorthy J; Messina GML; Deb A; Vivekanandan S; La Rosa C; Penner-Hahn JE; Ramamoorthy A Zinc Stabilization of Prefibrillar Oligomers of Human Islet Amyloid Polypeptide. Chem. Commun 2013, 49, 3339&#x2013;3341.</Citation><ArticleIdList><ArticleId IdType="pubmed">23505632</ArticleId></ArticleIdList></Reference><Reference><Citation>Wineman-Fisher V; Miller Y Effect of Zn2+ Ions on the Assembly of Amylin Oligomers: Insight Into the Molecular Mechanisms. Phys. Chem. Chem. Phys 2016, 18, 21590&#x2013;21599.</Citation><ArticleIdList><ArticleId IdType="pubmed">27425207</ArticleId></ArticleIdList></Reference><Reference><Citation>Wineman-Fisher V; Miller Y Insight Into a New Binding Site of Zinc Ions in Fibrillar Amylin. ACS Chem. Neurosci 2017, 8, 2078&#x2013;2087.</Citation><ArticleIdList><ArticleId IdType="pubmed">28692245</ArticleId></ArticleIdList></Reference><Reference><Citation>Uversky VN; Li J; Fink AL Metal-triggered Structural Transformations, Aggregation, and Fibrillation of Human Alpha-Synuclein. A Possible Molecular NK Between Parkinson&#x2019;s Disease and Heavy Metal Exposure. J. Biol. Chem 2001, 276, 44284&#x2013;44296.</Citation><ArticleIdList><ArticleId IdType="pubmed">11553618</ArticleId></ArticleIdList></Reference><Reference><Citation>Binolfi A; Rasia RM; Bertoncini CW; Ceolin M; Zweckstetter M; Griesinger C; Jovin TM; Fern&#xe1;ndez CO Interaction of Alpha-Synuclein With Divalent Metal Ions Reveals Key Differences: A Link Between Structure, Binding Specificity and Fibrillation Enhancement. J. Am. Chem. Soc 2006, 128, 9893&#x2013;9901.</Citation><ArticleIdList><ArticleId IdType="pubmed">16866548</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez N; Arcos-L&#xf3;pez T; K&#xf6;nig A; Quintanar L; Menacho Marquez M; Outeiro TF; Fern&#xe1;ndez CO Effects of Alpha-Synuclein Post-Translational Modifications on Metal Binding. J. Neurochem 2019, 150, 507&#x2013;521.</Citation><ArticleIdList><ArticleId IdType="pubmed">31099098</ArticleId></ArticleIdList></Reference><Reference><Citation>De Ricco R; Valensin D; Dell&#x2019;Acqua S; Casella L; Dorlet P; Faller P; Hureau C Remote His50 Acts as a Coordination Switch in the High-Affinity N-Terminal Centered Copper(II) Site of alpha-Synuclein. Inorg. Chem 2015, 54, 4744&#x2013;4751.</Citation><ArticleIdList><ArticleId IdType="pubmed">25926427</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y; Stanyon HF; Barritt JD; Mayet U; Patel P; Karamani E; Fusco G; Viles JH Copper2+ Binding to &#x3b1;-Synuclein. Histidine50 Can Form a Ternary Complex With Cu2+ at the N-Terminus but Not a Macrochelate. Inorg. Chem 2019, 58, 15580&#x2013;15589.</Citation><ArticleIdList><ArticleId IdType="pubmed">31697492</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandal M; Valle F; Tessari I; Mammi S; Bergantino E; Musiani F; Brucale M; Bubacco L; Samor&#xec; B Conformational Equilibria in Monomeric &#x3b1;-Synuclein at the Single-Molecule Level. PLoS Biol 2008, 6, No. e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2174973</ArticleId><ArticleId IdType="pubmed">18198943</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasia RM; Bertoncini CW; Marsh D; Hoyer W; Cherny D; Zweckstetter M; Griesinger C; Jovin TM; Fern&#xe1;ndez CO Structural Characterization of copper(II) Binding to Alpha-Synuclein: Insights Into the Bioinorganic Chemistry of Parkinson&#x2019;s Disease. Proc. Natl. Acad. Sci. U. S. A 2005, 102, 4294&#x2013;4299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC555498</ArticleId><ArticleId IdType="pubmed">15767574</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagakannan P; Tabeshmehr P; Eftekharpour E Oxidative Damage of Lysosomes in Regulated Cell Death Systems: Pathophysiology and Pharmacologic Interventions. Free Radic. Biol. Med 2020, S0891&#x2013;5849(20)30319&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pubmed">32259579</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang GJ; Liu H; Ma DL; Leung CH Rebalancing Metal Dyshomeostasis for Alzheimer&#x2019;s Disease Therapy. JBIC, J. Biol. Inorg. Chem 2019, 24, 1159&#x2013;1170.</Citation><ArticleIdList><ArticleId IdType="pubmed">31486954</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA; Hardiman O; Chio A; Al-Chalabi A; Pasterkamp RJ; Veldink JH; Van den Berg LH Amyotrophic Lateral Sclerosis. Lancet 2017, 390, 2084&#x2013;2098.</Citation><ArticleIdList><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Redler RL; Dokholyan NV The Complex Molecular Biology of Amyotrophic Lateral Sclerosis (ALS). Prog. Mol. Biol. Transl. Sci 2012, 107, 215&#x2013;262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3605887</ArticleId><ArticleId IdType="pubmed">22482452</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A; Hardiman O The Epidemiology of ALS: A Conspiracy of genes, Environment and Time. Nat. Rev. Neurol 2013, 9, 617&#x2013;628.</Citation><ArticleIdList><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R; Flynn LL; Pitout IL; Fletcher S; Wilton SD; Akkari PA ALS Genetics, Mechanisms, and Therapeutics: Where are we now? Front. Neurosci 2019, 13, 1310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsultan AA; Waller R; Heath PR; Kirby J The Genetics of Amyotrophic Lateral Sclerosis: Current Insights. Degener. Neurol. Neuromuscular Dis 2016, 6, 49&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6053097</ArticleId><ArticleId IdType="pubmed">30050368</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S; Sayana P; Zhang X; Le W Genetics of Amyotrophic Lateral Sclerosis: an update. Mol. Neurodegener 2013, 8, 28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3766231</ArticleId><ArticleId IdType="pubmed">23941283</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR; Siddique T; Patterson D; Figlewicz DA; Sapp P; Hentati A; Donaldson D; Goto J; O&#x2019;Regan JP; Deng HX; et al. Mutations in Cu/Zn Superoxide Dismutase Gene are associated with Familial Amyotrophic Lateral Sclerosis. Nature 1993, 362, 59&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi Y; Homma K; Ichijo H SOD1 in Neurotoxicity and its Controversial Roles in SOD1Mutation-negative ALS. Adv. Biol. Regul 2016, 60, 95&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">26563614</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME; Pu H; Chiu AY; Dal Canto MC; Polchow CY; Alexander DD; Caliendo J; Hentati A; Kwon YW; Deng HX; et al. Motor Neuron Degeneration in Mice that Express a Human Cu, Zn Superoxide Dismutase Mutation. Science 1994, 264, 1772&#x2013;1775.</Citation><ArticleIdList><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Reaume AG; Elliott JL; Hoffman EK; Kowall NW; Ferrante RJ; Siwek DR; Wilcox HM; Flood DG; Beal MF; Brown RH Jr; et al. Motor Neurons in Cu/Zn Superoxide Dismutase-deficient Mice Develop Normally but Exhibit Enhanced Cell Death after Axonal Injury. Nat. Genet 1996, 13, 43&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">8673102</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers JI; Fromholt SE; O&#x2019;Neal VM; Diamond JH; Borchelt DR Prion-like Propagation of Mutant SOD1Misfolding and Motor Neuron Disease Spread along Neuroanatomical Pathways. Acta Neuropathol 2016, 131, 103&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4699876</ArticleId><ArticleId IdType="pubmed">26650262</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K; Graffmo K; Pakkenberg B; Weber M; Nielsen M; Marklund S; Br&#xe4;nnstr&#xf6;m T; Andersen PM Misfolded SOD1 Inclusions in Patients with Mutations in C9orf72 and other ALS/FTD-associated Genes. J. Neurol., Neurosurg. Psychiatry 2019, 90, 861&#x2013;869.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6691870</ArticleId><ArticleId IdType="pubmed">30992335</ArticleId></ArticleIdList></Reference><Reference><Citation>Proctor EA; Fee L; Tao Y; Redler RL; Fay JM; Zhang Y; Lv Z; Mercer IP; Deshmukh M; Lyubchenko YL; et al. Nonnative SOD1 Trimer is Toxic to Motor Neurons in a Model of Amyotrophic Lateral Sclerosis. Proc. Natl. Acad. Sci. U. S. A 2016, 113, 614&#x2013;619.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4725519</ArticleId><ArticleId IdType="pubmed">26719414</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu C; Beck MV; Griffith JD; Deshmukh M; Dokholyan NV Large SOD1 Aggregates, unlike Trimeric SOD1, Do not Impact Cell Viability in a Model of Amyotrophic Lateral Sclerosis. Proc. Natl. Acad. Sci. U. S. A 2018, 115, 4661&#x2013;4665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5939103</ArticleId><ArticleId IdType="pubmed">29666246</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrawell NE; Lambert-Smith IA; Warraich ST; Blair IP; Saunders DN; Hatters DM; Yerbury JJ Distinct Partitioning of ALS Associated TDP-43, FUS and SOD1Mutants into Cellular Inclusions. Sci. Rep 2015, 5, 13416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4544019</ArticleId><ArticleId IdType="pubmed">26293199</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ; Taylor JP Lost in Transportation: Nucleocytoplasmic Transport Defects in ALS and other Neurodegenerative Diseases. Neuron 2017, 96, 285&#x2013;297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5678982</ArticleId><ArticleId IdType="pubmed">29024655</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam M; Jara JH; Kocak N; Rylaarsdam LE; Kim KD; Bigio EH; &#xd6;zdinler PH Mitochondria, ER, and Nuclear Membrane Defects Reveal Early Mechanisms for upper Motor Neuron Vulnerability with respect to TDP-43 Pathology. Acta Neuropathol 2019, 137, 47&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6339587</ArticleId><ArticleId IdType="pubmed">30450515</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou CC; Zhang Y; Umoh ME; Vaughan SW; Lorenzini I; Liu F; Sayegh M; Donlin-Asp PG; Chen YH; Duong DM; et al. TDP-43 pathology Disrupts Nuclear Pore Complexes and Nucleocytoplasmic Transport in ALS/FTD. Nat. Neurosci 2018, 21, 228&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Aulas A; Vande Velde C Alterations in Stress Granule Dynamics driven by TDP-43 and FUS: a Link to Pathological Inclusions in ALS? Front. Cell. Neurosci 2015, 9, 423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4615823</ArticleId><ArticleId IdType="pubmed">26557057</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeineddine R; Farrawell NE; Lambert-Smith IA; Yerbury JJ Addition of Exogenous SOD1 Aggregates Causes TDP-43 Mislocalisation and Aggregation. Cell Stress Chaperones 2017, 22, 893&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5655364</ArticleId><ArticleId IdType="pubmed">28560609</ArticleId></ArticleIdList></Reference><Reference><Citation>Vildan C; Sule D; Turker B; Hilmi U; Sibel KB Genetic Alterations of C9orf72, SOD1, TARDBP, FUS, and UBQLN2 Genes in Patients with Amyotrophic Lateral Sclerosis. Cogent Medicine 2019, 6, 1582400.</Citation></Reference><Reference><Citation>Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1Mutations. Mol. Neurobiol 2019, 56, 2007&#x2013;2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6394608</ArticleId><ArticleId IdType="pubmed">29982983</ArticleId></ArticleIdList></Reference><Reference><Citation>Higashi S; Tsuchiya Y; Araki T; Wada K; Kabuta T TDP-43 physically Interacts with Amyotrophic Lateral Sclerosis-linked Mutant CuZn Superoxide Dismutase. Neurochem. Int 2010, 57, 906&#x2013;913.</Citation><ArticleIdList><ArticleId IdType="pubmed">20933032</ArticleId></ArticleIdList></Reference><Reference><Citation>Pokrishevsky E; Grad LI; Yousefi M; Wang J; Mackenzie IR; Cashman NR Aberrant Localization of FUS and TDP43 is Associated with Misfolding of SOD1 in Amyotrophic Lateral Sclerosis. PLoS One 2012, 7, No. e35050.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3320864</ArticleId><ArticleId IdType="pubmed">22493728</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu EY; Cali CP; Lee EB RNA Metabolism in Neurodegenerative Disease. Dis. Model Mech 2017, 10, 509&#x2013;518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5451173</ArticleId><ArticleId IdType="pubmed">28468937</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewey CM; Cenik B; Sephton CF; Johnson BA; Herz J; Yu G TDP-43 Aggregation in Neurodegeneration: are Stress Granules the key? Brain Res 2012, 1462, 16&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3372581</ArticleId><ArticleId IdType="pubmed">22405725</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E; Baralle FE TDP-43: Gumming up Neurons through protein-protein and protein-RNA Interactions. Trends Biochem. Sci 2012, 37, 237&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pubmed">22534659</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis AM; Groen EJ; Koppers M; van den Berg LH; Pasterkamp RJ Protein Aggregation in Amyotrophic Lateral Sclerosis. Acta Neuropathol 2013, 125, 777&#x2013;794.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3661910</ArticleId><ArticleId IdType="pubmed">23673820</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vos KJ; Hafezparast M Neurobiology of Axonal Transport Defects in Motor Neuron Diseases: Opportunities for Translational Research? Neurobiol. Dis 2017, 105, 283&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5536153</ArticleId><ArticleId IdType="pubmed">28235672</ArticleId></ArticleIdList></Reference><Reference><Citation>Spaulding EL; Burgess RW Accumulating Evidence for Axonal Translation in Neuronal Homeostasis. Front. Neurosci 2017, 11, 312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5450000</ArticleId><ArticleId IdType="pubmed">28620277</ArticleId></ArticleIdList></Reference><Reference><Citation>Burk K; Pasterkamp RJ Disrupted Neuronal Trafficking in Amyotrophic Lateral Sclerosis. Acta Neuropathol 2019, 137, 859&#x2013;877.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6531423</ArticleId><ArticleId IdType="pubmed">30721407</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandizzi F; Barlowe C Organization of the ER-Golgi Interface for Membrane Traffic Control. Nat. Rev. Mol. Cell Biol 2013, 14, 382&#x2013;392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4064004</ArticleId><ArticleId IdType="pubmed">23698585</ArticleId></ArticleIdList></Reference><Reference><Citation>Heffernan LF; Simpson JC The Trials and Tubule-ations of Rab6 Involvement in Golgi-to-ER Retrograde Transport. Biochem. Soc. Trans 2014, 42, 1453&#x2013;1459.</Citation><ArticleIdList><ArticleId IdType="pubmed">25233431</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkin JD; Farg MA; Soo KY; Walker AK; Halloran M; Turner BJ; Nagley P; Horne MK Mutant SOD 1 Inhibits ER-Golgi Transport in Amyotrophic Lateral Sclerosis. J. Neurochem 2014, 129, 190&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">24134191</ArticleId></ArticleIdList></Reference><Reference><Citation>Soo KY; Halloran M; Sundaramoorthy V; Parakh S; Toth RP; Southam KA; McLean CA; Lock P; King A; Farg MA; et al. Rab1-dependent ER-Golgi Transport Dysfunction is a Common Pathogenic Mechanism in SOD1, TDP-43 and FUS-associated ALS. Acta Neuropathol 2015, 130, 679&#x2013;697.</Citation><ArticleIdList><ArticleId IdType="pubmed">26298469</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco DA; Morfini G; Karabacak NM; Song Y; Gros-Louis F; Pasinelli P; Goolsby H; Fontaine B; Lemay N; McKenna-Yasek D; et al. Wild-type and Mutant SOD1 Share an Aberrant Conformation and a Common Pathogenic Pathway in ALS. Nat. Neurosci 2010, 13, 1396&#x2013;1403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2967729</ArticleId><ArticleId IdType="pubmed">20953194</ArticleId></ArticleIdList></Reference><Reference><Citation>Morfini GA; Bosco DA; Brown H; Gatto R; Kaminska A; Song Y; Molla L; Baker L; Marangoni MN; Berth S; et al. Inhibition of Fast Axonal Transport by Pathogenic SOD1 Involves Activation of p38 MAP Kinase. PLoS One 2013, 8, No. e65235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3680447</ArticleId><ArticleId IdType="pubmed">23776455</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewil M; dela Cruz VF; Van Den Bosch L; Robberecht W Inhibition of p38 Mitogen Activated Protein Kinase Activation and Mutant SOD1G93A-induced Motor Neuron Death. Neurobiol. Dis 2007, 26, 332&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pubmed">17346981</ArticleId></ArticleIdList></Reference><Reference><Citation>Taes I; Timmers M; Hersmus N; Bento-Abreu A; Van Den Bosch L; Van Damme P; Auwerx J; Robberecht W Hdac6 Deletion Delays Disease Progression in the SOD1G93A Mouse Model of ALS. Hum. Mol. Genet 2013, 22, 1783&#x2013;1790.</Citation><ArticleIdList><ArticleId IdType="pubmed">23364049</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz DG; Greene C; Perl DP; Selkoe DJ Accumulation of Phosphorylated Neurofilaments in Anterior Horn Motoneurons of Amyotrophic Lateral Sclerosis Patients. J. Neuropathol. Exp. Neurol 1988, 47, 9&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">3334727</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson TL; Bruijn LI; Zhu Q; Anderson KL; Anderson SD; Julien JP; Cleveland DW Absence of Neurofilaments Reduces the Selective Vulnerability of Motor Neurons and Slows Disease caused by a Familial Amyotrophic Lateral Sclerosis-linked Superoxide Dismutase 1 Mutant. Proc. Natl. Acad. Sci. U. S. A 1998, 95, 9631&#x2013;9636.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC21390</ArticleId><ArticleId IdType="pubmed">9689132</ArticleId></ArticleIdList></Reference><Reference><Citation>Prahlad V; Helfand BT; Langford GM; Vale RD; Goldman RD Fast Transport of Neurofilament Protein along Microtubules in Squid Axoplasm. J. Cell Sci 2000, 113, 3939&#x2013;3946.</Citation><ArticleIdList><ArticleId IdType="pubmed">11058081</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunil N; Lee S; Shea TB Interference with Kinesin-based Anterograde Neurofilament Axonal Transport Increases Neurofilament-neurofilament Bundling. Cytoskeleton 2012, 69, 371&#x2013;379.</Citation><ArticleIdList><ArticleId IdType="pubmed">22434685</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilling AD; Horiuchi D; Lively CM; Saxton WM Kinesin-1 and Dynein are the Primary Motors for Fast Transport of Mitochondria in Drosophila Motor Axons. Mol. Biol. Cell 2006, 17, 2057&#x2013;2068.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1415296</ArticleId><ArticleId IdType="pubmed">16467387</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S; Owens GC; Makarenkova H; Edelman DB HDAC6 Regulates Mitochondrial Transport in Hippocampal Neurons. PLoS One 2010, 5, No. e10848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2877100</ArticleId><ArticleId IdType="pubmed">20520769</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vos KJ; Chapman AL; Tennant ME; Manser C; Tudor EL; Lau KF; Brownlees J; Ackerley S; Shaw PJ; McLoughlin DM; et al. Familial Amyotrophic Lateral Sclerosis-linked SOD1Mutants Perturb Fast Axonal Transport to Reduce Axonal Mitochondria Content. Hum. Mol. Genet 2007, 16, 2720&#x2013;2728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4516806</ArticleId><ArticleId IdType="pubmed">17725983</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y; Zhou B; Lin MY; Wang S; Foust KD; Sheng ZH Endolysosomal Deficits Augment Mitochondria Pathology in Spinal Motor Neurons of Asymptomatic fALS Mice. Neuron 2015, 87, 355&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4511489</ArticleId><ArticleId IdType="pubmed">26182418</ArticleId></ArticleIdList></Reference><Reference><Citation>Israelson A; Arbel N; Da Cruz S; Ilieva H; Yamanaka K; Shoshan-Barmatz V; Cleveland DW Misfolded Mutant SOD1 Directly Inhibits VDAC1 Conductance in a Mouse Model of Inherited ALS. Neuron 2010, 67, 575&#x2013;587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2941987</ArticleId><ArticleId IdType="pubmed">20797535</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkinezos IG; Bacman SR; Hernandez D; Oca-Cossio J; Arias LJ; Perez-Pinzon MA; Bradley WG; Moraes CT Cytochrome c Association with the Inner Mitochondrial Membrane is Impaired in the CNS of G93A-SOD1 mice. J. Neurosci 2005, 25, 164&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6725219</ArticleId><ArticleId IdType="pubmed">15634778</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattiazzi M; D&#x2019;Aurelio M; Gajewski CD; Martushova K; Kiaei M; Beal MF; Manfredi G Mutated Human SOD1 Causes Dysfunction of Oxidative Phosphorylation in Mitochondria of Transgenic Mice. J. Biol. Chem 2002, 277, 29626&#x2013;29633.</Citation><ArticleIdList><ArticleId IdType="pubmed">12050154</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P; Belford ME; Lennon N; Bacskai BJ; Hyman BT; Trotti D; Brown RH Jr, Amyotrophic Lateral Sclerosis-associated SOD1Mutant Proteins Bind and Aggregate with Bcl-2 in Spinal Cord Mitochondria. Neuron 2004, 43, 19&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">15233914</ArticleId></ArticleIdList></Reference><Reference><Citation>Edens BM; Miller N; Ma YC Impaired Autophagy and Defective Mitochondrial Function: Converging Paths on the Road to Motor Neuron Degeneration. Front. Cell. Neurosci 2016, 10, 44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4776126</ArticleId><ArticleId IdType="pubmed">26973461</ArticleId></ArticleIdList></Reference><Reference><Citation>Tadic V; Prell T; Lautenschlaeger J; Grosskreutz J The ER Mitochondria Calcium Cycle and ER Stress Response as Therapeutic Targets in Amyotrophic Lateral Sclerosis. Front. Cell. Neurosci 2014, 8, 147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4039088</ArticleId><ArticleId IdType="pubmed">24910594</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan S; Zhang ZW; Li ZL Cell Death-autophagy Loop and Glutamate-glutamine Cycle in Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci 2017, 10, 231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5519524</ArticleId><ArticleId IdType="pubmed">28785203</ArticleId></ArticleIdList></Reference><Reference><Citation>Foran E; Trotti D Glutamate Transporters and the Excitotoxic Path to Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis. Antioxid. Redox Signaling 2009, 11, 1587&#x2013;1602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2842587</ArticleId><ArticleId IdType="pubmed">19413484</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K; Lee S-G; Kegelman TP; Su ZZ; Das SK; Dash R; Dasgupta S; Barral PM; Hedvat M; Diaz P; et al. Role of Excitatory Amino Acid Transporter-2 (EAAT2) and Glutamate in Neurodegeneration: Opportunities for Developing Novel Therapeutics. J. Cell. Physiol 2011, 226, 2484&#x2013;2493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3130100</ArticleId><ArticleId IdType="pubmed">21792905</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortarolo M; Crossthwaite AJ; Conforti L; Spencer JP; Williams RJ; Bendotti C; Rattray M Expression of SOD1 G93A or wild-type SOD1 in Primary Cultures of Astrocytes down-regulates the Glutamate Transporter GLT-1: Lack of Involvement of Oxidative Stress. J. Neurochem 2004, 88, 481&#x2013;493.</Citation><ArticleIdList><ArticleId IdType="pubmed">14690536</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy J; Minotti S; Dong L; Figlewicz DA; Durham HD Glutamate Potentiates the Toxicity of Mutant Cu/Zn-Superoxide Dismutase in Motor Neurons by Postsynaptic calcium-dependent Mechanisms. J. Neurosci 1998, 18, 9673&#x2013;9684.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6793286</ArticleId><ArticleId IdType="pubmed">9822728</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendotti C; Tortarolo M; Suchak SK; Calvaresi N; Carvelli L; Bastone A; Rizzi M; Rattray M; Mennini T Transgenic SOD1 G93A Mice Develop Reduced GLT-1 in Spinal Cord without Alterations in Cerebrospinal Fluid Glutamate Levels. J. Neurochem 2001, 79, 737&#x2013;746.</Citation><ArticleIdList><ArticleId IdType="pubmed">11723166</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CLG; Kong Q; Cuny GD; Glicksman MA Glutamate Transporter EAAT2: a New Target for the Treatment of Neurodegenerative Diseases. Future Med. Chem 2012, 4, 1689&#x2013;1700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3580837</ArticleId><ArticleId IdType="pubmed">22924507</ArticleId></ArticleIdList></Reference><Reference><Citation>Doble A The Pharmacology and Mechanism of Action of Riluzole. Neurology 1996, 47, 233S&#x2013;241S.</Citation><ArticleIdList><ArticleId IdType="pubmed">8959995</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimori K; Ishikawa M; Otomo A; Atsuta N; Nakamura R; Akiyama T; Hadano S; Aoki M; Saya H; Sobue G; et al. Modeling Sporadic ALS in iPSC-derived Motor Neurons Identifies a Potential Therapeutic Agent. Nat. Med 2018, 24, 1579&#x2013;1589.</Citation><ArticleIdList><ArticleId IdType="pubmed">30127392</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Cruz S; Bui A; Saberi S; Lee SK; Stauffer J; McAlonis-Downes M; Schulte D; Pizzo DP; Parone PA; Cleveland D; et al. Misfolded SOD1 is not a Primary Component of Sporadic ALS. Acta Neuropathol 2017, 134, 97&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5472502</ArticleId><ArticleId IdType="pubmed">28247063</ArticleId></ArticleIdList></Reference><Reference><Citation>Atlasi RS; Malik R; Corrales CI; Tzeplaeff L; Whitelegge JP; Cashman NR; Bitan G Investigation of Anti-SOD1 Antibodies Yields New Structural Insight into SOD1Misfolding and Surprising Behavior of the Antibodies Themselves. ACS Chem. Biol 2018, 13, 2794&#x2013;2807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6475120</ArticleId><ArticleId IdType="pubmed">30110532</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; et al. Pathological TDP-43 Distinguishes Sporadic Amyotrophic Lateral Sclerosis from Amyotrophic Lateral Sclerosis with SOD1Mutations. Ann. Neurol 2007, 61, 427&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">17469116</ArticleId></ArticleIdList></Reference><Reference><Citation>Khare SD; Caplow M; Dokholyan NV The Rate and Equilibrium Constants for a Multistep reaction Sequence for the Aggregation of Superoxide Dismutase in Amyotrophic Lateral Sclerosis. Proc. Natl. Acad. Sci. U. S. A 2004, 101, 15094&#x2013;15099.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC524068</ArticleId><ArticleId IdType="pubmed">15475574</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel O; Powell JF; Andersen PM; Al-Chalabi A ALSoD: A user-friendly Online Bioinformatics Tool for Amyotrophic Lateral Sclerosis Genetics. Hum. Mutat 2012, 33, 1345&#x2013;1351.</Citation><ArticleIdList><ArticleId IdType="pubmed">22753137</ArticleId></ArticleIdList></Reference><Reference><Citation>Khare SD; Ding F; Dokholyan NV Folding of Cu, Zn Superoxide Dismutase and Familial Amyotrophic Lateral Sclerosis. J. Mol. Biol 2003, 334, 515&#x2013;525.</Citation><ArticleIdList><ArticleId IdType="pubmed">14623191</ArticleId></ArticleIdList></Reference><Reference><Citation>Khare SD; Dokholyan NV Common Dynamical Signatures of Familial Amyotrophic Lateral Sclerosis-associated Structurally Diverse Cu, Zn Superoxide Dismutase Mutants. Proc. Natl. Acad. Sci. U. S. A 2006, 103, 3147&#x2013;3152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1413921</ArticleId><ArticleId IdType="pubmed">16488975</ArticleId></ArticleIdList></Reference><Reference><Citation>Khare SD; Wilcox KC; Gong P; Dokholyan NV Sequence and Structural Determinants of Cu, Zn Superoxide Dismutase Aggregation. Proteins: Struct., Funct., Genet 2005, 61 (3), 617&#x2013;632.</Citation><ArticleIdList><ArticleId IdType="pubmed">16152647</ArticleId></ArticleIdList></Reference><Reference><Citation>Khare SD; Caplow M; Dokholyan NV FALS Mutations in Cu, Zn Superoxide Dismutase Destabilize the Dimer and Increase Dimer Dissociation Propensity: A Large-scale Thermodynamic Analysis. Amyloid 2006, 13, 226&#x2013;235.</Citation><ArticleIdList><ArticleId IdType="pubmed">17107883</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding F; Dokholyan NV Dynamical Roles of Metal Ions and the Disulfide Bond in Cu, Zn Superoxide Dismutase Folding and Aggregation. Proc. Natl. Acad. Sci. U. S. A 2008, 105, 19696&#x2013;19701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2604981</ArticleId><ArticleId IdType="pubmed">19052230</ArticleId></ArticleIdList></Reference><Reference><Citation>Redler RL; Shirvanyants D; Dagliyan O; Ding F; Kim DN; Kota P; Proctor EA; Ramachandran S; Tandon A; Dokholyan NV Computational Approaches to Understanding Protein Aggregation in Neurodegeneration. J. Mol. Cell Biol 2014, 6, 104&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3995224</ArticleId><ArticleId IdType="pubmed">24620031</ArticleId></ArticleIdList></Reference><Reference><Citation>Banks CJ; Andersen JL Mechanisms of SOD1 Regulation by Post-translational Modifications. Redox Biol 2019, 26, 101270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6658992</ArticleId><ArticleId IdType="pubmed">31344643</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilcox KC; Zhou L; Jordon JK; Huang Y; Yu Y; Redler RL; Dokholyan NV Modifications of Superoxide Dismutase (sod1) in Human Erythrocytes a Possible Role in Amyotrophic Lateral Sclerosis. J. Biol. Chem 2009, 284, 13940&#x2013;13947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2679493</ArticleId><ArticleId IdType="pubmed">19299510</ArticleId></ArticleIdList></Reference><Reference><Citation>Redler RL; Fee L; Fay JM; Caplow M; Dokholyan NV Non-native Soluble Oligomers of Cu/Zn Superoxide Dismutase (SOD1) Contain a Conformational Epitope Linked to Cytotoxicity in Amyotrophic Lateral Sclerosis (ALS). Biochemistry 2014, 53, 2423&#x2013;2432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4004233</ArticleId><ArticleId IdType="pubmed">24660965</ArticleId></ArticleIdList></Reference><Reference><Citation>Redler RL; Wilcox KC; Proctor EA; Fee L; Caplow M; Dokholyan NV Glutathionylation at Cys-111 Induces Dissociation of wild type and FALS Mutant SOD1 Dimers. Biochemistry 2011, 50, 7057&#x2013;7066.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3281512</ArticleId><ArticleId IdType="pubmed">21739997</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujiwara N; Nakano M; Kato S; Yoshihara D; Ookawara T; Eguchi H; Taniguchi N; Suzuki K Oxidative Modification to Cysteine Sulfonic Acid of Cys111 in Human copper-zinc Superoxide Dismutase. J. Biol. Chem 2007, 282, 35933&#x2013;35944.</Citation><ArticleIdList><ArticleId IdType="pubmed">17913710</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewhurst HM; Choudhury S; Torres MP Structural Analysis of PTM Hotspots (SAPH-ire)-a Quantitative Informatics Method Enabling the Discovery of Novel Regulatory Elements in Protein Families. Mol. Cell. Proteomics 2015, 14, 2285&#x2013;2297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4528253</ArticleId><ArticleId IdType="pubmed">26070665</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin EP; Derakhshan B; Lam TT; Davalos A; Sessa WC Endothelial Cell Palmitoylproteomic Identifies Novel lipid-modified Targets and Potential Substrates for Protein acyl transferases. Circ. Res 2012, 110, 1336&#x2013;1344.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3428238</ArticleId><ArticleId IdType="pubmed">22496122</ArticleId></ArticleIdList></Reference><Reference><Citation>Antinone SE; Ghadge GD; Lam TT; Wang L; Roos RP; Green WN Palmitoylation of Superoxide Dismutase 1 (SOD1) is Increased for Familial Amyotrophic Lateral Sclerosis-linked SOD1Mutants. J. Biol. Chem 2013, 288, 21606&#x2013;21617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3724620</ArticleId><ArticleId IdType="pubmed">23760509</ArticleId></ArticleIdList></Reference><Reference><Citation>Auclair JR; Brodkin HR; D&#x2019;Aquino JA; Petsko GA; Ringe D; Agar JN Structural Consequences of Cysteinylation of Cu/Zn-superoxide Dismutase. Biochemistry 2013, 52, 6145&#x2013;6150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3859770</ArticleId><ArticleId IdType="pubmed">23919400</ArticleId></ArticleIdList></Reference><Reference><Citation>Fay JM; Zhu C; Proctor EA; Tao Y; Cui W; Ke H; Dokholyan NV A Phosphomimetic Mutation Stabilizes SOD1 and Rescues Cell Viability in the Context of an ALS-associated Mutation. Structure 2016, 24, 1898&#x2013;1906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5093072</ArticleId><ArticleId IdType="pubmed">27667694</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu WC; Liang JZ; Li C; He ZX; Yuan HY; Huang BY; Liu XL; Tang B; Pang DW; Du HN; et al. Pathological Hydrogen Peroxide Triggers the Fibrillization of wild-type SOD1 via sulfenic acid Modification of Cys-111. Cell Death Dis 2018, 9, 1&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5833406</ArticleId><ArticleId IdType="pubmed">29358575</ArticleId></ArticleIdList></Reference><Reference><Citation>Hj&#xf8;rnevik LV; Fismen L; Young FM; Solstad T; Fladmark KE Nodularin Exposure Induces SOD1 Phosphorylation and Disrupts SOD1 Co-localization with Actin Filaments. Toxins 2012, 4, 1482&#x2013;1499.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3528258</ArticleId><ArticleId IdType="pubmed">23242317</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutedja NA; Veldink JH; Fischer K; Kromhout H; Heederik D; Huisman MH; Wokke JH; van den Berg LH Exposure to Chemicals and Metals and Risk of Amyotrophic Lateral Sclerosis: a Systematic Review. Amyotrophic Lateral Scler 2009, 10, 302&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">19922117</ArticleId></ArticleIdList></Reference><Reference><Citation>Proctor EA; Mowrey DD; Dokholyan NV &#x3b2;-Methylamino-L-alanine Substitution of Serine in SOD1 Suggests a Direct Role in ALS etiology. PLoS Comput. Biol 2019, 15, No. e1007225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6668853</ArticleId><ArticleId IdType="pubmed">31323035</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarei S; Carr K; Reiley L; Diaz K; Guerra O; Altamirano PF; Pagani W; Lodin D; Orozco G; Chinea A A Comprehensive Review of Amyotrophic Lateral Sclerosis. Surgical neurology international 2015, 6, 171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4653353</ArticleId><ArticleId IdType="pubmed">26629397</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur SJ; McKeown SR; Rashid S Mutant SOD1Mediated Pathogenesis of Amyotrophic Lateral Sclerosis. Gene 2016, 577, 109&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pubmed">26657039</ArticleId></ArticleIdList></Reference><Reference><Citation>Strange RW; Yong CW; Smith W; Hasnain SS Molecular Dynamics using Atomic-resolution Structure Reveal Structural Fluctuations that May Lead to Polymerization of Human Cu-Zn Superoxide Dismutase. Proc. Natl. Acad. Sci. U. S. A 2007, 104, 10040&#x2013;10044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1885824</ArticleId><ArticleId IdType="pubmed">17548825</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen P; Derreumaux P Understanding Amyloid Fibril Nucleation and A&#x3b2; Oligomer/Drug Interactions from Computer Simulations. Acc. Chem. Res 2014, 47, 603&#x2013;611.</Citation><ArticleIdList><ArticleId IdType="pubmed">24368046</ArticleId></ArticleIdList></Reference><Reference><Citation>Armiento V; Spanopoulou A; Kapurniotu A Peptide-Based Molecular Strategies To Interfere with Protein Misfolding, Aggregation, and Cell Degeneration. Angew. Chem., Int. Ed 2020, 59, 3372&#x2013;3384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7064928</ArticleId><ArticleId IdType="pubmed">31529602</ArticleId></ArticleIdList></Reference><Reference><Citation>Panza F; Lozupone M; Logroscino G; Imbimbo BP A Critical Appraisal of Amyloid-&#x3b2;-Targeting Therapies for Alzheimer Disease. Nat. Rev. Neurol 2019, 15, 73&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">30610216</ArticleId></ArticleIdList></Reference><Reference><Citation>Doig AJ; Derreumaux P Inhibition of Protein Aggregation and Amyloid Formation by Small Molecules. Curr. Opin. Struct. Biol 2015, 30, 50&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">25559306</ArticleId></ArticleIdList></Reference><Reference><Citation>Pujols J; Pe&#xf1;a-D&#xed;az S; Pallar&#xe8;s I; Ventura S Chemical Chaperones as Novel Drugs for Parkinson&#x2019;s Disease. Trends Mol. Med 2020, 26, 408&#x2013;421.</Citation><ArticleIdList><ArticleId IdType="pubmed">32277934</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoudi M; Kalhor HR; Laurent S; Lynch I Protein Fibrillation and Nanoparticle Interactions: Opportunities and Challenges. Nanoscale 2013, 5, 2570&#x2013;2588.</Citation><ArticleIdList><ArticleId IdType="pubmed">23463168</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M; Mao X; Yu Y; Wang C-X; Yang Y-L; Wang C Nanomaterials for Reducing Amyloid Cytotoxicity. Adv. Mater 2013, 25, 3780&#x2013;3801.</Citation><ArticleIdList><ArticleId IdType="pubmed">23722464</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke PC; Pilkington EH; Sun Y; Javed I; Kakinen A; Peng G; Ding F; Davis TP Mitigation of Amyloidosis with Nanomaterials. Adv. Mater 2020, 32, 1901690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6904546</ArticleId><ArticleId IdType="pubmed">31183916</ArticleId></ArticleIdList></Reference><Reference><Citation>Viswanathan GK; Shwartz D; Losev Y; Arad E; Shemesh C; Pichinuk E; Engel H; Raveh A; Jelinek R; Cooper I; et al. Purpurin Modulates Tau-Derived VQIVYK Fibrillization and Ameliorates Alzheimer&#x2019;s Disease-Like Symptoms in Animal Model. Cell. Mol. Life Sci 2020, 77, 2795&#x2013;2813.</Citation><ArticleIdList><ArticleId IdType="pubmed">31562564</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggett DW; Nath A The Rational Discovery of a Tau Aggregation Inhibitor. Biochemistry 2018, 57, 6099&#x2013;6107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7021323</ArticleId><ArticleId IdType="pubmed">30247897</ArticleId></ArticleIdList></Reference><Reference><Citation>Afitska K; Priss A; Yushchenko DA; Shvadchak VV Structural Optimization of Inhibitors of &#x3b1;-Synuclein Fibril Growth: Affinity to the Fibril End as a Crucial Factor. J. Mol. Biol 2020, 432, 967&#x2013;977.</Citation><ArticleIdList><ArticleId IdType="pubmed">31809698</ArticleId></ArticleIdList></Reference><Reference><Citation>Saravanan MS; Ryazanov S; Leonov A; Nicolai J; Praest P; Giese A; Winter R; Khemtemourian L; Griesinger C; Killian JA The Small Molecule Inhibitor Anle145c Thermodynamically Traps Human Islet Amyloid Peptide in the Form of Non-Cytotoxic Oligomers. Sci. Rep 2019, 9, 19023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6911113</ArticleId><ArticleId IdType="pubmed">31836748</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulton S; Selvaratnam R; Ahmed R; Van K; Cheng X; Melacini G Mechanisms of Specific versus Nonspecific Interactions of Aggregation-Prone Inhibitors and Attenuators. J. Med. Chem 2019, 62, 5063&#x2013;5079.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255057</ArticleId><ArticleId IdType="pubmed">31074269</ArticleId></ArticleIdList></Reference><Reference><Citation>Ara&#xfa;jo AR; Camero S; Taboada P; Reis RL; Pires RA Vescalagin and Castalagin Reduce the Toxicity of Amyloid-Beta42 Oligomers Through the Remodelling of its Secondary Structure. Chem. Commun 2020, 56, 3187&#x2013;3190.</Citation><ArticleIdList><ArticleId IdType="pubmed">32068230</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G; Yang W-Y; Li W-H; Luo Y-Y; Lim Y-J; Li Y; Paul A; Segal D; Hong L; Li Y-M Rational Design of a Cocktail of Inhibitors against A&#x3b2; Aggregation. Chem. - Eur. J 2020, 26, 3499&#x2013;3503.</Citation><ArticleIdList><ArticleId IdType="pubmed">32011042</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox SJ; Rodriguez Camargo DC; Lee Y-H; Ivanova MI; Padmini V; Reif B; Ramamoorthy A Small Molecule Induced Toxic Human-IAPP Species Characterized by NMR. Chem. Commun 2020, 56, 13129&#x2013;13132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7641245</ArticleId><ArticleId IdType="pubmed">33006345</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox SJ; Lam B; Prasad A; Marietta HA; Stander NV; Joel JG; Sahoo BR; Guo F; Stoddard AK; Ivanova MI; Ramamoorthy A High-Throughput Screening at the Membrane Interface Reveals Inhibitors of Amyloid-&#x3b2;. Biochemistry 2020, 59, 2249&#x2013;2258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10323872</ArticleId><ArticleId IdType="pubmed">32469202</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo J; Yu C-H; Yu H; Borstnar R; Kamerlin SCL; Gr&#xe4;slund A; Abrahams JP; W&#xe4;rml&#xe4;nder SKTS Cellular Polyamines Promote Amyloid-Beta (A&#x3b2;) Peptide Fibrillation and Modulate the Aggregation Pathways. ACS Chem. Neurosci 2013, 4, 454&#x2013;462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3605822</ArticleId><ArticleId IdType="pubmed">23509981</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo J; Mohammed I; W&#xe4;rml&#xe4;nder SKTS; Hiruma Y; Gr&#xe4;slund A; Abrahams JP Endogenous Polyamines Reduce the Toxicity of Soluble A&#x3b2; Peptide Aggregates Associated with Alzheimer&#x2019;s Disease. Biomacromolecules 2014, 15, 1985&#x2013;1991.</Citation><ArticleIdList><ArticleId IdType="pubmed">24750033</ArticleId></ArticleIdList></Reference><Reference><Citation>Limbocker R; Chia S; Ruggeri FS; Perni M; Cascella R; Heller GT; Meisl G; Mannini B; Habchi J; Michaels TCT; et al. Trodusquemine Enhances A&#x3b2;42 Aggregation but Suppresses its Toxicity by Displacing Oligomers from Cell Membranes. Nat. Commun 2019, 10, 225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6333784</ArticleId><ArticleId IdType="pubmed">30644384</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahoo BR; Genjo T; Nakayama TW; Stoddard AK; Ando T; Yasuhara K; Fierke CA; Ramamoorthy A A Cationic Polymethacrylate-Copolymer Acts as an Agonist for &#x3b2;-Amyloid and an Antagonist for Amylin Fibrillation. Chem. Sci 2019, 10, 3976&#x2013;3986.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6457205</ArticleId><ArticleId IdType="pubmed">31015938</ArticleId></ArticleIdList></Reference><Reference><Citation>Assarsson A; Linse S; Cabaleiro-Lago C Effects of Polyamino Acids and Polyelectrolytes on Amyloid &#x3b2; Fibril Formation. Langmuir 2014, 30, 8812&#x2013;8818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4191606</ArticleId><ArticleId IdType="pubmed">24978100</ArticleId></ArticleIdList></Reference><Reference><Citation>Prade E; Barucker C; Sarkar R; Althoff-Ospelt G; Lopez del Amo JM; Hossain S; Zhong Y; Multhaup G; Reif B Sulindac Sulfide Induces the Formation of Large Oligomeric Aggregates of the Alzheimer&#x2019;s Disease Amyloid-&#x3b2; Peptide Which Exhibit Reduced Neurotoxicity. Biochemistry 2016, 55, 1839&#x2013;1849.</Citation><ArticleIdList><ArticleId IdType="pubmed">26900939</ArticleId></ArticleIdList></Reference><Reference><Citation>Young LM; Ashcroft AE; Radford SE Small Molecule Probes of Protein Aggregation. Curr. Opin. Chem. Biol 2017, 39, 90&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">28649012</ArticleId></ArticleIdList></Reference><Reference><Citation>Davinelli S; Sapere N; Zella D; Bracale R; Intrieri M; Scapagnini G Pleiotropic Protective Effects of Phytochemicals in Alzheimer&#x2019;s Disease. Oxid. Med. Cell. Longevity 2012, 2012, 386527.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3368517</ArticleId><ArticleId IdType="pubmed">22690271</ArticleId></ArticleIdList></Reference><Reference><Citation>Sparks S; Liu G; Robbins KJ; Lazo ND Curcumin Modulates the Self-Assembly of the Islet Amyloid Polypeptide by Disassembling &#x3b1;-Helix. Biochem. Biophys. Res. Commun 2012, 422, 551&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pubmed">22579683</ArticleId></ArticleIdList></Reference><Reference><Citation>Daval M; Bedrood S; Gurlo T; Huang C-J; Costes S; Butler PC; Langen R The Effect of Curcumin on Human Islet Amyloid Polypeptide Misfolding and Toxicity. Amyloid 2010, 17, 118&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4394664</ArticleId><ArticleId IdType="pubmed">21067307</ArticleId></ArticleIdList></Reference><Reference><Citation>Pithadia AS; Bhunia A; Sribalan R; Padmini V; Fierke CA; Ramamoorthy A Influence of a Curcumin Derivative on hIAPP Aggregation in the Absence and Presence of Lipid Membranes. Chem. Commun 2016, 52, 942&#x2013;945.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4703533</ArticleId><ArticleId IdType="pubmed">26587568</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao P; Raleigh DP Analysis of the Inhibition and Remodeling of Islet Amyloid Polypeptide Amyloid Fibers by Flavanols. Biochemistry 2012, 51, 2670&#x2013;2683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3329122</ArticleId><ArticleId IdType="pubmed">22409724</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed R; VanSchouwen B; Jafari N; Ni X; Ortega J; Melacini G Molecular Mechanism for the (&#x2212;)-Epigallocatechin Gallate-Induced Toxic to Nontoxic Remodeling of A&#x3b2; Oligomers. J. Am. Chem. Soc 2017, 139, 13720&#x2013;13734.</Citation><ArticleIdList><ArticleId IdType="pubmed">28841302</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng F; Abedini A; Plesner A; Verchere CB; Raleigh DP The Flavanol (&#x2212;)-Epigallocatechin 3-Gallate Inhibits Amyloid Formation by Islet Amyloid Polypeptide, Disaggregates Amyloid Fibrils, and Protects Cultured Cells against IAPP-Induced Toxicity. Biochemistry 2010, 49, 8127&#x2013;8133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3199968</ArticleId><ArticleId IdType="pubmed">20707388</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y-H; Lin Y; Cox SJ; Kinoshita M; Sahoo BR; Ivanova M; Ramamoorthy A Zinc Boosts EGCG&#x2019;s hIAPP Amyloid Inhibition both in Solution and Membrane. Biochim. Biophys. Acta, Proteins Proteomics 2019, 1867, 529&#x2013;536.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6450719</ArticleId><ArticleId IdType="pubmed">30468883</ArticleId></ArticleIdList></Reference><Reference><Citation>Noor H; Cao P; Raleigh DP Morin Hydrate Inhibits Amyloid Formation by Islet Amyloid Polypeptide and Disaggregates Amyloid Fibers. Protein Sci 2012, 21, 373&#x2013;382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3375438</ArticleId><ArticleId IdType="pubmed">22238175</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng F; Abedini A; Plesner A; Middleton CT; Potter KJ; Zanni MT; Verchere CB; Raleigh DP The Sulfated Triphenyl Methane Derivative Acid Fuchsin Is a Potent Inhibitor of Amyloid Formation by Human Islet Amyloid Polypeptide and Protects against the Toxic Effects of Amyloid Formation. J. Mol. Biol 2010, 400, 555&#x2013;566.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2902639</ArticleId><ArticleId IdType="pubmed">20452363</ArticleId></ArticleIdList></Reference><Reference><Citation>Franko A; Rodriguez Camargo DC; B&#xf6;ddrich A; Garg D; Rodriguez Camargo A; Rathkolb B; Janik D; Aichler M; Feuchtinger A; Neff F; et al. Epigallocatechin Gallate (EGCG) Reduces the Intensity of Pancreatic Amyloid Fibrils in Human Islet Amyloid Polypeptide (hIAPP) Transgenic Mice. Sci. Rep 2018, 8, 1116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5773570</ArticleId><ArticleId IdType="pubmed">29348618</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthes D; Gapsys V; Griesinger C; de Groot BL Resolving the Atomistic Modes of Anle138b Inhibitory Action on Peptide Oligomer Formation. ACS Chem. Neurosci 2017, 8, 2791&#x2013;2808.</Citation><ArticleIdList><ArticleId IdType="pubmed">28906103</ArticleId></ArticleIdList></Reference><Reference><Citation>Sciacca MFM; Chillemi R; Sciuto S; Greco V; Messineo C; Kotler SA; Lee D-K; Brender JR; Ramamoorthy A; La Rosa C; et al. A Blend of two Resveratrol Derivatives Abolishes hIAPP Amyloid Growth and Membrane Damage. Biochim. Biophys. Acta, Biomembr 2018, 1860, 1793&#x2013;1802.</Citation><ArticleIdList><ArticleId IdType="pubmed">29555190</ArticleId></ArticleIdList></Reference><Reference><Citation>Lolicato F; Raudino A; Milardi D; La Rosa C Resveratrol Interferes with the Aggregation of Membrane-Bound Human-IAPP: A Molecular Dynamics Study. Eur. J. Med. Chem 2015, 92, 876&#x2013;881.</Citation><ArticleIdList><ArticleId IdType="pubmed">25638571</ArticleId></ArticleIdList></Reference><Reference><Citation>Brendel M; Deussing M; Blume T; Kaiser L; Probst F; Overhoff F; Peters F; von Ungern-Sternberg B; Ryazanov S; Leonov A; et al. Late-Stage Anle138b Treatment Ameliorates Tau Pathology and Metabolic Decline in a Mouse Model of Human Alzheimer&#x2019;s Disease Tau. Alzheimer&#x2019;s Res. Ther 2019, 11, 67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6670231</ArticleId><ArticleId IdType="pubmed">31370885</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambure P; Bhat J; Puzyn T; Roy K Identifying Natural Compounds as Multi-Target-Directed Ligands Against Alzheimer&#x2019;s Disease: an in silico Approach. J. Biomol. Struct. Dyn 2019, 37, 1282&#x2013;1306.</Citation><ArticleIdList><ArticleId IdType="pubmed">29578387</ArticleId></ArticleIdList></Reference><Reference><Citation>Perni M; Galvagnion C; Maltsev A; Meisl G; Muller MBD; Challa PK; Kirkegaard JB; Flagmeier P; Cohen SIA; Cascella R; et al. A Natural Product Inhibits the Initiation of alpha-synuclein Aggregation and Suppresses its Toxicity. Proc. Natl. Acad. Sci. U. S. A 2017, 114, E1009&#x2013;E1017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5307473</ArticleId><ArticleId IdType="pubmed">28096355</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoilova T; Colombo L; Forloni G; Tagliavini F; Salmona M A New Face for Old Antibiotics: Tetracyclines in Treatment of Amyloidoses. J. Med. Chem 2013, 56, 5987&#x2013;6006.</Citation><ArticleIdList><ArticleId IdType="pubmed">23611039</ArticleId></ArticleIdList></Reference><Reference><Citation>Young LM; Saunders JC; Mahood RA; Revill CH; Foster RJ; Tu L-H; Raleigh DP; Radford SE; Ashcroft AE Screening and Classifying Small-Molecule Inhibitors of Amyloid Formation using Ion Mobility Spectrometry-Mass Spectrometry. Nat. Chem 2015, 7, 73&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4280571</ArticleId><ArticleId IdType="pubmed">25515893</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladiwala ARA; Dordick JS; Tessier PM Aromatic Small Molecules Remodel Toxic Soluble Oligomers of Amyloid &#x3b2; through Three Independent Pathways. J. Biol. Chem 2011, 286, 3209&#x2013;3218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3030325</ArticleId><ArticleId IdType="pubmed">21098486</ArticleId></ArticleIdList></Reference><Reference><Citation>Alghazwi M; Smid S; Musgrave I; Zhang W In vitro Studies of the Neuroprotective Activities of Astaxanthin and Fucoxanthin Against Amyloid Beta (A&#x3b2;1&#x2013;42) Toxicity and Aggregation. Neurochem. Int 2019, 124, 215&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pubmed">30639263</ArticleId></ArticleIdList></Reference><Reference><Citation>Minh Hung H; Nguyen MT; Tran P-T; Truong VK; Chapman J; Quynh Anh LH; Derreumaux P; Vu VV; Ngo ST Impact of the Astaxanthin, Betanin and EGCG Compounds on Small Oligomers of the Amyloid A&#x3b2;40 Peptide. J. Chem. Inf. Model 2020, 60, 1399&#x2013;1408.</Citation><ArticleIdList><ArticleId IdType="pubmed">32105466</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D-H; Kim C-S; Lee YJ Astaxanthin Protects Against MPTP/MPP+-Induced Mitochondrial Dysfunction and ROS Production in vivo and in vitro. Food Chem. Toxicol 2011, 49, 271&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3010303</ArticleId><ArticleId IdType="pubmed">21056612</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishiki M; Nishida Y; Ishibashi H; Wada T; Fujisaka S; Takikawa A; Urakaze M; Sasaoka T; Usui I; Tobe K Impact of Divergent Effects of Astaxanthin on Insulin Signaling in L6 Cells. Endocrinology 2013, 154, 2600&#x2013;2612.</Citation><ArticleIdList><ArticleId IdType="pubmed">23715867</ArticleId></ArticleIdList></Reference><Reference><Citation>Isonaka R; Hiruma H; Katakura T; Kawakami T Inhibition of Superoxide Dismutase Selectively Suppresses Growth of Rat Spinal Motor Neurons: Comparison with Phosphorylated Neurofilament-Containing Spinal Neurons. Brain Res 2011, 1425, 13&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">22018668</ArticleId></ArticleIdList></Reference><Reference><Citation>Du W-J; Guo J-J; Gao M-T; Hu S-Q; Dong X-Y; Han Y-F; Liu F-F; Jiang S; Sun Y Brazilin Inhibits Amyloid &#x3b2;-Protein Fibrillogenesis, Remodels Amyloid Fibrils and Reduces Amyloid Cytotoxicity. Sci. Rep 2015, 5, 7992.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4303869</ArticleId><ArticleId IdType="pubmed">25613018</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu FF; Wang Y; Sang JC; Wei W; Zhao WP; Chen BB; Zhao F; Jia LG; Lu FP Brazilin Inhibits alpha-Synuclein Fibrillogenesis, Disrupts Mature Fibrils, and Protects against Amyloid-Induced Cytotoxicity. J. Agric. Food Chem 2019, 67, 11769&#x2013;11777.</Citation><ArticleIdList><ArticleId IdType="pubmed">31575115</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J; Sun W; Li L; Liu F; Lu W Brazilin Inhibits Fibrillogenesis of Human Islet Amyloid Polypeptide, Disassembles Mature Fibrils, and Alleviates Cytotoxicity. RSC Adv 2017, 7, 43491&#x2013;43501.</Citation></Reference><Reference><Citation>Ngo ST; Fang S-T; Huang S-H; Chou C-L; Huy PDQ; Li MS; Chen Y-C Anti-Arrhythmic Medication Propafenone a Potential Drug for Alzheimer&#x2019;s Disease Inhibiting Aggregation of A&#x3b2;: In Silico and In Vitro Studies. J. Chem. Inf. Model 2016, 56, 1344&#x2013;1356.</Citation><ArticleIdList><ArticleId IdType="pubmed">27304669</ArticleId></ArticleIdList></Reference><Reference><Citation>Kundu P; Das M; Tripathy K; Sahoo SK Delivery of Dual Drug Loaded Lipid Based Nanoparticles across the Blood-Brain Barrier Impart Enhanced Neuroprotection in a Rotenone Induced Mouse Model of Parkinson&#x2019;s Disease. ACS Chem. Neurosci 2016, 7, 1658&#x2013;1670.</Citation><ArticleIdList><ArticleId IdType="pubmed">27642670</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedumpully-Govindan P; Kakinen A; Pilkington EH; Davis TP; Chun Ke P; Ding F Stabilizing Off-pathway Oligomers by Polyphenol Nanoassemblies for IAPP Aggregation Inhibition. Sci. Rep 2016, 6, 19463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4725907</ArticleId><ArticleId IdType="pubmed">26763863</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatia NK; Srivastava A; Katyal N; Jain N; Khan MAI; Kundu B; Deep S Curcumin Binds to the Pre-Fibrillar Aggregates of Cu/Zn Superoxide Dismutase (SOD1) and Alters its Amyloidogenic Pathway Resulting in Reduced Cytotoxicity. Biochim. Biophys. Acta, Proteins Proteomics 2015, 1854, 426&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pubmed">25666897</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivasan E; Rajasekaran R Computational Investigation of Curcumin, a Natural Polyphenol that Inhibits the Destabilization and the Aggregation of Human SOD1Mutant (Ala4Val). RSC Adv 2016, 6, 102744&#x2013;102753.</Citation></Reference><Reference><Citation>Li J; Zhu M; Manning-Bog AB; Monte DAD; Fink AL Dopamine and L-dopa Disaggregate Amyloid Fibrils: Implications for Parkinson&#x2019;s and Alzheimer&#x2019;s Disease. FASEB J 2004, 18, 962&#x2013;964.</Citation><ArticleIdList><ArticleId IdType="pubmed">15059976</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavanti F; Pedone A; Menziani MC Computational Insight into the Effect of Natural Compounds on the Destabilization of Preformed Amyloid-&#x3b2;(1&#x2013;40) Fibrils. Molecules 2018, 23, 1320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6100107</ArticleId><ArticleId IdType="pubmed">29857500</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Y; Qian Z; Gong Y; Tang Y; Wei G; Zhang Q Critical Nucleus of Greek-key-like Core of &#x3b1;-synuclein Protofibril and its Disruption by Dopamine and Norepinephrine. Phys. Chem. Chem. Phys 2020, 22, 203&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pubmed">31799519</ArticleId></ArticleIdList></Reference><Reference><Citation>Lao Z; Chen Y; Tang Y; Wei G Molecular Dynamics Simulations Reveal the Inhibitory Mechanism of Dopamine against Human Islet Amyloid Polypeptide (hIAPP) Aggregation and Its Destabilization Effect on hIAPP Protofibrils. ACS Chem. Neurosci 2019, 10, 4151&#x2013;4159.</Citation><ArticleIdList><ArticleId IdType="pubmed">31436406</ArticleId></ArticleIdList></Reference><Reference><Citation>Saunders JC; Young LM; Mahood RA; Jackson MP; Revill CH; Foster RJ; Smith DA; Ashcroft AE; Brockwell DJ; Radford SE An in vivo Platform for Identifying Inhibitors of Protein Aggregation. Nat. Chem. Biol 2016, 12, 94&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4720988</ArticleId><ArticleId IdType="pubmed">26656088</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright GSA; Antonyuk SV; Kershaw NM; Strange RW; Samar Hasnain S Ligand Binding and Aggregation of Pathogenic SOD1. Nat. Commun 2013, 4, 1758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3644087</ArticleId><ArticleId IdType="pubmed">23612299</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H-J; Chang T-T; Chen H-Y; Chen CY-C Finding Inhibitors of Mutant Superoxide Dismutase-1 for Amyotrophic Lateral Sclerosis Therapy from Traditional Chinese Medicine. Evid. Based Complement Alternat. Med 2014, 2014, 156276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4052194</ArticleId><ArticleId IdType="pubmed">24963318</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrnhoefer DE; Bieschke J; Boeddrich A; Herbst M; Masino L; Lurz R; Engemann S; Pastore A; Wanker EE EGCG Redirects Amyloidogenic Polypeptides into Unstructured, Off-Pathway Oligomers. Nat. Struct. Mol. Biol 2008, 15, 558&#x2013;566.</Citation><ArticleIdList><ArticleId IdType="pubmed">18511942</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T; Zhang J; Derreumaux P; Mu Y Molecular Mechanism of the Inhibition of EGCG on the Alzheimer A&#x3b2;1&#x2013;42 Dimer. J. Phys. Chem. B 2013, 117, 3993&#x2013;4002.</Citation><ArticleIdList><ArticleId IdType="pubmed">23537203</ArticleId></ArticleIdList></Reference><Reference><Citation>Pujols J; Pe&#xf1;a-D&#xed;az S; L&#xe1;zaro DF; Peccati F; Pinheiro F; Gonz&#xe1;lez D; Carija A; Navarro S; Conde-Gim&#xe9;nez M; Garc&#xed;a J; et al. Small Molecule Inhibits &#x3b1;-Synuclein Aggregation, Disrupts Amyloid Fibrils, and Prevents Degeneration of Dopaminergic Neurons. Proc. Natl. Acad. Sci. U. S. A 2018, 115, 10481&#x2013;10486.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6187188</ArticleId><ArticleId IdType="pubmed">30249646</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo Y; Lei J; Sun Y; Zhang Q; Wei G Conformational Ensemble of hIAPP Dimer: Insight into the Molecular Mechanism by which a Green Tea Extract inhibits hIAPP Aggregation. Sci. Rep 2016, 6, 33076.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5020610</ArticleId><ArticleId IdType="pubmed">27620620</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao B; Zhuang X; Pi Z; Liu S; Liu Z; Song F Determining the Effect of Catechins on SOD1 Conformation and Aggregation by Ion Mobility Mass Spectrometry Combined with Optical Spectroscopy. J. Am. Soc. Mass Spectrom 2018, 29, 734&#x2013;741.</Citation><ArticleIdList><ArticleId IdType="pubmed">29392684</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivasan E; Rajasekaran R Probing the Inhibitory Activity of Epigallocatechin-Gallate on Toxic Aggregates of Mutant (L84F) SOD1 Protein Through Geometry Based Sampling and Steered Molecular Dynamics. J. Mol. Graphics Modell 2017, 74, 288&#x2013;295.</Citation><ArticleIdList><ArticleId IdType="pubmed">28458007</ArticleId></ArticleIdList></Reference><Reference><Citation>Regitz C; Fitzenberger E; Mahn FL; Dussling LM; Wenzel U Resveratrol Reduces Amyloid-Beta (A Beta(1&#x2013;42))-Induced Paralysis Through Targeting Proteostasis in an Alzheimer Model of Caenorhabditis Elegans. Eur. J. Nutr 2016, 55, 741&#x2013;747.</Citation><ArticleIdList><ArticleId IdType="pubmed">25851110</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam S; Karmakar S; Batra R; Sharma P; Pradhan P; Singh J; Kundu B; Chowdhury PK Polyphenols in Combination with &#x3b2;-Cyclodextrin can Inhibit and disaggregate &#x3b1;-Synuclein Amyloids under Cell Mimicking Conditions: A Promising Therapeutic Alternative. Biochim. Biophys. Acta, Proteins Proteomics 2017, 1865, 589&#x2013;603.</Citation><ArticleIdList><ArticleId IdType="pubmed">28238838</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang XY; Li XX; Zhao B; Liu ZQ; Song FR; Lu JZ Native Mass Spectrometry Based Method for Studying the Interactions between Superoxide Dismutase 1 and Stilbenoids. ACS Chem. Neurosci 2020, 11, 184&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">31820923</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivasan E; Rajasekaran R Quantum Chemical and Molecular Mechanics Studies on the Assessment of Interactions Between Resveratrol and Mutant SOD1 (G93A) Protein. J. Comput.-Aided Mol. Des 2018, 32, 1347&#x2013;1361.</Citation><ArticleIdList><ArticleId IdType="pubmed">30368622</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono K; Li L; Takamura Y; Yoshiike Y; Zhu LJ; Han F; Mao X; Ikeda T; Takasaki J; Nishijo H; et al. Phenolic Compounds Prevent Amyloid beta-Protein Oligomerization and Synaptic Dysfunction by Site-specific Binding. J. Biol. Chem 2012, 287, 14631&#x2013;14643.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3340280</ArticleId><ArticleId IdType="pubmed">22393064</ArticleId></ArticleIdList></Reference><Reference><Citation>Taguchi R; Hatayama K; Takahashi T; Hayashi T; Sato Y; Sato D; Ohta K; Nakano H; Seki C; Endo Y; Tokuraku K; Uwai K Structure-activity Relations of Rosmarinic Acid Derivatives for the amyloid beta Aggregation Inhibition and Antioxidant Properties. Eur. J. Med. Chem 2017, 138, 1066&#x2013;1075.</Citation><ArticleIdList><ArticleId IdType="pubmed">28759879</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi R; Ono K; Takamura Y; Mizuguchi M; Ikeda T; Nishijo H; Yamada M Phenolic Compounds Prevent the Oligomerization of &#x3b1;-Synuclein and Reduce Synaptic Toxicity. J. Neurochem 2015, 134, 943&#x2013;955.</Citation><ArticleIdList><ArticleId IdType="pubmed">26016728</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamelabad MR; Sardroodi JJ; Ebrahimzadeh AR The Interaction of Curcumin and Rosmarinic Acid with Non-Amyloid-Component Domain of Alpha-Synuclein: A Molecular Dynamics Study. Chemistry Select 2020, 5, 3312&#x2013;3320.</Citation></Reference><Reference><Citation>Zheng Q; Lazo ND Mechanistic Studies of the Inhibition of Insulin Fibril Formation by Rosmarinic Acid. J. Phys. Chem. B 2018, 122, 2323&#x2013;2331.</Citation><ArticleIdList><ArticleId IdType="pubmed">29401384</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimojo Y; Kosaka K; Noda Y; Shimizu T; Shirasawa T Effect of Rosmarinic Acid in Motor Dysfunction and Life Span in a Mouse Model of Familial Amyotrophic Lateral Sclerosis. J. Neurosci. Res 2010, 88, 896&#x2013;904.</Citation><ArticleIdList><ArticleId IdType="pubmed">19798750</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y; Ma B; McElheny D; Parthasarathy S; Long F; Hoshi M; Nussinov R; Ishii Y A&#x3b2;(1&#x2013;42) Fibril Structure Illuminates Self-Recognition and Replication of Amyloid in Alzheimer&#x2019;s Disease. Nat. Struct. Mol. Biol 2015, 22, 499&#x2013;505.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4476499</ArticleId><ArticleId IdType="pubmed">25938662</ArticleId></ArticleIdList></Reference><Reference><Citation>De Genst EJ; Guilliams T; Wellens J; O&#x2019;Day EM; Waudby CA; Meehan S; Dumoulin M; Hsu S-TD; Cremades N; Verschueren KHG; et al. Structure and Properties of a Complex of &#x3b1;-Synuclein and a Single-Domain Camelid Antibody. J. Mol. Biol 2010, 402, 326&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pubmed">20620148</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittingham JL; Scott DJ; Chance K; Wilson A; Finch J; Brange J; Dodson G Insulin at pH 2: Structural Analysis of the Conditions Promoting Insulin Fibre Formation. J. Mol. Biol 2002, 318, 479&#x2013;490.</Citation><ArticleIdList><ArticleId IdType="pubmed">12051853</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F; Wang H; Logan DT; Mu X; Danielsson J; Oliveberg M The Cost of Long Catalytic Loops in Folding and Stability of the ALS-Associated Protein SOD1. J. Am. Chem. Soc 2018, 140, 16570&#x2013;16579.</Citation><ArticleIdList><ArticleId IdType="pubmed">30359015</ArticleId></ArticleIdList></Reference><Reference><Citation>Trott O; Olson AJ Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading. J. Comput. Chem 2010, 31, 455&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3041641</ArticleId><ArticleId IdType="pubmed">19499576</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen NT; Nguyen TH; Pham TNH; Huy NT; Bay MV; Pham MQ; Nam PC; Vu VV; Ngo ST Autodock Vina Adopts More Accurate Binding Poses but Autodock4 Forms Better Binding Affinity. J. Chem. Inf. Model 2020, 60, 204&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pubmed">31887035</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuhara K; Arakida J; Ravula T; Ramadugu SK; Sahoo B; Kikuchi J-I; Ramamoorthy A Spontaneous Lipid Nanodisc Fomation by Amphiphilic Polymethacrylate Copolymers. J. Am. Chem. Soc 2017, 139, 18657&#x2013;18663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5826593</ArticleId><ArticleId IdType="pubmed">29171274</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilkington EH; Lai M; Ge X; Stanley WJ; Wang B; Wang M; Kakinen A; Sani M-A; Whittaker MR; Gurzov EN; et al. Star Polymers Reduce Islet Amyloid Polypeptide Toxicity via Accelerated Amyloid Aggregation. Biomacromolecules 2017, 18, 4249&#x2013;4260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5729549</ArticleId><ArticleId IdType="pubmed">29035554</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahoo BR; Souders CL; Ivanova M; Deng Z; Nakayama TW; Suladze S; Reif B; Ando T; Martyniuk CJ; Ramamoorthy A Conformational Tuning of Amylin by Charged SMA Copolymers. bioRxiv 2020, 2020.04.23.057547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8752516</ArticleId><ArticleId IdType="pubmed">34883118</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith JW; Jiang X; An H; Barclay AM; Licari G; Tajkhorshid E; Moore EG; Rienstra CM; Moore JS; Chen Q Polymer-Peptide Conjugates Convert Amyloid into Protein Nano-bundles through Fragmentation and Lateral Association. ACS Appl. Nano Mater 2020, 3, 937&#x2013;945.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7059651</ArticleId><ArticleId IdType="pubmed">32149271</ArticleId></ArticleIdList></Reference><Reference><Citation>Evgrafova Z; Voigt B; Roos AH; Hause G; Hinderberger D; Balbach J; Binder WH Modulation of Amyloid &#x3b2; Peptide Aggregation by Hydrophilic Polymers. Phys. Chem. Chem. Phys 2019, 21, 20999&#x2013;21006.</Citation><ArticleIdList><ArticleId IdType="pubmed">31528872</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H; Liu J; Li S; Zhou L; Wang J; Liu L; Lv F; Gu Q; Hu B; Ma Y; Wang S Reactive Amphiphilic Conjugated Polymers for Inhibiting Amyloid &#x3b2; Assembly. Angew. Chem., Int. Ed 2019, 58, 5988&#x2013;5993.</Citation><ArticleIdList><ArticleId IdType="pubmed">30817076</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y; Cai J; Liu Z; Li Y; Zheng C; Zheng Y; Chen Q; Chen H; Ma F; An Y; Xiao L; Jiang C; Shi L; Kang C; Liu Y Nanocomposites Inhibit the Formation, Mitigate the Neurotoxicity, and Facilitate the Removal of &#x3b2;-Amyloid Aggregates in Alzheimer&#x2019;s Disease Mice. Nano Lett 2019, 19, 674&#x2013;683.</Citation><ArticleIdList><ArticleId IdType="pubmed">30444372</ArticleId></ArticleIdList></Reference><Reference><Citation>Aso E; Martinsson I; Appelhans D; Effenberg C; Benseny-Cases N; Cladera J; Gouras G; Ferrer I; Klementieva O Poly(Propylene Imine) Dendrimers with Histidine-Maltose Shell as Novel Type of Nanoparticles for Synapse and Memory Protection. Nanomedicine 2019, 17, 198&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pubmed">30708052</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurzov EN; Wang B; Pilkington EH; Chen P; Kakinen A; Stanley WJ; Litwak SA; Hanssen EG; Davis TP; Ding F; et al. Inhibition of hIAPP Amyloid Aggregation and Pancreatic &#x3b2;-Cell Toxicity by OH-Terminated PAMAM Dendrimer. Small 2016, 12, 1615&#x2013;1626.</Citation><ArticleIdList><ArticleId IdType="pubmed">26808649</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabaleiro-Lago C; Lynch I; Dawson KA; Linse S Inhibition of IAPP and IAPP(20&#x2013;29) Fibrillation by Polymeric Nanoparticles. Langmuir 2010, 26, 3453&#x2013;3461.</Citation><ArticleIdList><ArticleId IdType="pubmed">20017535</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-Retana S; Cano-Sarabia M; Marazuela P; S&#xe1;nchez-Quesada JL; Garcia-Leon A; Monta&#xf1;ola A; Montaner J; Maspoch D; Hern&#xe1;ndez-Guillamon M Characterization of ApoJ-Reconstituted High-Density Lipoprotein (rHDL) Nanodisc for the Potential Treatment of Cerebral &#x3b2;-Amyloidosis. Sci. Rep 2017, 7, 14637.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5677083</ArticleId><ArticleId IdType="pubmed">29116115</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Z; Wei L; Li Y; Xiao L Efficient Modulation of &#x3b2;-Amyloid Peptide Fibrillation with Polymer Nanoparticles Revealed by Super-Resolution Optical Microscopy. Anal. Chem 2019, 91, 8582&#x2013;8590.</Citation><ArticleIdList><ArticleId IdType="pubmed">31148450</ArticleId></ArticleIdList></Reference><Reference><Citation>Mourtas S; Christodoulou P; Klepetsanis P; Gatos D; Barlos K; Antimisiaris SG Preparation of Benzothiazolyl-Decorated Nanoliposomes. Molecules 2019, 24, 1540.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6514897</ArticleId><ArticleId IdType="pubmed">31003552</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal D; Shuaib S; Mann S; Goyal B Rationally Designed Peptides and Peptidomimetics as Inhibitors of Amyloid-&#x3b2; (A&#x3b2;) Aggregation: Potential Therapeutics of Alzheimer&#x2019;s Disease. ACS Comb. Sci 2017, 19, 55&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">28045249</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu Z; Prade E; Malideli E; Hille K; Jussupow A; Mideksa YG; Yan L-M; Qian C; Fleisch M; Messias AC; et al. Structural Insight into IAPP-Derived Amyloid Inhibitors and Their Mechanism of Action. Angew. Chem., Int. Ed 2020, 59, 5771&#x2013;5781.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7154662</ArticleId><ArticleId IdType="pubmed">31863711</ArticleId></ArticleIdList></Reference><Reference><Citation>Griner S; Seidler P; Bowler J; Murray K; Yang T; Sahay S; Sawaya M; Cascio D; Rodriguez J; Philipp S; et al. Structure-Based Inhibitors of Amyloid Beta Core Suggest a Common Interface with Tau. eLife 2019, 8, No. e46924.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6850776</ArticleId><ArticleId IdType="pubmed">31612856</ArticleId></ArticleIdList></Reference><Reference><Citation>Elfgen A; Hupert M; Bochinsky K; Tusche M; Gonz&#xe1;lez de San Rom&#xe1;n Martin E; Gering I; Sacchi S; Pollegioni L; Huesgen PF; Hartmann R; et al. Metabolic Resistance of the D-peptide RD2 Developed for Direct Elimination of Amyloid-&#x3b2; Oligomers. Sci. Rep 2019, 9, 5715.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6450887</ArticleId><ArticleId IdType="pubmed">30952881</ArticleId></ArticleIdList></Reference><Reference><Citation>Dugan LL; Turetsky DM; Du C; Lobner D; Wheeler M; Almli CR; Shen CK-F; Luh T-Y; Choi DW; Lin T-S Carboxyfullerenes as Neuroprotective Agents. Proc. Natl. Acad. Sci. U. S. A 1997, 94, 9434&#x2013;9439.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC23208</ArticleId><ArticleId IdType="pubmed">9256500</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JE; Lee M Fullerene inhibits &#x3b2;-Amyloid Peptide Aggregation. Biochem. Biophys. Res. Commun 2003, 303, 576&#x2013;579.</Citation><ArticleIdList><ArticleId IdType="pubmed">12659858</ArticleId></ArticleIdList></Reference><Reference><Citation>Podolski IY; Podlubnaya ZA; Kosenko EA; Mugantseva EA; Makarova EG; Marsagishvili LG; Shpagina MD; Kaminsky YG; Andrievsky GV; Klochkov VK Effects of Hydrated Forms of C60 Fullerene on Amyloid 1-Peptide Fibrillization in vitro and Performance of the Cognitive Task. J. Nanosci. Nanotechnol 2007, 7, 1479&#x2013;1485.</Citation><ArticleIdList><ArticleId IdType="pubmed">17450915</ArticleId></ArticleIdList></Reference><Reference><Citation>Linse S; Cabaleiro-Lago C; Xue W-F; Lynch I; Lindman S; Thulin E; Radford SE; Dawson KA Nucleation of Protein Fibrillation by Nanoparticles. Proc. Natl. Acad. Sci. U. S. A 2007, 104, 8691&#x2013;8696.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1866183</ArticleId><ArticleId IdType="pubmed">17485668</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H; Luo Y; Derreumaux P; Wei G Carbon Nanotube Inhibits the Formation of &#x3b2;-Sheet-Rich Oligomers of the Alzheimer&#x2019;s Amyloid-&#x3b2;(16&#x2013;22) Peptide. Biophys. J 2011, 101, 2267&#x2013;2276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3207167</ArticleId><ArticleId IdType="pubmed">22067167</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie L; Lin D; Luo Y; Li H; Yang X; Wei G Effects of Hydroxylated Carbon Nanotubes on the Aggregation of A&#x3b2;16&#x2013;22 Peptides: A Combined Simulation and Experimental Study. Biophys. J 2014, 107, 1930&#x2013;1938.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4213673</ArticleId><ArticleId IdType="pubmed">25418174</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie L; Luo Y; Lin D; Xi W; Yang X; Wei G The Molecular Mechanism of Fullerene-Inhibited Aggregation of Alzheimer&#x2019;s &#x3b2;-Amyloid Peptide Fragment. Nanoscale 2014, 6, 9752&#x2013;9762.</Citation><ArticleIdList><ArticleId IdType="pubmed">25004796</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J; Zhu Z; Bortolini C; Hoffmann SV; Amari A; Zhang HX; Liu L; Dong MD Dimensionality of Carbon Nanomaterial Impacting on the Modulation of Amyloid Peptide Assembly. Nanotechnology 2016, 27, 304001.</Citation><ArticleIdList><ArticleId IdType="pubmed">27302044</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z; Ge C; Liu J; Chong Y; Gu Z; Jimenez-Cruz CA; Chai Z; Zhou R Destruction of Amyloid Fibrils by Graphene Through Penetration and Extraction of Peptides. Nanoscale 2015, 7, 18725&#x2013;18737.</Citation><ArticleIdList><ArticleId IdType="pubmed">26503908</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoudi M; Akhavan O; Ghavami M; Rezaee F; Ghiasi SMA Graphene Oxide Strongly inhibits Amyloid Beta Fibrillation. Nanoscale 2012, 4, 7322&#x2013;7325.</Citation><ArticleIdList><ArticleId IdType="pubmed">23079862</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y; Xu L-P; Dai W; Dong H; Wen Y; Zhang X Graphene Quantum Dots for the Inhibition of &#x3b2; Amyloid Aggregation. Nanoscale 2015, 7, 19060&#x2013;19065.</Citation><ArticleIdList><ArticleId IdType="pubmed">26515666</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y; Qian Z; Wei G The Inhibitory Mechanism of a Fullerene Derivative Against Amyloid-&#x3b2; Peptide Aggregation: an Atomistic Simulation Study. Phys. Chem. Chem. Phys 2016, 18, 12582&#x2013;12591.</Citation><ArticleIdList><ArticleId IdType="pubmed">27091578</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y; Sun Y; Chen Y; Lei J; Wei G Molecular Dynamics Simulations Reveal the Mechanism of Graphene Oxide Nanosheet Inhibition of A&#x3b2;1&#x2013;42 Peptide Aggregation. Phys. Chem. Chem. Phys 2019, 21, 10981&#x2013;10991.</Citation><ArticleIdList><ArticleId IdType="pubmed">31111835</ArticleId></ArticleIdList></Reference><Reference><Citation>Bednarikova Z; Huy PDQ; Mocanu M-M; Fedunova D; Li MS; Gazova Z Fullerenol C60(OH)16 Prevents Amyloid Fibrillization of A&#x3b2;40 - in vitro and in silico Approach. Phys. Chem. Chem. Phys 2016, 18, 18855&#x2013;18867.</Citation><ArticleIdList><ArticleId IdType="pubmed">27350395</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X; Xi W; Luo Y; Cao S; Wei G Interactions of a Water-Soluble Fullerene Derivative with Amyloid-&#x3b2; Protofibrils: Dynamics, Binding Mechanism, and the Resulting Salt-Bridge Disruption. J. Phys. Chem. B 2014, 118, 6733&#x2013;6741.</Citation><ArticleIdList><ArticleId IdType="pubmed">24857343</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z; Zou Y; Zhang Q; Chen P; Liu Y; Qian Z Distinct Binding Dynamics, Sites and Interactions of Fullerene and Fullerenols with Amyloid-&#x3b2; Peptides Revealed by Molecular Dynamics Simulations. Int. J. Mol. Sci 2019, 20, 2048.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6514889</ArticleId><ArticleId IdType="pubmed">31027286</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F; Wang W; Sang J; Jia L; Lu F Hydroxylated Single-Walled Carbon Nanotubes Inhibit A&#x3b2;42 Fibrillogenesis, Disaggregate Mature Fibrils, and Protect against A&#x3b2;42-Induced Cytotoxicity. ACS Chem. Neurosci 2019, 10, 588&#x2013;598.</Citation><ArticleIdList><ArticleId IdType="pubmed">30335950</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J; Cao Y; Li Q; Liu L; Dong M Size Effect of Graphene Oxide on Modulating Amyloid Peptide Assembly. Chem. - Eur. J 2015, 21, 9632&#x2013;9637.</Citation><ArticleIdList><ArticleId IdType="pubmed">26031933</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q; Liu L; Zhang S; Xu M; Wang X; Wang C; Besenbacher F; Dong M Modulating A&#x3b2;33&#x2013;42 Peptide Assembly by Graphene Oxide. Chem. - Eur. J 2014, 20, 7236&#x2013;7240.</Citation><ArticleIdList><ArticleId IdType="pubmed">24838837</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y; Chen Z; Sun Y; Lei J; Wei G Mechanistic Insights into the Inhibition and Size Effects of Graphene Oxide Nanosheets on the Aggregation of an Amyloid-&#x3b2; Peptide Fragment. Nanoscale 2018, 10, 8989&#x2013;8997.</Citation><ArticleIdList><ArticleId IdType="pubmed">29725676</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedumpully-Govindan P; Gurzov EN; Chen P; Pilkington EH; Stanley WJ; Litwak SA; Davis TP; Ke PC; Ding F Graphene Oxide Inhibits hIAPP Amyloid Fibrillation and Toxicity in Insulin-Producing NIT-1 Cells. Phys. Chem. Chem. Phys 2016, 18, 94&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4684718</ArticleId><ArticleId IdType="pubmed">26625841</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M; Sun Y; Cao X; Peng G; Javed I; Kakinen A; Davis TP; Lin S; Liu J; Ding F; Ke PC Graphene Quantum Dots Against Human IAPP Aggregation and Toxicity in vivo. Nanoscale 2018, 10, 19995&#x2013;20006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6212334</ArticleId><ArticleId IdType="pubmed">30350837</ArticleId></ArticleIdList></Reference><Reference><Citation>Faridi A; Sun Y; Mortimer M; Aranha RR; Nandakumar A; Li Y; Javed I; Kakinen A; Fan Q; Purcell AW; et al. Graphene Quantum Dots Rescue Protein Dysregulation of Pancreatic &#x3b2;-Cells Exposed to Human Islet Amyloid Polypeptide. Nano Res 2019, 12, 2827&#x2013;2834.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6834229</ArticleId><ArticleId IdType="pubmed">31695851</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo Y; Brahmachari S; Lei J; Gilead S; Tang Y; Gazit E; Wei G The Inhibitory Effect of Hydroxylated Carbon Nanotubes on the Aggregation of Human Islet Amyloid Polypeptide Revealed by a Combined Computational and Experimental Study. ACS Chem. Neurosci 2018, 9, 2741&#x2013;2752.</Citation><ArticleIdList><ArticleId IdType="pubmed">29986579</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai C; Lin D; Mo Y; Lei J; Sun Y; Xie L; Yang X; Wei G Influence of Fullerenol on hIAPP Aggregation: Amyloid Inhibition and Mechanistic Aspects. Phys. Chem. Chem. Phys 2019, 21, 4022&#x2013;4031.</Citation><ArticleIdList><ArticleId IdType="pubmed">30714593</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai C; Lao Z; Chen Y; Tang Y; Wei G Pristine and Hydroxylated Fullerenes Prevent the Aggregation of Human Islet Amyloid Polypeptide and Display Different Inhibitory Mechanisms. Front. Chem 2020, 8, 51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7013002</ArticleId><ArticleId IdType="pubmed">32117877</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y; Kakinen A; Zhang C; Yang Y; Faridi A; Davis TP; Cao W; Ke PC; Ding F Amphiphilic Surface Chemistry of Fullerenols is Necessary for Inhibiting the Amyloid Aggregation of Alpha-Synuclein NACore. Nanoscale 2019, 11, 11933&#x2013;11945.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6589440</ArticleId><ArticleId IdType="pubmed">31188372</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D; Yoo JM; Hwang H; Lee J; Lee SH; Yun SP; Park MJ; Lee M; Choi S; Kwon SH; et al. Graphene Quantum Dots Prevent &#x3b1;-Synucleinopathy in Parkinson&#x2019;s Disease. Nat. Nanotechnol 2018, 13, 812&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6351226</ArticleId><ArticleId IdType="pubmed">29988049</ArticleId></ArticleIdList></Reference><Reference><Citation>Golomidov I; Bolshakova O; Komissarov A; Sharoyko V; Slepneva E; Slobodina A; Latypova E; Zherebyateva O; Tennikova T; Sarantseva S The Neuroprotective Effect of Fullerenols on a Model of Parkinson&#x2019;s Disease in Drosophila Melanogaster. Biochem. Biophys. Res. Commun 2020, 523, 446&#x2013;451.</Citation><ArticleIdList><ArticleId IdType="pubmed">31879013</ArticleId></ArticleIdList></Reference><Reference><Citation>Reina G; Gonz&#xe1;lez-Dom&#xed;nguez JM; Criado A; V&#xe1;zquez E; Bianco A; Prato M Promises, Facts and Challenges for Graphene in Biomedical Applications. Chem. Soc. Rev 2017, 46, 4400&#x2013;4416.</Citation><ArticleIdList><ArticleId IdType="pubmed">28722038</ArticleId></ArticleIdList></Reference><Reference><Citation>Cacabelos R How Plausible is an Alzheimer&#x2019;s Disease Vaccine? Expert Opin. Drug Discovery 2020, 15, 6.</Citation><ArticleIdList><ArticleId IdType="pubmed">31526140</ArticleId></ArticleIdList></Reference><Reference><Citation>Baxter D Active and Passive Immunity, Vaccine Types, Excipients and Licensing. Occupational Medicine-Oxford 2007, 57, 552&#x2013;556.</Citation><ArticleIdList><ArticleId IdType="pubmed">18045976</ArticleId></ArticleIdList></Reference><Reference><Citation>Schenk D; Barbour R; Dunn W; Gordon G; Grajeda H; Guido T; Hu K; Huang J; Johnson-Wood K; Khan K; et al. Immunization with amyloid-beta Attenuates Alzheimer-disease-like Pathology in the PDAPP Mouse. Nature 1999, 400, 173&#x2013;177.</Citation><ArticleIdList><ArticleId IdType="pubmed">10408445</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicoll JAR; Wilkinson D; Holmes C; Steart P; Markham H; Weller RO Neuropathology of Human Alzheimer Disease after Immunization with amyloid-&#x3b2; Peptide: A Case Report. Nat. Med 2003, 9, 448&#x2013;452.</Citation><ArticleIdList><ArticleId IdType="pubmed">12640446</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M; Bard F; Johnson-Wood K; Lee C; Hu K; Griffith SG; Black RS; Schenk D; Seubert P Abeta42 Immunization in Alzheimer&#x2019;s Disease Generates Abeta N-terminal Antibodies. Ann. Neurol 2005, 58, 430&#x2013;435.</Citation><ArticleIdList><ArticleId IdType="pubmed">16130106</ArticleId></ArticleIdList></Reference><Reference><Citation>Vellas B; Black R; Thal LJ; Fox NC; Daniels M; McLennan G; Tompkins C; Leibman C; Pomfret M; Grundman M; Team AQ-S Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders. Curr. Alzheimer Res 2009, 6, 144&#x2013;151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2825665</ArticleId><ArticleId IdType="pubmed">19355849</ArticleId></ArticleIdList></Reference><Reference><Citation>Boche D; Donald J; Love S; Harris S; Neal JW; Holmes C; Nicoll JA Reduction of Aggregated Tau in Neuronal Processes but not in the Cell Bodies after Abeta42 Immunisation in Alzheimer&#x2019;s Disease. Acta Neuropathol 2010, 120, 13&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">20532897</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacosta AM; Pascual-Lucas M; Pesini P; Casabona D; Perez-Grijalba V; Marcos-Campos I; Sarasa L; Canudas J; Badi H; Monleon I; et al. Safety, Tolerability and Immunogenicity of an Active Anti-A beta(40) Vaccine (ABvac40) in Patients with Alzheimer&#x2019;s Disease: a Randomised, Double-blind, Placebo-controlled, Phase I Trial. Alzheimer&#x2019;s Res. Ther 2018, 10, 13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5789644</ArticleId><ArticleId IdType="pubmed">29378651</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang CY; Wang PN; Chiu MJ; Finstad CL; Lin F; Lynn S; Tai YH; De Fang X; Zhao K; Hung CH; et al. UB-311, a Novel UBITh amyloid &#x3b2; peptide Vaccine for Mild Alzheimer&#x2019;s Disease. Alzheimers Dement. (N Y) 2017, 3, 262&#x2013;272.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5651432</ArticleId><ArticleId IdType="pubmed">29067332</ArticleId></ArticleIdList></Reference><Reference><Citation>Congdon EE; Sigurdsson EM Tau-targeting therapies for Alzheimer disease. Nat. Rev. Neurol 2018, 14, 399&#x2013;415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6463489</ArticleId><ArticleId IdType="pubmed">29895964</ArticleId></ArticleIdList></Reference><Reference><Citation>Asuni AA; Boutajangout A; Quartermain D; Sigurdsson EM Immunotherapy Targeting Pathological Tau Conformers in a Tangle Mouse Model Reduces Brain Pathology with Associated Functional Improvements. J. Neurosci 2007, 27, 9115&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6672191</ArticleId><ArticleId IdType="pubmed">17715348</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutajangout A; Ingadottir J; Davies JP; Sigurdsson EM P3&#x2013;427: Passive Tau Immunotherapy Diminishes Functional Decline and Clears Tau aggregates in a Mouse Model of Tauopathy. Alzheimer&#x2019;s Dementia 2010, 6, S578&#x2013;S578.</Citation></Reference><Reference><Citation>Kontsekova E; Zilka N; Kovacech B; Novak P; Novak M First-in-man Tau Vaccine Targeting Structural Determinants Essential for Pathological tau-tau interaction Reduces Tau Oligomerisation and Neurofibrillary Degeneration in an Alzheimer&#x2019;s Disease Model. Alzheimer&#x2019;s Res. Ther 2014, 6, 44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4255368</ArticleId><ArticleId IdType="pubmed">25478017</ArticleId></ArticleIdList></Reference><Reference><Citation>Axon_Neuroscience, Axon announces Positive Results from Phase II ADAMANT Trial for AADvac1 in Alzheimer&#x2019;s Disease
2019. https://www.axon-neurosci.eu.</Citation></Reference><Reference><Citation>Congdon EE; Gu J; Sait HB; Sigurdsson EM Antibody Uptake into Neurons occurs primarily via Clathrin-dependent Fcgamma Receptor Endocytosis and is a Prerequisite for acute Tau Protein Clearance. J. Biol. Chem 2013, 288, 35452&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3853292</ArticleId><ArticleId IdType="pubmed">24163366</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HE; Lim D; Lee JY; Lim SM; Pae AN Recent Tau-targeted Clinical Strategies for the Treatment of Alzheimer&#x2019;s Disease. Future Med. Chem 2019, 11, 1845&#x2013;1848.</Citation><ArticleIdList><ArticleId IdType="pubmed">31517533</ArticleId></ArticleIdList></Reference><Reference><Citation>Kfoury N; Holmes BB; Jiang H; Holtzman DM; Diamond MI Trans-cellular Propagation of Tau Aggregation by Fibrillar Species. J. Biol. Chem 2012, 287, 19440&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3365982</ArticleId><ArticleId IdType="pubmed">22461630</ArticleId></ArticleIdList></Reference><Reference><Citation>Park HH; Lee KY; Kim S; Lee JW; Choi NY; Lee EH; Lee YJ; Lee SH; Koh SH Novel Vaccine Peptide GV1001 effectively Blocks beta-amyloid Toxicity by Mimicking the Extra-telomeric Functions of Human Telomerase Reverse Transcriptase. Neurobiol. Aging 2014, 35, 1255&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">24439482</ArticleId></ArticleIdList></Reference><Reference><Citation>Park HH; Yu HJ; Kim S; Kim G; Choi NY; Lee EH; Lee YJ; Yoon MY; Lee KY; Koh SH Neural stem Cells Injured by Oxidative Stress can be Rejuvenated by GV1001, a Novel Peptide, through Scavenging Free Radicals and enhancing survival Signals. NeuroToxicology 2016, 55, 131&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pubmed">27265016</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzforum, At CTAD, Early Failures and Hints of Success, from Small Trials
2019. https://www.alzforum.org/news/conference-coverage/ctad-early-failures-and-hints-success-small-trials#GV1001.</Citation></Reference><Reference><Citation>Vander Zanden CM; Chi EY Passive Immunotherapies Targeting Amyloid Beta and Tau Oligomers in Alzheimer&#x2019;s Disease. J. Pharm. Sci 2020, 109, 68&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6937375</ArticleId><ArticleId IdType="pubmed">31647950</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangialasche F; Solomon A; Winblad B; Mecocci P; Kivipelto M Alzheimer&#x2019;s Disease: Clinical trials and Drug development. Lancet Neurol 2010, 9, 702&#x2013;716.</Citation><ArticleIdList><ArticleId IdType="pubmed">20610346</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidarsson G; Dekkers G; Rispens T IgG Subclasses and Allotypes: from Structure to effector Functions. Front. Immunol 2014, 5, 17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4202688</ArticleId><ArticleId IdType="pubmed">25368619</ArticleId></ArticleIdList></Reference><Reference><Citation>Sevigny J; Chiao P; Bussi&#xe8;re T; Weinreb PH; Williams L; Maier M; Dunstan R; Salloway S; Chen T; Ling Y; et al. The Antibody Aducanumab Reduces A&#x3b2; Plaques in Alzheimer&#x2019;s Disease. Nature 2016, 537, 50&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">27582220</ArticleId></ArticleIdList></Reference><Reference><Citation>Sevigny J; Chiao P; Bussi&#xe8;re T; Weinreb PH; Williams L; Maier M; Dunstan R; Salloway S; Chen T; Ling Y; et al. Addendum: The Antibody Aducanumab Reduces A&#x3b2; Plaques in Alzheimer&#x2019;s Disease. Nature 2017, 546, 564&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pubmed">28640269</ArticleId></ArticleIdList></Reference><Reference><Citation>Arndt JW; Qian F; Smith BA; Quan C; Kilambi KP; Bush MW; Walz T; Pepinsky RB; Bussiere T; Hamann S; Cameron TO; Weinreb PH Structural and Kinetic Basis for the Selectivity of Aducanumab for Aggregated Forms of amyloid-beta. Sci. Rep 2018, 8, 6412.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5913127</ArticleId><ArticleId IdType="pubmed">29686315</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzforum, Biogen/Eisai Halt Phase 3 Aducanumab Trials
https://www.alzforum.org/news/research-news/biogeneisai-halt-phase-3-aducanumab-trials, 2019.</Citation></Reference><Reference><Citation>Selkoe DJ Alzheimer Disease and Aducanumab: Adjusting our approach. Nat. Rev. Neurol 2019, 15, 365&#x2013;366.</Citation><ArticleIdList><ArticleId IdType="pubmed">31138932</ArticleId></ArticleIdList></Reference><Reference><Citation>Biogen, Biogen Plans Regulatory Filing for Aducanumab in Alzheimer&#x2019;s Disease Based on New Analysis of Larger Dataset from Phase 3 Studies
https://investors.biogen.com/news-releases/news-release-details/biogen-plans-regulatory-filing-aducanumab-alzheimers-disease, 2019.</Citation></Reference><Reference><Citation>Howard R; Liu KY Questions EMERGE as Biogen Claims Aducanumab Turnaround. Nat. Rev. Neurol 2020, 16, 63&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">31784690</ArticleId></ArticleIdList></Reference><Reference><Citation>Lord A; Gumucio A; Englund H; Sehlin D; Sundquist VS; Soderberg L; M&#xf6;ller C; Gellerfors P; Lannfelt L; Pettersson FE; Nilsson LNG An Amyloid-beta Protofibril-selective Antibody Prevents Amyloid Formation in a Mouse Model of Alzheimer&#x2019;s Disease. Neurobiol. Dis 2009, 36, 425&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">19703562</ArticleId></ArticleIdList></Reference><Reference><Citation>Logovinsky V; Satlin A; Lai R; Swanson C; Kaplow J; Osswald G; Basun H; Lannfelt L Safety and Tolerability of BAN2401-a Clinical Study in Alzheimer&#x2019;s Disease with a Protofibril Selective Abeta Antibody. Alzheimer&#x2019;s Res. Ther 2016, 8, 10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4822297</ArticleId><ArticleId IdType="pubmed">27048170</ArticleId></ArticleIdList></Reference><Reference><Citation>Satlin A; Wang J; Logovinsky V; Berry S; Swanson C; Dhadda S; Berry DA Design of a Bayesian Adaptive Phase 2 Proof-of-concept Trial for BAN2401, a Putative Disease-modifying Monoclonal Antibody for the Treatment of Alzheimer&#x2019;s Disease. Alzheimers Dement (NY: ) 2016, 2, 1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5644271</ArticleId><ArticleId IdType="pubmed">29067290</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohrmann B; Baumann K; Benz J; Gerber F; Huber W; Knoflach F; Messer J; Oroszlan K; Rauchenberger R; Richter WF; et al. Gantenerumab: A Novel Human Anti-A beta Antibody Demonstrates Sustained Cerebral Amyloid-b Binding and Elicits Cell-Mediated Removal of Human Amyloid-beta. J. Alzheimer&#x2019;s Dis 2012, 28, 49&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">21955818</ArticleId></ArticleIdList></Reference><Reference><Citation>Honig LS; Vellas B; Woodward M; Boada M; Bullock R; Borrie M; Hager K; Andreasen N; Scarpini E; Liu-Seifert H; et al. Trial of Solanezumab for Mild Dementia Due to Alzheimer&#x2019;s Disease. N. Engl. J. Med 2018, 378, 321&#x2013;330.</Citation><ArticleIdList><ArticleId IdType="pubmed">29365294</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostrowitzki S; Lasser RA; Dorflinger E; Scheltens P; Barkhof F; Nikolcheva T; Ashford E; Retout S; Hofmann C; Delmar P; et al. A phase III Randomized Trial of Gantenerumab in Prodromal Alzheimer&#x2019;s Disease. Alzheimer&#x2019;s Res. Ther 2017, 9, 95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5723032</ArticleId><ArticleId IdType="pubmed">29221491</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzforum, Solanezumab
https://www.alzforum.org/therapeutics/solanezumab, 2019.</Citation></Reference><Reference><Citation>Jawhar S; Wirths O; Bayer TA Pyroglutamate Amyloid-beta (A beta): A Hatchet Man in Alzheimer Disease. J. Biol. Chem 2011, 286, 38825&#x2013;38832.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3234707</ArticleId><ArticleId IdType="pubmed">21965666</ArticleId></ArticleIdList></Reference><Reference><Citation>Demattos RB; Lu J; Tang Y; Racke MM; Delong CA; Tzaferis JA; Hole JT; Forster BM; McDonnell PC; Liu F; et al. A Plaque-specific Antibody Clears Existing beta-amyloid Plaques in Alzheimer&#x2019;s Disease mice. Neuron 2012, 76, 908&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">23217740</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzforum, Four Immunotherapies Now Banish Amyloid From the Brain
https://www.alzforum.org/news/conference-coverage/four-immunotherapies-now-banish-amyloid-brain, 2018.</Citation></Reference><Reference><Citation>Bright J; Hussain S; Dang V; Wright S; Cooper B; Byun T; Ramos C; Singh A; Parry G; Stagliano N; Griswold-Prenner I Human Secreted Tau Increases amyloid-beta Production. Neurobiol. Aging 2015, 36, 693&#x2013;709.</Citation><ArticleIdList><ArticleId IdType="pubmed">25442111</ArticleId></ArticleIdList></Reference><Reference><Citation>Doig AJ Positive Feedback Loops in Alzheimer&#x2019;s Disease: The Alzheimer&#x2019;s Feedback Hypothesis. J. Alzheimer&#x2019;s Dis 2018, 66, 25&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6484277</ArticleId><ArticleId IdType="pubmed">30282364</ArticleId></ArticleIdList></Reference><Reference><Citation>Boxer AL; Qureshi I; Ahlijanian M; Grundman M; Golbe LI; Litvan I; Honig LS; Tuite P; McFarland NR; O&#x2019;Suilleabhain P; et al. Safety of the Tau-directed Monoclonal Antibody BIIB092 in Progressive Supranuclear Palsy: a Randomised, Placebo-controlled, Multiple Ascending Dose Phase 1b Trial. Lancet Neurol 2019, 18, 549&#x2013;558.</Citation><ArticleIdList><ArticleId IdType="pubmed">31122495</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SH; Le Pichon CE; Adolfsson O; Gafner V; Pihlgren M; Lin H; Solanoy H; Brendza R; Ngu H; Foreman O; et al. Antibody-Mediated Targeting of Tau In Vivo Does Not Require Effector Function and Microglial Engagement. Cell Rep 2016, 16, 1690&#x2013;1700.</Citation><ArticleIdList><ArticleId IdType="pubmed">27475227</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzforum, Zagotenemab
2018, https://www.alzforum.org/therapeutics/zagotenemab.</Citation></Reference><Reference><Citation>Games D; Seubert P; Rockenstein E; Patrick C; Trejo M; Ubhi K; Ettle B; Ghassemiam M; Barbour R; Schenk D; et al. Axonopathy in an alpha-Synuclein Transgenic Model of Lewy Body Disease Is Associated with Extensive Accumulation of C-Terminal Truncated alpha-Synuclein. Am. J. Pathol 2013, 182, 940&#x2013;953.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3589076</ArticleId><ArticleId IdType="pubmed">23313024</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankovic J; Goodman I; Safirstein B; Schenk D; Kinney G; Koller M; Ness D; Griffith S; Grundman M; Soto J; et al. Results from a Phase 1b Multiple Ascending-dose study of prx002, an Anti-alpha-synuclein Monoclonal Antibody, in Patients with Parkinson&#x2019;s Disease. Mov. Disord 2017, 32, 1.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Weihofen A; Liu YT; Arndt JW; Huy C; Quan C; Smith BA; Baeriswyl JL; Cavegn N; Senn L; Su LH; et al. Development of an Aggregate-selective, Human-derived alpha-synuclein Antibody BIIB054 that Ameliorates Disease Phenotypes in Parkinson&#x2019;s Disease Models. Neurobiol. Dis 2019, 124, 276&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pubmed">30381260</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella R; Perni M; Chen SW; Fusco G; Cecchi C; Vendruscolo M; Chiti F; Dobson CM; De Simone A Probing the Origin of the Toxicity of Oligomeric Aggregates of &#x3b1;-Synuclein with Antibodies. ACS Chem. Biol 2019, 14, 1352&#x2013;1362.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7007184</ArticleId><ArticleId IdType="pubmed">31050886</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamblin MR Photobiomodulation for Alzheimer&#x2019;s Disease: Has the Light Dawned? Photonics 2019, 6, 77&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6664299</ArticleId><ArticleId IdType="pubmed">31363464</ArticleId></ArticleIdList></Reference><Reference><Citation>Saltmarche AE; Naeser MA; Ho KF; Hamblin MR; Lim L Significant Improvement in Cognition in Mild to Moderately Severe Dementia Cases Treated with Transcranial Plus Intranasal Photobiomodulation: Case Series Report. Photomed. Laser Surg 2017, 35, 432&#x2013;441.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5568598</ArticleId><ArticleId IdType="pubmed">28186867</ArticleId></ArticleIdList></Reference><Reference><Citation>De Taboada L; Yu J; Gattoni-Celli S; Richieri S; McCarthy T; Streeter J; Kindy MS Transcranial Laser Therapy Attenuates Amyloid-&#x3b2; Peptide Neuropathology in Amyloid-&#x3b2; Protein Precursor Transgenic Mice. J. Alzheimer&#x2019;s Dis 2011, 23, 521&#x2013;535.</Citation><ArticleIdList><ArticleId IdType="pubmed">21116053</ArticleId></ArticleIdList></Reference><Reference><Citation>Grillo SL; Duggett NA; Ennaceur A; Chazot PL Non-invasive Infra-red Therapy (1072 nm) Reduces &#x3b2;-amyloid Protein Levels in the Brain of an Alzheimer&#x2019;s Disease Mouse Model, TASTPM. J. Photochem. Photobiol., B 2013, 123, 13&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">23603448</ArticleId></ArticleIdList></Reference><Reference><Citation>Purushothuman S; et al. Near Infrared Light Mitigates Cerebellar Pathology in Transgenic Mouse Models of Dementia. Neurosci. Lett 2015, 591, 155&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pubmed">25703226</ArticleId></ArticleIdList></Reference><Reference><Citation>Purushothuman S; Johnstone DM; Nandasena C; Mitrofanis J; Stone J Photobiomodulation With Near Infrared Light Mitigates Alzheimer&#x2019;s Disease-related Pathology in Cerebral Cortex - Evidence from Two Transgenic Mouse Models. Alzheimer&#x2019;s Res. Ther 2014, 6, 2&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3978916</ArticleId><ArticleId IdType="pubmed">24387311</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M; Yang X; Ren J; Qu K; Qu X Using Graphene Oxide High Near-infrared Absorbance for Photothermal Treatment of Alzheimer&#x2019;s Disease. Adv. Mater 2012, 24, 1722&#x2013;1728.</Citation><ArticleIdList><ArticleId IdType="pubmed">22407491</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawasaki T; Fujioka J; Imai T; Torigoe K; Tsukiyama K Mid-infrared Free-electron Laser Tuned to the Amide I Band for Converting Insoluble Amyloid-like Protein Fibrils Into the Soluble Monomeric Form. Lasers Med. Sci 2014, 29, 1701&#x2013;1707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4149878</ArticleId><ArticleId IdType="pubmed">24760285</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawasaki T; Fujioka J; Imai T; Tsukiyama K Effect of Mid-infrared Free-Electron Laser Irradiation on Refolding of Amyloid-Like Fibrils of Lysozyme into Native Form. Protein J 2012, 31, 710&#x2013;716.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3483483</ArticleId><ArticleId IdType="pubmed">23054332</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawasaki T; Imai T; Tsukiyama K Use of a Mid-Infrared Free-Electron Laser (MIR-FEL) for Dissociation of the Amyloid Fibril Aggregates of a Peptide. J. Anal. Sci., Methods Instrum 2014, 4, 9&#x2013;18.</Citation></Reference><Reference><Citation>Kawasaki T; Yaji T; Imai T; Ohta T; Tsukiyama K Synchrotron-Infrared Microscopy Analysis of Amyloid Fibrils Irradiated by Mid-Infrared Free-Electron Laser. Am. J. Anal. Chem 2014, 5, 384&#x2013;394.</Citation></Reference><Reference><Citation>Shivu B; Seshadri S; Li J; Oberg KA; Uversky VN; Fink AL Distinct &#x3b2;-sheet Structure in Protein Aggregates Determined by ATR-FTIR Spectroscopy. Biochemistry 2013, 52, 5176&#x2013;5183.</Citation><ArticleIdList><ArticleId IdType="pubmed">23837615</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawasaki T; Tsukiyama K; Irizawa A Dissolution of a Fibrous Peptide by Terahertz Free Electron Laser. Sci. Rep 2019, 9, 10636.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6650392</ArticleId><ArticleId IdType="pubmed">31337794</ArticleId></ArticleIdList></Reference><Reference><Citation>Viet MH; Derreumaux P; Li MS; Christopher R; Sagui C; Nguyen PH Picosecond Dissociation of Amyloid Fibrils With Infrared Laser: a Nonequilibrium Simulation Study. J. Chem. Phys 2015, 143, 155101.</Citation><ArticleIdList><ArticleId IdType="pubmed">26493925</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawasaki T; Man HV; Sugimoto Y; Sugiyama N; Yamamoto H; Tsukiyama K; Wang J; Derreumaux P; Nguyen PH Infrared Laser Induced Amyloid Fibril Dissociation: A Joint experimental/theoretical Study on the GNNQQNY Peptide. J. Phys. Chem. B 2020, 124, 6266&#x2013;6277.</Citation><ArticleIdList><ArticleId IdType="pubmed">32560588</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y; Viet MH; Christopher R; Sagui C Amyloid Properties of Asparagine and Glutamine in Prion-like Proteins. ACS Chem. Neurosci 2016, 7, 576&#x2013;587.</Citation><ArticleIdList><ArticleId IdType="pubmed">26911543</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalecki D Mechanical bioeffects of ultrasound. Annu. Rev. Biomed. Eng 2004, 6, 229&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pubmed">15255769</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennen CE Cavitation and Bubble Dynamics; University Press: Oxford, 1995.</Citation></Reference><Reference><Citation>Souza RMDCE; da Silva ICS; Delgado ABT; da Silva PHV; Costa VRX Focused Ultrasound and Alzheimer&#x2019;s Disease A systematic Review. Dement. Neuropsychol 2018, 12, 353&#x2013;359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6289486</ArticleId><ArticleId IdType="pubmed">30546844</ArticleId></ArticleIdList></Reference><Reference><Citation>Jord&#xe1;o JF; Th&#xe9;venot E; Markham-Coultes K; Scarcelli T; Weng YQ; Xhima K; O&#x2019;Reilly M; Huang Y; McLaurin J; Hynynen K; et al. Amyloid-&#x3b2; Plaque Reduction, Endogenous Antibody Delivery and Glial Activation by Brain-targeted, Transcranial Focused Ultrasound . Exp. Neurol 2013, 248, 16&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4000699</ArticleId><ArticleId IdType="pubmed">23707300</ArticleId></ArticleIdList></Reference><Reference><Citation>Leinenga G; Gotz J Scanning Ultrasound Removes Amyloid-&#x3b2; and Restores Memory in an Alzheimer&#x2019;s Disease Mouse Model. Sci. Transl. Med 2015, 7, 278ra33.</Citation><ArticleIdList><ArticleId IdType="pubmed">25761889</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Reilly MA; Jones RM; Barrett E; Schwab A; Head E; Hynynen K Investigation of the Safety of Focused Ultrasound-Induced Blood-Brain Barrier Opening in a Natural Canine Model of Aging. Theranostics 2017, 7, 3573&#x2013;3584.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5596444</ArticleId><ArticleId IdType="pubmed">28912896</ArticleId></ArticleIdList></Reference><Reference><Citation>Beisteiner R; Matt E; Fan C; Baldysiak H; Sch&#xf6;nfeld M; Philippi Novak T; Amini A; Aslan T; Reinecke R; Lehrner J; et al. Transcranial Pulse Stimulation with Ultrasound in Alzheimer&#x2019;s Disease - A New Navigated Focal Brain. Therapy. Adv. Sci 2020, 7, 1902583.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7001626</ArticleId><ArticleId IdType="pubmed">32042569</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato N; Okochi M; Taniyama Y; Kurinami H; Shimamura M; Takeuchi D; Hamada H; Fukumori A; Kiyosue K; Taguchi T; et al. Development of New Screening System for Alzheimer Disease, in vitro Abeta Sink Assay, to Identify the Dissociation of Soluble Abeta From Fibrils. Neurobiol. Dis 2006, 22, 487&#x2013;495.</Citation><ArticleIdList><ArticleId IdType="pubmed">16488151</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagi H; Hasegawa K; Yoshimura Y; Goto Y Acceleration of the Depolymerization of Amyloid &#x3b2; Fibrils by Ultrasonication. Biochim. Biophys. Acta, Proteins Proteomics 2013, 1834, 2480&#x2013;2485.</Citation><ArticleIdList><ArticleId IdType="pubmed">24041501</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatani E; Lee YH; Yagi H; Yoshimura Y; Naiki H; Goto Y Ultrasonication-Dependent Production and Breakdown Lead to Minimum-Sized Amyloid Fibrils. Proc. Natl. Acad. Sci. U. S. A 2009, 106, 11119&#x2013;11124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2708754</ArticleId><ArticleId IdType="pubmed">19564620</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimura Y; Sakurai K; Lee YH; Ikegami T; Chatani E; Naiki H; Goto Y Direct Observation of Minimum-Sized Amyloid Fibrils Using Solution NMR Spectroscopy. Protein Sci 2010, 19, 2347&#x2013;2355.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3009402</ArticleId><ArticleId IdType="pubmed">20936689</ArticleId></ArticleIdList></Reference><Reference><Citation>Foguel D; Suarez MC; Ferr&#xe9;o-Gonzales AD; Porto TC; Palmieri L; Einsiedler CM; Andrade LR; Lashuel HA; Lansbury PT; Kelly J; et al. Dissociation of Amyloid Fibrils of alpha-Synuclein and Transthyretin by Pressure Reveals Their Reversible Nature and the Formation of Water-Excluded Cavities. Proc. Natl. Acad. Sci. U. S. A 2003, 100, 9831&#x2013;9836.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC187855</ArticleId><ArticleId IdType="pubmed">12900507</ArticleId></ArticleIdList></Reference><Reference><Citation>Okumura H; Itoh SG Amyloid Fibril Disruption by Ultrasonic Cavitation: Nonequilibrium Molecular Dynamics Simulations. J. Am. Chem. Soc 2014, 136, 10549&#x2013;10552.</Citation><ArticleIdList><ArticleId IdType="pubmed">24987794</ArticleId></ArticleIdList></Reference><Reference><Citation>Viet MH; Derreumaux P; Nguyen PH Nonequilibrium All-Atom Molecular Dynamics Simulation of the Ultrasound Induced Bubble Cavitation and Application to Dissociate Amyloid Fibril. J. Chem. Phys 2016, 145, 174113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5106436</ArticleId><ArticleId IdType="pubmed">27825231</ArticleId></ArticleIdList></Reference><Reference><Citation>Viet MH; Li MS; Derreumaux P; Nguyen PH Rayleigh-Plesset Equation of the Bubble Stable Cavitation in Water: A Nonequilibrium All-Atom Molecular Dynamics Simulation Study. J. Chem. Phys 2018, 148, 094505.</Citation></Reference><Reference><Citation>Miceli M; Muscat S; Morbiducci U; Cavagli&#xe0; M; Deriu MA Ultrasonic Waves Effect on S-Shaped &#x3b2;-Amyloids Conformational Dynamics by Non-equilibrium Molecular Dynamics. J. Mol. Graphics Modell 2020, 96, 107518.</Citation><ArticleIdList><ArticleId IdType="pubmed">31923804</ArticleId></ArticleIdList></Reference><Reference><Citation>Arendash GW Review of the Evidence that Transcranial Electromagnetic Treatment will be a Safe and Effective Therapeutic Against Alzheimer&#x2019;s Disease. J. Alzheimer&#x2019;s Dis 2016, 53, 753&#x2013;771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4981900</ArticleId><ArticleId IdType="pubmed">27258417</ArticleId></ArticleIdList></Reference><Reference><Citation>Dragicevic N; Bradshaw P; Mamcartz M; Lin X; Wang L; Cao C; Arendash GW Long-term Electromagnetic Field Treatment Enhances Brain Mitochondrial Function of both Alzheimer&#x2019;s Transgenic Mice and Normal Mice: A Mechanism for Electromagnetic Field-induced Cognitive Benefit? Neuroscience 2011, 185, 135&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pubmed">21514369</ArticleId></ArticleIdList></Reference><Reference><Citation>Arendash GW; Sanchez-Ramos J; Mori T; Mamcarz M; Lin X; Runfeldt M; Wang L; Zhang G; Sava V; Tan J; Cao C Electromagnetic Field Treatment Protects Against and Reverses Cognitive Impairment in Alzheimer&#x2019;s Transgenic Mice. J. Alzheimer&#x2019;s Dis 2010, 19, 191.</Citation><ArticleIdList><ArticleId IdType="pubmed">20061638</ArticleId></ArticleIdList></Reference><Reference><Citation>Arendash GW; Mori T; Dorsey M; Gonzalez R; Tajiri N; Borlongan C Electromagnetic Treatment to Old Alzheimer&#x2019;s Mice Reverses &#x3b2;-amyloid Deposition, Modifies Cerebral Blood Flow, and Provides Selected Cognitive Benefit. PLoS One 2012, 7, No. e35751.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3338462</ArticleId><ArticleId IdType="pubmed">22558216</ArticleId></ArticleIdList></Reference><Reference><Citation>Arendash GW; Cao C; Abulaban H; Baranowski R; Wisniewski G; Becerra L; Andel R; Lin X; Zhang X; Wittwer D; et al. A Clinical Trial of Transcranial Electromagnetic Treatment in Alzheimer&#x2019;s Disease: Cognitive Enhancement and Associated Changes in Cerebrospinal Fluid, Blood, and Brain Imaging. J. Alzheimer&#x2019;s Dis 2019, 71, 57&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6839500</ArticleId><ArticleId IdType="pubmed">31403948</ArticleId></ArticleIdList></Reference><Reference><Citation>Saikia J; Pandey G; Sasidharan S; Antony F; Nemade HB; Kumar S; Chaudhary N; Ramakrishnan V Electric Field Disruption of Amyloid Aggregation: Potential Noninvasive Therapy for Alzheimer&#x2019;s Disease. ACS Chem. Neurosci 2019, 10, 2250&#x2013;2262.</Citation><ArticleIdList><ArticleId IdType="pubmed">30707008</ArticleId></ArticleIdList></Reference><Reference><Citation>English N; Solomentsev G; O&#x2019;Brien P Non-equilibrium Molecular Dynamics Study of Electric and Low-frequency Microwave Fields on Hen Egg White Lysozyme. J. Chem. Phys 2009, 131, 035106.</Citation><ArticleIdList><ArticleId IdType="pubmed">19624238</ArticleId></ArticleIdList></Reference><Reference><Citation>Toschi F; Lugli F; Biscarini F; Zerbetto F Effects of Electric Field Stress on a &#x3b2;-Amyloid Peptide. J. Phys. Chem. B 2009, 113, 369&#x2013;376.</Citation><ArticleIdList><ArticleId IdType="pubmed">19063666</ArticleId></ArticleIdList></Reference><Reference><Citation>Todorova N; Bentveizen A; English N; Yarovsky I Electromagnetic-Field Effects on Structure and Dynamics of Amyloidogenic Peptides. J. Chem. Phys 2016, 144, 085101.</Citation><ArticleIdList><ArticleId IdType="pubmed">26931725</ArticleId></ArticleIdList></Reference><Reference><Citation>Todorova N; Bentveizen A; English N; Yarovsky I Electromagnetic Field Modulates Aggregation Propensity of Amyloid Peptides. J. Chem. Phys 2020, 152, 035104.</Citation><ArticleIdList><ArticleId IdType="pubmed">31968963</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J; Del Tredici K; Lee VM; Trojanowski JQ Spreading of Pathology in Neurodegenerative Diseases: a Focus on Human studies. Nat. Rev. Neurosci 2015, 16, 109&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4312418</ArticleId><ArticleId IdType="pubmed">25588378</ArticleId></ArticleIdList></Reference><Reference><Citation>Goedert M; Eisenberg DS; Crowther RA Propagation of Tau Aggregates and Neurodegeneration. Annu. Rev. Neurosci 2017, 40, 189&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pubmed">28772101</ArticleId></ArticleIdList></Reference><Reference><Citation>Jucker M; Walker LC Self-propagation of Pathogenic Protein Aggregates in Neurodegenerative Diseases. Nature 2013, 501, 45&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3963807</ArticleId><ArticleId IdType="pubmed">24005412</ArticleId></ArticleIdList></Reference><Reference><Citation>Jucker M; Walker LC Propagation and Spread of Pathogenic Protein Assemblies in Neurodegenerative Diseases. Nat. Neurosci 2018, 21, 1341&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6375686</ArticleId><ArticleId IdType="pubmed">30258241</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng C; Trojanowski JQ; Lee VM Protein Transmission in Neurodegenerative Disease. Nat. Rev. Neurol 2020, 16, 199&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9242841</ArticleId><ArticleId IdType="pubmed">32203399</ArticleId></ArticleIdList></Reference><Reference><Citation>Uemura N; Uemura MT; Luk KC; Lee VM; Trojanowski JQ Cell-to-Cell Transmission of Tau and &#x3b1;-Synuclein. Trends Mol. Med 2020, 26, 936&#x2013;952.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7529725</ArticleId><ArticleId IdType="pubmed">32371172</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasili E; Dominguez-Meijide A; Outeiro TF Spreading of alpha-Synuclein and Tau: A Systematic Comparison of the Mechanisms Involved. Front. Mol. Neurosci 2019, 12, 107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6494944</ArticleId><ArticleId IdType="pubmed">31105524</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson JL; Lee EB; Xie SX; Rennert L; Suh E; Bredenberg C; Caswell C; Van Deerlin VM; Yan N; Yousef A; et al. Neurodegenerative Disease Concomitant Proteinopathies are Prevalent, Age-related and APOE4-associated. Brain 2018, 141, 2181&#x2013;2193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6022546</ArticleId><ArticleId IdType="pubmed">29878075</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyle PA; Wilson RS; Yu L; Barr AM; Honer WG; Schneider JA; Bennett DA Much of Late Life Cognitive Decline is not due to Common Neurodegenerative Pathologies. Ann. Neurol 2013, 74, 478&#x2013;489.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3845973</ArticleId><ArticleId IdType="pubmed">23798485</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyle PA; Yu L; Wilson RS; Leurgans SE; Schneider JA; Bennett DA Person-specific Contribution of Neuropathologies to Cognitive Loss in Old Age. Ann. Neurol 2018, 83, 74&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5876116</ArticleId><ArticleId IdType="pubmed">29244218</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapasi A; DeCarli C; Schneider JA Impact of Multiple Pathologies on the Threshold for Clinically overt Dementia. Acta Neuropathol 2017, 134, 171&#x2013;186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5663642</ArticleId><ArticleId IdType="pubmed">28488154</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider JA; Arvanitakis Z; Bang W; Bennett DA Mixed Brain Pathologies Account for Most Dementia Cases in Community-dwelling Older Persons. Neurology 2007, 69, 2197&#x2013;2204.</Citation><ArticleIdList><ArticleId IdType="pubmed">17568013</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojanowski JQ; Lee VM Fatal attractions&#x201d; of Proteins. A Comprehensive Hypothetical Mechanism underlying Alzheimer&#x2019;s Disease and other Neurodegenerative Disorders. Ann. N. Y. Acad. Sci 2000, 924, 62&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">11193803</ArticleId></ArticleIdList></Reference><Reference><Citation>Uemura N; Yagi H; Uemura MT; Hatanaka Y; Yamakado H; Takahashi R Inoculation of alpha-synuclein Preformed Fibrils into the Mouse Gastrointestinal Tract Induces Lewy body-like Aggregates in the Brainstem via the Vagus Nerve. Mol. Neurodegener 2018, 13, 21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5948849</ArticleId><ArticleId IdType="pubmed">29751824</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono K; Takahashi R; Ikeda T; Yamada M Cross-seeding Effects of amyloid beta-protein and alpha-synuclein. J. Neurochem 2012, 122, 883&#x2013;890.</Citation><ArticleIdList><ArticleId IdType="pubmed">22734715</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsigelny IF; Crews L; Desplats P; Shaked GM; Sharikov Y; Mizuno H; Spencer B; Rockenstein E; Trejo M; Platoshyn O; et al. Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer&#x2019;s and Parkinson&#x2019;s Diseases. PLoS One 2008, 3, No. e3135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2519786</ArticleId><ArticleId IdType="pubmed">18769546</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia S; Flagmeier P; Habchi J; Lattanzi V; Linse S; Dobson CM; Knowles TPJ; Vendruscolo M Monomeric and Fibrillar alpha-synuclein Exert Opposite Effects on the Catalytic Cycle that Promotes the Proliferation of Abeta42 Aggregates. Proc. Natl. Acad. Sci. U. S. A 2017, 114, 8005&#x2013;8010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5544282</ArticleId><ArticleId IdType="pubmed">28698377</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal PK; Pettegrew JW; Masliah E; Hamilton RL; Mandal R Interaction between Abeta Peptide and alpha synuclein: Molecular Mechanisms in Overlapping Pathology of Alzheimer&#x2019;s and Parkinson&#x2019;s in Dementia with Lewy body Disease. Neurochem. Res 2006, 31, 1153&#x2013;1662.</Citation><ArticleIdList><ArticleId IdType="pubmed">16947080</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsh SE; Blurton-Jones M Examining the Mechanisms that Link beta-amyloid and alpha-synuclein Pathologies. Alzheimer&#x2019;s Res. Ther 2012, 4, 11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4054672</ArticleId><ArticleId IdType="pubmed">22546279</ArticleId></ArticleIdList></Reference><Reference><Citation>Masliah E; Mallory M; Alford M; DeTeresa R; Hansen LA; McKeel DW Jr; Morris JC Altered Expression of Synaptic Proteins Occurs early during Progression of Alzheimer&#x2019;s Disease. Neurology 2001, 56, 127&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pubmed">11148253</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts HL; Schneider BL; Brown DR alpha-Synuclein Increases beta-amyloid Secretion by Promoting beta-/gamma-secretase processing of APP. PLoS One 2017, 12, No. e0171925.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5302447</ArticleId><ArticleId IdType="pubmed">28187176</ArticleId></ArticleIdList></Reference><Reference><Citation>Koppen J; Schulze A; Machner L; Wermann M; Eichentopf R; Guthardt M; Hahnel A; Klehm J; Kriegeskorte MC; Hartlage-Rubsamen M; et al. Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro. Molecules 2020, 25, 580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7037551</ArticleId><ArticleId IdType="pubmed">32013170</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassil F; Brown HJ; Pattabhiraman S; Iwasyk JE; Maghames CM; Meymand ES; Cox TO; Riddle DM; Zhang B; Trojanowski JQ; et al. Amyloid-Beta (Abeta) Plaques Promote Seeding and Spreading of Alpha-Synuclein and Tau in a Mouse Model of Lewy Body Disorders with Abeta Pathology. Neuron 2020, 105, 260&#x2013;275 (e6).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6981053</ArticleId><ArticleId IdType="pubmed">31759806</ArticleId></ArticleIdList></Reference><Reference><Citation>Colom-Cadena M; Gelpi E; Marti MJ; Charif S; Dols-Icardo O; Blesa R; Clarimon J; Lleo A MAPT H1 Haplotype is Associated with Enhanced alpha-synuclein Deposition in Dementia with Lewy Bodies. Neurobiol. Aging 2013, 34, 936&#x2013;942.</Citation><ArticleIdList><ArticleId IdType="pubmed">22819391</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon-Sanchez J; Schulte C; Bras JM; Sharma M; Gibbs JR; Berg D; Paisan-Ruiz C; Lichtner P; Scholz SW; Hernandez DG; et al. Genome-wide Association Study Reveals Genetic Risk Underlying Parkinson&#x2019;s Disease. Nat. Genet 2009, 41, 1308&#x2013;1312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2787725</ArticleId><ArticleId IdType="pubmed">19915575</ArticleId></ArticleIdList></Reference><Reference><Citation>Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Ueda K; Ikeda K; Kawai M Cellular Co-localization of Phosphorylated tau- and NACP/alpha-synuclein-epitopes in Lewy Bodies in Sporadic Parkinson&#x2019;s Disease and in Dementia with Lewy Bodies. Brain Res 1999, 843, 53&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">10528110</ArticleId></ArticleIdList></Reference><Reference><Citation>Forman MS; Schmidt ML; Kasturi S; Perl DP; Lee VM; Trojanowski JQ Tau and alpha-synuclein Pathology in Amygdala of Parkinsonism-dementia Complex Patients of Guam. Am. J. Pathol 2002, 160, 1725&#x2013;1731.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1850878</ArticleId><ArticleId IdType="pubmed">12000724</ArticleId></ArticleIdList></Reference><Reference><Citation>Iseki E; Takayama N; Marui W; Ueda K; Kosaka K Relationship in the Formation Process between Neurofibrillary Tangles and Lewy Bodies in the Hippocampus of Dementia with Lewy Bodies Brains. J. Neurol. Sci 2002, 195, 85&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">11867079</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengupta U; Guerrero-Munoz MJ; Castillo-Carranza DL; Lasagna-Reeves CA; Gerson JE; Paulucci-Holthauzen AA; Krishnamurthy S; Farhed M; Jackson GR; Kayed R Pathological Interface between Oligomeric alpha-synuclein and tau in Synucleinopathies. Biol. Psychiatry 2015, 78, 672&#x2013;683.</Citation><ArticleIdList><ArticleId IdType="pubmed">25676491</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo-Carranza DL; Guerrero-Munoz MJ; Sengupta U; Gerson JE; Kayed R alpha-Synuclein Oligomers Induce a Unique Toxic Tau Strain. Biol. Psychiatry 2018, 84, 499&#x2013;508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6201292</ArticleId><ArticleId IdType="pubmed">29478699</ArticleId></ArticleIdList></Reference><Reference><Citation>Giasson BI; Forman MS; Higuchi M; Golbe LI; Graves CL; Kotzbauer PT; Trojanowski JQ; Lee VM Initiation and Synergistic Fibrillization of tau and alpha-synuclein. Science 2003, 300, 636&#x2013;640.</Citation><ArticleIdList><ArticleId IdType="pubmed">12714745</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo JL; Covell DJ; Daniels JP; Iba M; Stieber A; Zhang B; Riddle DM; Kwong LK; Xu Y; Trojanowski JQ; et al. Distinct alpha-synuclein Strains differentially Promote Tau Inclusions in Neurons. Cell 2013, 154, 103&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3820001</ArticleId><ArticleId IdType="pubmed">23827677</ArticleId></ArticleIdList></Reference><Reference><Citation>Nubling G; Bader B; Levin J; Hildebrandt J; Kretzschmar H; Giese A Synergistic Influence of Phosphorylation and Metal Ions on Tau Oligomer Formation and Coaggregation with alpha-synuclein at the Single Molecule Level. Mol. Neurodegener 2012, 7, 35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3472288</ArticleId><ArticleId IdType="pubmed">22824345</ArticleId></ArticleIdList></Reference><Reference><Citation>Waxman EA; Giasson BI Induction of Intracellular Tau Aggregation is Promoted by alpha-synuclein Qeeds and Provides Novel Insights into the Hyperphosphorylation of Tau. J. Neurosci 2011, 31, 7604&#x2013;7618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3122484</ArticleId><ArticleId IdType="pubmed">21613474</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J; Zhang S; Ma X; Jia C; Liu Z; Huang C; Liu C; Li D Structural Basis of the Interplay between alpha-synuclein and Tau in Regulating Pathological Amyloid Aggregation. J. Biol. Chem 2020, 295, 7470&#x2013;7480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7247300</ArticleId><ArticleId IdType="pubmed">32291284</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustke N; Trinczek B; Biernat J; Mandelkow EM; Mandelkow E Domains of Tau Protein and Interactions with Microtubules. Biochemistry 1994, 33, 9511&#x2013;9522.</Citation><ArticleIdList><ArticleId IdType="pubmed">8068626</ArticleId></ArticleIdList></Reference><Reference><Citation>Emmer KL; Waxman EA; Covy JP; Giasson BI E46K Human alpha-synuclein Transgenic Mice Develop Lewy-like and Tau Pathology associated with Age-dependent, Detrimental Motor Impairment. J. Biol. Chem 2011, 286, 35104&#x2013;35118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3186371</ArticleId><ArticleId IdType="pubmed">21846727</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerson JE; Farmer KM; Henson N; Castillo-Carranza DL; Carretero Murillo M; Sengupta U; Barrett A; Kayed R Tau Oligomers Mediate alpha-synuclein Toxicity and can be Targeted by Immunotherapy. Mol. Neurodegener 2018, 13, 13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5856311</ArticleId><ArticleId IdType="pubmed">29544548</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh B; Covelo A; Martell-Martinez H; Nanclares C; Sherman MA; Okematti E; Meints J; Teravskis PJ; Gallardo C; Savonenko AV; et al. Tau is Required for Progressive Synaptic and Memory Deficits in a Transgenic Mouse Model of alpha-synucleinopathy. Acta Neuropathol 2019, 138, 551&#x2013;574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6778173</ArticleId><ArticleId IdType="pubmed">31168644</ArticleId></ArticleIdList></Reference><Reference><Citation>Duka T; Duka V; Joyce JN; Sidhu A Alpha-Synuclein Contributes to GSK-3beta-catalyzed Tau Phosphorylation in Parkinson&#x2019;s Disease Models. FASEB J 2009, 23, 2820&#x2013;2830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2796901</ArticleId><ArticleId IdType="pubmed">19369384</ArticleId></ArticleIdList></Reference><Reference><Citation>Duka T; Rusnak M; Drolet RE; Duka V; Wersinger C; Goudreau JL; Sidhu A Alpha-synuclein Induces Hyperphosphorylation of Tau in the MPTP Model of Parkinsonism. FASEB J 2006, 20, 2302&#x2013;2312.</Citation><ArticleIdList><ArticleId IdType="pubmed">17077307</ArticleId></ArticleIdList></Reference><Reference><Citation>Haggerty T; Credle J; Rodriguez O; Wills J; Oaks AW; Masliah E; Sidhu A Hyperphosphorylated Tau in an alpha-synuclein-overexpressing Transgenic Model of Parkinson&#x2019;s Disease. Eur. J. Neurosci 2011, 33, 1598&#x2013;1610.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3086951</ArticleId><ArticleId IdType="pubmed">21453448</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan SS; LaCroix M; Boyle G; Sherman MA; Brown JL; Amar F; Aldaco J; Lee MK; Bloom GS; Lesne SE Bidirectional Modulation of Alzheimer Phenotype by alpha-synuclein in Mice and Primary Neurons. Acta Neuropathol 2018, 136, 589&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6329667</ArticleId><ArticleId IdType="pubmed">29995210</ArticleId></ArticleIdList></Reference><Reference><Citation>Teravskis PJ; Covelo A; Miller EC; Singh B; Martell-Martinez HA; Benneyworth MA; Gallardo C; Oxnard BR; Araque A; Lee MK; et al. A53T Mutant Alpha-Synuclein Induces Tau-Dependent Postsynaptic Impairment Independently of Neurodegenerative Changes. J. Neurosci 2018, 38, 9754&#x2013;9767.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6222065</ArticleId><ArticleId IdType="pubmed">30249789</ArticleId></ArticleIdList></Reference><Reference><Citation>Credle JJ; George JL; Wills J; Duka V; Shah K; Lee YC; Rodriguez O; Simkins T; Winter M; Moechars D; et al. GSK-3beta Dysregulation Contributes to Parkinson&#x2019;s-like Pathophysiology with associated Region-specific Phosphorylation and Accumulation of tau and alpha-synuclein. Cell Death Differ 2015, 22, 838&#x2013;851.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4392080</ArticleId><ArticleId IdType="pubmed">25394490</ArticleId></ArticleIdList></Reference><Reference><Citation>Gassowska M; Czapski GA; Pajak B; Cieslik M; Lenkiewicz AM; Adamczyk A Extracellular alpha-synuclein Leads to Microtubule Destabilization via GSK-3beta-dependent Tau Phosphorylation in PC12 Cells. PLoS One 2014, 9, No. e94259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3983155</ArticleId><ArticleId IdType="pubmed">24722055</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge X; Yang Y; Sun Y; Cao W; Ding F Islet Amyloid Polypeptide Promotes Amyloid-Beta Aggregation by Binding-Induced Helix-Unfolding of the Amyloidogenic Core. ACS Chem. Neurosci 2018, 9, 967&#x2013;975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5955824</ArticleId><ArticleId IdType="pubmed">29378116</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreetto E; Yan LM; Tatarek-Nossol M; Velkova A; Frank R; Kapurniotu A Identification of Hot Regions of the Abeta-IAPP Interaction Interface as High-affinity Binding Sites in both Cross- and Self-association. Angew. Chem., Int. Ed 2010, 49, 3081&#x2013;3085.</Citation><ArticleIdList><ArticleId IdType="pubmed">20309983</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeliger J; Weise K; Opitz N; Winter R The Effect of Abeta on IAPP Aggregation in the Presence of an Isolated beta-cell Lembrane. J. Mol. Biol 2012, 421, 348&#x2013;368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4075326</ArticleId><ArticleId IdType="pubmed">22321797</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M; Hu R; Chen H; Gong X; Zhou F; Zhang L; Zheng J Polymorphic Associations and Structures of the Cross-Seeding of Abeta1&#x2013;42 and hIAPP1&#x2013;37 Polypeptides. J. Chem. Inf. Model 2015, 55, 1628&#x2013;1639.</Citation><ArticleIdList><ArticleId IdType="pubmed">26173078</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M; Hu R; Ren B; Chen H; Jiang B; Ma J; Zheng J Molecular Understanding of Abeta-hIAPP Cross-Seeding Assemblies on Lipid Membranes. ACS Chem. Neurosci 2017, 8, 524&#x2013;537.</Citation><ArticleIdList><ArticleId IdType="pubmed">27936589</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson K; Barisone GA; Diaz E; Jin LW; DeCarli C; Despa F Amylin Deposition in the Brain: A second Amyloid in Alzheimer Disease? Ann. Neurol 2013, 74, 517&#x2013;526.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3818462</ArticleId><ArticleId IdType="pubmed">23794448</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskarsson ME; Paulsson JF; Schultz SW; Ingelsson M; Westermark P; Westermark GT In vivo Seeding and Cross-seeding of Localized Amyloidosis: a Molecular Link between Type 2 Diabetes and Alzheimer Disease. Am. J. Pathol 2015, 185, 834&#x2013;846.</Citation><ArticleIdList><ArticleId IdType="pubmed">25700985</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Gonzalez I; Edwards G Iii; Salvadores N; Shahnawaz M; Diaz-Espinoza R; Soto C Molecular Interaction between Type 2 Diabetes and Alzheimer&#x2019;s Disease through Cross-seeding of Protein Misfolding. Mol. Psychiatry 2017, 22, 1327&#x2013;1334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5495631</ArticleId><ArticleId IdType="pubmed">28044060</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath I; Wittung-Stafshede P Cross-talk between Amyloidogenic proteins in Type-2 Diabetes and Parkinson&#x2019;s Disease. Proc. Natl. Acad. Sci. U. S. A 2016, 113, 12473&#x2013;12477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5098634</ArticleId><ArticleId IdType="pubmed">27791129</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauren J; Gimbel DA; Nygaard HB; Gilbert JW; Strittmatter SM Cellular Prion Protein Mediates Impairment of Synaptic Plasticity by amyloid-beta Oligomers. Nature 2009, 457, 1128&#x2013;1132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2748841</ArticleId><ArticleId IdType="pubmed">19242475</ArticleId></ArticleIdList></Reference><Reference><Citation>Um JW; Nygaard HB; Heiss JK; Kostylev MA; Stagi M; Vortmeyer A; Wisniewski T; Gunther EC; Strittmatter SM Alzheimer amyloid-beta Oligomer Bound to Postsynaptic Prion Protein Activates Fyn to Impair Neurons. Nat. Neurosci 2012, 15, 1227&#x2013;1235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3431439</ArticleId><ArticleId IdType="pubmed">22820466</ArticleId></ArticleIdList></Reference><Reference><Citation>Larson ME; Sherman MA; Greimel S; Kuskowski M; Schneider JA; Bennett DA; Lesne SE Soluble alpha-synuclein is a Novel Modulator of Alzheimer&#x2019;s Disease Pathophysiology. J. Neurosci 2012, 32, 10253&#x2013;10266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3425439</ArticleId><ArticleId IdType="pubmed">22836259</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou WQ; Xiao X; Yuan J; Puoti G; Fujioka H; Wang X; Richardson S; Zhou X; Zou R; Li S; et al. Amyloid-beta42 Interacts Mainly with Insoluble Prion Protein in the Alzheimer Brain. J. Biol. Chem 2011, 286, 15095&#x2013;15105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3083157</ArticleId><ArticleId IdType="pubmed">21393248</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales R; Estrada LD; Diaz-Espinoza R; Morales-Scheihing D; Jara MC; Castilla J; Soto C Molecular Cross Talk between Misfolded Proteins in Animal Models of Alzheimer&#x2019;s and Prion Diseases. J. Neurosci 2010, 30, 4528&#x2013;4535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2859074</ArticleId><ArticleId IdType="pubmed">20357103</ArticleId></ArticleIdList></Reference><Reference><Citation>Canu N; Filesi I; Pristera A; Ciotti MT; Biocca S Altered Intracellular Distribution of PrPC and Impairment of Proteasome Activity in tau overexpressing Cortical Neurons. J. Alzheimer&#x2019;s Dis 2011, 27, 603&#x2013;613.</Citation><ArticleIdList><ArticleId IdType="pubmed">21841253</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishizawa K; Komori T; Shimazu T; Yamamoto T; Kitamoto T; Shimazu K; Hirose T Hyperphosphorylated tau Deposition Parallels Prion Protein Burden in a Case of Gerstmann-Straussler-Scheinker Syndrome P102L Mutation Complicated with Dementia. Acta Neuropathol 2002, 104, 342&#x2013;350.</Citation><ArticleIdList><ArticleId IdType="pubmed">12200619</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiniger L; Lukic A; Linehan J; Rudge P; Collinge J; Mead S; Brandner S Tau, Prions and Abeta: the Triad of Neurodegeneration. Acta Neuropathol 2011, 121, 5&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3015202</ArticleId><ArticleId IdType="pubmed">20473510</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero-Munoz MJ; Castillo-Carranza DL; Krishnamurthy S; Paulucci-Holthauzen AA; Sengupta U; Lasagna-Reeves CA; Ahmad Y; Jackson GR; Kayed R Amyloid-beta oligomers as a template for secondary amyloidosis in Alzheimer&#x2019;s disease. Neurobiol. Dis 2014, 71, 14&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">25134727</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiltzius JJ; Sievers SA; Sawaya MR; Cascio D; Popov D; Riekel C; Eisenberg D Atomic Structure of the Cross-beta Spine of Islet Amyloid Polypeptide (IAPP). Protein Sci 2008, 17, 1467&#x2013;1474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2525530</ArticleId><ArticleId IdType="pubmed">18556473</ArticleId></ArticleIdList></Reference><Reference><Citation>Wineman-Fisher V; Atsmon-Raz Y; Miller Y Orientations of Residues along the beta-arch of Self-assembled IAPP Fibril-like Structures lead to Polymorphism. Biomacromolecules 2015, 16, 156&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">25420121</ArticleId></ArticleIdList></Reference><Reference><Citation>Baram M; Atsmon-Raz Y; Ma B; Nussinov R; Miller Y IAPP-Abeta Oligomers at Atomic Resolution using Molecular Dynamics Simulations: a Link between Type 2 Diabetes and Alzheimer&#x2019;s Disease. Phys. Chem. Chem. Phys 2016, 18, 2330&#x2013;2338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4720542</ArticleId><ArticleId IdType="pubmed">26349542</ArticleId></ArticleIdList></Reference><Reference><Citation>Sciacca MF; Milardi D; Messina GM; Marletta G; Brender JR; Ramamoorthy A; La Rosa C Cations as Switches of Amyloid-mediated Membrane Disruption Mechanisms: Calcium and IAPP. Biophys. J 2013, 104, 173&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3540246</ArticleId><ArticleId IdType="pubmed">23332070</ArticleId></ArticleIdList></Reference><Reference><Citation>Atsmon-Raz Y; Miller Y A Proposed Atomic Structure of the Self-Assembly of the Non-Amyloid-beta Component of Human alpha-Synuclein As Derived by Computational Tools. J. Phys. Chem. B 2015, 119, 10005&#x2013;10015.</Citation><ArticleIdList><ArticleId IdType="pubmed">26147432</ArticleId></ArticleIdList></Reference><Reference><Citation>Atsmon-Raz Y; Miller Y Non-Amyloid-beta Component of Human alpha-synuclein Oligomers Induces Formation of new Abeta Oligomers: Insight into the Mechanisms that Link Parkinson&#x2019;s and Alzheimer&#x2019;s Diseases. ACS Chem. Neurosci 2016, 7, 46&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">26479553</ArticleId></ArticleIdList></Reference><Reference><Citation>Atsmon-Raz Y; Miller Y Molecular Mechanisms of the Bindings between Non-amyloid beta Component Oligomers and IAPP Oligomers. J. Phys. Chem. B 2016, 120, 10649&#x2013;10659.</Citation><ArticleIdList><ArticleId IdType="pubmed">27662503</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhein V; Song X; Wiesner A; Ittner LM; Baysang G; Meier F; Ozmen L; Bluethmann H; Drose S; Brandt U; et al. Amyloid-beta and Tau Synergistically Impair the Oxidative Phosphorylation System in Triple Transgenic Alzheimer&#x2019;s Disease Mice. Proc. Natl. Acad. Sci. U. S. A 2009, 106, 20057&#x2013;20062.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2774257</ArticleId><ArticleId IdType="pubmed">19897719</ArticleId></ArticleIdList></Reference><Reference><Citation>David DC; Hauptmann S; Scherping I; Schuessel K; Keil U; Rizzu P; Ravid R; Drose S; Brandt U; Muller WE; et al. Proteomic and Functional Analyses Reveal a Mitochondrial Dysfunction in P301L Tau Transgenic Mice. J. Biol. Chem 2005, 280, 23802&#x2013;23814.</Citation><ArticleIdList><ArticleId IdType="pubmed">15831501</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauptmann S; Keil U; Scherping I; Bonert A; Eckert A; Muller WE Mitochondrial Dysfunction in Sporadic and Genetic Alzheimer&#x2019;s Disease. Exp. Gerontol 2006, 41, 668&#x2013;673.</Citation><ArticleIdList><ArticleId IdType="pubmed">16677790</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckert A; Hauptmann S; Scherping I; Rhein V; Muller-Spahn F; Gotz J; Muller WE Soluble beta-amyloid Leads to Mitochondrial Defects in Amyloid Precursor Protein and Tau Transgenic Mice. Neurodegener. Dis 2008, 5, 157&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18322377</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotz J; Lim YA; Ke YD; Eckert A; Ittner LM Dissecting Toxicity of tau and beta-amyloid. Neurodegener. Dis 2010, 7, 10&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">20160450</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis J; Dickson DW; Lin WL; Chisholm L; Corral A; Jones G; Yen SH; Sahara N; Skipper L; Yager D; et al. Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP. Science 2001, 293, 1487&#x2013;1491.</Citation><ArticleIdList><ArticleId IdType="pubmed">11520987</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotz J; Chen F; van Dorpe J; Nitsch RM Formation of Neurofibrillary Tangles in P301l Tau Transgenic Mice Induced by Abeta42 Fibrils. Science 2001, 293, 1491&#x2013;1495.</Citation><ArticleIdList><ArticleId IdType="pubmed">11520988</ArticleId></ArticleIdList></Reference><Reference><Citation>Oddo S; Caccamo A; Shepherd JD; Murphy MP; Golde TE; Kayed R; Metherate R; Mattson MP; Akbari Y; LaFerla FM Triple-transgenic Model of Alzheimer&#x2019;s Disease with Plaques and Tangles: Intracellular Abeta and Synaptic Dysfunction. Neuron 2003, 39, 409&#x2013;421.</Citation><ArticleIdList><ArticleId IdType="pubmed">12895417</ArticleId></ArticleIdList></Reference><Reference><Citation>von Bergen M; Friedhoff P; Biernat J; Heberle J; Mandelkow EM; Mandelkow E Assembly of tau Protein into Alzheimer Paired Helical Filaments Depends on a Local Sequence Motif ((306)VQIVYK(311)) Forming beta Structure. Proc. Natl. Acad. Sci. U. S. A 2000, 97, 5129&#x2013;5134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC25793</ArticleId><ArticleId IdType="pubmed">10805776</ArticleId></ArticleIdList></Reference><Reference><Citation>Goux WJ; Kopplin L; Nguyen AD; Leak K; Rutkofsky M; Shanmuganandam VD; Sharma D; Inouye H; Kirschner DA Formation of Straight and Twisted Filaments from Short tau Peptides. J. Biol. Chem 2004, 279, 26868&#x2013;26875.</Citation><ArticleIdList><ArticleId IdType="pubmed">15100221</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrantes A; Sotres J; Hernando-Perez M; Benitez MJ; de Pablo PJ; Baro AM; Avila J; Jimenez JS Tau Aggregation Followed by Atomic Force Microscopy and Surface Plasmon Resonance, and Single Molecule tau-tau Interaction Probed by Atomic Force Spectroscopy. J. Alzheimer&#x2019;s Dis 2009, 18, 141&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">19625749</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson DW; Zhou H; Dahlquist FW; Lew J A soluble Oligomer of Tau associated with Fiber Formation Analyzed by NMR. Biochemistry 2008, 47, 7393&#x2013;7404.</Citation><ArticleIdList><ArticleId IdType="pubmed">18558718</ArticleId></ArticleIdList></Reference><Reference><Citation>Margittai M; Langen R Side Chain-dependent Stacking Modulates Tau Filament Structure. J. Biol. Chem 2006, 281, 37820&#x2013;37827.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023423</ArticleId></ArticleIdList></Reference><Reference><Citation>Do TD; Economou NJ; Chamas A; Buratto SK; Shea JE; Bowers MT Interactions between amyloid-&#x3b2; and Tau Fragments Promote Aberrant Aggregates: Implications for amyloid Toxicity. J. Phys. Chem. B 2014, 118, 11220&#x2013;11230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4174992</ArticleId><ArticleId IdType="pubmed">25153942</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller Y; Ma B; Nussinov R Synergistic Interactions between Repeats in Tau Protein and Abeta amyloids May be Responsible for Accelerated Aggregation via Polymorphic States. Biochemistry 2011, 50, 5172&#x2013;5181.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3109766</ArticleId><ArticleId IdType="pubmed">21506544</ArticleId></ArticleIdList></Reference><Reference><Citation>Raz Y; Miller Y Interactions between Abeta and Mutated Tau Lead to Polymorphism and Induce Aggregation of Abeta-mutated Tau Oligomeric Complexes. PLoS One 2013, 8, No. e73303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3741189</ArticleId><ArticleId IdType="pubmed">23951348</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimm A; Eckert A Brain Aging and Neurodegeneration: from a Mitochondrial Point of View. J. Neurochem 2017, 143, 418&#x2013;431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5724505</ArticleId><ArticleId IdType="pubmed">28397282</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahul-Mellier AL; Burtscher J; Maharjan N; Weerens L; Croisier M; Kuttler F; Leleu M; Knott GW; Lashuel HA The process of Lewy Body Formation, rather than simply &#x3b1;-synuclein Fibrillization, is one of the Major Drivers of Neurodegeneration. Proc. Natl. Acad. Sci. U. S. A 2020, 117, 4971&#x2013;4982.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7060668</ArticleId><ArticleId IdType="pubmed">32075919</ArticleId></ArticleIdList></Reference><Reference><Citation>Esparza TJ; Wildburger NC; Jiang H; Gangolli M; Cairns NJ; Bateman RJ; Brody DL Soluble Amyloid-beta Aggregates from Human Alzheimer&#x2019;s Disease Brains. Sci. Rep 2016, 6, 38187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5137165</ArticleId><ArticleId IdType="pubmed">27917876</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanaan NM; Hamel C; Grabinski T; Combs B Liquid-liquid Phase Separation Induces Pathogenic Tau Conformations in vitro. Nat. Commun 2020, 11, 2809.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7272632</ArticleId><ArticleId IdType="pubmed">32499559</ArticleId></ArticleIdList></Reference><Reference><Citation>Tetz G; Pinho M; Pritzkow S; Mendez N; Soto C; Tetz V Bacterial DNA Promotes Tau aggregation. Sci. Rep 2020, 10, 2369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7012890</ArticleId><ArticleId IdType="pubmed">32047247</ArticleId></ArticleIdList></Reference><Reference><Citation>Ait-Bouziad N; Lv G; Mahul-Mellier AL; Xiao S; Zorludemir G; Eliezer D; Walz T; Lashuel HA Discovery and Characterization of Stable and Toxic Tau/phospholipid Oligomeric Complexes. Nat. Commun 2017, 8, 1678.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5698329</ArticleId><ArticleId IdType="pubmed">29162800</ArticleId></ArticleIdList></Reference><Reference><Citation>Habchi J; Chia S; Galvagnion C; Michaels TCT; Bellaiche MMJ; Ruggeri FS; Sanguanini M; Idini I; Kumita JR; Sparr E; et al. Cholesterol Catalyses A&#x3b2;42 Aggregation through a Heterogeneous Nucleation Pathway in the Presence of Lipid Membranes. Nat. Chem 2018, 10, 673&#x2013;683.</Citation><ArticleIdList><ArticleId IdType="pubmed">29736006</ArticleId></ArticleIdList></Reference><Reference><Citation>Thijssen EH; La Joie R; Wolf A; Strom A; Wang P; Iaccarino L; Bourakova V; Cobigo Y; Heuer H; Spina S; et al. Diagnostic Value of Plasma Phosphorylated tau181 in Alzheimer&#x2019;s Disease and Frontotemporal Lobar Degeneration. Nat. Med 2020, 26, 387&#x2013;397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7101073</ArticleId><ArticleId IdType="pubmed">32123386</ArticleId></ArticleIdList></Reference><Reference><Citation>Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; et al. Blood Phosphorylated tau 181 as a Biomarker for Alzheimer&#x2019;s Disease: a Diagnostic Performance and Prediction Modelling Study using Data from four Prospective Cohorts. Lancet Neurol 2020, 19, 422&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pubmed">32333900</ArticleId></ArticleIdList></Reference><Reference><Citation>Soria FN; Paviolo C; Doudnikoff E; Arotcarena ML; Lee A; Dann&#xe9; N; Mandal AK; Gosset P; Dehay B; Groc L; et al. Synucleinopathy Alters Nanoscale Organization and Diffusion in the Brain Extracellular Space through Hyaluronan Remodeling. Nat. Commun 2020, 11, 3440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7351768</ArticleId><ArticleId IdType="pubmed">32651387</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingsmore KM; Vaccari A; Abler D; Cui SX; Epstein FH; Rockne RC; Acton ST; et al. MRI Analysis to Map Interstitial Flow in the Brain Tumor Microenvironment. APL Bioeng 2018, 2, 031905.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6238644</ArticleId><ArticleId IdType="pubmed">30456343</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee K; Carman-Esparza CM; Munson JM Methods to Measure, Model and Manipulate Fluid Flow in Brain. J. Neurosci. Methods 2020, 333, 108541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7607555</ArticleId><ArticleId IdType="pubmed">31838183</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei Y; Han H; Yuan F; Javeed A; Zhao Y The Brain Interstitial System: Anatomy, Modeling, in vivo Measurement, and Applications. Prog. Neurobiol 2017, 157, 230&#x2013;246.</Citation><ArticleIdList><ArticleId IdType="pubmed">26837044</ArticleId></ArticleIdList></Reference><Reference><Citation>Brini E; Simmerling C; Dill K Protein Storytelling through Physics. Science 2020, 370 (6520), No. eaaz3041.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7945008</ArticleId><ArticleId IdType="pubmed">33243857</ArticleId></ArticleIdList></Reference><Reference><Citation>Man VH; He X; Derreumaux P; Ji B; Xie XQ; Nguyen PH; Wang J Effects of All-Atom Molecular Mechanics Force Fields on Amyloid Peptide Assembly: The Case of A&#x3b2;16&#x2013;22 Dimer. J. Chem. Theory Comput 2019, 15, 1440&#x2013;1452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6745714</ArticleId><ArticleId IdType="pubmed">30633867</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen PH; Sterpone F; Derreumaux P Aggregation of Disease-related Peptides. Prog. Mol. Biol. Transl. Sci 2020, 170, 435&#x2013;460.</Citation><ArticleIdList><ArticleId IdType="pubmed">32145950</ArticleId></ArticleIdList></Reference><Reference><Citation>Strodel B Amyloid aggregation Simulations: Challenges, Advances and Perspectives. Curr. Opin. Struct. Biol 2021, 67, 145&#x2013;152.</Citation><ArticleIdList><ArticleId IdType="pubmed">33279865</ArticleId></ArticleIdList></Reference><Reference><Citation>Krausser J; Knowles TPJ; &#x160;ari&#x107; A Physical Mechanisms of Amyloid Nucleation on Fluid Membranes. Proc. Natl. Acad. Sci. U. S. A 2020, 117, 33090&#x2013;33098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7777200</ArticleId><ArticleId IdType="pubmed">33328273</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J; Olsson S; Wehmeyer C; P&#xe9;rez A; Charron NE; de Fabritiis G; No&#xe9; F; Clementi C Machine Learning of Coarse-Grained Molecular Dynamics Force Fields. ACS Cent. Sci 2019, 5, 755&#x2013;767.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6535777</ArticleId><ArticleId IdType="pubmed">31139712</ArticleId></ArticleIdList></Reference><Reference><Citation>Chebaro Y; Jiang P; Zang T; Mu Y; Nguyen PH; Mousseau N; Derreumaux P Structures of A&#x3b2;17&#x2013;42 Trimers in Isolation and with Five Small-molecule Drugs using a Hierarchical Computational Procedure. J. Phys. Chem. B 2012, 116, 8412&#x2013;8422.</Citation><ArticleIdList><ArticleId IdType="pubmed">22283547</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengupta U; Carballo-Pacheco M; Strodel B Automated Markov State Models for Molecular Dynamics Simulations of Aggregation and Self-assembly. J. Chem. Phys 2019, 150, 115101.</Citation><ArticleIdList><ArticleId IdType="pubmed">30901988</ArticleId></ArticleIdList></Reference><Reference><Citation>No&#xe9; F; Olsson S; K&#xf6;hler J; Wu H Boltzmann Generators: Sampling Equilibrium States of Many-body Systems with Deep Learning. Science 2019, 365, No. eaaw1147.</Citation><ArticleIdList><ArticleId IdType="pubmed">31488660</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings J; Lee G; Ritter A; Sabbagh M; Zhong K Alzheimer&#x2019;s Disease Drug Development Pipeline. Alzheimer&#x2019;s Dement (N.Y.) 2019, 5, 272&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6617248</ArticleId><ArticleId IdType="pubmed">31334330</ArticleId></ArticleIdList></Reference><Reference><Citation>Bullain S; Doody RJ What Works and What doesn&#x2019;t Work in Alzheimer&#x2019;s Disease? From Interventions on Risk Factors to Anti-amyloid Trials. J. Neurochem 2020, 155, 120&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pubmed">32277473</ArticleId></ArticleIdList></Reference><Reference><Citation>Lao K; Ji N; Qiao W; Tang Z; Gou X Drug Development for Alzheimer&#x2019;s Disease: Review. J. Drug Target 2019, 27, 164&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pubmed">29732929</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballard C; Aarsland D; Cummings J; O&#x2019;Brien J; Mills R; Molinuevo JL; Fladby T; Williams G; Doherty P; Corbett A; Sultana J Drug Repositioning and Repurposing for Alzheimer Disease. Nat. Rev. Neurol 2020, 16, 661&#x2013;673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8291993</ArticleId><ArticleId IdType="pubmed">32939050</ArticleId></ArticleIdList></Reference><Reference><Citation>Jucker M The Benefits and Limitations of Animal Models for Translational Research in Neurodegenerative Diseases. Nat. Med 2010, 16, 1210&#x2013;1214.</Citation><ArticleIdList><ArticleId IdType="pubmed">21052075</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher EMC; Bannerman DM Mouse Models of Neurodegeneration: Know your Question, Know your Mouse. Sci. Transl. Med 2019, 11, No. eaaq1818.</Citation><ArticleIdList><ArticleId IdType="pubmed">31118292</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson SJ; Andrews N; Ball D; Bellantuono I; Gray J; Hachoumi L; Holmes A; Latcham J; Petrie A; Potter P; et al. Does Age Matter? The Impact of Rodent Age on Study Outcomes. Lab. Anim 2017, 51, 160&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5367550</ArticleId><ArticleId IdType="pubmed">27307423</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui JH; Hansen DV; Kriegstein AR Development and Evolution of the Human Neocortex. Cell 2011, 146, 18&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3610574</ArticleId><ArticleId IdType="pubmed">21729779</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberheim NA; Wang X; Goldman S; Nedergaard M Astrocytic Complexity Distinguishes the Human Brain. Trends Neurosci 2006, 29, 547&#x2013;543.</Citation><ArticleIdList><ArticleId IdType="pubmed">16938356</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens JC; Banks GT; Festing MF; Fisher EM Quiet Mutations in Inbred Strains of Mice. Trends Mol. Med 2007, 13, 512&#x2013;519.</Citation><ArticleIdList><ArticleId IdType="pubmed">17981508</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankowsky JL; Zheng H Practical Considerations for Choosing a Mouse Model of Alzheimer&#x2019;s Disease. Mol. Neurodegener 2017, 12, 89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5741956</ArticleId><ArticleId IdType="pubmed">29273078</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamache J; Benzow K; Forster C; Kemper L; Hlynialuk C; Furrow E; Ashe KH; Koob MD Factors other than hTau Overexpression that Contribute to Tauopathy-like Phenotype in rTg4510 Mice. Nat. Commun 2019, 10, 2479.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6554306</ArticleId><ArticleId IdType="pubmed">31171783</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JH Applications and Limitations of Genetically Modified Mouse Models in Drug Discovery and Development. Curr. Drug Metab 2008, 9, 419&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pubmed">18537578</ArticleId></ArticleIdList></Reference><Reference><Citation>Karran E; De Strooper B The Amyloid Cascade Hypothesis: Are we Poised for Success or Failure? J. Neurochem 2016, 139 (2), 237&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pubmed">27255958</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S; Mims PN; Roman RJ; Fan F Accumulation a Cause or Consequence of Alzheimer&#x2019;s Disease? J. Alzheimers Parkinsonism Dement 2016, 1, 7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5555607</ArticleId><ArticleId IdType="pubmed">28815226</ArticleId></ArticleIdList></Reference><Reference><Citation>Semorinemab. https://www.alzforum.org/.</Citation></Reference><Reference><Citation>Abbott A Neuroscience: The Plaque Plan. Nature 2008, 456, 161&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">19005527</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois B The Emergence of a New Conceptual Framework for Alzheimer&#x2019;s Disease. J. Alzheimer&#x2019;s Dis 2018, 62, 1059&#x2013;1066.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5870001</ArticleId><ArticleId IdType="pubmed">29036825</ArticleId></ArticleIdList></Reference><Reference><Citation>Scial&#xf2; C; De Cecco E; Manganotti P; Legname G Prion and Prion-Like Protein Strains: Deciphering the Molecular Basis of Heterogeneity in Neurodegeneration. Viruses 2019, 11, 261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6466326</ArticleId><ArticleId IdType="pubmed">30875755</ArticleId></ArticleIdList></Reference><Reference><Citation>Sims R; Hill M; Williams J The Multiplex Model of the Genetics of Alzheimer&#x2019;s Disease. Nat. Neurosci 2020, 23, 311&#x2013;322.</Citation><ArticleIdList><ArticleId IdType="pubmed">32112059</ArticleId></ArticleIdList></Reference><Reference><Citation>De Cecco E; Celauro L; Vanni S; Grandolfo M; Bistaffa E; Moda F; Aguzzi A; Legname G The Uptake of tau Amyloid Fibrils is Facilitated by the Cellular Prion Protein and Hampers Prion Propagation in Cultured Cells. J. Neurochem 2020, 155, 577&#x2013;591.</Citation><ArticleIdList><ArticleId IdType="pubmed">32394432</ArticleId></ArticleIdList></Reference><Reference><Citation>Therriault J; Benedet AL; Pascoal TA; Mathotaarachchi S; Savard M; Chamoun M; Thomas E; Kang MS; Lussier F; Tissot C et al. APOE&#x3b5;4 Potentiates the Relationship between amyloid-&#x3b2; and tau Pathologies. Mol. Psychiatry 2020, DOI: 10.1038/s41380-020-0688-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-020-0688-6</ArticleId><ArticleId IdType="pmc">PMC8758492</ArticleId><ArticleId IdType="pubmed">32161362</ArticleId></ArticleIdList></Reference><Reference><Citation>Sala Frigerio C; Wolfs L; Fattorelli N; Thrupp N; Voytyuk I; Schmidt I; Mancuso R; Chen WT; Woodbury ME; Srivastava G; et al. The Major Risk Factors for Alzheimer&#x2019;s Disease: Age, Sex, and Genes Modulate the Microglia Response to A&#x3b2; Plaques. Cell Rep 2019, 27, 1293&#x2013;1306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7340153</ArticleId><ArticleId IdType="pubmed">31018141</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauch JN; Luna G; Guzman E; Audouard M; Challis C; Sibih YE; Leshuk C; Hernandez I; Wegmann S; Hyman BT; et al. LRP1 is a Master Regulator of tau Uptake and Spread. Nature 2020, 580, 381&#x2013;385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7687380</ArticleId><ArticleId IdType="pubmed">32296178</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellano JM; Deane R; Gottesdiener AJ; Verghese PB; Stewart FR; West T; Paoletti AC; Kasper TR; DeMattos RB; Zlokovic BV; et al. Low-density Lipoprotein Receptor Overexpression Enhances the Rate of Brain-to-Blood A&#x3b2; Clearance in a Mouse Model of &#x3b2;-amyloidosis. Proc. Natl. Acad. Sci. U. S. A 2012, 109, 15502&#x2013;15507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3458349</ArticleId><ArticleId IdType="pubmed">22927427</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda T; Ono K; Elashoff D; Condron MM; Noguchi-Shinohara M; Yoshita M; Teplow DB; Yamada M Cerebrospinal Fluid from Alzheimer&#x2019;s Disease Patients Promotes amyloid beta-protein Oligomerization. J. Alzheimer&#x2019;s Dis 2010, 21, 81&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">20413863</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandt R; Bakota L Microtubule Dynamics and the Neurodegenerative Triad of Alzheimer&#x2019;s Disease: The Hidden Connection. J. Neurochem 2017, 143, 409&#x2013;417.</Citation><ArticleIdList><ArticleId IdType="pubmed">28267200</ArticleId></ArticleIdList></Reference><Reference><Citation>Aisen PS; Cummings J; Doody R; Kramer L; Sallloway S; Selkoe DJ; Sims J; Sperling RA; Vellas B The Future of Anti-Amyloid Trials. J. Prev. Alzheimers Dis 2020, 7, 146&#x2013;151.</Citation><ArticleIdList><ArticleId IdType="pubmed">32463066</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>